森田 智視

最終更新日時: 2021/06/25 18:06:11

印刷する

氏名(漢字/フリガナ/アルファベット表記)
森田 智視/モリタ サトシ/Morita, Satoshi
所属部署・職名(部局/所属/講座等/職名)
医学部附属病院/先端医療研究開発機構/教授
学部兼担
部局 所属 講座等 職名
医学部
電子メールアドレス
メールアドレス
smorita @ kuhp.kyoto-u.ac.jp
所属学会(国内)
学会名(日本語) 学会名(英語)
日本計量生物学会
日本癌治療学会
日本臨床試験学会
所属学会(海外)
学会名(英語) 国名
The International Biometric Society
American Statistical Association
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士(保健学) 東京大学
使用言語
言語名(japanese) 言語名(english) コード
日本語 Japanese jpn
英語 English eng
researchmap URL
https://researchmap.jp/7000002723
研究テーマ
(日本語)
ベイズ流統計手法 臨床試験デザイン 臨床試験におけるアダプティブディシジョンメイキング
(英語)
Bayesian statistical methods Clinical trial designs Adaptive decision making in clinical trials
研究概要
(日本語)
医学統計学とバイオインフォマティックスを通じて早期臨床開発から臨床研究までを連動的にサポートするための研究活動を行っています。医学統計ではベイズ流統計に基づいた新規臨床試験デザイン開発を行います。ゲノム情報などのバイオマーカーデータを新治療法開発(効果予測因子探索など)に活用するためのバイオインフォマティックス研究にも積極的に取り組みます。また、患者quality of lifeをはじめとするpatient-reported outcomesの評価法とデータ解析法に関する研究も行います。医学研究者とのコラボレーションの中で議論した問題点の解決を大きなモティベーションとしてこれらの研究活動を積極的に推進しています。
(英語)
Our research interests are on study designs and data analysis of early to late phase clinical trials. In biomedical statistics, we are mainly focusing on developing new Bayesian approaches. In bioinformatics, we are performing collaborative research projects to find useful markers to predict the treatment effect. Furthermore, we are also interested in patient-reported outcome researches, e.g., quality of life assessment of cancer patients.
研究分野(キーワード)
キーワード(日本語) キーワード(英語)
医学統計学 Medical statistics
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno Erratum: Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD) (Trials (2020) 21 1 (391)) Erratum: Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD) (Trials (2020) 21 1 (391)) Erratum: Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD) (Trials (2020) 21 1 (391)) Trials, 21, 1, 503 Trials, 21, 1, 503 Trials, 21, 1, 503 2020/06/08 研究論文(学術雑誌) 公開
Kazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Hiroko Hasegawa, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Kazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Hiroko Hasegawa, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Kazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Hiroko Hasegawa, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial European Journal of Cancer, 132, 159-167 European Journal of Cancer, 132, 159-167 European Journal of Cancer, 132, 159-167 2020/06 英語 研究論文(学術雑誌) 公開
Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD). Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD). Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD). Trials, 21, 1, 391-391 Trials, 21, 1, 391-391 Trials, 21, 1, 391-391 2020/05/07 英語 研究論文(学術雑誌) 公開
Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management ANNALS OF THE AMERICAN THORACIC SOCIETY, 17, 3, 329-337 ANNALS OF THE AMERICAN THORACIC SOCIETY, 17, 3, 329-337 ANNALS OF THE AMERICAN THORACIC SOCIETY, 17, 3, 329-337 2020/03 英語 研究論文(学術雑誌) 公開
Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management. A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management. A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management. Annals of the American Thoracic Society, 17, 3, 329-337 Annals of the American Thoracic Society, 17, 3, 329-337 Annals of the American Thoracic Society, 17, 3, 329-337 2020/03 英語 研究論文(学術雑誌) 公開
Eiji Sunami, Tetsuya Kusumoto, Mitsuyoshi Ota, Yoshiyuki Sakamoto, Kazuhiro Yoshida, Naohiro Tomita, Atsuyuki Maeda, Jin Teshima, Michio Okabe, Chihiro Tanaka, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Naruhito Takenaka, Ryota Okude, Kenichi Sugihara Eiji Sunami, Tetsuya Kusumoto, Mitsuyoshi Ota, Yoshiyuki Sakamoto, Kazuhiro Yoshida, Naohiro Tomita, Atsuyuki Maeda, Jin Teshima, Michio Okabe, Chihiro Tanaka, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Naruhito Takenaka, Ryota Okude, Kenichi Sugihara Eiji Sunami, Tetsuya Kusumoto, Mitsuyoshi Ota, Yoshiyuki Sakamoto, Kazuhiro Yoshida, Naohiro Tomita, Atsuyuki Maeda, Jin Teshima, Michio Okabe, Chihiro Tanaka, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Naruhito Takenaka, Ryota Okude, Kenichi Sugihara S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial. S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial. S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial. Clinical colorectal cancer, 19, 1, 22-31 Clinical colorectal cancer, 19, 1, 22-31 Clinical colorectal cancer, 19, 1, 22-31 2020/03 英語 公開
Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer Breast Cancer Res and Treat Breast Cancer Res and Treat Breast Cancer Res and Treat 2020/03 英語 研究論文(学術雑誌) 公開
Koshiro Morino, Satoru Seo, Tomoaki Yoh, Ken Fukumitsu, Takamichi Ishii, Kojiro Taura, Satoshi Morita, Toshimi Kaido, Shinji Uemoto Koshiro Morino, Satoru Seo, Tomoaki Yoh, Ken Fukumitsu, Takamichi Ishii, Kojiro Taura, Satoshi Morita, Toshimi Kaido, Shinji Uemoto Koshiro Morino, Satoru Seo, Tomoaki Yoh, Ken Fukumitsu, Takamichi Ishii, Kojiro Taura, Satoshi Morita, Toshimi Kaido, Shinji Uemoto Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis. Annals of surgical oncology Annals of surgical oncology Annals of surgical oncology 2020/01/14 英語 公開
Yasuhide Yamada, Kei Muro, Keiichi Takahashi, Hideo Baba, Yoshito Komatsu, Taroh Satoh, Masahiro Goto, Hideyuki Mishima, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Naruhito Takenaka, Tadashi Hirooka, Kenichi Sugihara Yasuhide Yamada, Kei Muro, Keiichi Takahashi, Hideo Baba, Yoshito Komatsu, Taroh Satoh, Masahiro Goto, Hideyuki Mishima, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Naruhito Takenaka, Tadashi Hirooka, Kenichi Sugihara Yasuhide Yamada, Kei Muro, Keiichi Takahashi, Hideo Baba, Yoshito Komatsu, Taroh Satoh, Masahiro Goto, Hideyuki Mishima, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Naruhito Takenaka, Tadashi Hirooka, Kenichi Sugihara Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial Global Health & Medicine Global Health & Medicine Global Health & Medicine 2020 研究論文(学術雑誌) 公開
Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin Kimihiko Murase, Kiminobu Tanizawa, Takuma Minami, Takeshi Matsumoto, Ryo Tachikawa, Naomi Takahashi, Toru Tsuda, Yoshiro Toyama, Motoharu Ohi, Toshiki Akahoshi, Yasuhiro Tomita, Koji Narui, Hiroshi Nakamura, Tetsuro Ohdaira, Hiroyuki Yoshimine, Tomomasa Tsuboi, Yoshihiro Yamashiro, Shinichi Ando, Takatoshi Kasai, Hideo Kita, Koichiro Tatsumi, Naoto Burioka, Keisuke Tomii, Yasuhiro Kondoh, Hirofumi Takeyama, Tomohiro Handa, Satoshi Hamada, Toru Oga, Takeo Nakayama, Tetsuo Sakamaki, Satoshi Morita, Tomohiro Kuroda, Toyohiro Hirai, Kazuo Chin A randomized controlled trial of telemedicine for long-term sleep apnea continuous positive airway pressure management A randomized controlled trial of telemedicine for long-term sleep apnea continuous positive airway pressure management A randomized controlled trial of telemedicine for long-term sleep apnea continuous positive airway pressure management Annals of the American Thoracic Society, 17, 3, 329-337 Annals of the American Thoracic Society, 17, 3, 329-337 Annals of the American Thoracic Society, 17, 3, 329-337 2020 研究論文(学術雑誌) 公開
Hanako Ohashi Ikeda, Yuki Muraoka, Masayuki Hata, Eriko Sumi, Takafumi Ikeda, Takayuki Nakagawa, Hiroyasu Abe, Harue Tada, Satoshi Morita, Akira Kakizuka, Nagahisa Yoshimura, Akitaka Tsujikawa Hanako Ohashi Ikeda, Yuki Muraoka, Masayuki Hata, Eriko Sumi, Takafumi Ikeda, Takayuki Nakagawa, Hiroyasu Abe, Harue Tada, Satoshi Morita, Akira Kakizuka, Nagahisa Yoshimura, Akitaka Tsujikawa Hanako Ohashi Ikeda, Yuki Muraoka, Masayuki Hata, Eriko Sumi, Takafumi Ikeda, Takayuki Nakagawa, Hiroyasu Abe, Harue Tada, Satoshi Morita, Akira Kakizuka, Nagahisa Yoshimura, Akitaka Tsujikawa Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial. Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial. Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial. PloS one, 15, 2, e0229068 PloS one, 15, 2, e0229068 PloS one, 15, 2, e0229068 2020 英語 公開
Trotta L, Kabeya Y, Buyse M, Doffagne E, Venet D, Desmet L, Burzykowski T, Tsuburaya A, Yoshida K, Miyashita Y, Morita S, Sakamoto J, Praveen P, Oba K Trotta L, Kabeya Y, Buyse M, Doffagne E, Venet D, Desmet L, Burzykowski T, Tsuburaya A, Yoshida K, Miyashita Y, Morita S, Sakamoto J, Praveen P, Oba K Laura Trotta, Yuusuke Kabeya, Marc Buyse, Erik Doffagne, David Venet, Lieven Desmet, Tomasz Burzykowski, Akira Tsuburaya, Kazuhiro Yoshida, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto, Paurush Praveen, Koji Oba Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring. Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring. Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring. Clinical trials (London, England), 16, 5, 512-522 Clinical trials (London, England), 16, 5, 512-522 Clinical trials (London, England), 16, 5, 512-522 2019/10 英語 公開
Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y, Kumanogoh A, Kawase I, Oka Y, Azuma I, Morita S, Sugiyama H Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y, Kumanogoh A, Kawase I, Oka Y, Azuma I, Morita S, Sugiyama H Sumiyuki Nishida, Akihiro Tsuboi, Atsushi Tanemura, Toshinori Ito, Hiroko Nakajima, Toshiaki Shirakata, Soyoko Morimoto, Fumihiro Fujiki, Naoki Hosen, Yusuke Oji, Atsushi Kumanogoh, Ichiro Kawase, Yoshihiro Oka, Ichiro Azuma, Satoshi Morita, Haruo Sugiyama Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments. Medicine, 98, 33, e16771 Medicine, 98, 33, e16771 Medicine, 98, 33, e16771 2019/08 英語 公開
Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Kunihito Gotoh, Daisuke Sakai, Etsuro Hatano, Satoru Seo, Hiroaki Terajima, Yoichiro Uchida, Tetsuo Ajiki, Hironaga Satake, Keiko Kamei, Taiji Tohyama, Tetsuro Hirose, Iwao Ikai, Satoshi Morita, Tatsuya Ioka Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Kunihito Gotoh, Daisuke Sakai, Etsuro Hatano, Satoru Seo, Hiroaki Terajima, Yoichiro Uchida, Tetsuo Ajiki, Hironaga Satake, Keiko Kamei, Taiji Tohyama, Tetsuro Hirose, Iwao Ikai, Satoshi Morita, Tatsuya Ioka Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Kunihito Gotoh, Daisuke Sakai, Etsuro Hatano, Satoru Seo, Hiroaki Terajima, Yoichiro Uchida, Tetsuo Ajiki, Hironaga Satake, Keiko Kamei, Taiji Tohyama, Tetsuro Hirose, Iwao Ikai, Satoshi Morita, Tatsuya Ioka A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group. A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group. A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group. Annals of surgery, 270, 2, 230-237 Annals of surgery, 270, 2, 230-237 Annals of surgery, 270, 2, 230-237 2019/08 英語 研究論文(学術雑誌) 公開
Iwaki K, Yagi S, Morita S, Hamaguchi Y, Masano Y, Yamamoto G, Ogawa E, Nagai K, Kamo N, Hata K, Taura K, Okajima H, Kaido T, Uemoto S Iwaki K, Yagi S, Morita S, Hamaguchi Y, Masano Y, Yamamoto G, Ogawa E, Nagai K, Kamo N, Hata K, Taura K, Okajima H, Kaido T, Uemoto S Iwaki K, Yagi S, Morita S, Hamaguchi Y, Masano Y, Yamamoto G, Ogawa E, Nagai K, Kamo N, Hata K, Taura K, Okajima H, Kaido T, Uemoto S Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation. Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation. Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation. Transplantation proceedings, 51, 6, 1779-1784 Transplantation proceedings, 51, 6, 1779-1784 Transplantation proceedings, 51, 6, 1779-1784 2019/07 公開
Kazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Hiroko Hasegawa, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Kazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Hiroko Hasegawa, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Kazuhiro Nishikawa, Kenta Murotani, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Hiroko Hasegawa, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial. A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial. A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial. Cancer chemotherapy and pharmacology, 83, 5, 867-874 Cancer chemotherapy and pharmacology, 83, 5, 867-874 Cancer chemotherapy and pharmacology, 83, 5, 867-874 2019/05 英語 公開
Sugawara S, Nakagawa K, Yamamoto N, Nokihara H, Ohe Y, Nishio M, Takahashi T, Goto K, Maemondo M, Ichinose Y, Seto T, Sakai H, Gemma A, Imamura F, Shingyoji M, Saka H, Inoue A, Takeda K, Okamoto I, Kiura K, Morita S, Tamura T Sugawara S, Nakagawa K, Yamamoto N, Nokihara H, Ohe Y, Nishio M, Takahashi T, Goto K, Maemondo M, Ichinose Y, Seto T, Sakai H, Gemma A, Imamura F, Shingyoji M, Saka H, Inoue A, Takeda K, Okamoto I, Kiura K, Morita S, Tamura T Sugawara S, Nakagawa K, Yamamoto N, Nokihara H, Ohe Y, Nishio M, Takahashi T, Goto K, Maemondo M, Ichinose Y, Seto T, Sakai H, Gemma A, Imamura F, Shingyoji M, Saka H, Inoue A, Takeda K, Okamoto I, Kiura K, Morita S, Tamura T Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. International journal of clinical oncology, 24, 5, 485-493 International journal of clinical oncology, 24, 5, 485-493 International journal of clinical oncology, 24, 5, 485-493 2019/05 公開
Saito Haruhiro, Fukuhara Tatsuro, Furuya Naoki, Watanabe Kana, Sugawara Shunichi, Iwasawa Shunichiro, Tsunezuka Yoshio, Yamaguchi Ou, Okada Morihito, Yoshimori Kozo, Nakachi Ichiro, Gemma Akihiko, Azuma Koichi, Kurimoto Futoshi, Tsubata Yukari, Fujita Yuka, Nagashima Hiromi, Asai Gyo, Watanabe Satoshi, Miyazaki Masaki, Hagiwara Koichi, Nukiwa Toshihiro, Morita Satoshi, Kobayashi Kunihiko, Maemondo Makoto Saito Haruhiro, Fukuhara Tatsuro, Furuya Naoki, Watanabe Kana, Sugawara Shunichi, Iwasawa Shunichiro, Tsunezuka Yoshio, Yamaguchi Ou, Okada Morihito, Yoshimori Kozo, Nakachi Ichiro, Gemma Akihiko, Azuma Koichi, Kurimoto Futoshi, Tsubata Yukari, Fujita Yuka, Nagashima Hiromi, Asai Gyo, Watanabe Satoshi, Miyazaki Masaki, Hagiwara Koichi, Nukiwa Toshihiro, Morita Satoshi, Kobayashi Kunihiko, Maemondo Makoto Saito Haruhiro, Fukuhara Tatsuro, Furuya Naoki, Watanabe Kana, Sugawara Shunichi, Iwasawa Shunichiro, Tsunezuka Yoshio, Yamaguchi Ou, Okada Morihito, Yoshimori Kozo, Nakachi Ichiro, Gemma Akihiko, Azuma Koichi, Kurimoto Futoshi, Tsubata Yukari, Fujita Yuka, Nagashima Hiromi, Asai Gyo, Watanabe Satoshi, Miyazaki Masaki, Hagiwara Koichi, Nukiwa Toshihiro, Morita Satoshi, Kobayashi Kunihiko, Maemondo Makoto Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial LANCET ONCOLOGY, 20, 5, 625-635 LANCET ONCOLOGY, 20, 5, 625-635 LANCET ONCOLOGY, 20, 5, 625-635 2019/05 公開
Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience. Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience. Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience. Hepatology research : the official journal of the Japan Society of Hepatology Hepatology research : the official journal of the Japan Society of Hepatology Hepatology research : the official journal of the Japan Society of Hepatology 2019/01 公開
Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma. A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma. A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma. Cancer immunology, immunotherapy : CII, 68, 2, 331-340 Cancer immunology, immunotherapy : CII, 68, 2, 331-340 Cancer immunology, immunotherapy : CII, 68, 2, 331-340 2018/11 公開
Toshimi Kaido, Masahiro Shinoda, Yukihiro Inomata, Takahito Yagi, Nobuhisa Akamatsu, Yasutsugu Takada, Hideki Ohdan, Tsuyoshi Shimamura, Yasuhiro Ogura, Susumu Eguchi, Hidetoshi Eguchi, Satoshi Ogata, Tomoharu Yoshizumi, Toshihiko Ikegami, Michio Yamamoto, Satoshi Morita, Shinji Uemoto Toshimi Kaido, Masahiro Shinoda, Yukihiro Inomata, Takahito Yagi, Nobuhisa Akamatsu, Yasutsugu Takada, Hideki Ohdan, Tsuyoshi Shimamura, Yasuhiro Ogura, Susumu Eguchi, Hidetoshi Eguchi, Satoshi Ogata, Tomoharu Yoshizumi, Toshihiko Ikegami, Michio Yamamoto, Satoshi Morita, Shinji Uemoto Toshimi Kaido, Masahiro Shinoda, Yukihiro Inomata, Takahito Yagi, Nobuhisa Akamatsu, Yasutsugu Takada, Hideki Ohdan, Tsuyoshi Shimamura, Yasuhiro Ogura, Susumu Eguchi, Hidetoshi Eguchi, Satoshi Ogata, Tomoharu Yoshizumi, Toshihiko Ikegami, Michio Yamamoto, Satoshi Morita, Shinji Uemoto Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial. Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial. Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial. Nutrition (Burbank, Los Angeles County, Calif.), 54, 68-75 Nutrition (Burbank, Los Angeles County, Calif.), 54, 68-75 Nutrition (Burbank, Los Angeles County, Calif.), 54, 68-75 2018/10 英語 公開
Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Breast cancer (Tokyo, Japan) Breast cancer (Tokyo, Japan) Breast cancer (Tokyo, Japan) 2018/10 公開
Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Naruto Taira, Masahiro Kashiwaba, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Naruto Taira, Masahiro Kashiwaba, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Naruto Taira, Masahiro Kashiwaba, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48, 9, 855-859 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48, 9, 855-859 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48, 9, 855-859 2018/09 英語 研究論文(学術雑誌) 公開
Kazuhiro Nishikawa, Akira Tsuburaya, Takaki Yoshikawa, Masazumi Takahashi, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Toru Aoyama, Yasushi Rino, Junji Kawada, Akihito Tsuji, Koichi Taira, Yutaka Kimura, Yasuhiro Kodera, Yoshinori Hirashima, Hiroshi Yabusaki, Naoki Hirabayashi, Kazumasa Fujitani, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto Kazuhiro Nishikawa, Akira Tsuburaya, Takaki Yoshikawa, Masazumi Takahashi, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Toru Aoyama, Yasushi Rino, Junji Kawada, Akihito Tsuji, Koichi Taira, Yutaka Kimura, Yasuhiro Kodera, Yoshinori Hirashima, Hiroshi Yabusaki, Naoki Hirabayashi, Kazumasa Fujitani, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto Kazuhiro Nishikawa, Akira Tsuburaya, Takaki Yoshikawa, Masazumi Takahashi, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Toru Aoyama, Yasushi Rino, Junji Kawada, Akihito Tsuji, Koichi Taira, Yutaka Kimura, Yasuhiro Kodera, Yoshinori Hirashima, Hiroshi Yabusaki, Naoki Hirabayashi, Kazumasa Fujitani, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial. A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 21, 5, 811-818 Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 21, 5, 811-818 Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 21, 5, 811-818 2018/09 英語 研究論文(学術雑誌) 公開
Mie Torii, Motomu Hashimoto, Akiko Hanai, Takao Fujii, Moritoshi Furu, Hiromu Ito, Ryuji Uozumi, Masahide Hamaguchi, Chikashi, Terao, Wataru Yamamoto, Miyabi Uda, Kazuko nin, Satoshi Morita, Hidenori Arai, Tsuneyo Mimori Mie Torii, Motomu Hashimoto, Akiko Hanai, Takao Fujii, Moritoshi Furu, Hiromu Ito, Ryuji Uozumi, Masahide Hamaguchi, Chikashi, Terao, Wataru Yamamoto, Miyabi Uda, Kazuko nin, Satoshi Morita, Hidenori Arai, Tsuneyo Mimori Mie Torii, Motomu Hashimoto, Akiko Hanai, Takao Fujii, Moritoshi Furu, Hiromu Ito, Ryuji Uozumi, Masahide Hamaguchi, Chikashi, Terao, Wataru Yamamoto, Miyabi Uda, Kazuko nin, Satoshi Morita, Hidenori Arai, Tsuneyo Mimori Prevalence and factors associated with sarcopeniain patients with rheumatoid arthritis Prevalence and factors associated with sarcopeniain patients with rheumatoid arthritis Prevalence and factors associated with sarcopeniain patients with rheumatoid arthritis Modern Rheumatology, 1-7 Modern Rheumatology, 1-7 Modern Rheumatology, 1-7 2018/09 英語 研究論文(学術雑誌) 公開
N. Masuda, M. Toi, N. Yamamoto, H. Iwata, K. Kuroi, H. Bando, S. Ohtani, T. Takano, K. Inoue, Y. Yanagita, H. Kasai, S. Morita, T. Sakurai, S. Ohno N. Masuda, M. Toi, N. Yamamoto, H. Iwata, K. Kuroi, H. Bando, S. Ohtani, T. Takano, K. Inoue, Y. Yanagita, H. Kasai, S. Morita, T. Sakurai, S. Ohno N. Masuda, M. Toi, N. Yamamoto, H. Iwata, K. Kuroi, H. Bando, S. Ohtani, T. Takano, K. Inoue, Y. Yanagita, H. Kasai, S. Morita, T. Sakurai, S. Ohno Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial Breast Cancer, 25, 4, 407-415 Breast Cancer, 25, 4, 407-415 Breast Cancer, 25, 4, 407-415 2018/07/01 英語 研究論文(学術雑誌) 公開
Yusuke Oji, Masayoshi Inoue, Yoshito Takeda, Naoki Hosen, Yasushi Shintani, Manabu Kawakami, Takuya Harada, Yui Murakami, Miki Iwai, Mari Fukuda, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Toshiaki Shirakata, Hiroko Nakajima, Kana Hasegawa, Hiroshi Kida, Takashi Kijima, Soyoko Morimoto, Fumihiro Fujiki, Akihiro Tsuboi, Eiichi Morii, Satoshi Morita, Junichi Sakamoto, Atsushi Kumanogoh, Yoshihiro Oka, Meinoshin Okumura, Haruo Sugiyama Yusuke Oji, Masayoshi Inoue, Yoshito Takeda, Naoki Hosen, Yasushi Shintani, Manabu Kawakami, Takuya Harada, Yui Murakami, Miki Iwai, Mari Fukuda, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Toshiaki Shirakata, Hiroko Nakajima, Kana Hasegawa, Hiroshi Kida, Takashi Kijima, Soyoko Morimoto, Fumihiro Fujiki, Akihiro Tsuboi, Eiichi Morii, Satoshi Morita, Junichi Sakamoto, Atsushi Kumanogoh, Yoshihiro Oka, Meinoshin Okumura, Haruo Sugiyama Yusuke Oji, Masayoshi Inoue, Yoshito Takeda, Naoki Hosen, Yasushi Shintani, Manabu Kawakami, Takuya Harada, Yui Murakami, Miki Iwai, Mari Fukuda, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Toshiaki Shirakata, Hiroko Nakajima, Kana Hasegawa, Hiroshi Kida, Takashi Kijima, Soyoko Morimoto, Fumihiro Fujiki, Akihiro Tsuboi, Eiichi Morii, Satoshi Morita, Junichi Sakamoto, Atsushi Kumanogoh, Yoshihiro Oka, Meinoshin Okumura, Haruo Sugiyama WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies. WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies. WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies. International journal of cancer, 142, 11, 2375-2382 International journal of cancer, 142, 11, 2375-2382 International journal of cancer, 142, 11, 2375-2382 2018/06/01 英語 研究論文(学術雑誌) 公開
Sakura Iizumi, Atsuo Takashima, Kentaro Sakamaki, Satoshi Morita, Narikazu Boku Sakura Iizumi, Atsuo Takashima, Kentaro Sakamaki, Satoshi Morita, Narikazu Boku Sakura Iizumi, Atsuo Takashima, Kentaro Sakamaki, Satoshi Morita, Narikazu Boku Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis. Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis. Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis. Cancer chemotherapy and pharmacology, 81, 6, 981-989 Cancer chemotherapy and pharmacology, 81, 6, 981-989 Cancer chemotherapy and pharmacology, 81, 6, 981-989 2018/06 英語 公開
Tetsuya Kusumoto, Eiji Sunami, Mitsuyoshi Ota, Kazuhiro Yoshida, Yoshiyuki Sakamoto, Naohiro Tomita, Atsuyuki Maeda, Izumi Mochizuki, Michio Okabe, Katsuyuki Kunieda, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Kenichi Sugihara Tetsuya Kusumoto, Eiji Sunami, Mitsuyoshi Ota, Kazuhiro Yoshida, Yoshiyuki Sakamoto, Naohiro Tomita, Atsuyuki Maeda, Izumi Mochizuki, Michio Okabe, Katsuyuki Kunieda, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Kenichi Sugihara Tetsuya Kusumoto, Eiji Sunami, Mitsuyoshi Ota, Kazuhiro Yoshida, Yoshiyuki Sakamoto, Naohiro Tomita, Atsuyuki Maeda, Izumi Mochizuki, Michio Okabe, Katsuyuki Kunieda, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Kenichi Sugihara Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer. Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer. Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer. Clinical colorectal cancer, 17, 2, e153-e161-e161 Clinical colorectal cancer, 17, 2, e153-e161-e161 Clinical colorectal cancer, 17, 2, e153-e161-e161 2018/06 英語 公開
Dahy Khaled Gamal, Takahashi Katsu, Saito Kazuyuki, Kakeno Azumi, Kiso Honoka, Isobe Yu, Mishima Sayaka, Asai Keita, Moussa Abd-Elmateen, Shahat Badawy, Rezk Ibrahim, Oga Toru, Morita Satoshi, Chin Kazuo, Bessho Kazuhisa Dahy Khaled Gamal, Takahashi Katsu, Saito Kazuyuki, Kakeno Azumi, Kiso Honoka, Isobe Yu, Mishima Sayaka, Asai Keita, Moussa Abd-Elmateen, Shahat Badawy, Rezk Ibrahim, Oga Toru, Morita Satoshi, Chin Kazuo, Bessho Kazuhisa Dahy Khaled Gamal, Takahashi Katsu, Saito Kazuyuki, Kakeno Azumi, Kiso Honoka, Isobe Yu, Mishima Sayaka, Asai Keita, Moussa Abd-Elmateen, Shahat Badawy, Rezk Ibrahim, Oga Toru, Morita Satoshi, Chin Kazuo, Bessho Kazuhisa The Relationship Between Cephalogram Analysis and Oxygen Desaturation Index During Sleep in Patients Submitted for Mandibular Setback Surgery The Relationship Between Cephalogram Analysis and Oxygen Desaturation Index During Sleep in Patients Submitted for Mandibular Setback Surgery The Relationship Between Cephalogram Analysis and Oxygen Desaturation Index During Sleep in Patients Submitted for Mandibular Setback Surgery JOURNAL OF CRANIOFACIAL SURGERY, 29, 4, E375-E380 JOURNAL OF CRANIOFACIAL SURGERY, 29, 4, E375-E380 JOURNAL OF CRANIOFACIAL SURGERY, 29, 4, E375-E380 2018/06 公開
三上 芳喜 三上 芳喜 Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. Cancer Med, 7, 6, 2442-2451 Cancer Med, 7, 6, 2442-2451 Cancer Med, 7, 6, 2442-2451 2018/06 英語 研究論文(学術雑誌) 公開
Takayoshi Tachibana, Kanto Study Group for Cell Therapy (KSGCT), Junya Kanda, Shinichiro Machida, Takeshi Saito, Masatsugu Tanaka, Yuho Najima, Satoshi Koyama, Takuya Miyazaki, Eri Yamamoto, Masahiro Takeuchi, Satoshi Morita, Yoshinobu Kanda, Heiwa Kanamori, Shinichiro Okamoto Takayoshi Tachibana, Kanto Study Group for Cell Therapy (KSGCT), Junya Kanda, Shinichiro Machida, Takeshi Saito, Masatsugu Tanaka, Yuho Najima, Satoshi Koyama, Takuya Miyazaki, Eri Yamamoto, Masahiro Takeuchi, Satoshi Morita, Yoshinobu Kanda, Heiwa Kanamori, Shinichiro Okamoto Takayoshi Tachibana, Kanto Study Group for Cell Therapy (KSGCT), Junya Kanda, Shinichiro Machida, Takeshi Saito, Masatsugu Tanaka, Yuho Najima, Satoshi Koyama, Takuya Miyazaki, Eri Yamamoto, Masahiro Takeuchi, Satoshi Morita, Yoshinobu Kanda, Heiwa Kanamori, Shinichiro Okamoto Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302) Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302) Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302) International Journal of Hematology, 107, 5, 578-585 International Journal of Hematology, 107, 5, 578-585 International Journal of Hematology, 107, 5, 578-585 2018/05/01 英語 研究論文(学術雑誌) 公開
Yuka Ito, Takashi Tsuda, Hiroko Minatogawa, Sayaka Kano, Kentaro Sakamaki, Masahiko Ando, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, Sadatoshi Sugae, Ichiro Ohta, Hitoshi Arioka, Yutaka Tokuda, Kazutaka Narui, Ayako Tsuboya, Takashi Suda, Satoshi Morita, Narikazu Boku, Takeharu Yamanaka, Takako Eguchi Nakajima Yuka Ito, Takashi Tsuda, Hiroko Minatogawa, Sayaka Kano, Kentaro Sakamaki, Masahiko Ando, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, Sadatoshi Sugae, Ichiro Ohta, Hitoshi Arioka, Yutaka Tokuda, Kazutaka Narui, Ayako Tsuboya, Takashi Suda, Satoshi Morita, Narikazu Boku, Takeharu Yamanaka, Takako Eguchi Nakajima Yuka Ito, Takashi Tsuda, Hiroko Minatogawa, Sayaka Kano, Kentaro Sakamaki, Masahiko Ando, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, Sadatoshi Sugae, Ichiro Ohta, Hitoshi Arioka, Yutaka Tokuda, Kazutaka Narui, Ayako Tsuboya, Takashi Suda, Satoshi Morita, Narikazu Boku, Takeharu Yamanaka, Takako Eguchi Nakajima Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy. Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy. Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36, 10, 1000-1006 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36, 10, 1000-1006 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36, 10, 1000-1006 2018/04/01 英語 公開
Naoto Takahashi, Mitsuro Kanda, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Katsufumi Miyamoto, Yuichi Ito, Osamu Takayama, Motohiro Imano, Norio Mitsumori, Junichi Sakamoto, Satoshi Morita, Yasuhiro Kodera Naoto Takahashi, Mitsuro Kanda, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Katsufumi Miyamoto, Yuichi Ito, Osamu Takayama, Motohiro Imano, Norio Mitsumori, Junichi Sakamoto, Satoshi Morita, Yasuhiro Kodera Naoto Takahashi, Mitsuro Kanda, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Katsufumi Miyamoto, Yuichi Ito, Osamu Takayama, Motohiro Imano, Norio Mitsumori, Junichi Sakamoto, Satoshi Morita, Yasuhiro Kodera A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial Gastric Cancer, 1-10 Gastric Cancer, 1-10 Gastric Cancer, 1-10 2018/03/13 英語 研究論文(学術雑誌) 公開
Isamu Okamoto, Satoshi Morita, Naoki Tashiro, Fumio Imamura, Akira Inoue, Takashi Seto, Nobuyuki Yamamoto, Yuichiro Ohe, Kazuhiko Nakagawa, Masahiro Fukuoka Isamu Okamoto, Satoshi Morita, Naoki Tashiro, Fumio Imamura, Akira Inoue, Takashi Seto, Nobuyuki Yamamoto, Yuichiro Ohe, Kazuhiko Nakagawa, Masahiro Fukuoka Isamu Okamoto, Satoshi Morita, Naoki Tashiro, Fumio Imamura, Akira Inoue, Takashi Seto, Nobuyuki Yamamoto, Yuichiro Ohe, Kazuhiko Nakagawa, Masahiro Fukuoka Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort Lung Cancer, 117, 14-19 Lung Cancer, 117, 14-19 Lung Cancer, 117, 14-19 2018/03/01 英語 研究論文(学術雑誌) 公開
村瀬 公彦, 谷澤 公伸, 津田 徹, 大井 元晴, 赤星 俊樹, 成井 浩司, 名嘉村 博, 大平 徹郎, 吉嶺 裕之, 坪井 知正, 山城 義広, 安藤 眞一, 葛西 隆敏, 北 英夫, 巽 浩一郎, 鰤岡 直人, 富井 啓介, 近藤 康博, 小賀 徹, 酒巻 哲夫, 森田 智視, 平井 豊博, 黒田 知宏, 陳 和夫, 厚生労働科学研究遠隔モニタリング研究班 村瀬 公彦, 谷澤 公伸, 津田 徹, 大井 元晴, 赤星 俊樹, 成井 浩司, 名嘉村 博, 大平 徹郎, 吉嶺 裕之, 坪井 知正, 山城 義広, 安藤 眞一, 葛西 隆敏, 北 英夫, 巽 浩一郎, 鰤岡 直人, 富井 啓介, 近藤 康博, 小賀 徹, 酒巻 哲夫, 森田 智視, 平井 豊博, 黒田 知宏, 陳 和夫, 厚生労働科学研究遠隔モニタリング研究班 遠隔モニタリングシステム導入によるCPAPアドヒアランスの変化 多施設共同無作為化比較試験 遠隔モニタリングシステム導入によるCPAPアドヒアランスの変化 多施設共同無作為化比較試験 日本呼吸器学会誌, 7, 増刊, 265-265 日本呼吸器学会誌, 7, 増刊, 265-265 , 7, 増刊, 265-265 2018/03 日本語 公開
Sumiyuki Nishida, Takeshi Ishikawa, Shinichi Egawa, Shigeo Koido, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Satoshi Kokura, Hiroaki Yasuda, Mari Saito Oba, Maho Sato, Soyoko Morimoto, Fumihiro Fujiki, Hidetoshi Eguchi, Hiroaki Nagano, Atsushi Kumanogoh, Michiaki Unno, Masanori Kon, Hideaki Shimada, Kei Ito, Sadamu Homma, Yoshihiro Oka, Satoshi Morita, Haruo Sugiyama Sumiyuki Nishida, Takeshi Ishikawa, Shinichi Egawa, Shigeo Koido, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Satoshi Kokura, Hiroaki Yasuda, Mari Saito Oba, Maho Sato, Soyoko Morimoto, Fumihiro Fujiki, Hidetoshi Eguchi, Hiroaki Nagano, Atsushi Kumanogoh, Michiaki Unno, Masanori Kon, Hideaki Shimada, Kei Ito, Sadamu Homma, Yoshihiro Oka, Satoshi Morita, Haruo Sugiyama Sumiyuki Nishida, Takeshi Ishikawa, Shinichi Egawa, Shigeo Koido, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Satoshi Kokura, Hiroaki Yasuda, Mari Saito Oba, Maho Sato, Soyoko Morimoto, Fumihiro Fujiki, Hidetoshi Eguchi, Hiroaki Nagano, Atsushi Kumanogoh, Michiaki Unno, Masanori Kon, Hideaki Shimada, Kei Ito, Sadamu Homma, Yoshihiro Oka, Satoshi Morita, Haruo Sugiyama Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study. Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study. Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study. Cancer immunology research, 6, 3, 320-331 Cancer immunology research, 6, 3, 320-331 Cancer immunology research, 6, 3, 320-331 2018/03 英語 公開
Louis W.C. Chow, Satoshi Morita, Christopher Y.C. Chow, Wai-Kuen Ng, Masakazu Toi Louis W.C. Chow, Satoshi Morita, Christopher Y.C. Chow, Wai-Kuen Ng, Masakazu Toi Louis W.C. Chow, Satoshi Morita, Christopher Y.C. Chow, Wai-Kuen Ng, Masakazu Toi Neoadjuvant palbociclib on ER+ breast cancer (N007): Clinical response and EndoPredict's value Neoadjuvant palbociclib on ER+ breast cancer (N007): Clinical response and EndoPredict's value Neoadjuvant palbociclib on ER+ breast cancer (N007): Clinical response and EndoPredict's value Endocrine-Related Cancer, 25, 2, 123-130 Endocrine-Related Cancer, 25, 2, 123-130 Endocrine-Related Cancer, 25, 2, 123-130 2018/02/01 英語 研究論文(学術雑誌) 公開
Terashima Masanori, Fujitani Kazumasa, Ando Masahiko, Sakamaki Kentaro, Kawabata Ryohei, Ito Yuichi, Yoshikawa Takaki, Kondo Masato, Kodera Yasuhiro, Kaji Masahide, Oka Yoshio, Imamura Hiroshi, Kawada Junji, Takagane Akinori, Shimada Hideaki, Tanizawa Yutaka, Yamanaka Takeharu, Morita Satoshi, Ninomiya Motoki, Yoshida Kazuhiro Terashima Masanori, Fujitani Kazumasa, Ando Masahiko, Sakamaki Kentaro, Kawabata Ryohei, Ito Yuichi, Yoshikawa Takaki, Kondo Masato, Kodera Yasuhiro, Kaji Masahide, Oka Yoshio, Imamura Hiroshi, Kawada Junji, Takagane Akinori, Shimada Hideaki, Tanizawa Yutaka, Yamanaka Takeharu, Morita Satoshi, Ninomiya Motoki, Yoshida Kazuhiro Terashima Masanori, Fujitani Kazumasa, Ando Masahiko, Sakamaki Kentaro, Kawabata Ryohei, Ito Yuichi, Yoshikawa Takaki, Kondo Masato, Kodera Yasuhiro, Kaji Masahide, Oka Yoshio, Imamura Hiroshi, Kawada Junji, Takagane Akinori, Shimada Hideaki, Tanizawa Yutaka, Yamanaka Takeharu, Morita Satoshi, Ninomiya Motoki, Yoshida Kazuhiro A survival analysis of a prospective multicenter observational study of surgical palliation in patients treated for malignant gastric outlet obstruction caused by incurable advanced gastric cancer A survival analysis of a prospective multicenter observational study of surgical palliation in patients treated for malignant gastric outlet obstruction caused by incurable advanced gastric cancer A survival analysis of a prospective multicenter observational study of surgical palliation in patients treated for malignant gastric outlet obstruction caused by incurable advanced gastric cancer JOURNAL OF CLINICAL ONCOLOGY, 36, 4, . JOURNAL OF CLINICAL ONCOLOGY, 36, 4, . JOURNAL OF CLINICAL ONCOLOGY, 36, 4, . 2018/02/01 英語 研究論文(学術雑誌) 公開
Hidetoshi Kawaguchi, Norikazu Masuda, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Yoshinori Ito, Shoichiro Ohtani, Nobuaki Sato, Shigehira Saji, Toshimi Takano, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Satoshi Morita, Miki Yamaguchi, Hiroko Yamashita, Toshinari Yamashita, Yutaka Yamamoto, Daisuke Yotsumoto, Masakazu Toi, Shinji Ohno Hidetoshi Kawaguchi, Norikazu Masuda, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Yoshinori Ito, Shoichiro Ohtani, Nobuaki Sato, Shigehira Saji, Toshimi Takano, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Satoshi Morita, Miki Yamaguchi, Hiroko Yamashita, Toshinari Yamashita, Yutaka Yamamoto, Daisuke Yotsumoto, Masakazu Toi, Shinji Ohno Hidetoshi Kawaguchi, Norikazu Masuda, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Yoshinori Ito, Shoichiro Ohtani, Nobuaki Sato, Shigehira Saji, Toshimi Takano, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Satoshi Morita, Miki Yamaguchi, Hiroko Yamashita, Toshinari Yamashita, Yutaka Yamamoto, Daisuke Yotsumoto, Masakazu Toi, Shinji Ohno Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study Current Medical Research and Opinion, 34, 1, 49-54 Current Medical Research and Opinion, 34, 1, 49-54 Current Medical Research and Opinion, 34, 1, 49-54 2018/01/02 英語 研究論文(学術雑誌) 公開
Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Naruto Taira, Masahiro Kashiwaba, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Naruto Taira, Masahiro Kashiwaba, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Naruto Taira, Masahiro Kashiwaba, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno A randomized, open-label, phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic Breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: The Japan Breast cancer research group-M05 PRECIOUS study A randomized, open-label, phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic Breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: The Japan Breast cancer research group-M05 PRECIOUS study A randomized, open-label, phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic Breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: The Japan Breast cancer research group-M05 PRECIOUS study Japanese Journal of Clinical Oncology, 48, 9, 855-859 Japanese Journal of Clinical Oncology, 48, 9, 855-859 Japanese Journal of Clinical Oncology, 48, 9, 855-859 2018 研究論文(学術雑誌) 公開
Kazuhiro Nishikawa, Toru Aoyama, Mari S. Oba, Takaki Yoshikawa, Chu Matsuda, Yoshinori Munemoto, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoki Nagata, Motohiro Imano, Mitsuru Oshiro, Ryoji Fukushima, Masato Kataoka, Satoshi Morita, Akira Tsuburaya, Hideyuki Mishima, Toru Kono, Junichi Sakamoto Kazuhiro Nishikawa, Toru Aoyama, Mari S. Oba, Takaki Yoshikawa, Chu Matsuda, Yoshinori Munemoto, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoki Nagata, Motohiro Imano, Mitsuru Oshiro, Ryoji Fukushima, Masato Kataoka, Satoshi Morita, Akira Tsuburaya, Hideyuki Mishima, Toru Kono, Junichi Sakamoto Kazuhiro Nishikawa, Toru Aoyama, Mari S. Oba, Takaki Yoshikawa, Chu Matsuda, Yoshinori Munemoto, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoki Nagata, Motohiro Imano, Mitsuru Oshiro, Ryoji Fukushima, Masato Kataoka, Satoshi Morita, Akira Tsuburaya, Hideyuki Mishima, Toru Kono, Junichi Sakamoto The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C) The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C) The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C) Journal of Cancer, 9, 10, 1725-1730 Journal of Cancer, 9, 10, 1725-1730 Journal of Cancer, 9, 10, 1725-1730 2018 英語 研究論文(学術雑誌) 公開
Noriyoshi Iriyama, Kazuteru Ohashi, Satoshi Hashino, Shinya Kimura, Chiaki Nakaseko, Hina Takano, Masayuki Hino, Michihiro Uchiyama, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi Noriyoshi Iriyama, Kazuteru Ohashi, Satoshi Hashino, Shinya Kimura, Chiaki Nakaseko, Hina Takano, Masayuki Hino, Michihiro Uchiyama, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi Noriyoshi Iriyama, Kazuteru Ohashi, Satoshi Hashino, Shinya Kimura, Chiaki Nakaseko, Hina Takano, Masayuki Hino, Michihiro Uchiyama, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi The efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the kanto CML study group The efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the kanto CML study group The efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the kanto CML study group Internal Medicine, 57, 1, 17-23 Internal Medicine, 57, 1, 17-23 Internal Medicine, 57, 1, 17-23 2018 英語 研究論文(学術雑誌) 公開
Masatoshi Kudo, Ann-Lii Cheng, Joong-Won Park, Jae Hyung Park, Po-Chin Liang, Hisashi Hidaka, Namiki Izumi, Jeong Heo, Youn Jae Lee, I-Shyan Sheen, Chang-Fang Chiu, Hitoshi Arioka, Satoshi Morita, Yasuaki Arai Masatoshi Kudo, Ann-Lii Cheng, Joong-Won Park, Jae Hyung Park, Po-Chin Liang, Hisashi Hidaka, Namiki Izumi, Jeong Heo, Youn Jae Lee, I-Shyan Sheen, Chang-Fang Chiu, Hitoshi Arioka, Satoshi Morita, Yasuaki Arai Masatoshi Kudo, Ann-Lii Cheng, Joong-Won Park, Jae Hyung Park, Po-Chin Liang, Hisashi Hidaka, Namiki Izumi, Jeong Heo, Youn Jae Lee, I-Shyan Sheen, Chang-Fang Chiu, Hitoshi Arioka, Satoshi Morita, Yasuaki Arai Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study The Lancet Gastroenterology and Hepatology, 3, 1, 37-46 The Lancet Gastroenterology and Hepatology, 3, 1, 37-46 The Lancet Gastroenterology and Hepatology, 3, 1, 37-46 2018/01/01 英語 研究論文(学術雑誌) 公開
Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi, the Kanto CML and Shimousa Hematology Study Groups Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi, the Kanto CML and Shimousa Hematology Study Groups Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi, the Kanto CML and Shimousa Hematology Study Groups Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation Cancer Science, 109, 1, 182-192 Cancer Science, 109, 1, 182-192 Cancer Science, 109, 1, 182-192 2018/01/01 英語 研究論文(学術雑誌) 公開
Yamashiro H, Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M Yamashiro H, Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M Yamashiro H, Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study Breast cancer : basic and clinical research, 12, 1178223418786243 Breast cancer : basic and clinical research, 12, 1178223418786243 Breast cancer : basic and clinical research, 12, 1178223418786243 2018 公開
Okuno K, Aoyama T, Oba K, Yokoyama N, Matsuhashi N, Kunieda K, Nishimura Y, Akamatsu H, Kobatake T, Morita S, Yoshikawa T, Sakamoto J, Saji S Okuno K, Aoyama T, Oba K, Yokoyama N, Matsuhashi N, Kunieda K, Nishimura Y, Akamatsu H, Kobatake T, Morita S, Yoshikawa T, Sakamoto J, Saji S Kiyotaka Okuno, Toru Aoyama, Koji Oba, Noboru Yokoyama, Nobuhisa Matsuhashi, Katsuyuki Kunieda, Yoji Nishimura, Hiroki Akamatsu, Takaya Kobatake, Satoshi Morita, Takaki Yoshikawa, Junichi Sakamoto, Shigetoyo Saji Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial). Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial). Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial). Cancer chemotherapy and pharmacology, 81, 1, 65-71 Cancer chemotherapy and pharmacology, 81, 1, 65-71 Cancer chemotherapy and pharmacology, 81, 1, 65-71 2018/01 英語 公開
Hattori M, Ishiguro H, Masuda N, Yoshimura A, Ohtani S, Yasojima H, Morita S, Ohno S, Iwata H Hattori M, Ishiguro H, Masuda N, Yoshimura A, Ohtani S, Yasojima H, Morita S, Ohno S, Iwata H Hattori M, Ishiguro H, Masuda N, Yoshimura A, Ohtani S, Yasojima H, Morita S, Ohno S, Iwata H Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study Breast Cancer, 25, 1, 108-117 Breast Cancer, 25, 1, 108-117 Breast Cancer, 25, 1, 108-117 2018/01 英語 研究論文(学術雑誌) 公開
Yuki Honda, Atsushi Otsuka, Sachiko Ono, Yosuke Yamamoto, Judith A. Seidel, Satoshi Morita, Masahiro Hirata, Tatsuki R. Kataoka, Tatsuya Takenouchi, Kazuyasu Fujii, Takuro Kanekura, Yuko Okubo, Kenzo Takahashi, Teruki Yanagi, Daichi Hoshina, Hiroo Hata, Riichiro Abe, Taku Fujimura, Takeru Funakoshi, Koji Yoshino, Mamiko Masuzawa, Yasuyuki Amoh, Ryota Tanaka, Yasuhiro Fujisawa, Tetsuya Honda, Kenji Kabashima Yuki Honda, Atsushi Otsuka, Sachiko Ono, Yosuke Yamamoto, Judith A. Seidel, Satoshi Morita, Masahiro Hirata, Tatsuki R. Kataoka, Tatsuya Takenouchi, Kazuyasu Fujii, Takuro Kanekura, Yuko Okubo, Kenzo Takahashi, Teruki Yanagi, Daichi Hoshina, Hiroo Hata, Riichiro Abe, Taku Fujimura, Takeru Funakoshi, Koji Yoshino, Mamiko Masuzawa, Yasuyuki Amoh, Ryota Tanaka, Yasuhiro Fujisawa, Tetsuya Honda, Kenji Kabashima Yuki Honda, Atsushi Otsuka, Sachiko Ono, Yosuke Yamamoto, Judith A. Seidel, Satoshi Morita, Masahiro Hirata, Tatsuki R. Kataoka, Tatsuya Takenouchi, Kazuyasu Fujii, Takuro Kanekura, Yuko Okubo, Kenzo Takahashi, Teruki Yanagi, Daichi Hoshina, Hiroo Hata, Riichiro Abe, Taku Fujimura, Takeru Funakoshi, Koji Yoshino, Mamiko Masuzawa, Yasuyuki Amoh, Ryota Tanaka, Yasuhiro Fujisawa, Tetsuya Honda, Kenji Kabashima Infiltration of PD-1-positive cells in combination with tumor site PD-l1 expression is a positive prognostic factor in cutaneous angiosarcoma Infiltration of PD-1-positive cells in combination with tumor site PD-l1 expression is a positive prognostic factor in cutaneous angiosarcoma Infiltration of PD-1-positive cells in combination with tumor site PD-l1 expression is a positive prognostic factor in cutaneous angiosarcoma OncoImmunology, 6, 1 OncoImmunology, 6, 1 OncoImmunology, 6, 1 2017/12/23 英語 研究論文(学術雑誌) 公開
Fumihiro Asano, Takashi Ishida, Naofumi Shinagawa, Noriaki Sukoh, Masaki Anzai, Kenya Kanazawa, Akifumi Tsuzuku, Satoshi Morita Fumihiro Asano, Takashi Ishida, Naofumi Shinagawa, Noriaki Sukoh, Masaki Anzai, Kenya Kanazawa, Akifumi Tsuzuku, Satoshi Morita Fumihiro Asano, Takashi Ishida, Naofumi Shinagawa, Noriaki Sukoh, Masaki Anzai, Kenya Kanazawa, Akifumi Tsuzuku, Satoshi Morita Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial BMC PULMONARY MEDICINE, 17 BMC PULMONARY MEDICINE, 17 BMC PULMONARY MEDICINE, 17 2017/12 英語 研究論文(学術雑誌) 公開
Hiroaki Tanaka, Mitsuro Kanda, Satoshi Morita, Masataka Taguri, Kazuhiro Nishikawa, Mitsuo Shimada, Kazuya Muguruma, Keisuke Koeda, Masazumi Takahashi, Mikihito Nakamori, Hiroyuki Konno, Akihito Tsuji, Yoshinori Hosoya, Tetsuhiko Shirasaka, Susumu Yamamitsu, Michio Sowa, Masaki Kitajima, Masazumi Okajima, Michiya Kobayashi, Junichi Sakamoto, Shigetoyo Saji, Kosei Hirakawa Hiroaki Tanaka, Mitsuro Kanda, Satoshi Morita, Masataka Taguri, Kazuhiro Nishikawa, Mitsuo Shimada, Kazuya Muguruma, Keisuke Koeda, Masazumi Takahashi, Mikihito Nakamori, Hiroyuki Konno, Akihito Tsuji, Yoshinori Hosoya, Tetsuhiko Shirasaka, Susumu Yamamitsu, Michio Sowa, Masaki Kitajima, Masazumi Okajima, Michiya Kobayashi, Junichi Sakamoto, Shigetoyo Saji, Kosei Hirakawa Hiroaki Tanaka, Mitsuro Kanda, Satoshi Morita, Masataka Taguri, Kazuhiro Nishikawa, Mitsuo Shimada, Kazuya Muguruma, Keisuke Koeda, Masazumi Takahashi, Mikihito Nakamori, Hiroyuki Konno, Akihito Tsuji, Yoshinori Hosoya, Tetsuhiko Shirasaka, Susumu Yamamitsu, Michio Sowa, Masaki Kitajima, Masazumi Okajima, Michiya Kobayashi, Junichi Sakamoto, Shigetoyo Saji, Kosei Hirakawa Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003) Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003) Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003) INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 6, 1052-1059 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 6, 1052-1059 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 6, 1052-1059 2017/12 英語 研究論文(学術雑誌) 公開
H. Nokihara, S. Lu, T. S. K. Mok, K. Nakagawa, N. Yamamoto, Y. K. Shi, L. Zhang, R. A. Soo, J. C. Yang, S. Sugawara, M. Nishio, T. Takahashi, K. Goto, J. Chang, M. Maemondo, Y. Ichinose, Y. Cheng, W. T. Lim, S. Morita, T. Tamura H. Nokihara, S. Lu, T. S. K. Mok, K. Nakagawa, N. Yamamoto, Y. K. Shi, L. Zhang, R. A. Soo, J. C. Yang, S. Sugawara, M. Nishio, T. Takahashi, K. Goto, J. Chang, M. Maemondo, Y. Ichinose, Y. Cheng, W. T. Lim, S. Morita, T. Tamura H. Nokihara, S. Lu, T. S. K. Mok, K. Nakagawa, N. Yamamoto, Y. K. Shi, L. Zhang, R. A. Soo, J. C. Yang, S. Sugawara, M. Nishio, T. Takahashi, K. Goto, J. Chang, M. Maemondo, Y. Ichinose, Y. Cheng, W. T. Lim, S. Morita, T. Tamura Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer) Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer) Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer) ANNALS OF ONCOLOGY, 28, 11, 2698-2706 ANNALS OF ONCOLOGY, 28, 11, 2698-2706 ANNALS OF ONCOLOGY, 28, 11, 2698-2706 2017/11 英語 研究論文(学術雑誌) 公開
Masayuki Shiseki, Chikashi Yoshida, Naoki Takezako, Akira Ohwada, Takashi Kumagai, Kaichi Nishiwaki, Akira Horikoshi, Tetsuya Fukuda, Hina Takano, Yasuji Kouzai, Junji Tanaka, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi Masayuki Shiseki, Chikashi Yoshida, Naoki Takezako, Akira Ohwada, Takashi Kumagai, Kaichi Nishiwaki, Akira Horikoshi, Tetsuya Fukuda, Hina Takano, Yasuji Kouzai, Junji Tanaka, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi Masayuki Shiseki, Chikashi Yoshida, Naoki Takezako, Akira Ohwada, Takashi Kumagai, Kaichi Nishiwaki, Akira Horikoshi, Tetsuya Fukuda, Hina Takano, Yasuji Kouzai, Junji Tanaka, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy International Journal of Clinical Oncology, 22, 5, 972-979 International Journal of Clinical Oncology, 22, 5, 972-979 International Journal of Clinical Oncology, 22, 5, 972-979 2017/10/01 英語 研究論文(学術雑誌) 公開
Kiminori Kimura, Akemi Ikoma, Maki Shibakawa, Shinji Shimoda, Kenichi Harada, Masanao Saio, Jun Imamura, Yosuke Osawa, Masamichi Kimura, Koji Nishikawa, Takuji Okusaka, Satoshi Morita, Kazuaki Inoue, Tatsuya Kanto, Koji Todaka, Yoichi Nakanishi, Michinori Kohara, Masashi Mizokami Kiminori Kimura, Akemi Ikoma, Maki Shibakawa, Shinji Shimoda, Kenichi Harada, Masanao Saio, Jun Imamura, Yosuke Osawa, Masamichi Kimura, Koji Nishikawa, Takuji Okusaka, Satoshi Morita, Kazuaki Inoue, Tatsuya Kanto, Koji Todaka, Yoichi Nakanishi, Michinori Kohara, Masashi Mizokami Kiminori Kimura, Akemi Ikoma, Maki Shibakawa, Shinji Shimoda, Kenichi Harada, Masanao Saio, Jun Imamura, Yosuke Osawa, Masamichi Kimura, Koji Nishikawa, Takuji Okusaka, Satoshi Morita, Kazuaki Inoue, Tatsuya Kanto, Koji Todaka, Yoichi Nakanishi, Michinori Kohara, Masashi Mizokami Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial. EBioMedicine, 23, 79-87 EBioMedicine, 23, 79-87 EBioMedicine, 23, 79-87 2017/09 英語 研究論文(学術雑誌) 公開
Yugo Yamashita, Ryuji Uozumi, Yasuhiro Hamatani, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Satoshi Morita, Masaharu Akao Yugo Yamashita, Ryuji Uozumi, Yasuhiro Hamatani, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Satoshi Morita, Masaharu Akao Yugo Yamashita, Ryuji Uozumi, Yasuhiro Hamatani, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Satoshi Morita, Masaharu Akao Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF Registry - Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF Registry - Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF Registry - CIRCULATION JOURNAL, 81, 9, 1278-+ CIRCULATION JOURNAL, 81, 9, 1278-+ CIRCULATION JOURNAL, 81, 9, 1278-+ 2017/09 英語 研究論文(学術雑誌) 公開
Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi, Hiroaki Magotani, Hirotaka Onoe, Takuya Hayashi, Hiroshi Mizuma, Sayuki Takara, Ryosuke Takahashi, Haruhisa Inoue, Satoshi Morita, Michio Yamamoto, Keisuke Okita, Masato Nakagawa, Malin Parmar, Jun Takahashi Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi, Hiroaki Magotani, Hirotaka Onoe, Takuya Hayashi, Hiroshi Mizuma, Sayuki Takara, Ryosuke Takahashi, Haruhisa Inoue, Satoshi Morita, Michio Yamamoto, Keisuke Okita, Masato Nakagawa, Malin Parmar, Jun Takahashi Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi, Hiroaki Magotani, Hirotaka Onoe, Takuya Hayashi, Hiroshi Mizuma, Sayuki Takara, Ryosuke Takahashi, Haruhisa Inoue, Satoshi Morita, Michio Yamamoto, Keisuke Okita, Masato Nakagawa, Malin Parmar, Jun Takahashi Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature, 548, 7669, 592-596 Nature, 548, 7669, 592-596 Nature, 548, 7669, 592-596 2017/08/30 英語 研究論文(学術雑誌) 公開
Maki Tanioka, Satoshi Yamaguchi, Muneaki Shimada, Shoji Nagao, Kazuhiro Takehara, Masato Nishimura, Satoshi Morita, Shunichi Negoro, Kiyoshi Fujiwara, Junzo Kigawa Maki Tanioka, Satoshi Yamaguchi, Muneaki Shimada, Shoji Nagao, Kazuhiro Takehara, Masato Nishimura, Satoshi Morita, Shunichi Negoro, Kiyoshi Fujiwara, Junzo Kigawa Maki Tanioka, Satoshi Yamaguchi, Muneaki Shimada, Shoji Nagao, Kazuhiro Takehara, Masato Nishimura, Satoshi Morita, Shunichi Negoro, Kiyoshi Fujiwara, Junzo Kigawa Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study Medical Oncology, 34, 8 Medical Oncology, 34, 8 Medical Oncology, 34, 8 2017/08/01 英語 研究論文(学術雑誌) 公開
Shuichiro Nakabo, Motomu Hashimoto, Shinji Ito, Moritoshi Furu, Hiromu Ito, Takao Fujii, Hajime Yoshifuji, Yoshitaka Imura, Ran Nakashima, Kosaku Murakami, Nobuo Kuramoto, Masao Tanaka, Junko Satoh, Akihito Ishigami, Satoshi Morita, Tsuneyo Mimori, Koichiro Ohmura Shuichiro Nakabo, Motomu Hashimoto, Shinji Ito, Moritoshi Furu, Hiromu Ito, Takao Fujii, Hajime Yoshifuji, Yoshitaka Imura, Ran Nakashima, Kosaku Murakami, Nobuo Kuramoto, Masao Tanaka, Junko Satoh, Akihito Ishigami, Satoshi Morita, Tsuneyo Mimori, Koichiro Ohmura Shuichiro Nakabo, Motomu Hashimoto, Shinji Ito, Moritoshi Furu, Hiromu Ito, Takao Fujii, Hajime Yoshifuji, Yoshitaka Imura, Ran Nakashima, Kosaku Murakami, Nobuo Kuramoto, Masao Tanaka, Junko Satoh, Akihito Ishigami, Satoshi Morita, Tsuneyo Mimori, Koichiro Ohmura Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies Rheumatology (United Kingdom), 56, 7, 1217-1226 Rheumatology (United Kingdom), 56, 7, 1217-1226 Rheumatology (United Kingdom), 56, 7, 1217-1226 2017/07/01 英語 研究論文(学術雑誌) 公開
Rokutan-Kurata M, Yoshizawa A, Sumiyoshi S, Sonobe M, Menju T, Momose M, Koyama M, Shigeto S, Fujimoto M, Zhang M, Morita S, Date H, Haga H Rokutan-Kurata M, Yoshizawa A, Sumiyoshi S, Sonobe M, Menju T, Momose M, Koyama M, Shigeto S, Fujimoto M, Zhang M, Morita S, Date H, Haga H Rokutan-Kurata M, Yoshizawa A, Sumiyoshi S, Sonobe M, Menju T, Momose M, Koyama M, Shigeto S, Fujimoto M, Zhang M, Morita S, Date H, Haga H Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases. Clinical lung cancer, 18, 4, e273-e281 Clinical lung cancer, 18, 4, e273-e281 Clinical lung cancer, 18, 4, e273-e281 2017/07 公開
Hiromasa Inoue, Takahide Nagase, Satoshi Morita, Atsushi Yoshida, Tatsunori Jinnai, Masakazu Ichinose Hiromasa Inoue, Takahide Nagase, Satoshi Morita, Atsushi Yoshida, Tatsunori Jinnai, Masakazu Ichinose Hiromasa Inoue, Takahide Nagase, Satoshi Morita, Atsushi Yoshida, Tatsunori Jinnai, Masakazu Ichinose Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach International Journal of COPD, 12, 1803-1810 International Journal of COPD, 12, 1803-1810 International Journal of COPD, 12, 1803-1810 2017/06/20 英語 研究論文(学術雑誌) 公開
Takashi Ishiguro, Naho Kagiyama, Ryuji Uozumi, Kyuto Odashima, Yotaro Takaku, Kazuyoshi Kurashima, Satoshi Morita, Noboru Takayanagi Takashi Ishiguro, Naho Kagiyama, Ryuji Uozumi, Kyuto Odashima, Yotaro Takaku, Kazuyoshi Kurashima, Satoshi Morita, Noboru Takayanagi Takashi Ishiguro, Naho Kagiyama, Ryuji Uozumi, Kyuto Odashima, Yotaro Takaku, Kazuyoshi Kurashima, Satoshi Morita, Noboru Takayanagi Clinical characteristics of influenza-associated pneumonia of adults: Clinical features and factors contributing to severity and mortality Clinical characteristics of influenza-associated pneumonia of adults: Clinical features and factors contributing to severity and mortality Clinical characteristics of influenza-associated pneumonia of adults: Clinical features and factors contributing to severity and mortality Yale Journal of Biology and Medicine, 90, 2, 165-181 Yale Journal of Biology and Medicine, 90, 2, 165-181 Yale Journal of Biology and Medicine, 90, 2, 165-181 2017/06/01 英語 研究論文(学術雑誌) 公開
Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama, Shinichi Mizuki, Akitomo Okada, Masayuki Miyata, Yuichi Handa, Masatoshi Hayashi, Yoshinobu Koyama, Kaoru Arii, Toshiyuki Kitaori, Hiroyuki Hagiyama, Yoshinori Urushidani, Takahito Yamasaki, Yoshihiko Ikeno, Tsuyoshi Suzuki, Atsushi Omoto, Toshifumi Sugitani, Satoshi Morita, Shigeko Inokuma Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama, Shinichi Mizuki, Akitomo Okada, Masayuki Miyata, Yuichi Handa, Masatoshi Hayashi, Yoshinobu Koyama, Kaoru Arii, Toshiyuki Kitaori, Hiroyuki Hagiyama, Yoshinori Urushidani, Takahito Yamasaki, Yoshihiko Ikeno, Tsuyoshi Suzuki, Atsushi Omoto, Toshifumi Sugitani, Satoshi Morita, Shigeko Inokuma Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama, Shinichi Mizuki, Akitomo Okada, Masayuki Miyata, Yuichi Handa, Masatoshi Hayashi, Yoshinobu Koyama, Kaoru Arii, Toshiyuki Kitaori, Hiroyuki Hagiyama, Yoshinori Urushidani, Takahito Yamasaki, Yoshihiko Ikeno, Tsuyoshi Suzuki, Atsushi Omoto, Toshifumi Sugitani, Satoshi Morita, Shigeko Inokuma Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: A multicentre, prospective, observational study in Japan Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: A multicentre, prospective, observational study in Japan Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: A multicentre, prospective, observational study in Japan Annals of the Rheumatic Diseases, 76, 6, 1051-1056 Annals of the Rheumatic Diseases, 76, 6, 1051-1056 Annals of the Rheumatic Diseases, 76, 6, 1051-1056 2017/06/01 英語 研究論文(学術雑誌) 公開
Hida K, Okamura R, Sakai Y, Konishi T, Akagi T, Yamaguchi T, Akiyoshi T, Fukuda M, Yamamoto S, Yamamoto M, Nishigori T, Kawada K, Hasegawa S, Morita S, Watanabe M, Japan, Society of, Laparoscopic Colorectal Surgery Hida K, Okamura R, Sakai Y, Konishi T, Akagi T, Yamaguchi T, Akiyoshi T, Fukuda M, Yamamoto S, Yamamoto M, Nishigori T, Kawada K, Hasegawa S, Morita S, Watanabe M, Japan, Society of, Laparoscopic Colorectal Surgery Hida K, Okamura R, Sakai Y, Konishi T, Akagi T, Yamaguchi T, Akiyoshi T, Fukuda M, Yamamoto S, Yamamoto M, Nishigori T, Kawada K, Hasegawa S, Morita S, Watanabe M, Japan, Society of, Laparoscopic Colorectal Surgery Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer: A Large, Multicenter, Propensity Score Matched Cohort Study in Japan. Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer: A Large, Multicenter, Propensity Score Matched Cohort Study in Japan. Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer: A Large, Multicenter, Propensity Score Matched Cohort Study in Japan. Annals of surgery, 268, 2, 318-324 Annals of surgery, 268, 2, 318-324 Annals of surgery, 268, 2, 318-324 2017/06 公開
Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yoichi Makari, Kenji Amagai, Shinya Ueda, Kazuhiro Yoshida, Hideki Shimodaira, Tomohiro Nishina, Masahiro Tsuda, Yukinori Kurokawa, Takao Tamura, Yasutsuna Sasaki, Satoshi Morita, Wasaburo Koizumi Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yoichi Makari, Kenji Amagai, Shinya Ueda, Kazuhiro Yoshida, Hideki Shimodaira, Tomohiro Nishina, Masahiro Tsuda, Yukinori Kurokawa, Takao Tamura, Yasutsuna Sasaki, Satoshi Morita, Wasaburo Koizumi Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yoichi Makari, Kenji Amagai, Shinya Ueda, Kazuhiro Yoshida, Hideki Shimodaira, Tomohiro Nishina, Masahiro Tsuda, Yukinori Kurokawa, Takao Tamura, Yasutsuna Sasaki, Satoshi Morita, Wasaburo Koizumi Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. The lancet. Gastroenterology & hepatology, 2, 4, 277-287 The lancet. Gastroenterology & hepatology, 2, 4, 277-287 The lancet. Gastroenterology & hepatology, 2, 4, 277-287 2017/04 英語 公開
Hata A, Katakami N, Hattori Y, Tanaka K, Fujita S, Kotani Y, Nishimura T, Imamura F, Yokota S, Satouchi M, Monden K, Otsuka K, Nishiyama A, Tsubouchi K, Kaneda T, Yoshioka H, Morita S, Negoro S Hata A, Katakami N, Hattori Y, Tanaka K, Fujita S, Kotani Y, Nishimura T, Imamura F, Yokota S, Satouchi M, Monden K, Otsuka K, Nishiyama A, Tsubouchi K, Kaneda T, Yoshioka H, Morita S, Negoro S Akito Hata, Nobuyuki Katakami, Yoshihiro Hattori, Kosuke Tanaka, Shiro Fujita, Yoshikazu Kotani, Takashi Nishimura, Fumio Imamura, Soichiro Yokota, Miyako Satouchi, Kazuya Monden, Kojiro Otsuka, Akihiro Nishiyama, Kazuya Tsubouchi, Toshihiko Kaneda, Hiroshige Yoshioka, Satoshi Morita, Shunichi Negoro Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003). Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003). Pemetrexed monotherapy for chemo-na < ve elderly (aged ae<yen>80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003) Cancer chemotherapy and pharmacology, 79, 4, 689-695 Cancer chemotherapy and pharmacology, 79, 4, 689-695 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 4, 689-695 2017/04 英語 研究論文(学術雑誌) 公開
Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients NPJ Precis Oncol, 1, 6 NPJ Precis Oncol, 1, 6 NPJ Precis Oncol, 1, 6 2017/04 英語 公開
Tomonori Yano, Hiroi Kasai, Takahiro Horimatsu, Kenichi Yoshimura, Satoshi Teramukai, Satoshi Morita, Harue Tada, Yoshinobu Yamamoto, Hiromi Kataoka, Naomi Kakushima, Ryu Ishihara, Hajime Isomoto, Manabu Muto Tomonori Yano, Hiroi Kasai, Takahiro Horimatsu, Kenichi Yoshimura, Satoshi Teramukai, Satoshi Morita, Harue Tada, Yoshinobu Yamamoto, Hiromi Kataoka, Naomi Kakushima, Ryu Ishihara, Hajime Isomoto, Manabu Muto Tomonori Yano, Hiroi Kasai, Takahiro Horimatsu, Kenichi Yoshimura, Satoshi Teramukai, Satoshi Morita, Harue Tada, Yoshinobu Yamamoto, Hiromi Kataoka, Naomi Kakushima, Ryu Ishihara, Hajime Isomoto, Manabu Muto A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer. Oncotarget, 8, 13, 22135-22144 Oncotarget, 8, 13, 22135-22144 Oncotarget, 8, 13, 22135-22144 2017/03/28 英語 公開
Satoshi Morita, Peter F. Thall, Kentaro Takeda Satoshi Morita, Peter F. Thall, Kentaro Takeda Satoshi Morita, Peter F. Thall, Kentaro Takeda A simulation study of methods for selecting subgroup-specific doses in phase 1 trials A simulation study of methods for selecting subgroup-specific doses in phase 1 trials A simulation study of methods for selecting subgroup-specific doses in phase 1 trials PHARMACEUTICAL STATISTICS, 16, 2, 143-156 PHARMACEUTICAL STATISTICS, 16, 2, 143-156 PHARMACEUTICAL STATISTICS, 16, 2, 143-156 2017/03 英語 研究論文(学術雑誌) 公開
H. Baba, Y. Yamada, D. Takahari, H. Matsumoto, K. Yoshida, M. Nakamura, M. Yoshida, S. Iwamoto, K. Shimada, Y. Komatsu, Y. Sasaki, T. Satoh, K. Takahashi, H. Mishima, K. Muro, M. Watanabe, Y. Sakata, S. Morita, Y. Shimada, K. Sugihara H. Baba, Y. Yamada, D. Takahari, H. Matsumoto, K. Yoshida, M. Nakamura, M. Yoshida, S. Iwamoto, K. Shimada, Y. Komatsu, Y. Sasaki, T. Satoh, K. Takahashi, H. Mishima, K. Muro, M. Watanabe, Y. Sakata, S. Morita, Y. Shimada, K. Sugihara H. Baba, Y. Yamada, D. Takahari, H. Matsumoto, K. Yoshida, M. Nakamura, M. Yoshida, S. Iwamoto, K. Shimada, Y. Komatsu, Y. Sasaki, T. Satoh, K. Takahashi, H. Mishima, K. Muro, M. Watanabe, Y. Sakata, S. Morita, Y. Shimada, K. Sugihara S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomized phase 3: SOFT study S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomized phase 3: SOFT study S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomized phase 3: SOFT study ESMO Open, 2, 1, e000135 ESMO Open, 2, 1, e000135 ESMO Open, 2, 1, e000135 2017/03 英語 公開
Toru Aoyama, Kazuhiro Nishikawa, Mari Oba, Takaki Yoshikawa, Chu Matsuda, Yoshinori Munemoto, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoki Nagata, Motohiro Imano, Mitsuru Oshiro, Ryoji Fukushima, Masato Kataoka, Satoshi Morita, Akira Tsuburaya, Hideyuki Mishima, Toru Kono, Junichi Sakamoto Toru Aoyama, Kazuhiro Nishikawa, Mari Oba, Takaki Yoshikawa, Chu Matsuda, Yoshinori Munemoto, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoki Nagata, Motohiro Imano, Mitsuru Oshiro, Ryoji Fukushima, Masato Kataoka, Satoshi Morita, Akira Tsuburaya, Hideyuki Mishima, Toru Kono, Junichi Sakamoto Toru Aoyama, Kazuhiro Nishikawa, Mari Oba, Takaki Yoshikawa, Chu Matsuda, Yoshinori Munemoto, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoki Nagata, Motohiro Imano, Mitsuru Oshiro, Ryoji Fukushima, Masato Kataoka, Satoshi Morita, Akira Tsuburaya, Hideyuki Mishima, Toru Kono, Junichi Sakamoto Meta-analysis of Patient-level Data on Therapeutic Effects of TJ-14 (Hangeshashinto) for Gastroenterological Cancer Chemotherapy-induced Severe Oral Mucositis with the HANGESHA-G and HANGESHA-Cs : protocol paper Meta-analysis of Patient-level Data on Therapeutic Effects of TJ-14 (Hangeshashinto) for Gastroenterological Cancer Chemotherapy-induced Severe Oral Mucositis with the HANGESHA-G and HANGESHA-Cs : protocol paper Meta-analysis of Patient-level Data on Therapeutic Effects of TJ-14 (Hangeshashinto) for Gastroenterological Cancer Chemotherapy-induced Severe Oral Mucositis with the HANGESHA-G and HANGESHA-Cs : protocol paper Annals of Cancer Research and Therapy, 25, 2, 92-94 Annals of Cancer Research and Therapy, 25, 2, 92-94 Annals of Cancer Research and Therapy, 25, 2, 92-94 2017 英語 研究論文(学術雑誌) 公開
Kazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, Takeharu Yamanaka, Satoshi Morita, Kazumasa Fujitani, Yusuke Akamaru, Ken Shimada, Hisashi Hosaka, Norisuke Nakayama, Toshimasa Tsujinaka, Junichi Sakamoto Kazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, Takeharu Yamanaka, Satoshi Morita, Kazumasa Fujitani, Yusuke Akamaru, Ken Shimada, Hisashi Hosaka, Norisuke Nakayama, Toshimasa Tsujinaka, Junichi Sakamoto Kazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, Takeharu Yamanaka, Satoshi Morita, Kazumasa Fujitani, Yusuke Akamaru, Ken Shimada, Hisashi Hosaka, Norisuke Nakayama, Toshimasa Tsujinaka, Junichi Sakamoto Meta-analysis of patient-level data on biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer with the TCOG GI-0801 BIRIP and ECRIN TRICS RCTS: Protocol paper Meta-analysis of patient-level data on biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer with the TCOG GI-0801 BIRIP and ECRIN TRICS RCTS: Protocol paper Meta-analysis of patient-level data on biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer with the TCOG GI-0801 BIRIP and ECRIN TRICS RCTS: Protocol paper Annals of Cancer Research and Therapy, 25, 2, 48-51 Annals of Cancer Research and Therapy, 25, 2, 48-51 Annals of Cancer Research and Therapy, 25, 2, 48-51 2017 英語 研究論文(学術雑誌) 公開
Toru Kono, Mitsuo Shimada, Masaaki Nishi, Yuji Morine, Kozo Yoshikawa, Hidetoshi Katsuno, Koutarou Maeda, Keisuke Koeda, Satoshi Morita, Masahiko Watanabe, Mitsuo Kusano, Junichi Sakamoto, Shigetoyo Saji, Hiroki Sokuoka, Yuya Ohtake, Yasuto Sato, Takashi Kanematsu, Masaki Kitajima Toru Kono, Mitsuo Shimada, Masaaki Nishi, Yuji Morine, Kozo Yoshikawa, Hidetoshi Katsuno, Koutarou Maeda, Keisuke Koeda, Satoshi Morita, Masahiko Watanabe, Mitsuo Kusano, Junichi Sakamoto, Shigetoyo Saji, Hiroki Sokuoka, Yuya Ohtake, Yasuto Sato, Takashi Kanematsu, Masaki Kitajima Toru Kono, Mitsuo Shimada, Masaaki Nishi, Yuji Morine, Kozo Yoshikawa, Hidetoshi Katsuno, Koutarou Maeda, Keisuke Koeda, Satoshi Morita, Masahiko Watanabe, Mitsuo Kusano, Junichi Sakamoto, Shigetoyo Saji, Hiroki Sokuoka, Yuya Ohtake, Yasuto Sato, Takashi Kanematsu, Masaki Kitajima Daikenchuto administration for intestinal hypomotility after open abdominal surgery: A pooled analysis of three randomized controlled trials Daikenchuto administration for intestinal hypomotility after open abdominal surgery: A pooled analysis of three randomized controlled trials Daikenchuto administration for intestinal hypomotility after open abdominal surgery: A pooled analysis of three randomized controlled trials Annals of Cancer Research and Therapy, 25, 1, 41-43 Annals of Cancer Research and Therapy, 25, 1, 41-43 Annals of Cancer Research and Therapy, 25, 1, 41-43 2017 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Peter Müller Satoshi Morita, Peter Müller Satoshi Morita, Peter Müller Bayesian population finding with biomarkers in a randomized clinical trial Bayesian population finding with biomarkers in a randomized clinical trial Bayesian population finding with biomarkers in a randomized clinical trial Biometrics, 73, 4, 1355-1365 Biometrics, 73, 4, 1355-1365 Biometrics, 73, 4, 1355-1365 2017 英語 研究論文(学術雑誌) 公開
Shinsuke Nagami, Yoshitaka Oku, Naomi Yagi, Susumu Sato, Ryuji Uozumi, Satoshi Morita, Yoshie Yamagata, Jun Kayashita, Kazuya Tanimura, Atsuyasu Sato, Ryosuke Takahashi, Shigeo Muro Shinsuke Nagami, Yoshitaka Oku, Naomi Yagi, Susumu Sato, Ryuji Uozumi, Satoshi Morita, Yoshie Yamagata, Jun Kayashita, Kazuya Tanimura, Atsuyasu Sato, Ryosuke Takahashi, Shigeo Muro Shinsuke Nagami, Yoshitaka Oku, Naomi Yagi, Susumu Sato, Ryuji Uozumi, Satoshi Morita, Yoshie Yamagata, Jun Kayashita, Kazuya Tanimura, Atsuyasu Sato, Ryosuke Takahashi, Shigeo Muro Breathing-swallowing discoordination is associated with frequent exacerbations of COPD. Breathing-swallowing discoordination is associated with frequent exacerbations of COPD. Breathing-swallowing discoordination is associated with frequent exacerbations of COPD. BMJ open respiratory research, 4, 1, e000202 BMJ open respiratory research, 4, 1, e000202 BMJ open respiratory research, 4, 1, e000202 2017 英語 研究論文(学術雑誌) 公開
Yasuto Yoneshima, Satoshi Morita, Masahiko Ando, Satoru Miura, Hiroshige Yoshioka, Tetsuya Abe, Terufumi Kato, Masashi Kondo, Yukio Hosomi, Katsuyuki Hotta, Nobuyuki Yamamoto, Junji Kishimoto, Yoichi Nakanishi, Isamu Okamoto Yasuto Yoneshima, Satoshi Morita, Masahiko Ando, Satoru Miura, Hiroshige Yoshioka, Tetsuya Abe, Terufumi Kato, Masashi Kondo, Yukio Hosomi, Katsuyuki Hotta, Nobuyuki Yamamoto, Junji Kishimoto, Yoichi Nakanishi, Isamu Okamoto Yasuto Yoneshima, Satoshi Morita, Masahiko Ando, Satoru Miura, Hiroshige Yoshioka, Tetsuya Abe, Terufumi Kato, Masashi Kondo, Yukio Hosomi, Katsuyuki Hotta, Nobuyuki Yamamoto, Junji Kishimoto, Yoichi Nakanishi, Isamu Okamoto Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer CLINICAL LUNG CANCER, 18, 1, 100-103 CLINICAL LUNG CANCER, 18, 1, 100-103 CLINICAL LUNG CANCER, 18, 1, 100-103 2017/01 英語 研究論文(学術雑誌) 公開
Kazuhiro Nishikawa, Tsunehiro Takahashi, Hiromasa Takaishi, Akira Miki, Hirokazu Noshiro, Takaki Yoshikawa, Yasunori Nishida, Satoru Iwasa, Hiroto Miwa, Toshiki Masuishi, Narikazu Boku, Yasuhide Yamada, Yasuhiro Kodera, Kazuhiro Yoshida, Satoshi Morita, Junichi Sakamoto, Shigetoyo Saji, Yuko Kitagawa Kazuhiro Nishikawa, Tsunehiro Takahashi, Hiromasa Takaishi, Akira Miki, Hirokazu Noshiro, Takaki Yoshikawa, Yasunori Nishida, Satoru Iwasa, Hiroto Miwa, Toshiki Masuishi, Narikazu Boku, Yasuhide Yamada, Yasuhiro Kodera, Kazuhiro Yoshida, Satoshi Morita, Junichi Sakamoto, Shigetoyo Saji, Yuko Kitagawa Kazuhiro Nishikawa, Tsunehiro Takahashi, Hiromasa Takaishi, Akira Miki, Hirokazu Noshiro, Takaki Yoshikawa, Yasunori Nishida, Satoru Iwasa, Hiroto Miwa, Toshiki Masuishi, Narikazu Boku, Yasuhide Yamada, Yasuhiro Kodera, Kazuhiro Yoshida, Satoshi Morita, Junichi Sakamoto, Shigetoyo Saji, Yuko Kitagawa Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naive patients with HER2-positive, previously treated, advanced, or recurrent gastric cancer (JFMC45-1102) Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naive patients with HER2-positive, previously treated, advanced, or recurrent gastric cancer (JFMC45-1102) Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naive patients with HER2-positive, previously treated, advanced, or recurrent gastric cancer (JFMC45-1102) INTERNATIONAL JOURNAL OF CANCER, 140, 1, 188-196 INTERNATIONAL JOURNAL OF CANCER, 140, 1, 188-196 INTERNATIONAL JOURNAL OF CANCER, 140, 1, 188-196 2017/01 英語 研究論文(学術雑誌) 公開
Yasuhiro Kodera, Naoto Takahashi, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Yuichi Ito, Katsufumi Miyamoto, Osamu Takayama, Motohiro Imano, Daisuke Kobayashi, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto Yasuhiro Kodera, Naoto Takahashi, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Yuichi Ito, Katsufumi Miyamoto, Osamu Takayama, Motohiro Imano, Daisuke Kobayashi, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto Yasuhiro Kodera, Naoto Takahashi, Takaki Yoshikawa, Nobuhiro Takiguchi, Kazumasa Fujitani, Yuichi Ito, Katsufumi Miyamoto, Osamu Takayama, Motohiro Imano, Daisuke Kobayashi, Yumi Miyashita, Satoshi Morita, Junichi Sakamoto Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial GASTRIC CANCER, 20, 1, 190-199 GASTRIC CANCER, 20, 1, 190-199 GASTRIC CANCER, 20, 1, 190-199 2017/01 英語 研究論文(学術雑誌) 公開
Kentaro Sakamaki, Yosuke Kito, Kentaro Yamazaki, Naoki Izawa, Takashi Tsuda, Satoshi Morita, Narikazu Boku Kentaro Sakamaki, Yosuke Kito, Kentaro Yamazaki, Naoki Izawa, Takashi Tsuda, Satoshi Morita, Narikazu Boku Kentaro Sakamaki, Yosuke Kito, Kentaro Yamazaki, Naoki Izawa, Takashi Tsuda, Satoshi Morita, Narikazu Boku Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size. Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size. Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size. ESMO open, 2, 5, e000275 ESMO open, 2, 5, e000275 ESMO open, 2, 5, e000275 2017 英語 公開
Masayuki Hori, Takahiro Yasumi, Saeko Shimodera, Hirofumi Shibata, Eitaro Hiejima, Hirotsugu Oda, Kazushi Izawa, Tomoki Kawai, Masataka Ishimura, Naoko Nakano, Ryutaro Shirakawa, Ryuta Nishikomori, Hidetoshi Takada, Satoshi Morita, Hisanori Horiuchi, Osamu Ohara, Eiichi Ishii, Toshio Heike Masayuki Hori, Takahiro Yasumi, Saeko Shimodera, Hirofumi Shibata, Eitaro Hiejima, Hirotsugu Oda, Kazushi Izawa, Tomoki Kawai, Masataka Ishimura, Naoko Nakano, Ryutaro Shirakawa, Ryuta Nishikomori, Hidetoshi Takada, Satoshi Morita, Hisanori Horiuchi, Osamu Ohara, Eiichi Ishii, Toshio Heike Masayuki Hori, Takahiro Yasumi, Saeko Shimodera, Hirofumi Shibata, Eitaro Hiejima, Hirotsugu Oda, Kazushi Izawa, Tomoki Kawai, Masataka Ishimura, Naoko Nakano, Ryutaro Shirakawa, Ryuta Nishikomori, Hidetoshi Takada, Satoshi Morita, Hisanori Horiuchi, Osamu Ohara, Eiichi Ishii, Toshio Heike A CD57(+) CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients A CD57(+) CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients A CD57(+) CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients JOURNAL OF CLINICAL IMMUNOLOGY, 37, 1, 92-99 JOURNAL OF CLINICAL IMMUNOLOGY, 37, 1, 92-99 JOURNAL OF CLINICAL IMMUNOLOGY, 37, 1, 92-99 2017/01 英語 研究論文(学術雑誌) 公開
Okuno K, Aoyama T, Oba K, Yokoyama N, Yoshida K, Kunieda K, Nishimura E, Akamatsu H, Obatake T, Morita S, Yoshikawa T, Saji S Okuno K, Aoyama T, Oba K, Yokoyama N, Yoshida K, Kunieda K, Nishimura E, Akamatsu H, Obatake T, Morita S, Yoshikawa T, Saji S Okuno K, Aoyama T, Oba K, Yokoyama N, Yoshida K, Kunieda K, Nishimura E, Akamatsu H, Obatake T, Morita S, Yoshikawa T, Saji S Clinical trial comparing UFT-PSK combination adjuvant therapy and surgery-alone for stage II rectal cancer Clinical trial comparing UFT-PSK combination adjuvant therapy and surgery-alone for stage II rectal cancer Clinical trial comparing UFT-PSK combination adjuvant therapy and surgery-alone for stage II rectal cancer Annals of Cancer Research and Therapy, 25, 1, 15-16 Annals of Cancer Research and Therapy, 25, 1, 15-16 Annals of Cancer Research and Therapy, 25, 1, 15-16 2017 公開
Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Breast Cancer, 24, 1, 111-120 Breast Cancer, 24, 1, 111-120 Breast Cancer, 24, 1, 111-120 2017 公開
Masahito Kotaka, Ruihua Xu, Kei Muro, Young Suk Park, Satoshi Morita, Satoru Iwasa, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Wei Wang, Joong Bae Ahn, Yanhong Deng, Sang-Hee Cho, Yi Ba, Keun-Wook Lee, Tao Zhang, Taroh Satoh, Marc E. Buyse, Baek-Yeol Ryoo, Lin Shen, Junichi Sakamoto, Tae Won Kim Masahito Kotaka, Ruihua Xu, Kei Muro, Young Suk Park, Satoshi Morita, Satoru Iwasa, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Wei Wang, Joong Bae Ahn, Yanhong Deng, Sang-Hee Cho, Yi Ba, Keun-Wook Lee, Tao Zhang, Taroh Satoh, Marc E. Buyse, Baek-Yeol Ryoo, Lin Shen, Junichi Sakamoto, Tae Won Kim Masahito Kotaka, Ruihua Xu, Kei Muro, Young Suk Park, Satoshi Morita, Satoru Iwasa, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Wei Wang, Joong Bae Ahn, Yanhong Deng, Sang-Hee Cho, Yi Ba, Keun-Wook Lee, Tao Zhang, Taroh Satoh, Marc E. Buyse, Baek-Yeol Ryoo, Lin Shen, Junichi Sakamoto, Tae Won Kim Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab CHINESE JOURNAL OF CANCER, 35, 1, 102 CHINESE JOURNAL OF CANCER, 35, 1, 102 CHINESE JOURNAL OF CANCER, 35, 1, 102 2016/12 英語 研究論文(学術雑誌) 公開
Takehito Shukuya, Keita Mori, Joseph M. Amann, Erin M. Bertino, Gregory A. Otterson, Peter G. Shields, Satoshi Morita, David P. Carbone Takehito Shukuya, Keita Mori, Joseph M. Amann, Erin M. Bertino, Gregory A. Otterson, Peter G. Shields, Satoshi Morita, David P. Carbone Takehito Shukuya, Keita Mori, Joseph M. Amann, Erin M. Bertino, Gregory A. Otterson, Peter G. Shields, Satoshi Morita, David P. Carbone Relationship between overall survival and response or progression-free survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 antibodies Relationship between overall survival and response or progression-free survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 antibodies Relationship between overall survival and response or progression-free survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 antibodies Journal of Thoracic Oncology, 11, 11, 1927-1939 Journal of Thoracic Oncology, 11, 11, 1927-1939 Journal of Thoracic Oncology, 11, 11, 1927-1939 2016/11/13 英語 研究論文(学術雑誌) 公開
Maki Hagihara, Noriyoshi Iriyama, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Maki Hagihara, Noriyoshi Iriyama, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Maki Hagihara, Noriyoshi Iriyama, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Association of pleural effusion with an early molecular response. in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study Association of pleural effusion with an early molecular response. in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study Association of pleural effusion with an early molecular response. in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study ONCOLOGY REPORTS, 36, 5, 2976-2982 ONCOLOGY REPORTS, 36, 5, 2976-2982 ONCOLOGY REPORTS, 36, 5, 2976-2982 2016/11 英語 研究論文(学術雑誌) 公開
Hiromichi Maeda, Maho Sato, Michiya Kobayashi, Nobuhiro Takiguchi, Takaki Yoshikawa, Shigefumi Yoshino, Kazuhiro Yoshida, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita Hiromichi Maeda, Maho Sato, Michiya Kobayashi, Nobuhiro Takiguchi, Takaki Yoshikawa, Shigefumi Yoshino, Kazuhiro Yoshida, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita Hiromichi Maeda, Maho Sato, Michiya Kobayashi, Nobuhiro Takiguchi, Takaki Yoshikawa, Shigefumi Yoshino, Kazuhiro Yoshida, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants SUPPORTIVE CARE IN CANCER, 24, 11, 4515-4521 SUPPORTIVE CARE IN CANCER, 24, 11, 4515-4521 SUPPORTIVE CARE IN CANCER, 24, 11, 4515-4521 2016/11 英語 研究論文(学術雑誌) 公開
Masahiro Sekiguchi, Takao Fujii, Kiyoshi Matsui, Kosaku Murakami, Satoshi Morita, Koichiro Ohmura, Yutaka Kawahito, Norihiro Nishimoto, Tsuneyo Mimori, Hajime Sano Masahiro Sekiguchi, Takao Fujii, Kiyoshi Matsui, Kosaku Murakami, Satoshi Morita, Koichiro Ohmura, Yutaka Kawahito, Norihiro Nishimoto, Tsuneyo Mimori, Hajime Sano Masahiro Sekiguchi, Takao Fujii, Kiyoshi Matsui, Kosaku Murakami, Satoshi Morita, Koichiro Ohmura, Yutaka Kawahito, Norihiro Nishimoto, Tsuneyo Mimori, Hajime Sano Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study JOURNAL OF RHEUMATOLOGY, 43, 11, 1974-1983 JOURNAL OF RHEUMATOLOGY, 43, 11, 1974-1983 JOURNAL OF RHEUMATOLOGY, 43, 11, 1974-1983 2016/11 英語 研究論文(学術雑誌) 公開
Shoichi Ohwada, Satoshi Morita Shoichi Ohwada, Satoshi Morita Shoichi Ohwada, Satoshi Morita Bayesian adaptive patient enrollment restriction to identify a sensitive subpopulation using a continuous biomarker in a randomized phase 2 trial Bayesian adaptive patient enrollment restriction to identify a sensitive subpopulation using a continuous biomarker in a randomized phase 2 trial Bayesian adaptive patient enrollment restriction to identify a sensitive subpopulation using a continuous biomarker in a randomized phase 2 trial Pharmaceutical Statistics, 15, 5, 420-429 Pharmaceutical Statistics, 15, 5, 420-429 Pharmaceutical Statistics, 15, 5, 420-429 2016/09/01 英語 研究論文(学術雑誌) 公開
Takashi Ishiguro, Naho Kagiyama, Ryuji Uozumi, Kyuto Odashima, Kazuyoshi Kurashima, Satoshi Morita, Noboru Takayanagi Takashi Ishiguro, Naho Kagiyama, Ryuji Uozumi, Kyuto Odashima, Kazuyoshi Kurashima, Satoshi Morita, Noboru Takayanagi Takashi Ishiguro, Naho Kagiyama, Ryuji Uozumi, Kyuto Odashima, Kazuyoshi Kurashima, Satoshi Morita, Noboru Takayanagi Risk factors for the severity and mortality of pneumococcal pneumonia: Importance of premorbid patients' performance status Risk factors for the severity and mortality of pneumococcal pneumonia: Importance of premorbid patients' performance status Risk factors for the severity and mortality of pneumococcal pneumonia: Importance of premorbid patients' performance status JOURNAL OF INFECTION AND CHEMOTHERAPY, 22, 9-10, 685-691 JOURNAL OF INFECTION AND CHEMOTHERAPY, 22, 9-10, 685-691 JOURNAL OF INFECTION AND CHEMOTHERAPY, 22, 9-10, 685-691 2016/09 英語 研究論文(学術雑誌) 公開
Shigefumi Yoshino, Kazuhiro Nishikawa, Satoshi Morita, Tsuyoshi Takahashi, Koichiro Sakata, Jiro Nagao, Hiroshi Nemoto, Nozomu Murakami, Takeru Matsuda, Hiroyasu Hasegawa, Ryoichi Shimizu, Takaki Yoshikawa, Hiroyuki Osanai, Motohiro Imano, Hiroshi Naitoh, Akiyoshi Tanaka, Takashi Tajiri, Akira Gochi, Michinari Suzuki, Junichi Sakamoto, Shigetoyo Saji, Masaaki Oka Shigefumi Yoshino, Kazuhiro Nishikawa, Satoshi Morita, Tsuyoshi Takahashi, Koichiro Sakata, Jiro Nagao, Hiroshi Nemoto, Nozomu Murakami, Takeru Matsuda, Hiroyasu Hasegawa, Ryoichi Shimizu, Takaki Yoshikawa, Hiroyuki Osanai, Motohiro Imano, Hiroshi Naitoh, Akiyoshi Tanaka, Takashi Tajiri, Akira Gochi, Michinari Suzuki, Junichi Sakamoto, Shigetoyo Saji, Masaaki Oka Shigefumi Yoshino, Kazuhiro Nishikawa, Satoshi Morita, Tsuyoshi Takahashi, Koichiro Sakata, Jiro Nagao, Hiroshi Nemoto, Nozomu Murakami, Takeru Matsuda, Hiroyasu Hasegawa, Ryoichi Shimizu, Takaki Yoshikawa, Hiroyuki Osanai, Motohiro Imano, Hiroshi Naitoh, Akiyoshi Tanaka, Takashi Tajiri, Akira Gochi, Michinari Suzuki, Junichi Sakamoto, Shigetoyo Saji, Masaaki Oka Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701) Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701) Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701) EUROPEAN JOURNAL OF CANCER, 65, 164-171 EUROPEAN JOURNAL OF CANCER, 65, 164-171 EUROPEAN JOURNAL OF CANCER, 65, 164-171 2016/09 英語 研究論文(学術雑誌) 公開
Yoshiko Urata, Nobuyuki Katakami, Satoshi Morita, Reiko Kaji, Hiroshige Yoshioka, Takashi Seto, Miyako Satouchi, Yasuo Iwamoto, Masashi Kanehara, Daichi Fujimoto, Norihiko Ikeda, Haruyasu Murakami, Haruko Daga, Tetsuya Oguri, Isao Goto, Fumio Imamura, Shunichi Sugawara, Hideo Saka, Naoyuki Nogami, Shunichi Negoro, Kazuhiko Nakagawa, Yoichi Nakanishi Yoshiko Urata, Nobuyuki Katakami, Satoshi Morita, Reiko Kaji, Hiroshige Yoshioka, Takashi Seto, Miyako Satouchi, Yasuo Iwamoto, Masashi Kanehara, Daichi Fujimoto, Norihiko Ikeda, Haruyasu Murakami, Haruko Daga, Tetsuya Oguri, Isao Goto, Fumio Imamura, Shunichi Sugawara, Hideo Saka, Naoyuki Nogami, Shunichi Negoro, Kazuhiko Nakagawa, Yoichi Nakanishi Yoshiko Urata, Nobuyuki Katakami, Satoshi Morita, Reiko Kaji, Hiroshige Yoshioka, Takashi Seto, Miyako Satouchi, Yasuo Iwamoto, Masashi Kanehara, Daichi Fujimoto, Norihiko Ikeda, Haruyasu Murakami, Haruko Daga, Tetsuya Oguri, Isao Goto, Fumio Imamura, Shunichi Sugawara, Hideo Saka, Naoyuki Nogami, Shunichi Negoro, Kazuhiko Nakagawa, Yoichi Nakanishi Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L JOURNAL OF CLINICAL ONCOLOGY, 34, 27, 3248-+ JOURNAL OF CLINICAL ONCOLOGY, 34, 27, 3248-+ JOURNAL OF CLINICAL ONCOLOGY, 34, 27, 3248-+ 2016/09 英語 研究論文(学術雑誌) 公開
Yusuke Oji, Naoya Hashimoto, Akihiro Tsuboi, Yui Murakami, Miki Iwai, Naoki Kagawa, Yasuyoshi Chiba, Shuichi Izumoto, Olga Elisseeva, Ryo Ichinohasama, Junichi Sakamoto, Satoshi Morita, Hiroko Nakajima, Satoshi Takashima, Yoshiki Nakae, Jun Nakata, Manabu Kawakami, Sumiyuki Nishida, Naoki Hosen, Fumihiro Fujiki, Soyoko Morimoto, Mayuko Adachi, Masahiro Iwamoto, Yoshihiro Oka, Toshiki Yoshimine, Haruo Sugiyama Yusuke Oji, Naoya Hashimoto, Akihiro Tsuboi, Yui Murakami, Miki Iwai, Naoki Kagawa, Yasuyoshi Chiba, Shuichi Izumoto, Olga Elisseeva, Ryo Ichinohasama, Junichi Sakamoto, Satoshi Morita, Hiroko Nakajima, Satoshi Takashima, Yoshiki Nakae, Jun Nakata, Manabu Kawakami, Sumiyuki Nishida, Naoki Hosen, Fumihiro Fujiki, Soyoko Morimoto, Mayuko Adachi, Masahiro Iwamoto, Yoshihiro Oka, Toshiki Yoshimine, Haruo Sugiyama Yusuke Oji, Naoya Hashimoto, Akihiro Tsuboi, Yui Murakami, Miki Iwai, Naoki Kagawa, Yasuyoshi Chiba, Shuichi Izumoto, Olga Elisseeva, Ryo Ichinohasama, Junichi Sakamoto, Satoshi Morita, Hiroko Nakajima, Satoshi Takashima, Yoshiki Nakae, Jun Nakata, Manabu Kawakami, Sumiyuki Nishida, Naoki Hosen, Fumihiro Fujiki, Soyoko Morimoto, Mayuko Adachi, Masahiro Iwamoto, Yoshihiro Oka, Toshiki Yoshimine, Haruo Sugiyama Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide INTERNATIONAL JOURNAL OF CANCER, 139, 6, 1391-1401 INTERNATIONAL JOURNAL OF CANCER, 139, 6, 1391-1401 INTERNATIONAL JOURNAL OF CANCER, 139, 6, 1391-1401 2016/09 英語 研究論文(学術雑誌) 公開
Kentaro Yamazaki, M. Nagase, H. Tamagawa, S. Ueda, T. Tamura, K. Murata, T. Eguchi Nakajima, E. Baba, M. Tsuda, T. Moriwaki, T. Esaki, Y. Tsuji, K. Muro, K. Taira, T. Denda, S. Funai, K. Shinozaki, H. Yamashita, N. Sugimoto, T. Okuno, T. Nishina, M. Umeki, T. Kurimoto, T. Takayama, A. Tsuji, M. Yoshida, A. Hosokawa, Y. Shibata, K. Suyama, M. Okabe, K. Suzuki, N. Seki, K. Kawakami, M. Sato, K. Fujikawa, T. Hirashima, T. Shimura, K. Taku, T. Otsuji, F. Tamura, E. Shinozaki, K. Nakashima, H. Hara, T. Tsushima, M. Ando, S. Morita, N. Boku, I. Hyodo Kentaro Yamazaki, M. Nagase, H. Tamagawa, S. Ueda, T. Tamura, K. Murata, T. Eguchi Nakajima, E. Baba, M. Tsuda, T. Moriwaki, T. Esaki, Y. Tsuji, K. Muro, K. Taira, T. Denda, S. Funai, K. Shinozaki, H. Yamashita, N. Sugimoto, T. Okuno, T. Nishina, M. Umeki, T. Kurimoto, T. Takayama, A. Tsuji, M. Yoshida, A. Hosokawa, Y. Shibata, K. Suyama, M. Okabe, K. Suzuki, N. Seki, K. Kawakami, M. Sato, K. Fujikawa, T. Hirashima, T. Shimura, K. Taku, T. Otsuji, F. Tamura, E. Shinozaki, K. Nakashima, H. Hara, T. Tsushima, M. Ando, S. Morita, N. Boku, I. Hyodo Kentaro Yamazaki, M. Nagase, H. Tamagawa, S. Ueda, T. Tamura, K. Murata, T. Eguchi Nakajima, E. Baba, M. Tsuda, T. Moriwaki, T. Esaki, Y. Tsuji, K. Muro, K. Taira, T. Denda, S. Funai, K. Shinozaki, H. Yamashita, N. Sugimoto, T. Okuno, T. Nishina, M. Umeki, T. Kurimoto, T. Takayama, A. Tsuji, M. Yoshida, A. Hosokawa, Y. Shibata, K. Suyama, M. Okabe, K. Suzuki, N. Seki, K. Kawakami, M. Sato, K. Fujikawa, T. Hirashima, T. Shimura, K. Taku, T. Otsuji, F. Tamura, E. Shinozaki, K. Nakashima, H. Hara, T. Tsushima, M. Ando, S. Morita, N. Boku, I. Hyodo Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G) Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G) Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G) Annals of Oncology, 27, 8, 1539-1546 Annals of Oncology, 27, 8, 1539-1546 Annals of Oncology, 27, 8, 1539-1546 2016/08/01 英語 研究論文(学術雑誌) 公開
Yutaka Kuroda, Ryuta Asada, Kazutaka So, Atsushi Yonezawa, Manabu Nankaku, Kumi Mukai, Toshiko Ito-Ihara, Harue Tada, Michio Yamamoto, Toshinori Murayama, Satoshi Morita, Yasuhiko Tabata, Masayuki Yokode, Akira Shimizu, Shuichi Matsuda, Haruhiko Akiyama Yutaka Kuroda, Ryuta Asada, Kazutaka So, Atsushi Yonezawa, Manabu Nankaku, Kumi Mukai, Toshiko Ito-Ihara, Harue Tada, Michio Yamamoto, Toshinori Murayama, Satoshi Morita, Yasuhiko Tabata, Masayuki Yokode, Akira Shimizu, Shuichi Matsuda, Haruhiko Akiyama Yutaka Kuroda, Ryuta Asada, Kazutaka So, Atsushi Yonezawa, Manabu Nankaku, Kumi Mukai, Toshiko Ito-Ihara, Harue Tada, Michio Yamamoto, Toshinori Murayama, Satoshi Morita, Yasuhiko Tabata, Masayuki Yokode, Akira Shimizu, Shuichi Matsuda, Haruhiko Akiyama A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head International Orthopaedics, 40, 8, 1747-1754 International Orthopaedics, 40, 8, 1747-1754 International Orthopaedics, 40, 8, 1747-1754 2016/08/01 英語 研究論文(学術雑誌) 公開
Takashi Ishiguro, Noboru Takayanagi, Ryuji Uozumi, Yuri Baba, Eriko Kawate, Yoichi Kobayashi, Yotaro Takaku, Naho Kagiyama, Yoshihiko Shimizu, Satoshi Morita, Yutaka Sugita Takashi Ishiguro, Noboru Takayanagi, Ryuji Uozumi, Yuri Baba, Eriko Kawate, Yoichi Kobayashi, Yotaro Takaku, Naho Kagiyama, Yoshihiko Shimizu, Satoshi Morita, Yutaka Sugita Takashi Ishiguro, Noboru Takayanagi, Ryuji Uozumi, Yuri Baba, Eriko Kawate, Yoichi Kobayashi, Yotaro Takaku, Naho Kagiyama, Yoshihiko Shimizu, Satoshi Morita, Yutaka Sugita Diagnostic criteria that can most accurately differentiate allergic bronchopulmonary mycosis from other eosinophilic lung diseases: A retrospective, single-center study Diagnostic criteria that can most accurately differentiate allergic bronchopulmonary mycosis from other eosinophilic lung diseases: A retrospective, single-center study Diagnostic criteria that can most accurately differentiate allergic bronchopulmonary mycosis from other eosinophilic lung diseases: A retrospective, single-center study Respiratory Investigation, 54, 4, 264-271 Respiratory Investigation, 54, 4, 264-271 Respiratory Investigation, 54, 4, 264-271 2016/07/01 英語 研究論文(学術雑誌) 公開
Tomoya Yokota, Hiroyuki Tachibana, Tetsuhito Konishi, Takashi Yurikusa, Satoshi Hamauchi, Kensuke Sakai, Masaya Nishikawa, Miho Suzuki, Yayoi Naganawa, Tomoka Hagihara, Hiromi Tsumaki, Tomo Kubo, Maho Sato, Masataka Taguri, Satoshi Morita, Toru Eguchi, Kaoru Kubota, Sadamoto Zenda Tomoya Yokota, Hiroyuki Tachibana, Tetsuhito Konishi, Takashi Yurikusa, Satoshi Hamauchi, Kensuke Sakai, Masaya Nishikawa, Miho Suzuki, Yayoi Naganawa, Tomoka Hagihara, Hiromi Tsumaki, Tomo Kubo, Maho Sato, Masataka Taguri, Satoshi Morita, Toru Eguchi, Kaoru Kubota, Sadamoto Zenda Tomoya Yokota, Hiroyuki Tachibana, Tetsuhito Konishi, Takashi Yurikusa, Satoshi Hamauchi, Kensuke Sakai, Masaya Nishikawa, Miho Suzuki, Yayoi Naganawa, Tomoka Hagihara, Hiromi Tsumaki, Tomo Kubo, Maho Sato, Masataka Taguri, Satoshi Morita, Toru Eguchi, Kaoru Kubota, Sadamoto Zenda Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy SUPPORTIVE CARE IN CANCER, 24, 7, 3029-3036 SUPPORTIVE CARE IN CANCER, 24, 7, 3029-3036 SUPPORTIVE CARE IN CANCER, 24, 7, 3029-3036 2016/07 英語 研究論文(学術雑誌) 公開
Yuichi Ito, Takaki Yoshikawa, Michitaka Fujiwara, Hiroshi Kojima, Takanori Matsui, Yoshinari Mochizuki, Haruhiko Cho, Toru Aoyama, Seiji Ito, Kazunari Misawa, Hiroshi Nakayama, Yuki Morioka, Akiharu Ishiyama, Chie Tanaka, Satoshi Morita, Junichi Sakamoto, Yasuhiro Kodera Yuichi Ito, Takaki Yoshikawa, Michitaka Fujiwara, Hiroshi Kojima, Takanori Matsui, Yoshinari Mochizuki, Haruhiko Cho, Toru Aoyama, Seiji Ito, Kazunari Misawa, Hiroshi Nakayama, Yuki Morioka, Akiharu Ishiyama, Chie Tanaka, Satoshi Morita, Junichi Sakamoto, Yasuhiro Kodera Yuichi Ito, Takaki Yoshikawa, Michitaka Fujiwara, Hiroshi Kojima, Takanori Matsui, Yoshinari Mochizuki, Haruhiko Cho, Toru Aoyama, Seiji Ito, Kazunari Misawa, Hiroshi Nakayama, Yuki Morioka, Akiharu Ishiyama, Chie Tanaka, Satoshi Morita, Junichi Sakamoto, Yasuhiro Kodera Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101 Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101 Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101 GASTRIC CANCER, 19, 3, 977-985 GASTRIC CANCER, 19, 3, 977-985 GASTRIC CANCER, 19, 3, 977-985 2016/07 英語 研究論文(学術雑誌) 公開
Satoshi Matsusaka, Atsushi Nashimoto, Kazuhiro Nishikawa, Akira Miki, Hiroto Miwa, Kazuya Yamaguchi, Takaki Yoshikawa, Atsushi Ochiai, Satoshi Morita, Takeshi Sano, Yasuhiro Kodera, Yoshihiro Kakeji, Junichi Sakamoto, Shigetoyo Saji, Kazuhiro Yoshida Satoshi Matsusaka, Atsushi Nashimoto, Kazuhiro Nishikawa, Akira Miki, Hiroto Miwa, Kazuya Yamaguchi, Takaki Yoshikawa, Atsushi Ochiai, Satoshi Morita, Takeshi Sano, Yasuhiro Kodera, Yoshihiro Kakeji, Junichi Sakamoto, Shigetoyo Saji, Kazuhiro Yoshida Satoshi Matsusaka, Atsushi Nashimoto, Kazuhiro Nishikawa, Akira Miki, Hiroto Miwa, Kazuya Yamaguchi, Takaki Yoshikawa, Atsushi Ochiai, Satoshi Morita, Takeshi Sano, Yasuhiro Kodera, Yoshihiro Kakeji, Junichi Sakamoto, Shigetoyo Saji, Kazuhiro Yoshida Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) GASTRIC CANCER, 19, 3, 839-851 GASTRIC CANCER, 19, 3, 839-851 GASTRIC CANCER, 19, 3, 839-851 2016/07 英語 研究論文(学術雑誌) 公開
Takaki Yoshikawa, Satoshi Morita, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Kazumasa Fujitani, Yutaka Kimura, Junya Fujita, Toru Aoyama, Tsutomu Hayashi, Haruhiko Cho, Akira Tsuburaya, Yumi Miyashita, Junichi Sakamoto Takaki Yoshikawa, Satoshi Morita, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Kazumasa Fujitani, Yutaka Kimura, Junya Fujita, Toru Aoyama, Tsutomu Hayashi, Haruhiko Cho, Akira Tsuburaya, Yumi Miyashita, Junichi Sakamoto Takaki Yoshikawa, Satoshi Morita, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Kazumasa Fujitani, Yutaka Kimura, Junya Fujita, Toru Aoyama, Tsutomu Hayashi, Haruhiko Cho, Akira Tsuburaya, Yumi Miyashita, Junichi Sakamoto Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer EUROPEAN JOURNAL OF CANCER, 62, 103-111 EUROPEAN JOURNAL OF CANCER, 62, 103-111 EUROPEAN JOURNAL OF CANCER, 62, 103-111 2016/07 英語 研究論文(学術雑誌) 公開
Masashi Takano, Kaichiro Yamamoto, Tsutomu Tabata, Yuji Minegishi, Takuma Yokoyama, Eiji Hirata, Takeshi Ikeda, Muneaki Shimada, Kouzo Yamada, Satoshi Morita, Yuichi Ando, Koji Hirata, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Masashi Takano, Kaichiro Yamamoto, Tsutomu Tabata, Yuji Minegishi, Takuma Yokoyama, Eiji Hirata, Takeshi Ikeda, Muneaki Shimada, Kouzo Yamada, Satoshi Morita, Yuichi Ando, Koji Hirata, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Masashi Takano, Kaichiro Yamamoto, Tsutomu Tabata, Yuji Minegishi, Takuma Yokoyama, Eiji Hirata, Takeshi Ikeda, Muneaki Shimada, Kouzo Yamada, Satoshi Morita, Yuichi Ando, Koji Hirata, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum Asia-Pacific Journal of Clinical Oncology, 12, 2, 115-124 Asia-Pacific Journal of Clinical Oncology, 12, 2, 115-124 Asia-Pacific Journal of Clinical Oncology, 12, 2, 115-124 2016/06/01 英語 研究論文(学術雑誌) 公開
Koki Nakanishi, Daisuke Kobayashi, Yoshinari Mochizuki, Kiyoshi Ishigure, Seiji Ito, Hiroshi Kojima, Akiharu Ishiyama, Shinichi Fujitake, Toshio Shikano, Satoshi Morita, Yasuhiro Kodera Koki Nakanishi, Daisuke Kobayashi, Yoshinari Mochizuki, Kiyoshi Ishigure, Seiji Ito, Hiroshi Kojima, Akiharu Ishiyama, Shinichi Fujitake, Toshio Shikano, Satoshi Morita, Yasuhiro Kodera Koki Nakanishi, Daisuke Kobayashi, Yoshinari Mochizuki, Kiyoshi Ishigure, Seiji Ito, Hiroshi Kojima, Akiharu Ishiyama, Shinichi Fujitake, Toshio Shikano, Satoshi Morita, Yasuhiro Kodera Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701) Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701) Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701) INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21, 3, 557-565 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21, 3, 557-565 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21, 3, 557-565 2016/06 英語 研究論文(学術雑誌) 公開
Kunihiro Matsuzaki, Yuka Ito, Mamoru Fukuda, Kentaro Sakamaki, Masahiko Ando, Yasuyuki Kojima, Naoki Furuya, Takashi Tsuda, Hiroko Minatogawa, Yasushi Ichikawa, Ichiro Ohta, Saori Takei, Yutaka Tokuda, Kazutaka Narui, Ayako Tsuboya, Takashi Suda, Satoshi Morita, Takeharu Yamanaka, Narikazu Boku, Takako Eguchi Nakajima Kunihiro Matsuzaki, Yuka Ito, Mamoru Fukuda, Kentaro Sakamaki, Masahiko Ando, Yasuyuki Kojima, Naoki Furuya, Takashi Tsuda, Hiroko Minatogawa, Yasushi Ichikawa, Ichiro Ohta, Saori Takei, Yutaka Tokuda, Kazutaka Narui, Ayako Tsuboya, Takashi Suda, Satoshi Morita, Takeharu Yamanaka, Narikazu Boku, Takako Eguchi Nakajima Kunihiro Matsuzaki, Yuka Ito, Mamoru Fukuda, Kentaro Sakamaki, Masahiko Ando, Yasuyuki Kojima, Naoki Furuya, Takashi Tsuda, Hiroko Minatogawa, Yasushi Ichikawa, Ichiro Ohta, Saori Takei, Yutaka Tokuda, Kazutaka Narui, Ayako Tsuboya, Takashi Suda, Satoshi Morita, Takeharu Yamanaka, Narikazu Boku, Takako Eguchi Nakajima Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy. Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy. Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy. JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 公開
Akira Inoue, Kazushi Yoshida, Satoshi Morita, Fumio Imamura, Takashi Seto, Isamu Okamoto, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Satoshi Muto, Masahiro Fukuoka Akira Inoue, Kazushi Yoshida, Satoshi Morita, Fumio Imamura, Takashi Seto, Isamu Okamoto, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Satoshi Muto, Masahiro Fukuoka Akira Inoue, Kazushi Yoshida, Satoshi Morita, Fumio Imamura, Takashi Seto, Isamu Okamoto, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Satoshi Muto, Masahiro Fukuoka Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46, 5, 462-467 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46, 5, 462-467 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46, 5, 462-467 2016/05 英語 研究論文(学術雑誌) 公開
Ken-ichi Okada, Manabu Kawai, Seiko Hirono, Tsutomu Fujii, Yasuhiro Kodera, Masayuki Sho, Yoshiyuki Nakajima, Sohei Satoi, A-Hon Kwon, Yasuhiro Shimizu, Yoshiyasu Ambo, Naru Kondo, Yoshiaki Murakami, Jiro Ohuchida, Hidetoshi Eguchi, Hiroaki Nagano, Mari S Oba, Satoshi Morita, Junichi Sakamoto, Hiroki Yamaue Ken-ichi Okada, Manabu Kawai, Seiko Hirono, Tsutomu Fujii, Yasuhiro Kodera, Masayuki Sho, Yoshiyuki Nakajima, Sohei Satoi, A-Hon Kwon, Yasuhiro Shimizu, Yoshiyasu Ambo, Naru Kondo, Yoshiaki Murakami, Jiro Ohuchida, Hidetoshi Eguchi, Hiroaki Nagano, Mari S Oba, Satoshi Morita, Junichi Sakamoto, Hiroki Yamaue Ken-ichi Okada, Manabu Kawai, Seiko Hirono, Tsutomu Fujii, Yasuhiro Kodera, Masayuki Sho, Yoshiyuki Nakajima, Sohei Satoi, A-Hon Kwon, Yasuhiro Shimizu, Yoshiyasu Ambo, Naru Kondo, Yoshiaki Murakami, Jiro Ohuchida, Hidetoshi Eguchi, Hiroaki Nagano, Mari S Oba, Satoshi Morita, Junichi Sakamoto, Hiroki Yamaue Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial. Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial. Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial. Surgery, 159, 5, 1333-41 Surgery, 159, 5, 1333-41 Surgery, 159, 5, 1333-41 2016/05 英語 公開
Hidetoshi Katsuno, Koutarou Maeda, Masatoshi Ohya, Kazuhiko Yoshioka, Akira Tsunoda, Keiji Koda, Hiroyoshi Matsuoka, Hiroki Ohge, Satoshi Morita, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Hidetoshi Katsuno, Koutarou Maeda, Masatoshi Ohya, Kazuhiko Yoshioka, Akira Tsunoda, Keiji Koda, Hiroyoshi Matsuoka, Hiroki Ohge, Satoshi Morita, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Hidetoshi Katsuno, Koutarou Maeda, Masatoshi Ohya, Kazuhiko Yoshioka, Akira Tsunoda, Keiji Koda, Hiroyoshi Matsuoka, Hiroki Ohge, Satoshi Morita, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study) Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study) Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study) Journal of Gastroenterology, 51, 3, 222-229 Journal of Gastroenterology, 51, 3, 222-229 Journal of Gastroenterology, 51, 3, 222-229 2016/03/01 英語 研究論文(学術雑誌) 公開
Jo Nagakura, Tadashi Yamakawa, Masataka Taguri, Hirohisa Tsuchiya, Erina Shigematsu, Jun Suzuki, Satoshi Morita, Kazuaki Kadonosono, Yasuo Terauchi Jo Nagakura, Tadashi Yamakawa, Masataka Taguri, Hirohisa Tsuchiya, Erina Shigematsu, Jun Suzuki, Satoshi Morita, Kazuaki Kadonosono, Yasuo Terauchi Jo Nagakura, Tadashi Yamakawa, Masataka Taguri, Hirohisa Tsuchiya, Erina Shigematsu, Jun Suzuki, Satoshi Morita, Kazuaki Kadonosono, Yasuo Terauchi Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes ENDOCRINE JOURNAL, 63, 3, 239-247 ENDOCRINE JOURNAL, 63, 3, 239-247 ENDOCRINE JOURNAL, 63, 3, 239-247 2016/03 英語 研究論文(学術雑誌) 公開
Rika Sakai, Masataka Taguri, Kumi Oshima, Takehiko Mori, Hiroatsu Ago, Souichi Adachi, Satoshi Morita, Shuichi Taniguchi, Takahiro Fukuda, Kazuteru Ohashi, Tetsuya Eto, Koichi Miyamura, Koji Iwato, Naoki Kobayashi, Heiwa Kanamori, Yasuo Morishima, Tokiko Nagamura-Inoue, Hisashi Sakamaki, Yoshiko Atsuta, Makoto Murata Rika Sakai, Masataka Taguri, Kumi Oshima, Takehiko Mori, Hiroatsu Ago, Souichi Adachi, Satoshi Morita, Shuichi Taniguchi, Takahiro Fukuda, Kazuteru Ohashi, Tetsuya Eto, Koichi Miyamura, Koji Iwato, Naoki Kobayashi, Heiwa Kanamori, Yasuo Morishima, Tokiko Nagamura-Inoue, Hisashi Sakamaki, Yoshiko Atsuta, Makoto Murata Rika Sakai, Masataka Taguri, Kumi Oshima, Takehiko Mori, Hiroatsu Ago, Souichi Adachi, Satoshi Morita, Shuichi Taniguchi, Takahiro Fukuda, Kazuteru Ohashi, Tetsuya Eto, Koichi Miyamura, Koji Iwato, Naoki Kobayashi, Heiwa Kanamori, Yasuo Morishima, Tokiko Nagamura-Inoue, Hisashi Sakamaki, Yoshiko Atsuta, Makoto Murata A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 3, 322-333 INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 3, 322-333 INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 3, 322-333 2016/03 英語 研究論文(学術雑誌) 公開
R. Sakai, M. Taguri, K. Oshima, T. Mori, H. Ago, S. Adachi, S. Morita, S. Taniguchi, T. Fukuda, K. Ohashi, T. Eto, K. Miyamura, K. Iwato, N. Kobayashi, H. Kanamori, Y. Morishima, T. Nagamura-Inoue, H. Sakamaki, Y. Atsuta, M. Murata R. Sakai, M. Taguri, K. Oshima, T. Mori, H. Ago, S. Adachi, S. Morita, S. Taniguchi, T. Fukuda, K. Ohashi, T. Eto, K. Miyamura, K. Iwato, N. Kobayashi, H. Kanamori, Y. Morishima, T. Nagamura-Inoue, H. Sakamaki, Y. Atsuta, M. Murata R. Sakai, M. Taguri, K. Oshima, T. Mori, H. Ago, S. Adachi, S. Morita, S. Taniguchi, T. Fukuda, K. Ohashi, T. Eto, K. Miyamura, K. Iwato, N. Kobayashi, H. Kanamori, Y. Morishima, T. Nagamura-Inoue, H. Sakamaki, Y. Atsuta, M. Murata A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey Int J Hematol, 103, 3, 322-33 Int J Hematol, 103, 3, 322-33 Int J Hematol, 103, 3, 322-33 2016/03 英語 公開
Naoko Sueoka-Aragane, Nobuyuki Katakami, Miyako Satouchi, Soichiro Yokota, Keisuke Aoe, Kentaro Iwanaga, Kojiro Otsuka, Satoshi Morita, Shinya Kimura, Shunichi Negoro Naoko Sueoka-Aragane, Nobuyuki Katakami, Miyako Satouchi, Soichiro Yokota, Keisuke Aoe, Kentaro Iwanaga, Kojiro Otsuka, Satoshi Morita, Shinya Kimura, Shunichi Negoro Naoko Sueoka-Aragane, Nobuyuki Katakami, Miyako Satouchi, Soichiro Yokota, Keisuke Aoe, Kentaro Iwanaga, Kojiro Otsuka, Satoshi Morita, Shinya Kimura, Shunichi Negoro Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study CANCER SCIENCE, 107, 2, 162-167 CANCER SCIENCE, 107, 2, 162-167 CANCER SCIENCE, 107, 2, 162-167 2016/02 英語 研究論文(学術雑誌) 公開
Enyu Imai, Shoichi Maruyama, Masaomi Nangaku, Hideki Hirakata, Terumasa Hayashi, Ichiei Narita, Hideki Kono, Eiji Nakatani, Satoshi Morita, Yoshiharu Tsubakihara, Tadao Akizawa Enyu Imai, Shoichi Maruyama, Masaomi Nangaku, Hideki Hirakata, Terumasa Hayashi, Ichiei Narita, Hideki Kono, Eiji Nakatani, Satoshi Morita, Yoshiharu Tsubakihara, Tadao Akizawa Enyu Imai, Shoichi Maruyama, Masaomi Nangaku, Hideki Hirakata, Terumasa Hayashi, Ichiei Narita, Hideki Kono, Eiji Nakatani, Satoshi Morita, Yoshiharu Tsubakihara, Tadao Akizawa Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial) Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial) Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial) CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20, 1, 71-76 CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20, 1, 71-76 CLINICAL AND EXPERIMENTAL NEPHROLOGY, 20, 1, 71-76 2016/02 英語 研究論文(学術雑誌) 公開
Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. International journal of clinical oncology, 21, 1, 118-125 International journal of clinical oncology, 21, 1, 118-125 International journal of clinical oncology, 21, 1, 118-125 2016/02 公開
Takashi Ishiguro, Noboru Takayanagi, Tetsu Kanauchi, Ryuji Uozumi, Eriko Kawate, Yotaro Takaku, Naho Kagiyama, Yoshihiko Shimizu, Toshiko Hoshi, Satoshi Morita, Yutaka Sugita Takashi Ishiguro, Noboru Takayanagi, Tetsu Kanauchi, Ryuji Uozumi, Eriko Kawate, Yotaro Takaku, Naho Kagiyama, Yoshihiko Shimizu, Toshiko Hoshi, Satoshi Morita, Yutaka Sugita Takashi Ishiguro, Noboru Takayanagi, Tetsu Kanauchi, Ryuji Uozumi, Eriko Kawate, Yotaro Takaku, Naho Kagiyama, Yoshihiko Shimizu, Toshiko Hoshi, Satoshi Morita, Yutaka Sugita Clinical and Radiographic Comparison of Influenza Virus-associated Pneumonia among Three Viral Subtypes Clinical and Radiographic Comparison of Influenza Virus-associated Pneumonia among Three Viral Subtypes Clinical and Radiographic Comparison of Influenza Virus-associated Pneumonia among Three Viral Subtypes INTERNAL MEDICINE, 55, 7, 731-737 INTERNAL MEDICINE, 55, 7, 731-737 INTERNAL MEDICINE, 55, 7, 731-737 2016 英語 研究論文(学術雑誌) 公開
Takashi Ishiguro, Noboru Takayanagi, Ryuji Uozumi, Mami Tada, Naho Kagiyama, Yotaro Takaku, Yoshihiko Shimizu, Yutaka Sugita, Satoshi Morita Takashi Ishiguro, Noboru Takayanagi, Ryuji Uozumi, Mami Tada, Naho Kagiyama, Yotaro Takaku, Yoshihiko Shimizu, Yutaka Sugita, Satoshi Morita Takashi Ishiguro, Noboru Takayanagi, Ryuji Uozumi, Mami Tada, Naho Kagiyama, Yotaro Takaku, Yoshihiko Shimizu, Yutaka Sugita, Satoshi Morita The Long-term Clinical Course of Chronic Eosinophilic Pneumonia The Long-term Clinical Course of Chronic Eosinophilic Pneumonia The Long-term Clinical Course of Chronic Eosinophilic Pneumonia INTERNAL MEDICINE, 55, 17, 2373-2377 INTERNAL MEDICINE, 55, 17, 2373-2377 INTERNAL MEDICINE, 55, 17, 2373-2377 2016 英語 研究論文(学術雑誌) 公開
Uneno Y, Yokoyama A, Nishikawa Y, Funakoshi T, Ozaki Y, Aoyama I, Baba K, Yamaguchi D, Morita S, Mori Y, Kanai M, Kinoshita H, Inoue T, Sawamoto N, Matsumoto R, Matsumoto S, Muto M Uneno Y, Yokoyama A, Nishikawa Y, Funakoshi T, Ozaki Y, Aoyama I, Baba K, Yamaguchi D, Morita S, Mori Y, Kanai M, Kinoshita H, Inoue T, Sawamoto N, Matsumoto R, Matsumoto S, Muto M Uneno Y, Yokoyama A, Nishikawa Y, Funakoshi T, Ozaki Y, Aoyama I, Baba K, Yamaguchi D, Morita S, Mori Y, Kanai M, Kinoshita H, Inoue T, Sawamoto N, Matsumoto R, Matsumoto S, Muto M Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review. Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review. Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review. Internal medicine (Tokyo, Japan), 55, 18, 2605-2609 Internal medicine (Tokyo, Japan), 55, 18, 2605-2609 Internal medicine (Tokyo, Japan), 55, 18, 2605-2609 2016 公開
Yusuke Takahashi, Hirotoshi Horio, Tai Hato, Masahiko Harada, Noriyuki Matsutani, Satoshi Morita, Masafumi Kawamura Yusuke Takahashi, Hirotoshi Horio, Tai Hato, Masahiko Harada, Noriyuki Matsutani, Satoshi Morita, Masafumi Kawamura Yusuke Takahashi, Hirotoshi Horio, Tai Hato, Masahiko Harada, Noriyuki Matsutani, Satoshi Morita, Masafumi Kawamura Prognostic Significance of Preoperative Neutrophil–Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection Prognostic Significance of Preoperative Neutrophil–Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection Prognostic Significance of Preoperative Neutrophil–Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection Annals of Surgical Oncology, 22, 1324-1331 Annals of Surgical Oncology, 22, 1324-1331 Annals of Surgical Oncology, 22, 1324-1331 2015/12/01 英語 研究論文(学術雑誌) 公開
Taishi Hata, Michitaka Honda, Michiya Kobayashi, Akihiro Toyokawa, Masahiro Tsuda, Yukihiko Tokunaga, Kozo Takase, Masakazu Miyake, Satoshi Morita, Naoki Nagata, Junichi Sakamoto, Masahiko Gosho, Hideyuki Mishima Taishi Hata, Michitaka Honda, Michiya Kobayashi, Akihiro Toyokawa, Masahiro Tsuda, Yukihiko Tokunaga, Kozo Takase, Masakazu Miyake, Satoshi Morita, Naoki Nagata, Junichi Sakamoto, Masahiko Gosho, Hideyuki Mishima Taishi Hata, Michitaka Honda, Michiya Kobayashi, Akihiro Toyokawa, Masahiro Tsuda, Yukihiko Tokunaga, Kozo Takase, Masakazu Miyake, Satoshi Morita, Naoki Nagata, Junichi Sakamoto, Masahiko Gosho, Hideyuki Mishima Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO) Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO) Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO) CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 6, 1209-1215 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 6, 1209-1215 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 6, 1209-1215 2015/12 英語 研究論文(学術雑誌) 公開
Jun Imagawa, Hideo Tanaka, Masaya Okada, Hirohisa Nakamae, Masayuki Hino, Kazunori Murai, Yoji Ishida, Takashi Kumagai, Seiichi Sato, Kazuteru Ohashi, Hisashi Sakamaki, Hisashi Wakita, Nobuhiko Uoshima, Yasunori Nakagawa, Yosuke Minami, Masahiro Ogasawara, Tomoharu Takeoka, Hiroshi Akasaka, Takahiko Utsumi, Naokuni Uike, Tsutomu Sato, Sachiko Ando, Kensuke Usuki, Satoshi Morita, Junichi Sakamoto, Shinya Kimura Jun Imagawa, Hideo Tanaka, Masaya Okada, Hirohisa Nakamae, Masayuki Hino, Kazunori Murai, Yoji Ishida, Takashi Kumagai, Seiichi Sato, Kazuteru Ohashi, Hisashi Sakamaki, Hisashi Wakita, Nobuhiko Uoshima, Yasunori Nakagawa, Yosuke Minami, Masahiro Ogasawara, Tomoharu Takeoka, Hiroshi Akasaka, Takahiko Utsumi, Naokuni Uike, Tsutomu Sato, Sachiko Ando, Kensuke Usuki, Satoshi Morita, Junichi Sakamoto, Shinya Kimura Jun Imagawa, Hideo Tanaka, Masaya Okada, Hirohisa Nakamae, Masayuki Hino, Kazunori Murai, Yoji Ishida, Takashi Kumagai, Seiichi Sato, Kazuteru Ohashi, Hisashi Sakamaki, Hisashi Wakita, Nobuhiko Uoshima, Yasunori Nakagawa, Yosuke Minami, Masahiro Ogasawara, Tomoharu Takeoka, Hiroshi Akasaka, Takahiko Utsumi, Naokuni Uike, Tsutomu Sato, Sachiko Ando, Kensuke Usuki, Satoshi Morita, Junichi Sakamoto, Shinya Kimura Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial LANCET HAEMATOLOGY, 2, 12, E528-E535 LANCET HAEMATOLOGY, 2, 12, E528-E535 LANCET HAEMATOLOGY, 2, 12, E528-E535 2015/12 英語 研究論文(学術雑誌) 公開
Tsutomu Fujii, Suguru Yamada, Kenta Murotani, Yukiyasu Okamura, Kiyoshi Ishigure, Mitsuro Kanda, Shin Takeda, Satoshi Morita, Akimasa Nakao, Yasuhiro Kodera Tsutomu Fujii, Suguru Yamada, Kenta Murotani, Yukiyasu Okamura, Kiyoshi Ishigure, Mitsuro Kanda, Shin Takeda, Satoshi Morita, Akimasa Nakao, Yasuhiro Kodera Tsutomu Fujii, Suguru Yamada, Kenta Murotani, Yukiyasu Okamura, Kiyoshi Ishigure, Mitsuro Kanda, Shin Takeda, Satoshi Morita, Akimasa Nakao, Yasuhiro Kodera Oral Food Intake Versus Fasting on Postoperative Pancreatic Fistula After Distal Pancreatectomy: A Multi-Institutional Randomized Controlled Trial. Oral Food Intake Versus Fasting on Postoperative Pancreatic Fistula After Distal Pancreatectomy: A Multi-Institutional Randomized Controlled Trial. Oral Food Intake Versus Fasting on Postoperative Pancreatic Fistula After Distal Pancreatectomy: A Multi-Institutional Randomized Controlled Trial. Medicine, 94, 52, e2398 Medicine, 94, 52, e2398 Medicine, 94, 52, e2398 2015/12 英語 公開
Sadahiro, Sotaro, Morita, Satoshi, Sasaki, Kazuaki, Sakamoto, Kazuhiro, Ohge, Hiroki, Takahashi, Takao, Tsuchiya, Takashi, Sato, Toshihiko, Kondo, Ken, Ogata, Yutaka, Masuko, Hiroyuki, Baba, Hideo, Maeda, Kiyoshi, Hamada, Madoka, Itabashi, Michio, Nishimu Sadahiro, Sotaro, Morita, Satoshi, Sasaki, Kazuaki, Sakamoto, Kazuhiro, Ohge, Hiroki, Takahashi, Takao, Tsuchiya, Takashi, Sato, Toshihiko, Kondo, Ken, Ogata, Yutaka, Masuko, Hiroyuki, Baba, Hideo, Maeda, Kiyoshi, Hamada, Madoka, Itabashi, Michio, Nishimu Sadahiro, Sotaro, Morita, Satoshi, Sasaki, Kazuaki, Sakamoto, Kazuhiro, Ohge, Hiroki, Takahashi, Takao, Tsuchiya, Takashi, Sato, Toshihiko, Kondo, Ken, Ogata, Yutaka, Masuko, Hiroyuki, Baba, Hideo, Maeda, Kiyoshi, Hamada, Madoka, Itabashi, Michio, Nishimu Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201) Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201) Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201) CLINICAL COLORECTAL CANCER, 14, 4, 277-280 CLINICAL COLORECTAL CANCER, 14, 4, 277-280 CLINICAL COLORECTAL CANCER, 14, 4, 277-280 2015/12 研究論文(学術雑誌) 公開
Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer Journal of Clinical Oncology, 33, 34, 4015-4022 Journal of Clinical Oncology, 33, 34, 4015-4022 Journal of Clinical Oncology, 33, 34, 4015-4022 2015/12 英語 研究論文(学術雑誌) 公開
Tsutomu Fujii, Akimasa Nakao, Kenta Murotani, Yukiyasu Okamura, Kiyoshi Ishigure, Tsuyoshi Hatsuno, Mitsuru Sakai, Suguru Yamada, Mitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Yasuhiro Kodera Tsutomu Fujii, Akimasa Nakao, Kenta Murotani, Yukiyasu Okamura, Kiyoshi Ishigure, Tsuyoshi Hatsuno, Mitsuru Sakai, Suguru Yamada, Mitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Yasuhiro Kodera Tsutomu Fujii, Akimasa Nakao, Kenta Murotani, Yukiyasu Okamura, Kiyoshi Ishigure, Tsuyoshi Hatsuno, Mitsuru Sakai, Suguru Yamada, Mitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Yasuhiro Kodera Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial. Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial. Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial. Annals of surgical oncology, 22, 12, 3905-12 Annals of surgical oncology, 22, 12, 3905-12 Annals of surgical oncology, 22, 12, 3905-12 2015/11 英語 公開
Muto Manabu, Uneno Yu, Nishikawa Yoshitaka, Mori Yukiko, Kanai Masashi, Mastumoto Shigemi, Kato Genta, Kuroda Tomohiro, Morita Satoshi, Okuno Yasushi Muto Manabu, Uneno Yu, Nishikawa Yoshitaka, Mori Yukiko, Kanai Masashi, Mastumoto Shigemi, Kato Genta, Kuroda Tomohiro, Morita Satoshi, Okuno Yasushi Muto Manabu, Uneno Yu, Nishikawa Yoshitaka, Mori Yukiko, Kanai Masashi, Mastumoto Shigemi, Kato Genta, Kuroda Tomohiro, Morita Satoshi, Okuno Yasushi A new approach to collecting biobank and bioinformatics data at Kyoto University Cancer Center A new approach to collecting biobank and bioinformatics data at Kyoto University Cancer Center A new approach to collecting biobank and bioinformatics data at Kyoto University Cancer Center ANNALS OF ONCOLOGY, 26, 90 ANNALS OF ONCOLOGY, 26, 90 ANNALS OF ONCOLOGY, 26, 90 2015/11 公開
Kanai Masashi, Sakuma Tomohiro, Yanagisawa Koji, Koyanagi Tomoyoshi, Matsumoto Shigemi, Kuroda Tomohiro, Morita Satoshi, Kosugi Shinji, Okuno Yasushi Kanai Masashi, Sakuma Tomohiro, Yanagisawa Koji, Koyanagi Tomoyoshi, Matsumoto Shigemi, Kuroda Tomohiro, Morita Satoshi, Kosugi Shinji, Okuno Yasushi Kanai Masashi, Sakuma Tomohiro, Yanagisawa Koji, Koyanagi Tomoyoshi, Matsumoto Shigemi, Kuroda Tomohiro, Morita Satoshi, Kosugi Shinji, Okuno Yasushi Introduction of clinical sequence using a comprehensive cancer gene panel (OncoPrime) to daily clinical practice Introduction of clinical sequence using a comprehensive cancer gene panel (OncoPrime) to daily clinical practice Introduction of clinical sequence using a comprehensive cancer gene panel (OncoPrime) to daily clinical practice ANNALS OF ONCOLOGY, 26, 87 ANNALS OF ONCOLOGY, 26, 87 ANNALS OF ONCOLOGY, 26, 87 2015/11 公開
Taroh Satoh, Kyung Hee Lee, Sun Young Rha, Yasutsuna Sasaki, Se Hoon Park, Yoshito Komatsu, Hirofumi Yasui, Tae-You Kim, Kensei Yamaguchi, Nozomu Fuse, Yasuhide Yamada, Takashi Ura, Si-Young Kim, Masaki Munakata, Soh Saitoh, Kazuto Nishio, Satoshi Morita, Eriko Yamamoto, Qingwei Zhang, Jung-mi Kim, Yeul Hong Kim, Yuh Sakata Taroh Satoh, Kyung Hee Lee, Sun Young Rha, Yasutsuna Sasaki, Se Hoon Park, Yoshito Komatsu, Hirofumi Yasui, Tae-You Kim, Kensei Yamaguchi, Nozomu Fuse, Yasuhide Yamada, Takashi Ura, Si-Young Kim, Masaki Munakata, Soh Saitoh, Kazuto Nishio, Satoshi Morita, Eriko Yamamoto, Qingwei Zhang, Jung-mi Kim, Yeul Hong Kim, Yuh Sakata Taroh Satoh, Kyung Hee Lee, Sun Young Rha, Yasutsuna Sasaki, Se Hoon Park, Yoshito Komatsu, Hirofumi Yasui, Tae-You Kim, Kensei Yamaguchi, Nozomu Fuse, Yasuhide Yamada, Takashi Ura, Si-Young Kim, Masaki Munakata, Soh Saitoh, Kazuto Nishio, Satoshi Morita, Eriko Yamamoto, Qingwei Zhang, Jung-mi Kim, Yeul Hong Kim, Yuh Sakata Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer GASTRIC CANCER, 18, 4, 824-832 GASTRIC CANCER, 18, 4, 824-832 GASTRIC CANCER, 18, 4, 824-832 2015/10 英語 研究論文(学術雑誌) 公開
Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: Results of the D-first study Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: Results of the D-first study Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: Results of the D-first study American Journal of Hematology, 90, 9, 819-824 American Journal of Hematology, 90, 9, 819-824 American Journal of Hematology, 90, 9, 819-824 2015/09/01 英語 研究論文(学術雑誌) 公開
Tomoyoshi Hatayama, Satoshi Morita, Kentaro Sakamaki Tomoyoshi Hatayama, Satoshi Morita, Kentaro Sakamaki Tomoyoshi Hatayama, Satoshi Morita, Kentaro Sakamaki Bayesian response adaptive randomization using longitudinal outcomes Bayesian response adaptive randomization using longitudinal outcomes Bayesian response adaptive randomization using longitudinal outcomes PHARMACEUTICAL STATISTICS, 14, 5, 369-376 PHARMACEUTICAL STATISTICS, 14, 5, 369-376 PHARMACEUTICAL STATISTICS, 14, 5, 369-376 2015/09 英語 研究論文(学術雑誌) 公開
Kazuhiko Yamada, Hiromi Aono, Yukio Hosomi, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Koichi Azuma, Hiroaki Takeoka, Yusuke Okuma, Yoshiro Nakahara, Akira Sato, Mari S. Oba, Satoshi Morita, Hideo Kunitoh, Koshiro Watanabe Kazuhiko Yamada, Hiromi Aono, Yukio Hosomi, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Koichi Azuma, Hiroaki Takeoka, Yusuke Okuma, Yoshiro Nakahara, Akira Sato, Mari S. Oba, Satoshi Morita, Hideo Kunitoh, Koshiro Watanabe Kazuhiko Yamada, Hiromi Aono, Yukio Hosomi, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Koichi Azuma, Hiroaki Takeoka, Yusuke Okuma, Yoshiro Nakahara, Akira Sato, Mari S. Oba, Satoshi Morita, Hideo Kunitoh, Koshiro Watanabe A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911 A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911 A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911 EUROPEAN JOURNAL OF CANCER, 51, 14, 1904-1910 EUROPEAN JOURNAL OF CANCER, 51, 14, 1904-1910 EUROPEAN JOURNAL OF CANCER, 51, 14, 1904-1910 2015/09 英語 研究論文(学術雑誌) 公開
Yoshito Komatsu, Chikashi Ishioka, Ken Shimada, Yasuhide Yamada, Makio Gamoh, Atsushi Sato, Tatsuro Yamaguchi, Satoshi Yuki, Satoshi Morita, Shin Takahashi, Rei Goto, Minoru Kurihara Yoshito Komatsu, Chikashi Ishioka, Ken Shimada, Yasuhide Yamada, Makio Gamoh, Atsushi Sato, Tatsuro Yamaguchi, Satoshi Yuki, Satoshi Morita, Shin Takahashi, Rei Goto, Minoru Kurihara Yoshito Komatsu, Chikashi Ishioka, Ken Shimada, Yasuhide Yamada, Makio Gamoh, Atsushi Sato, Tatsuro Yamaguchi, Satoshi Yuki, Satoshi Morita, Shin Takahashi, Rei Goto, Minoru Kurihara Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer BMC CANCER, 15, 626 BMC CANCER, 15, 626 BMC CANCER, 15, 626 2015/09 英語 研究論文(学術雑誌) 公開
Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 2015/09 英語 研究論文(国際会議プロシーディングス) 公開
Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 2015/09 英語 研究論文(学術雑誌) 公開
Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Gender differences in patients undergoing surgery for acute type A aortic dissection Gender differences in patients undergoing surgery for acute type A aortic dissection Gender differences in patients undergoing surgery for acute type A aortic dissection Journal of Thoracic and Cardiovascular Surgery, 150, 3, 581-587.e1 Journal of Thoracic and Cardiovascular Surgery, 150, 3, 581-587.e1 Journal of Thoracic and Cardiovascular Surgery, 150, 3, 581-587.e1 2015/09/01 英語 研究論文(学術雑誌) 公開
Nishiyama A, Katakami N, Yoshioka H, Iwasaku M, Korogi Y, Hata A, Takeshita J, Otsuka K, Nishino K, Uchida J, Okuyama T, Namba Y, Mori M, Fujita S, Morita S Nishiyama A, Katakami N, Yoshioka H, Iwasaku M, Korogi Y, Hata A, Takeshita J, Otsuka K, Nishino K, Uchida J, Okuyama T, Namba Y, Mori M, Fujita S, Morita S Nishiyama A, Katakami N, Yoshioka H, Iwasaku M, Korogi Y, Hata A, Takeshita J, Otsuka K, Nishino K, Uchida J, Okuyama T, Namba Y, Mori M, Fujita S, Morita S Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer. Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer. Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 89, 3, 301-305 Lung cancer (Amsterdam, Netherlands), 89, 3, 301-305 Lung cancer (Amsterdam, Netherlands), 89, 3, 301-305 2015/09 公開
Kazumi Nishino, Fumio Imamura, Toru Kumagai, Nobuyuki Katakami, Akito Hata, Chiyuki Okuda, Yoshiko Urata, Yosihihiro Hattori, Motoko Tachihara, Souichirou Yokota, Takashi Nishimura, Toshihiko Kaneda, Miyako Satouchi, Satoshi Morita, Shunichi Negoro Kazumi Nishino, Fumio Imamura, Toru Kumagai, Nobuyuki Katakami, Akito Hata, Chiyuki Okuda, Yoshiko Urata, Yosihihiro Hattori, Motoko Tachihara, Souichirou Yokota, Takashi Nishimura, Toshihiko Kaneda, Miyako Satouchi, Satoshi Morita, Shunichi Negoro Kazumi Nishino, Fumio Imamura, Toru Kumagai, Nobuyuki Katakami, Akito Hata, Chiyuki Okuda, Yoshiko Urata, Yosihihiro Hattori, Motoko Tachihara, Souichirou Yokota, Takashi Nishimura, Toshihiko Kaneda, Miyako Satouchi, Satoshi Morita, Shunichi Negoro A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110) A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110) A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110) LUNG CANCER, 89, 2, 146-153 LUNG CANCER, 89, 2, 146-153 LUNG CANCER, 89, 2, 146-153 2015/08 英語 研究論文(学術雑誌) 公開
Kozo Yoshikawa, Mitsuo Shimada, Go Wakabayashi, Koichiro Ishida, Takashi Kaiho, Yuko Kitagawa, Junichi Sakamoto, Norio Shiraishi, Keisuke Koeda, Erito Mochiki, Yoshiro Saikawa, Kazuya Yamaguchi, Masayuki Watanabe, Satoshi Morita, Seigo Kitano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Kozo Yoshikawa, Mitsuo Shimada, Go Wakabayashi, Koichiro Ishida, Takashi Kaiho, Yuko Kitagawa, Junichi Sakamoto, Norio Shiraishi, Keisuke Koeda, Erito Mochiki, Yoshiro Saikawa, Kazuya Yamaguchi, Masayuki Watanabe, Satoshi Morita, Seigo Kitano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Kozo Yoshikawa, Mitsuo Shimada, Go Wakabayashi, Koichiro Ishida, Takashi Kaiho, Yuko Kitagawa, Junichi Sakamoto, Norio Shiraishi, Keisuke Koeda, Erito Mochiki, Yoshiro Saikawa, Kazuya Yamaguchi, Masayuki Watanabe, Satoshi Morita, Seigo Kitano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221, 2, 571-578 JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221, 2, 571-578 JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221, 2, 571-578 2015/08 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Kentaro Sakamaki, Guosheng Yin Satoshi Morita, Kentaro Sakamaki, Guosheng Yin Satoshi Morita, Kentaro Sakamaki, Guosheng Yin Detecting overall survival benefit derived from survival postprogression rather than progression-free survival. Detecting overall survival benefit derived from survival postprogression rather than progression-free survival. Detecting overall survival benefit derived from survival postprogression rather than progression-free survival. Journal of the National Cancer Institute, 107, 8 Journal of the National Cancer Institute, 107, 8 Journal of the National Cancer Institute, 107, 8 2015/08 英語 公開
Tomoyuki Otsuka, Masahde Mori, Yukihiro Yano, Junji Uchida, Kazumi Nishino, Reiko Kaji, Akito Hata, Yoshihiro Hattori, Yoshiko Urata, Toshihiko Kaneda, Motoko Tachihara, Fumio Imamura, Nobuyuki Katakami, Shunichi Negoro, Satoshi Morita, Soichiro Yokota Tomoyuki Otsuka, Masahde Mori, Yukihiro Yano, Junji Uchida, Kazumi Nishino, Reiko Kaji, Akito Hata, Yoshihiro Hattori, Yoshiko Urata, Toshihiko Kaneda, Motoko Tachihara, Fumio Imamura, Nobuyuki Katakami, Shunichi Negoro, Satoshi Morita, Soichiro Yokota Tomoyuki Otsuka, Masahde Mori, Yukihiro Yano, Junji Uchida, Kazumi Nishino, Reiko Kaji, Akito Hata, Yoshihiro Hattori, Yoshiko Urata, Toshihiko Kaneda, Motoko Tachihara, Fumio Imamura, Nobuyuki Katakami, Shunichi Negoro, Satoshi Morita, Soichiro Yokota Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212) Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212) Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212) ANTICANCER RESEARCH, 35, 7, 3885-3891 ANTICANCER RESEARCH, 35, 7, 3885-3891 ANTICANCER RESEARCH, 35, 7, 3885-3891 2015/07 英語 研究論文(学術雑誌) 公開
Chu Matsuda, Yoshinori Munemoto, Hideyuki Mishima, Naoki Nagata, Mitsuru Oshiro, Masato Kataoka, Junichi Sakamoto, Toru Aoyama, Satoshi Morita, Toru Kono Chu Matsuda, Yoshinori Munemoto, Hideyuki Mishima, Naoki Nagata, Mitsuru Oshiro, Masato Kataoka, Junichi Sakamoto, Toru Aoyama, Satoshi Morita, Toru Kono Chu Matsuda, Yoshinori Munemoto, Hideyuki Mishima, Naoki Nagata, Mitsuru Oshiro, Masato Kataoka, Junichi Sakamoto, Toru Aoyama, Satoshi Morita, Toru Kono Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 1, 97-103 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 1, 97-103 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 1, 97-103 2015/07 英語 研究論文(学術雑誌) 公開
H. Fujikawa, K. Sakamaki, T. Kawabe, T. Hayashi, T. Aoyama, T. Sato, T. Oshima, Y. Rino, S. Morita, M. Masuda, T. Ogata, H. Cho, T. Yoshikawa H. Fujikawa, K. Sakamaki, T. Kawabe, T. Hayashi, T. Aoyama, T. Sato, T. Oshima, Y. Rino, S. Morita, M. Masuda, T. Ogata, H. Cho, T. Yoshikawa H. Fujikawa, K. Sakamaki, T. Kawabe, T. Hayashi, T. Aoyama, T. Sato, T. Oshima, Y. Rino, S. Morita, M. Masuda, T. Ogata, H. Cho, T. Yoshikawa A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment ANNALS OF SURGICAL ONCOLOGY, 22, 7, 2317-2322 ANNALS OF SURGICAL ONCOLOGY, 22, 7, 2317-2322 ANNALS OF SURGICAL ONCOLOGY, 22, 7, 2317-2322 2015/07 英語 研究論文(学術雑誌) 公開
Hata A, Katakami N, Fujita S, Nanjo S, Takeshita J, Tanaka K, Kaneda T, Nishiyama A, Nishimura T, Nakagawa A, Otsuka K, Morita S, Urata Y, Negoro S Hata A, Katakami N, Fujita S, Nanjo S, Takeshita J, Tanaka K, Kaneda T, Nishiyama A, Nishimura T, Nakagawa A, Otsuka K, Morita S, Urata Y, Negoro S Hata A, Katakami N, Fujita S, Nanjo S, Takeshita J, Tanaka K, Kaneda T, Nishiyama A, Nishimura T, Nakagawa A, Otsuka K, Morita S, Urata Y, Negoro S A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002). A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002). A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002). Cancer chemotherapy and pharmacology, 75, 6, 1267-1272 Cancer chemotherapy and pharmacology, 75, 6, 1267-1272 Cancer chemotherapy and pharmacology, 75, 6, 1267-1272 2015/06 公開
Hashimoto N, Tsuboi A, Kagawa N, Chiba Y, Izumoto S, Kinoshita M, Kijima N, Oka Y, Morimoto S, Nakajima H, Morita S, Sakamoto J, Nishida S, Hosen N, Oji Y, Arita N, Yoshimine T, Sugiyama H Hashimoto N, Tsuboi A, Kagawa N, Chiba Y, Izumoto S, Kinoshita M, Kijima N, Oka Y, Morimoto S, Nakajima H, Morita S, Sakamoto J, Nishida S, Hosen N, Oji Y, Arita N, Yoshimine T, Sugiyama H Hashimoto N, Tsuboi A, Kagawa N, Chiba Y, Izumoto S, Kinoshita M, Kijima N, Oka Y, Morimoto S, Nakajima H, Morita S, Sakamoto J, Nishida S, Hosen N, Oji Y, Arita N, Yoshimine T, Sugiyama H Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response. Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response. Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response. Cancer immunology, immunotherapy : CII, 64, 6, 707-716 Cancer immunology, immunotherapy : CII, 64, 6, 707-716 Cancer immunology, immunotherapy : CII, 64, 6, 707-716 2015/06 公開
Hamanishi Junzo, Mandai Masaki, Ikeda Takafumi, Minami Manabu, Kawaguchi Atsushi, Matsumura Noriomi, Abiko Kaoru, Baba Tsukasa, Yamaguchi Ken, Ueda Akihiko, Hosoe Yuko, Morita Satoshi, Shimizu Akira, Honjo Tasuku, Konishi Ikuo Hamanishi Junzo, Mandai Masaki, Ikeda Takafumi, Minami Manabu, Kawaguchi Atsushi, Matsumura Noriomi, Abiko Kaoru, Baba Tsukasa, Yamaguchi Ken, Ueda Akihiko, Hosoe Yuko, Morita Satoshi, Shimizu Akira, Honjo Tasuku, Konishi Ikuo Hamanishi Junzo, Mandai Masaki, Ikeda Takafumi, Minami Manabu, Kawaguchi Atsushi, Matsumura Noriomi, Abiko Kaoru, Baba Tsukasa, Yamaguchi Ken, Ueda Akihiko, Hosoe Yuko, Morita Satoshi, Shimizu Akira, Honjo Tasuku, Konishi Ikuo Durable tumor remission in patients with platinum-resistant ovarian cancer receiving nivolumab. Durable tumor remission in patients with platinum-resistant ovarian cancer receiving nivolumab. Durable tumor remission in patients with platinum-resistant ovarian cancer receiving nivolumab. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05/20 公開
Yasuhiro Hamatani, Hisashi Ogawa, Ryuji Uozumi, Moritake Iguchi, Yugo Yamashita, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Satoshi Morita, Masaharu Akao Yasuhiro Hamatani, Hisashi Ogawa, Ryuji Uozumi, Moritake Iguchi, Yugo Yamashita, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Satoshi Morita, Masaharu Akao Yasuhiro Hamatani, Hisashi Ogawa, Ryuji Uozumi, Moritake Iguchi, Yugo Yamashita, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Satoshi Morita, Masaharu Akao Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry CIRCULATION JOURNAL, 79, 5, 1009-1017 CIRCULATION JOURNAL, 79, 5, 1009-1017 CIRCULATION JOURNAL, 79, 5, 1009-1017 2015/05 英語 研究論文(学術雑誌) 公開
Yasuhide Miyoshi, Kazumi Noguchi, Masahiro Yanagisawa, Masataka Taguri, Satoshi Morita, Ichiro Ikeda, Kiyoshi Fujinami, Takeshi Miura, Kazuki Kobayashi, Hiroji Uemura Yasuhide Miyoshi, Kazumi Noguchi, Masahiro Yanagisawa, Masataka Taguri, Satoshi Morita, Ichiro Ikeda, Kiyoshi Fujinami, Takeshi Miura, Kazuki Kobayashi, Hiroji Uemura Yasuhide Miyoshi, Kazumi Noguchi, Masahiro Yanagisawa, Masataka Taguri, Satoshi Morita, Ichiro Ikeda, Kiyoshi Fujinami, Takeshi Miura, Kazuki Kobayashi, Hiroji Uemura Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer BMC CANCER, 15 BMC CANCER, 15 BMC CANCER, 15 2015/05 英語 研究論文(学術雑誌) 公開
Kazuhiro Nishikawa, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Kazuhiro Nishikawa, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Kazuhiro Nishikawa, Kazumasa Fujitani, Hitoshi Inagaki, Yusuke Akamaru, Shinya Tokunaga, Masakazu Takagi, Shigeyuki Tamura, Naotoshi Sugimoto, Tadashi Shigematsu, Takaki Yoshikawa, Tohru Ishiguro, Masato Nakamura, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Toshimasa Tsujinaka Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial EUROPEAN JOURNAL OF CANCER, 51, 7, 808-816 EUROPEAN JOURNAL OF CANCER, 51, 7, 808-816 EUROPEAN JOURNAL OF CANCER, 51, 7, 808-816 2015/05 英語 研究論文(学術雑誌) 公開
Fukuhara T, Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Saijo Y, Hagiwara K, Morita S, Nukiwa T Fukuhara T, Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Saijo Y, Hagiwara K, Morita S, Nukiwa T Fukuhara T, Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Saijo Y, Hagiwara K, Morita S, Nukiwa T Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation. Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation. Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation. Lung cancer (Amsterdam, Netherlands), 88, 2, 181-186 Lung cancer (Amsterdam, Netherlands), 88, 2, 181-186 Lung cancer (Amsterdam, Netherlands), 88, 2, 181-186 2015/05 公開
Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, Kimihiro Kawakami, Naoki Takezako, Takashi Kumagai, Koiti Inokuchi, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group American Journal of Hematology, 90, 4, 282-287 American Journal of Hematology, 90, 4, 282-287 American Journal of Hematology, 90, 4, 282-287 2015/04/01 英語 研究論文(学術雑誌) 公開
Kazunari Misawa, Michitaka Fujiwara, Masahiko Ando, Seiji Ito, Yoshinari Mochizuki, Yuichi Ito, Eiji Onishi, Kiyoshi Ishigure, Yuki Morioka, Tsunenobu Takase, Takuya Watanabe, Yoshitaka Yamamura, Satoshi Morita, Yasuhiro Kodera Kazunari Misawa, Michitaka Fujiwara, Masahiko Ando, Seiji Ito, Yoshinari Mochizuki, Yuichi Ito, Eiji Onishi, Kiyoshi Ishigure, Yuki Morioka, Tsunenobu Takase, Takuya Watanabe, Yoshitaka Yamamura, Satoshi Morita, Yasuhiro Kodera Kazunari Misawa, Michitaka Fujiwara, Masahiko Ando, Seiji Ito, Yoshinari Mochizuki, Yuichi Ito, Eiji Onishi, Kiyoshi Ishigure, Yuki Morioka, Tsunenobu Takase, Takuya Watanabe, Yoshitaka Yamamura, Satoshi Morita, Yasuhiro Kodera Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial GASTRIC CANCER, 18, 2, 417-425 GASTRIC CANCER, 18, 2, 417-425 GASTRIC CANCER, 18, 2, 417-425 2015/04 英語 研究論文(学術雑誌) 公開
Wasaburo Koizumi, Satoshi Morita, Yuh Sakata Wasaburo Koizumi, Satoshi Morita, Yuh Sakata Wasaburo Koizumi, Satoshi Morita, Yuh Sakata A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial) A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial) A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial) JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45, 3, 303-306 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45, 3, 303-306 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45, 3, 303-306 2015/03 英語 研究論文(学術雑誌) 公開
Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Yusuke Okuwaki, Chiaki Okuse, Kotaro Matsunaga, Michihiro Suzuki, Satoshi Morita, Masataka Taguri, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Yusuke Okuwaki, Chiaki Okuse, Kotaro Matsunaga, Michihiro Suzuki, Satoshi Morita, Masataka Taguri, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Yusuke Okuwaki, Chiaki Okuse, Kotaro Matsunaga, Michihiro Suzuki, Satoshi Morita, Masataka Taguri, Katsuaki Tanaka Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis HEPATOLOGY RESEARCH, 45, 3, 279-287 HEPATOLOGY RESEARCH, 45, 3, 279-287 HEPATOLOGY RESEARCH, 45, 3, 279-287 2015/03 英語 研究論文(学術雑誌) 公開
Masatsugu Hamaji, Fengshi Chen, Yukinori Matsuo, Atsushi Kawaguchi, Satoshi Morita, Nami Ueki, Makoto Sonobe, Yasushi Nagata, Masahiro Hiraoka, Hiroshi Date Masatsugu Hamaji, Fengshi Chen, Yukinori Matsuo, Atsushi Kawaguchi, Satoshi Morita, Nami Ueki, Makoto Sonobe, Yasushi Nagata, Masahiro Hiraoka, Hiroshi Date Masatsugu Hamaji, Fengshi Chen, Yukinori Matsuo, Atsushi Kawaguchi, Satoshi Morita, Nami Ueki, Makoto Sonobe, Yasushi Nagata, Masahiro Hiraoka, Hiroshi Date Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer ANNALS OF THORACIC SURGERY, 99, 4, 1122-1129 ANNALS OF THORACIC SURGERY, 99, 4, 1122-1129 ANNALS OF THORACIC SURGERY, 99, 4, 1122-1129 2015/03 英語 研究論文(学術雑誌) 公開
Masaaki Kondo, Manabu Morimoto, Tomohiro Ishii, Akito Nozaki, Hiroyuki Fukuda, Kazushi Numata, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Chiaki Okuse, Michihiro Suzuki, Kentaro Sakamaki, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Masaaki Kondo, Manabu Morimoto, Tomohiro Ishii, Akito Nozaki, Hiroyuki Fukuda, Kazushi Numata, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Chiaki Okuse, Michihiro Suzuki, Kentaro Sakamaki, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Masaaki Kondo, Manabu Morimoto, Tomohiro Ishii, Akito Nozaki, Hiroyuki Fukuda, Kazushi Numata, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Chiaki Okuse, Michihiro Suzuki, Kentaro Sakamaki, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting. Journal of digestive diseases, 16, 3, 143-51 Journal of digestive diseases, 16, 3, 143-51 Journal of digestive diseases, 16, 3, 143-51 2015/03 英語 公開
Eiichi Akiyama, Seigo Sugiyama, Junichi Matsubara, Hirofumi Kurokawa, Masaaki Konishi, Toshimitsu Nozaki, Keisuke Ohba, Kouichirou Fujisue, Hirofumi Maeda, Kenji Sakamoto, Koichi Sugamura, Hitoshi Sumida, Hideaki Jinnouchi, Kentaro Sakamaki, Satoshi Morita, Kazuo Kimura, Satoshi Umemura, Hisao Ogawa Eiichi Akiyama, Seigo Sugiyama, Junichi Matsubara, Hirofumi Kurokawa, Masaaki Konishi, Toshimitsu Nozaki, Keisuke Ohba, Kouichirou Fujisue, Hirofumi Maeda, Kenji Sakamoto, Koichi Sugamura, Hitoshi Sumida, Hideaki Jinnouchi, Kentaro Sakamaki, Satoshi Morita, Kazuo Kimura, Satoshi Umemura, Hisao Ogawa Eiichi Akiyama, Seigo Sugiyama, Junichi Matsubara, Hirofumi Kurokawa, Masaaki Konishi, Toshimitsu Nozaki, Keisuke Ohba, Kouichirou Fujisue, Hirofumi Maeda, Kenji Sakamoto, Koichi Sugamura, Hitoshi Sumida, Hideaki Jinnouchi, Kentaro Sakamaki, Satoshi Morita, Kazuo Kimura, Satoshi Umemura, Hisao Ogawa Decreased plasma levels of active glucagon-like peptide-1 in coronary artery disease. Decreased plasma levels of active glucagon-like peptide-1 in coronary artery disease. Decreased plasma levels of active glucagon-like peptide-1 in coronary artery disease. Journal of the American College of Cardiology, 65, 7, 754-5 Journal of the American College of Cardiology, 65, 7, 754-5 Journal of the American College of Cardiology, 65, 7, 754-5 2015/02/24 英語 公開
Toru Aoyama, Hirohito Fujikawa, Haruhiko Cho, Takashi Ogata, Junya Shirai, Tsutomu Hayashi, Yasushi Rino, Munetaka Masuda, Mari S. Oba, Satoshi Morita, Takaki Yoshikawa Toru Aoyama, Hirohito Fujikawa, Haruhiko Cho, Takashi Ogata, Junya Shirai, Tsutomu Hayashi, Yasushi Rino, Munetaka Masuda, Mari S. Oba, Satoshi Morita, Takaki Yoshikawa Toru Aoyama, Hirohito Fujikawa, Haruhiko Cho, Takashi Ogata, Junya Shirai, Tsutomu Hayashi, Yasushi Rino, Munetaka Masuda, Mari S. Oba, Satoshi Morita, Takaki Yoshikawa A Methylene Blue-assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer A Prospective, Randomized, Controlled Study A Methylene Blue-assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer A Prospective, Randomized, Controlled Study A Methylene Blue-assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer A Prospective, Randomized, Controlled Study AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 39, 2, 266-273 AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 39, 2, 266-273 AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 39, 2, 266-273 2015/02 英語 研究論文(学術雑誌) 公開
Hattori Y, Satouchi M, Shimada T, Urata Y, Yoneda T, Mori M, Nishimura T, Sunadome H, Kumagai T, Imamura F, Fujita S, Kaji R, Hata A, Tachihara M, Morita S, Negoro S Hattori Y, Satouchi M, Shimada T, Urata Y, Yoneda T, Mori M, Nishimura T, Sunadome H, Kumagai T, Imamura F, Fujita S, Kaji R, Hata A, Tachihara M, Morita S, Negoro S Hattori Y, Satouchi M, Shimada T, Urata Y, Yoneda T, Mori M, Nishimura T, Sunadome H, Kumagai T, Imamura F, Fujita S, Kaji R, Hata A, Tachihara M, Morita S, Negoro S A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors Lung cancer (Amsterdam, Netherlands), 87, 2, 136-140 Lung cancer (Amsterdam, Netherlands), 87, 2, 136-140 Lung cancer (Amsterdam, Netherlands), 87, 2, 136-140 2015/02 公開
Masashi Kanai, Etsuro Hatano, Shogo Kobayashi, Yutaka Fujiwara, Shigeru Marubashi, Atsushi Miyamoto, Hisanori Shiomi, Shoji Kubo, Shinichi Ikuta, Hiroaki Yanagimoto, Hiroaki Terajima, Hisashi Ikoma, Daisuke Sakai, Yuzo Kodama, Satoru Seo, Satoshi Morita, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka Masashi Kanai, Etsuro Hatano, Shogo Kobayashi, Yutaka Fujiwara, Shigeru Marubashi, Atsushi Miyamoto, Hisanori Shiomi, Shoji Kubo, Shinichi Ikuta, Hiroaki Yanagimoto, Hiroaki Terajima, Hisashi Ikoma, Daisuke Sakai, Yuzo Kodama, Satoru Seo, Satoshi Morita, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka Masashi Kanai, Etsuro Hatano, Shogo Kobayashi, Yutaka Fujiwara, Shigeru Marubashi, Atsushi Miyamoto, Hisanori Shiomi, Shoji Kubo, Shinichi Ikuta, Hiroaki Yanagimoto, Hiroaki Terajima, Hisashi Ikoma, Daisuke Sakai, Yuzo Kodama, Satoru Seo, Satoshi Morita, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002) A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002) A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002) Cancer Chemotherapy and Pharmacology, 75, 2, 293-300 Cancer Chemotherapy and Pharmacology, 75, 2, 293-300 Cancer Chemotherapy and Pharmacology, 75, 2, 293-300 2015/02 研究論文(学術雑誌) 公開
Yamshiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Ohno S, Kuroi K, Takano T, Takada M, Yasuno S, Morita S, Toi M Yamshiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Ohno S, Kuroi K, Takano T, Takada M, Yasuno S, Morita S, Toi M Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients. Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients. Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients. Int J Clin Oncol, 20, 4, 723-724 Int J Clin Oncol, 20, 4, 723-724 Int J Clin Oncol, 20, 4, 723-724 2015/02 公開
Mitsuo Shimada, Yuji Morine, Hiroaki Nagano, Etsuro Hatano, Takashi Kaiho, Masaru Miyazaki, Toru Kono, Toshiya Kamiyama, Satoshi Morita, Junichi Sakamoto, Mitsuo Kusano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Mitsuo Shimada, Yuji Morine, Hiroaki Nagano, Etsuro Hatano, Takashi Kaiho, Masaru Miyazaki, Toru Kono, Toshiya Kamiyama, Satoshi Morita, Junichi Sakamoto, Mitsuo Kusano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Mitsuo Shimada, Yuji Morine, Hiroaki Nagano, Etsuro Hatano, Takashi Kaiho, Masaru Miyazaki, Toru Kono, Toshiya Kamiyama, Satoshi Morita, Junichi Sakamoto, Mitsuo Kusano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001) Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001) Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001) INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 1, 95-104 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 1, 95-104 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 1, 95-104 2015/02 英語 研究論文(学術雑誌) 公開
Uneno Yu, Kou Tadayuki, Kanai Masashi, Yamamoto Michio, Xue Peng, Mori Yukiko, Kudo Yasushi, Kurita Akira, Uza Norimitsu, Kodama Yuzo, Asada Masanori, Masui Toshihiko, Yazumi Shujiro, Matsumoto Shigemi, Takaori Kyoichi, Morita Satoshi, Muto Manabu, Chiba Tsutomu Uneno Yu, Kou Tadayuki, Kanai Masashi, Yamamoto Michio, Xue Peng, Mori Yukiko, Kudo Yasushi, Kurita Akira, Uza Norimitsu, Kodama Yuzo, Asada Masanori, Masui Toshihiko, Yazumi Shujiro, Matsumoto Shigemi, Takaori Kyoichi, Morita Satoshi, Muto Manabu, Chiba Tsutomu Uneno Yu, Kou Tadayuki, Kanai Masashi, Yamamoto Michio, Xue Peng, Mori Yukiko, Kudo Yasushi, Kurita Akira, Uza Norimitsu, Kodama Yuzo, Asada Masanori, Masui Toshihiko, Yazumi Shujiro, Matsumoto Shigemi, Takaori Kyoichi, Morita Satoshi, Muto Manabu, Chiba Tsutomu Prognostic model for survival in patients with advanced pancreatic cancer receiving palliative chemotherapy. Prognostic model for survival in patients with advanced pancreatic cancer receiving palliative chemotherapy. Prognostic model for survival in patients with advanced pancreatic cancer receiving palliative chemotherapy. JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 2015/01/20 公開
Kentaro Takeda, Satoshi Morita Kentaro Takeda, Satoshi Morita Kentaro Takeda, Satoshi Morita Incorporating Historical Data in Bayesian Phase I Trial Design: The Caucasian-to-Asian Toxicity Tolerability Problem Incorporating Historical Data in Bayesian Phase I Trial Design: The Caucasian-to-Asian Toxicity Tolerability Problem Incorporating Historical Data in Bayesian Phase I Trial Design: The Caucasian-to-Asian Toxicity Tolerability Problem Therapeutic Innovation and Regulatory Science, 49, 1, 93-99 Therapeutic Innovation and Regulatory Science, 49, 1, 93-99 Therapeutic Innovation and Regulatory Science, 49, 1, 93-99 2015/01/17 英語 研究論文(学術雑誌) 公開
Hidetoshi Katsuno, Koutarou Maeda, Takashi Kaiho, Katsuyuki Kunieda, Kimihiko Funahashi, Junichi Sakamoto, Toru Kono, Hirotoshi Hasegawa, Yoshiyuki Furukawa, Yoshihiro Imazu, Satoshi Morita, Masahiko Watanabe Hidetoshi Katsuno, Koutarou Maeda, Takashi Kaiho, Katsuyuki Kunieda, Kimihiko Funahashi, Junichi Sakamoto, Toru Kono, Hirotoshi Hasegawa, Yoshiyuki Furukawa, Yoshihiro Imazu, Satoshi Morita, Masahiko Watanabe Hidetoshi Katsuno, Koutarou Maeda, Takashi Kaiho, Katsuyuki Kunieda, Kimihiko Funahashi, Junichi Sakamoto, Toru Kono, Hirotoshi Hasegawa, Yoshiyuki Furukawa, Yoshihiro Imazu, Satoshi Morita, Masahiko Watanabe Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: A randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902) Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: A randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902) Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: A randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902) Japanese Journal of Clinical Oncology, 45, 7, 650-656 Japanese Journal of Clinical Oncology, 45, 7, 650-656 Japanese Journal of Clinical Oncology, 45, 7, 650-656 2015 英語 研究論文(学術雑誌) 公開
Masazumi Takahashi, Akira Tsuburaya, Kazuhiro Nishikawa, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Takaki Yoshikawa, Yasushi Rino, Junji Kawada, Akihito Tsuji, Koichi Taira, Ryohei Kawabata, Yasuhiro Kodera, Yoshinori Hirashima, Hiroshi Yabusaki, Naoki Hirabayashi, Kazumasa Fujitani, Satoshi Morita, Junichi Sakamoto Masazumi Takahashi, Akira Tsuburaya, Kazuhiro Nishikawa, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Takaki Yoshikawa, Yasushi Rino, Junji Kawada, Akihito Tsuji, Koichi Taira, Ryohei Kawabata, Yasuhiro Kodera, Yoshinori Hirashima, Hiroshi Yabusaki, Naoki Hirabayashi, Kazumasa Fujitani, Satoshi Morita, Junichi Sakamoto Masazumi Takahashi, Akira Tsuburaya, Kazuhiro Nishikawa, Kazuaki Tanabe, Kensei Yamaguchi, Shigefumi Yoshino, Tsutomu Namikawa, Takaki Yoshikawa, Yasushi Rino, Junji Kawada, Akihito Tsuji, Koichi Taira, Ryohei Kawabata, Yasuhiro Kodera, Yoshinori Hirashima, Hiroshi Yabusaki, Naoki Hirabayashi, Kazumasa Fujitani, Satoshi Morita, Junichi Sakamoto A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer who relapsed after S-1 adjuvant therapy, XP after TS-1 adjuvant failure (XParTS) A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer who relapsed after S-1 adjuvant therapy, XP after TS-1 adjuvant failure (XParTS) A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer who relapsed after S-1 adjuvant therapy, XP after TS-1 adjuvant failure (XParTS) JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 2015/01 英語 公開
Masato Nakamura, Yasuhide Yamada, Kei Muro, Keiichi Takahashi, Hideo Baba, Yasutsuna Sasaki, Yoshito Komatsu, Taroh Satoh, Hideyuki Mishima, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Masato Nakamura, Yasuhide Yamada, Kei Muro, Keiichi Takahashi, Hideo Baba, Yasutsuna Sasaki, Yoshito Komatsu, Taroh Satoh, Hideyuki Mishima, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Masato Nakamura, Yasuhide Yamada, Kei Muro, Keiichi Takahashi, Hideo Baba, Yasutsuna Sasaki, Yoshito Komatsu, Taroh Satoh, Hideyuki Mishima, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer FUTURE ONCOLOGY, 11, 10, 1471-1478 FUTURE ONCOLOGY, 11, 10, 1471-1478 FUTURE ONCOLOGY, 11, 10, 1471-1478 2015 英語 研究論文(学術雑誌) 公開
Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Yoshitake Oshima, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Yoshitake Oshima, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Yoshitake Oshima, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial BMJ OPEN, 5, 8, e007316 BMJ OPEN, 5, 8, e007316 BMJ OPEN, 5, 8, e007316 2015 英語 研究論文(学術雑誌) 公開
Hirofumi Yasui, Kei Muro, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hideo Baba, Taroh Satoh, Tadamichi Denda, Kenji Ina, Tomohiro Nishina, Kensei Yamaguchi, Taito Esaki, Shinya Tokunaga, Hiroyuki Kuwano, Narikazu Boku, Yoshito Komatsu, Masahiko Watanabe, Ichinosuke Hyodo, Satoshi Morita, Kenichi Sugihara Hirofumi Yasui, Kei Muro, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hideo Baba, Taroh Satoh, Tadamichi Denda, Kenji Ina, Tomohiro Nishina, Kensei Yamaguchi, Taito Esaki, Shinya Tokunaga, Hiroyuki Kuwano, Narikazu Boku, Yoshito Komatsu, Masahiko Watanabe, Ichinosuke Hyodo, Satoshi Morita, Kenichi Sugihara Hirofumi Yasui, Kei Muro, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hideo Baba, Taroh Satoh, Tadamichi Denda, Kenji Ina, Tomohiro Nishina, Kensei Yamaguchi, Taito Esaki, Shinya Tokunaga, Hiroyuki Kuwano, Narikazu Boku, Yoshito Komatsu, Masahiko Watanabe, Ichinosuke Hyodo, Satoshi Morita, Kenichi Sugihara A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 141, 1, 153-160 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 141, 1, 153-160 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 141, 1, 153-160 2015/01 英語 研究論文(学術雑誌) 公開
Kaido T, Morita S, Tanaka S, Ogawa K, Mori A, Hatano E, Uemoto S Kaido T, Morita S, Tanaka S, Ogawa K, Mori A, Hatano E, Uemoto S Kaido T, Morita S, Tanaka S, Ogawa K, Mori A, Hatano E, Uemoto S Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Disease markers, 2015, 425926 Disease markers, 2015, 425926 Disease markers, 2015, 425926 2015 公開
T. Mihara, K. Uchimoto, S. Morita, T. Goto T. Mihara, K. Uchimoto, S. Morita, T. Goto T. Mihara, K. Uchimoto, S. Morita, T. Goto The efficacy of lidocaine to prevent laryngospasm in children: a systematic review and meta-analysis The efficacy of lidocaine to prevent laryngospasm in children: a systematic review and meta-analysis The efficacy of lidocaine to prevent laryngospasm in children: a systematic review and meta-analysis ANAESTHESIA, 69, 12, 1388-1396 ANAESTHESIA, 69, 12, 1388-1396 ANAESTHESIA, 69, 12, 1388-1396 2014/12 英語 公開
Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, Kentaro Yamazaki, Takashi Ura, Takako Nakajima, Ayumu Goto, Ken Shimada, Norisuke Nakayama, Junichi Sakamoto, Satoshi Morita, Yasuhide Yamada Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, Kentaro Yamazaki, Takashi Ura, Takako Nakajima, Ayumu Goto, Ken Shimada, Norisuke Nakayama, Junichi Sakamoto, Satoshi Morita, Yasuhide Yamada Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, Kentaro Yamazaki, Takashi Ura, Takako Nakajima, Ayumu Goto, Ken Shimada, Norisuke Nakayama, Junichi Sakamoto, Satoshi Morita, Yasuhide Yamada A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study). A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study). A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study). The oncologist, 19, 11, 1131-2 The oncologist, 19, 11, 1131-2 The oncologist, 19, 11, 1131-2 2014/11 英語 研究論文(学術雑誌) 公開
Yukinori Matsuo, Fengshi Chen, Masatsugu Hamaji, Atsushi Kawaguchi, Nami Ueki, Yasushi Nagata, Makoto Sonobe, Satoshi Morita, Hiroshi Date, Masahiro Hiraoka Yukinori Matsuo, Fengshi Chen, Masatsugu Hamaji, Atsushi Kawaguchi, Nami Ueki, Yasushi Nagata, Makoto Sonobe, Satoshi Morita, Hiroshi Date, Masahiro Hiraoka Yukinori Matsuo, Fengshi Chen, Masatsugu Hamaji, Atsushi Kawaguchi, Nami Ueki, Yasushi Nagata, Makoto Sonobe, Satoshi Morita, Hiroshi Date, Masahiro Hiraoka Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis EUROPEAN JOURNAL OF CANCER, 50, 17, 2932-2938 EUROPEAN JOURNAL OF CANCER, 50, 17, 2932-2938 EUROPEAN JOURNAL OF CANCER, 50, 17, 2932-2938 2014/11 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Hideharu Yamamoto, Yasuo Sugitani Satoshi Morita, Hideharu Yamamoto, Yasuo Sugitani Satoshi Morita, Hideharu Yamamoto, Yasuo Sugitani Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation STATISTICS IN MEDICINE, 33, 23, 4008-4016 STATISTICS IN MEDICINE, 33, 23, 4008-4016 STATISTICS IN MEDICINE, 33, 23, 4008-4016 2014/10 英語 研究論文(学術雑誌) 公開
Koido Shigeo, Nishida Sumiyuki, Homma Sadamu, Takeda Yutaka, Komita Hideo, Morita Satoshi, Ito Toshinori, Morimoto Soyoko, Oka Yoshihiro, Yanagisawa Satoru, Toyama Yoichi, Ikegami Masahiro, Nagano Hiroaki, Ohkusa Toshifumi, Tajiri Hisao, Sugiyama Haruo Koido Shigeo, Nishida Sumiyuki, Homma Sadamu, Takeda Yutaka, Komita Hideo, Morita Satoshi, Ito Toshinori, Morimoto Soyoko, Oka Yoshihiro, Yanagisawa Satoru, Toyama Yoichi, Ikegami Masahiro, Nagano Hiroaki, Ohkusa Toshifumi, Tajiri Hisao, Sugiyama Haruo Koido Shigeo, Nishida Sumiyuki, Homma Sadamu, Takeda Yutaka, Komita Hideo, Morita Satoshi, Ito Toshinori, Morimoto Soyoko, Oka Yoshihiro, Yanagisawa Satoru, Toyama Yoichi, Ikegami Masahiro, Nagano Hiroaki, Ohkusa Toshifumi, Tajiri Hisao, Sugiyama Haruo Wilms' tumor gene 1 (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer Wilms' tumor gene 1 (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer Wilms' tumor gene 1 (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10/01 公開
Toshio Ogihara, Takao Saruta, Hiromi Rakugi, Ikuo Saito, Kazuaki Shimamoto, Hiroaki Matsuoka, Kazuyuki Shimada, Sadayoshi Ito, Masatsugu Horiuchi, Tsutomu Imaizumi, Shuichi Takishita, Jitsuo Higaki, Shigehiro Katayama, Genjiroh Kimura, Satoshi Umemura, Nobuyuki Ura, Koichi Hayashi, Masato Odawara, Norio Tanahashi, Toshihiko Ishimitsu, Naoki Kashihara, Satoshi Morita, Satoshi Teramukai Toshio Ogihara, Takao Saruta, Hiromi Rakugi, Ikuo Saito, Kazuaki Shimamoto, Hiroaki Matsuoka, Kazuyuki Shimada, Sadayoshi Ito, Masatsugu Horiuchi, Tsutomu Imaizumi, Shuichi Takishita, Jitsuo Higaki, Shigehiro Katayama, Genjiroh Kimura, Satoshi Umemura, Nobuyuki Ura, Koichi Hayashi, Masato Odawara, Norio Tanahashi, Toshihiko Ishimitsu, Naoki Kashihara, Satoshi Morita, Satoshi Teramukai Toshio Ogihara, Takao Saruta, Hiromi Rakugi, Ikuo Saito, Kazuaki Shimamoto, Hiroaki Matsuoka, Kazuyuki Shimada, Sadayoshi Ito, Masatsugu Horiuchi, Tsutomu Imaizumi, Shuichi Takishita, Jitsuo Higaki, Shigehiro Katayama, Genjiroh Kimura, Satoshi Umemura, Nobuyuki Ura, Koichi Hayashi, Masato Odawara, Norio Tanahashi, Toshihiko Ishimitsu, Naoki Kashihara, Satoshi Morita, Satoshi Teramukai Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial JOURNAL OF HYPERTENSION, 32, 10, 2054-2063 JOURNAL OF HYPERTENSION, 32, 10, 2054-2063 JOURNAL OF HYPERTENSION, 32, 10, 2054-2063 2014/10 英語 研究論文(学術雑誌) 公開
Shogo Kobayashi, Hiroaki Nagano, Daisuke Sakai, Hidetoshi Eguchi, Etsuro Hatano, Masashi Kanai, Satoru Seo, Kojiro Taura, Yutaka Fujiwara, Tetsuo Ajiki, Shigekazu Takemura, Shoji Kubo, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Akihito Tsuji, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Shogo Kobayashi, Hiroaki Nagano, Daisuke Sakai, Hidetoshi Eguchi, Etsuro Hatano, Masashi Kanai, Satoru Seo, Kojiro Taura, Yutaka Fujiwara, Tetsuo Ajiki, Shigekazu Takemura, Shoji Kubo, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Akihito Tsuji, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Shogo Kobayashi, Hiroaki Nagano, Daisuke Sakai, Hidetoshi Eguchi, Etsuro Hatano, Masashi Kanai, Satoru Seo, Kojiro Taura, Yutaka Fujiwara, Tetsuo Ajiki, Shigekazu Takemura, Shoji Kubo, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Akihito Tsuji, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Cancer chemotherapy and pharmacology, 74, 4, 699-709 Cancer chemotherapy and pharmacology, 74, 4, 699-709 Cancer chemotherapy and pharmacology, 74, 4, 699-709 2014/10 英語 公開
Ken Murakami, Masataka Kohno, Masatoshi Kadoya, Hidetake Nagahara, Wataru Fujii, Takahiro Seno, Aihiro Yamamoto, Ryo Oda, Hiroyoshi Fujiwara, Toshikazu Kubo, Satoshi Morita, Hiroshi Nakada, Timothy Hla, Yutaka Kawahito Ken Murakami, Masataka Kohno, Masatoshi Kadoya, Hidetake Nagahara, Wataru Fujii, Takahiro Seno, Aihiro Yamamoto, Ryo Oda, Hiroyoshi Fujiwara, Toshikazu Kubo, Satoshi Morita, Hiroshi Nakada, Timothy Hla, Yutaka Kawahito Ken Murakami, Masataka Kohno, Masatoshi Kadoya, Hidetake Nagahara, Wataru Fujii, Takahiro Seno, Aihiro Yamamoto, Ryo Oda, Hiroyoshi Fujiwara, Toshikazu Kubo, Satoshi Morita, Hiroshi Nakada, Timothy Hla, Yutaka Kawahito Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung Injury Mice Model Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung Injury Mice Model Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung Injury Mice Model PLoS ONE, 9, 9 PLoS ONE, 9, 9 PLoS ONE, 9, 9 2014/09/08 英語 研究論文(学術雑誌) 公開
Mari S. Oba, Shigeru Imoto, Uhi Toh, Noriaki Wada, Masaya Kawada, Masahiro Kitada, Norikazu Masuda, Tetsuya Taguchi, Shigeki Minami, Hiromitsu Jinno, Junichi Sakamoto, Satoshi Morita Mari S. Oba, Shigeru Imoto, Uhi Toh, Noriaki Wada, Masaya Kawada, Masahiro Kitada, Norikazu Masuda, Tetsuya Taguchi, Shigeki Minami, Hiromitsu Jinno, Junichi Sakamoto, Satoshi Morita Mari S. Oba, Shigeru Imoto, Uhi Toh, Noriaki Wada, Masaya Kawada, Masahiro Kitada, Norikazu Masuda, Tetsuya Taguchi, Shigeki Minami, Hiromitsu Jinno, Junichi Sakamoto, Satoshi Morita Observational Study of Axilla Treatment for Breast Cancer Patients with 1-3 Positive Micrometastases or Macrometastases in Sentinel Lymph Nodes Observational Study of Axilla Treatment for Breast Cancer Patients with 1-3 Positive Micrometastases or Macrometastases in Sentinel Lymph Nodes Observational Study of Axilla Treatment for Breast Cancer Patients with 1-3 Positive Micrometastases or Macrometastases in Sentinel Lymph Nodes JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 9, 876-879 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 9, 876-879 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 9, 876-879 2014/09 英語 研究論文(学術雑誌) 公開
Tsutomu Hayashi, Toru Aoyama, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takashi Ogata, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Takaki Yoshikawa Tsutomu Hayashi, Toru Aoyama, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takashi Ogata, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Takaki Yoshikawa Tsutomu Hayashi, Toru Aoyama, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takashi Ogata, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Takaki Yoshikawa Low Creatinine Clearance is a Risk Factor for D2 Gastrectomy after Neoadjuvant Chemotherapy Low Creatinine Clearance is a Risk Factor for D2 Gastrectomy after Neoadjuvant Chemotherapy Low Creatinine Clearance is a Risk Factor for D2 Gastrectomy after Neoadjuvant Chemotherapy ANNALS OF SURGICAL ONCOLOGY, 21, 9, 3015-3022 ANNALS OF SURGICAL ONCOLOGY, 21, 9, 3015-3022 ANNALS OF SURGICAL ONCOLOGY, 21, 9, 3015-3022 2014/09 英語 研究論文(学術雑誌) 公開
Takashi Ogura, Satoshi Morita, Kan Yonemori, Takahiro Nonaka, Tsutomu Urano Takashi Ogura, Satoshi Morita, Kan Yonemori, Takahiro Nonaka, Tsutomu Urano Takashi Ogura, Satoshi Morita, Kan Yonemori, Takahiro Nonaka, Tsutomu Urano Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 48, 5, 644-650 THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 48, 5, 644-650 THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 48, 5, 644-650 2014/09 英語 研究論文(学術雑誌) 公開
H. Fujikawa, T. Yoshikawa, S. Hasegawa, T. Hayashi, T. Aoyama, T. Ogata, H. Cho, T. Oshima, Y. Rino, S. Morita, M. Masuda H. Fujikawa, T. Yoshikawa, S. Hasegawa, T. Hayashi, T. Aoyama, T. Ogata, H. Cho, T. Oshima, Y. Rino, S. Morita, M. Masuda H. Fujikawa, T. Yoshikawa, S. Hasegawa, T. Hayashi, T. Aoyama, T. Ogata, H. Cho, T. Oshima, Y. Rino, S. Morita, M. Masuda Diagnostic Value of Computed Tomography for Staging of Clinical T1 Gastric Cancer Diagnostic Value of Computed Tomography for Staging of Clinical T1 Gastric Cancer Diagnostic Value of Computed Tomography for Staging of Clinical T1 Gastric Cancer ANNALS OF SURGICAL ONCOLOGY, 21, 9, 3002-3007 ANNALS OF SURGICAL ONCOLOGY, 21, 9, 3002-3007 ANNALS OF SURGICAL ONCOLOGY, 21, 9, 3002-3007 2014/09 英語 研究論文(学術雑誌) 公開
Masato Nakamura, Shinsuke Nanto, Atsushi Hirayama, Tadateru Takayama, Masakatsu Nishikawa, Kazuo Kimura, Satoshi Morita, Tadanori Aizawa, Ryuta Asano, Yuji Matsumaru, Chikuma Hamada, Takaaki Isshiki Masato Nakamura, Shinsuke Nanto, Atsushi Hirayama, Tadateru Takayama, Masakatsu Nishikawa, Kazuo Kimura, Satoshi Morita, Tadanori Aizawa, Ryuta Asano, Yuji Matsumaru, Chikuma Hamada, Takaaki Isshiki Masato Nakamura, Shinsuke Nanto, Atsushi Hirayama, Tadateru Takayama, Masakatsu Nishikawa, Kazuo Kimura, Satoshi Morita, Tadanori Aizawa, Ryuta Asano, Yuji Matsumaru, Chikuma Hamada, Takaaki Isshiki Optimal Duration of Dual Antiplatelet Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Japanese Patients with Coronary Artery Disease (OPERA): Study Design and Rationale Optimal Duration of Dual Antiplatelet Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Japanese Patients with Coronary Artery Disease (OPERA): Study Design and Rationale Optimal Duration of Dual Antiplatelet Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Japanese Patients with Coronary Artery Disease (OPERA): Study Design and Rationale CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 84, 3, 368-374 CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 84, 3, 368-374 CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 84, 3, 368-374 2014/09 英語 研究論文(学術雑誌) 公開
Hiroshi Miyamoto, Chikara Kunisaki, Yuichi Otsuka, Masazumi Takahashi, Ryo Takagawa, Koichiro Misuta, Kunio Kameda, Hirochika Makino, Goro Matsuda, Naotaka Yamaguchi, Noriyuki Kamiya, Takashi Murakami, Satoshi Morita, Hirotoshi Akiyama, Itaru Endo Hiroshi Miyamoto, Chikara Kunisaki, Yuichi Otsuka, Masazumi Takahashi, Ryo Takagawa, Koichiro Misuta, Kunio Kameda, Hirochika Makino, Goro Matsuda, Naotaka Yamaguchi, Noriyuki Kamiya, Takashi Murakami, Satoshi Morita, Hirotoshi Akiyama, Itaru Endo Hiroshi Miyamoto, Chikara Kunisaki, Yuichi Otsuka, Masazumi Takahashi, Ryo Takagawa, Koichiro Misuta, Kunio Kameda, Hirochika Makino, Goro Matsuda, Naotaka Yamaguchi, Noriyuki Kamiya, Takashi Murakami, Satoshi Morita, Hirotoshi Akiyama, Itaru Endo Macroscopic Type Is a Prognostic Factor for Recurrence-free Survival After Resection of Gastric GIST Macroscopic Type Is a Prognostic Factor for Recurrence-free Survival After Resection of Gastric GIST Macroscopic Type Is a Prognostic Factor for Recurrence-free Survival After Resection of Gastric GIST ANTICANCER RESEARCH, 34, 8, 4267-4273 ANTICANCER RESEARCH, 34, 8, 4267-4273 ANTICANCER RESEARCH, 34, 8, 4267-4273 2014/08 英語 研究論文(学術雑誌) 公開
Hiroyuki Fukuda, Kazushi Numata, Satoshi Moriya, Yu Shimoyama, Tomohiro Ishii, Akito Nozaki, Masaaki Kondo, Manabu Morimoto, Shin Maeda, Kentaro Sakamaki, Satoshi Morita, Katsuaki Tanaka Hiroyuki Fukuda, Kazushi Numata, Satoshi Moriya, Yu Shimoyama, Tomohiro Ishii, Akito Nozaki, Masaaki Kondo, Manabu Morimoto, Shin Maeda, Kentaro Sakamaki, Satoshi Morita, Katsuaki Tanaka Hiroyuki Fukuda, Kazushi Numata, Satoshi Moriya, Yu Shimoyama, Tomohiro Ishii, Akito Nozaki, Masaaki Kondo, Manabu Morimoto, Shin Maeda, Kentaro Sakamaki, Satoshi Morita, Katsuaki Tanaka Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis. Radiology, 272, 2, 598-604 Radiology, 272, 2, 598-604 Radiology, 272, 2, 598-604 2014/08 英語 公開
N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 2014/08 英語 研究論文(学術雑誌) 公開
Tsutomu Takashima, Takahiro Nakayama, Katsuhide Yoshidome, Hidemi Kawajiri, Shunji Kamigaki, Junji Tsurutani, Takashi Arai, Toshikazu Ito, Yoshihumi Komoike, Takako Doi, Norikazu Masuda, Keisuke Miyauchi, Yasuo Miyoshi, Junichi Sakamoto, Satoshi Morita, Tetsuya Taguchi Tsutomu Takashima, Takahiro Nakayama, Katsuhide Yoshidome, Hidemi Kawajiri, Shunji Kamigaki, Junji Tsurutani, Takashi Arai, Toshikazu Ito, Yoshihumi Komoike, Takako Doi, Norikazu Masuda, Keisuke Miyauchi, Yasuo Miyoshi, Junichi Sakamoto, Satoshi Morita, Tetsuya Taguchi Tsutomu Takashima, Takahiro Nakayama, Katsuhide Yoshidome, Hidemi Kawajiri, Shunji Kamigaki, Junji Tsurutani, Takashi Arai, Toshikazu Ito, Yoshihumi Komoike, Takako Doi, Norikazu Masuda, Keisuke Miyauchi, Yasuo Miyoshi, Junichi Sakamoto, Satoshi Morita, Tetsuya Taguchi Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer ANTICANCER RESEARCH, 34, 7, 3583-3588 ANTICANCER RESEARCH, 34, 7, 3583-3588 ANTICANCER RESEARCH, 34, 7, 3583-3588 2014/07 英語 研究論文(学術雑誌) 公開
Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Nozaki I, Kojima H, Miyashita Y, Oba K, Buyse M, Morita S, Sakamoto J Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Nozaki I, Kojima H, Miyashita Y, Oba K, Buyse M, Morita S, Sakamoto J Akira Tsuburaya, Kazuhiro Yoshida, Michiya Kobayashi, Shigefumi Yoshino, Masazumi Takahashi, Nobuhiro Takiguchi, Kazuaki Tanabe, Naoto Takahashi, Hiroshi Imamura, Naokuni Tatsumoto, Akinori Hara, Kazuhiro Nishikawa, Ryoji Fukushima, Isao Nozaki, Hiroshi Kojima, Yumi Miyashita, Koji Oba, Marc Buyse, Satoshi Morita, Junichi Sakamoto Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. The Lancet. Oncology, 15, 8, 886-93 The Lancet. Oncology, 15, 8, 886-93 The Lancet. Oncology, 15, 8, 886-93 2014/07 英語 公開
Tomohiko Sasaki, Tomohiko Sasaki, Tomohiko Sasaki, Reiko Kunisaki, Hiroto Kinoshita, Hideaki Kimura, Teruaki Kodera, Akinori Nozawa, Akiho Hanzawa, Naomi Shibata, Hiromi Yonezawa, Eiji Miyajima, Satoshi Morita, Shoichi Fujii, Kazushi Numata, Katsuaki Tanaka, Masanori Tanaka, Shin Maeda Tomohiko Sasaki, Tomohiko Sasaki, Tomohiko Sasaki, Reiko Kunisaki, Hiroto Kinoshita, Hideaki Kimura, Teruaki Kodera, Akinori Nozawa, Akiho Hanzawa, Naomi Shibata, Hiromi Yonezawa, Eiji Miyajima, Satoshi Morita, Shoichi Fujii, Kazushi Numata, Katsuaki Tanaka, Masanori Tanaka, Shin Maeda Tomohiko Sasaki, Tomohiko Sasaki, Tomohiko Sasaki, Reiko Kunisaki, Hiroto Kinoshita, Hideaki Kimura, Teruaki Kodera, Akinori Nozawa, Akiho Hanzawa, Naomi Shibata, Hiromi Yonezawa, Eiji Miyajima, Satoshi Morita, Shoichi Fujii, Kazushi Numata, Katsuaki Tanaka, Masanori Tanaka, Shin Maeda Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn's disease Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn's disease Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn's disease BMC Research Notes, 7, 363 BMC Research Notes, 7, 363 BMC Research Notes, 7, 363 2014/06/14 公開
Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 6, 1295-1301 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 6, 1295-1301 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 6, 1295-1301 2014/06 英語 研究論文(学術雑誌) 公開
Toru Aoyama, Takaki Yoshikawa, Hirohito Fujikawa, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Takanobu Yamada, Shinichi Hasegawa, Kazuhito Tsuchida, Norio Yukawa, Takashi Oshima, Mari S. Oba, Satoshi Morita, Yasushi Rino, Munetaka Masuda Toru Aoyama, Takaki Yoshikawa, Hirohito Fujikawa, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Takanobu Yamada, Shinichi Hasegawa, Kazuhito Tsuchida, Norio Yukawa, Takashi Oshima, Mari S. Oba, Satoshi Morita, Yasushi Rino, Munetaka Masuda Toru Aoyama, Takaki Yoshikawa, Hirohito Fujikawa, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Takanobu Yamada, Shinichi Hasegawa, Kazuhito Tsuchida, Norio Yukawa, Takashi Oshima, Mari S. Oba, Satoshi Morita, Yasushi Rino, Munetaka Masuda Prognostic factors in stage IB gastric cancer Prognostic factors in stage IB gastric cancer Prognostic factors in stage IB gastric cancer WORLD JOURNAL OF GASTROENTEROLOGY, 20, 21, 6580-6585 WORLD JOURNAL OF GASTROENTEROLOGY, 20, 21, 6580-6585 WORLD JOURNAL OF GASTROENTEROLOGY, 20, 21, 6580-6585 2014/06 英語 研究論文(学術雑誌) 公開
Cho H, Yoshikawa T, Oba MS, Hirabayashi N, Shirai J, Aoyama T, Hayashi T, Yamada T, Oba K, Morita S, Sakamoto J, Tsuburaya A Cho H, Yoshikawa T, Oba MS, Hirabayashi N, Shirai J, Aoyama T, Hayashi T, Yamada T, Oba K, Morita S, Sakamoto J, Tsuburaya A Haruhiko Cho, Takaki Yoshikawa, Mari S Oba, Naoki Hirabayashi, Junya Shirai, Toru Aoyama, Tsutomu Hayashi, Takanobu Yamada, Koji Oba, Satoshi Morita, Junichi Sakamoto, Akira Tsuburaya Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group. Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group. Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group. Annals of surgical oncology, 21, 6, 2044-50 Annals of surgical oncology, 21, 6, 2044-50 Annals of surgical oncology, 21, 6, 2044-50 2014/06 英語 公開
Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Yutaka Kimura, Shinichi Hasegawa, Toru Aoyama, Tsutomu Hayashi, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Yutaka Kimura, Shinichi Hasegawa, Toru Aoyama, Tsutomu Hayashi, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Yutaka Kimura, Shinichi Hasegawa, Toru Aoyama, Tsutomu Hayashi, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study ANNALS OF SURGICAL ONCOLOGY, 21, 385-389 ANNALS OF SURGICAL ONCOLOGY, 21, 385-389 ANNALS OF SURGICAL ONCOLOGY, 21, 385-389 2014/06 英語 研究論文(学術雑誌) 公開
Kentaro Yamazaki, Michitaka Nagase, Hiroshi Tamagawa, Shinya Ueda, Takao Tamura, Kohei Murata, Takashi Tsuda, Eishi Baba, Masahiro Tsuda, Toshikazu Moriwaki, Taito Esaki, Yasushi Tsuji, Kei Muro, Koichi Taira, Tadamichi Denda, Takahiro Tsushima, Masahiko Ando, Satoshi Morita, Narikazu Boku, Ichinosuke Hyodo Kentaro Yamazaki, Michitaka Nagase, Hiroshi Tamagawa, Shinya Ueda, Takao Tamura, Kohei Murata, Takashi Tsuda, Eishi Baba, Masahiro Tsuda, Toshikazu Moriwaki, Taito Esaki, Yasushi Tsuji, Kei Muro, Koichi Taira, Tadamichi Denda, Takahiro Tsushima, Masahiko Ando, Satoshi Morita, Narikazu Boku, Ichinosuke Hyodo Kentaro Yamazaki, Michitaka Nagase, Hiroshi Tamagawa, Shinya Ueda, Takao Tamura, Kohei Murata, Takashi Tsuda, Eishi Baba, Masahiro Tsuda, Toshikazu Moriwaki, Taito Esaki, Yasushi Tsuji, Kei Muro, Koichi Taira, Tadamichi Denda, Takahiro Tsushima, Masahiko Ando, Satoshi Morita, Narikazu Boku, Ichinosuke Hyodo A randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer: West Japan Oncology Group study 4407G (WJOG4407G). A randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer: West Japan Oncology Group study 4407G (WJOG4407G). A randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer: West Japan Oncology Group study 4407G (WJOG4407G). JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 公開
Takayuki Yoshino, Toshiaki Watanabe, Masaki Mori, Atsushi Ohtsu, Tsunekazu Mizushima, Kentaro Yamazaki, Eiji Sunami, Kunlaki Shirao, Atsushi Sato, Satoshi Morita, Takeharu Yamanaka, Axel Gzothey, Daniel J. Sargent, Junichi Sakamoto, Shigetoyo Saji Takayuki Yoshino, Toshiaki Watanabe, Masaki Mori, Atsushi Ohtsu, Tsunekazu Mizushima, Kentaro Yamazaki, Eiji Sunami, Kunlaki Shirao, Atsushi Sato, Satoshi Morita, Takeharu Yamanaka, Axel Gzothey, Daniel J. Sargent, Junichi Sakamoto, Shigetoyo Saji Takayuki Yoshino, Toshiaki Watanabe, Masaki Mori, Atsushi Ohtsu, Tsunekazu Mizushima, Kentaro Yamazaki, Eiji Sunami, Kunlaki Shirao, Atsushi Sato, Satoshi Morita, Takeharu Yamanaka, Axel Gzothey, Daniel J. Sargent, Junichi Sakamoto, Shigetoyo Saji Two phase III studies comparing 6 months of either mFOLFOX6 or XELOX with 3 months of the same regimen as adjuvant chemotherapy in patients with completely resected stage III colon cancer (ACHIEVE) or high-risk stage II colon cancer (ACHIEVE-2). Two phase III studies comparing 6 months of either mFOLFOX6 or XELOX with 3 months of the same regimen as adjuvant chemotherapy in patients with completely resected stage III colon cancer (ACHIEVE) or high-risk stage II colon cancer (ACHIEVE-2). Two phase III studies comparing 6 months of either mFOLFOX6 or XELOX with 3 months of the same regimen as adjuvant chemotherapy in patients with completely resected stage III colon cancer (ACHIEVE) or high-risk stage II colon cancer (ACHIEVE-2). JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 公開
Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Ken-ichi Fujita, Toshikazu Moriwaki, Masato Nakamura, Takehiro Takahashi, Akihito Tsuji, Katsunori Shinozaki, Satoshi Morita, Yuichi Ando, Yukihiro Okutani, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Ken-ichi Fujita, Toshikazu Moriwaki, Masato Nakamura, Takehiro Takahashi, Akihito Tsuji, Katsunori Shinozaki, Satoshi Morita, Yuichi Ando, Yukihiro Okutani, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Ken-ichi Fujita, Toshikazu Moriwaki, Masato Nakamura, Takehiro Takahashi, Akihito Tsuji, Katsunori Shinozaki, Satoshi Morita, Yuichi Ando, Yukihiro Okutani, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata An internally and externally validated nomogram to predict severe neutropenia in Japanese patients (pts) with advanced colorectal cancer (aCRC) treated with irinotecan (IR1)-based regimens. An internally and externally validated nomogram to predict severe neutropenia in Japanese patients (pts) with advanced colorectal cancer (aCRC) treated with irinotecan (IR1)-based regimens. An internally and externally validated nomogram to predict severe neutropenia in Japanese patients (pts) with advanced colorectal cancer (aCRC) treated with irinotecan (IR1)-based regimens. JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 公開
Kazutaka Narui, Takashi Ishikawa, Kazuhiro Shimada, Kumiko Kida, Daisuke Shimizu, Ikuko Ota, Kounosuke Kiuchi, Mikiko Tanabe, Mari Saito Oba, Satoshi Morita, Sadatoshi Sugae, Takako Doi, Satoshi Hasegawa, Tomoyuki Morita, Ayako Kito, Takashi Chishima, Yasushi Ichikawa, Itaru Endo Kazutaka Narui, Takashi Ishikawa, Kazuhiro Shimada, Kumiko Kida, Daisuke Shimizu, Ikuko Ota, Kounosuke Kiuchi, Mikiko Tanabe, Mari Saito Oba, Satoshi Morita, Sadatoshi Sugae, Takako Doi, Satoshi Hasegawa, Tomoyuki Morita, Ayako Kito, Takashi Chishima, Yasushi Ichikawa, Itaru Endo Kazutaka Narui, Takashi Ishikawa, Kazuhiro Shimada, Kumiko Kida, Daisuke Shimizu, Ikuko Ota, Kounosuke Kiuchi, Mikiko Tanabe, Mari Saito Oba, Satoshi Morita, Sadatoshi Sugae, Takako Doi, Satoshi Hasegawa, Tomoyuki Morita, Ayako Kito, Takashi Chishima, Yasushi Ichikawa, Itaru Endo First-line gemcitabine versus treatment of physician's choice in patients with metastatic and stage IV breast cancer: A prospective cohort study First-line gemcitabine versus treatment of physician's choice in patients with metastatic and stage IV breast cancer: A prospective cohort study First-line gemcitabine versus treatment of physician's choice in patients with metastatic and stage IV breast cancer: A prospective cohort study JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 公開
Shigehira Saji, Masakazu Toi, Takashi Ishikawa, Takanori Ishida, Shoichiro Ohtani, Masahiro Kashiwaba, Yasuaki Sagara, Shigenori E. Nagai, Yoshie Hasegawa, Tomomi Fujisawa, Norikazu Masuda, Koji Matsumoto, Yutaka Yamamoto, Hiroshi Yoshibayashi, Naruto Taira, Satoshi Morita, Shinji Ohno Shigehira Saji, Masakazu Toi, Takashi Ishikawa, Takanori Ishida, Shoichiro Ohtani, Masahiro Kashiwaba, Yasuaki Sagara, Shigenori E. Nagai, Yoshie Hasegawa, Tomomi Fujisawa, Norikazu Masuda, Koji Matsumoto, Yutaka Yamamoto, Hiroshi Yoshibayashi, Naruto Taira, Satoshi Morita, Shinji Ohno Shigehira Saji, Masakazu Toi, Takashi Ishikawa, Takanori Ishida, Shoichiro Ohtani, Masahiro Kashiwaba, Yasuaki Sagara, Shigenori E. Nagai, Yoshie Hasegawa, Tomomi Fujisawa, Norikazu Masuda, Koji Matsumoto, Yutaka Yamamoto, Hiroshi Yoshibayashi, Naruto Taira, Satoshi Morita, Shinji Ohno Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 公開
Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Hirohisa Yoshizawa, Kazuhiko Ito, Akihiko Gemma, Masaru Nishitsuji, Masao Harada, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Minoru Kurihara, Toshihiro Nukiwa Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Hirohisa Yoshizawa, Kazuhiko Ito, Akihiko Gemma, Masaru Nishitsuji, Masao Harada, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Minoru Kurihara, Toshihiro Nukiwa Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Hirohisa Yoshizawa, Kazuhiko Ito, Akihiko Gemma, Masaru Nishitsuji, Masao Harada, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Minoru Kurihara, Toshihiro Nukiwa Randomized phase II study of concurrent gefitinib and chemotherapy versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive EGFR mutations: NEJ005/TCOG0902. Randomized phase II study of concurrent gefitinib and chemotherapy versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive EGFR mutations: NEJ005/TCOG0902. Randomized phase II study of concurrent gefitinib and chemotherapy versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive EGFR mutations: NEJ005/TCOG0902. JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 公開
Toru Aoyama, Kazuhiro Nishikawa, Nobuhiro Takiguchi, Kazuaki Tanabe, Motohiro Imano, Ryoji Fukushima, Junichi Sakamoto, Mari S. Oba, Satoshi Morita, Toru Kono, Akira Tsuburaya Toru Aoyama, Kazuhiro Nishikawa, Nobuhiro Takiguchi, Kazuaki Tanabe, Motohiro Imano, Ryoji Fukushima, Junichi Sakamoto, Mari S. Oba, Satoshi Morita, Toru Kono, Akira Tsuburaya Toru Aoyama, Kazuhiro Nishikawa, Nobuhiro Takiguchi, Kazuaki Tanabe, Motohiro Imano, Ryoji Fukushima, Junichi Sakamoto, Mari S. Oba, Satoshi Morita, Toru Kono, Akira Tsuburaya Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 5, 1047-1054 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 5, 1047-1054 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 5, 1047-1054 2014/05 英語 研究論文(学術雑誌) 公開
M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 2014/05 英語 研究論文(学術雑誌) 公開
Shin'ichi Nagata, Satoshi Morita, Kiyoshi Ichimoto, Keisuke Nishida, Yoshikazu Nakatani, Goichi Kimura, Naoki Kaneda, Reizaburou Kitai, Satoru UeNo, Takako T. Ishii Shin'ichi Nagata, Satoshi Morita, Kiyoshi Ichimoto, Keisuke Nishida, Yoshikazu Nakatani, Goichi Kimura, Naoki Kaneda, Reizaburou Kitai, Satoru UeNo, Takako T. Ishii Shin'ichi Nagata, Satoshi Morita, Kiyoshi Ichimoto, Keisuke Nishida, Yoshikazu Nakatani, Goichi Kimura, Naoki Kaneda, Reizaburou Kitai, Satoru UeNo, Takako T. Ishii The Tandem Etalon Magnetograph of the Solar Magnetic Activity Research Telescope (SMART) at Hida Observatory The Tandem Etalon Magnetograph of the Solar Magnetic Activity Research Telescope (SMART) at Hida Observatory The Tandem Etalon Magnetograph of the Solar Magnetic Activity Research Telescope (SMART) at Hida Observatory PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 66, 2 PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 66, 2 PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 66, 2 2014/04 英語 研究論文(学術雑誌) 公開
Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Miyo Inoue, Yoshiaki Ishigatsubo, Takeshi Kaneko Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Miyo Inoue, Yoshiaki Ishigatsubo, Takeshi Kaneko Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Miyo Inoue, Yoshiaki Ishigatsubo, Takeshi Kaneko Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease RESPIRATORY RESEARCH, 15 RESPIRATORY RESEARCH, 15 RESPIRATORY RESEARCH, 15 2014/04 英語 研究論文(学術雑誌) 公開
Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Hiroshige Yoshioka, Hiroyasu Kaneda, Koji Takeda, Tomonori Hirashima, Yoshihito Kogure, Tatsuo Kimura, Toshiaki Takahashi, Shinji Atagi, Takashi Seto, Toshiyuki Sawa, Masashi Yamamoto, Miyako Satouchi, Motoyasu Okuno, Seisuke Nagase, Koichi Takayama, Keisuke Tomii, Tadashi Maeda, Satoshi Oizumi, Shinji Fujii, Yusaku Akashi, Kazumi Nishino, Noriyuki Ebi, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Hiroshige Yoshioka, Hiroyasu Kaneda, Koji Takeda, Tomonori Hirashima, Yoshihito Kogure, Tatsuo Kimura, Toshiaki Takahashi, Shinji Atagi, Takashi Seto, Toshiyuki Sawa, Masashi Yamamoto, Miyako Satouchi, Motoyasu Okuno, Seisuke Nagase, Koichi Takayama, Keisuke Tomii, Tadashi Maeda, Satoshi Oizumi, Shinji Fujii, Yusaku Akashi, Kazumi Nishino, Noriyuki Ebi, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Hiroshige Yoshioka, Hiroyasu Kaneda, Koji Takeda, Tomonori Hirashima, Yoshihito Kogure, Tatsuo Kimura, Toshiaki Takahashi, Shinji Atagi, Takashi Seto, Toshiyuki Sawa, Masashi Yamamoto, Miyako Satouchi, Motoyasu Okuno, Seisuke Nagase, Koichi Takayama, Keisuke Tomii, Tadashi Maeda, Satoshi Oizumi, Shinji Fujii, Yusaku Akashi, Kazumi Nishino, Noriyuki Ebi, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study ONCOTARGET, 5, 8, 2293-2304 ONCOTARGET, 5, 8, 2293-2304 ONCOTARGET, 5, 8, 2293-2304 2014/04 英語 研究論文(学術雑誌) 公開
Nobuyuki Horita, Makiko Yomota, Masahiro Sasaki, Satoshi Morita, Masaharu Shinkai, Yoshiaki Ishigatsubo, Takeshi Kaneko Nobuyuki Horita, Makiko Yomota, Masahiro Sasaki, Satoshi Morita, Masaharu Shinkai, Yoshiaki Ishigatsubo, Takeshi Kaneko Nobuyuki Horita, Makiko Yomota, Masahiro Sasaki, Satoshi Morita, Masaharu Shinkai, Yoshiaki Ishigatsubo, Takeshi Kaneko Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients CLINICAL RESPIRATORY JOURNAL, 8, 2, 213-219 CLINICAL RESPIRATORY JOURNAL, 8, 2, 213-219 CLINICAL RESPIRATORY JOURNAL, 8, 2, 213-219 2014/04 英語 研究論文(学術雑誌) 公開
Jun Watanabe, Kenji Tatsumi, Mitsuyoshi Ota, Yusuke Suwa, Shinsuke Suzuki, Akira Watanabe, Atsushi Ishibe, Kazuteru Watanabe, Hirotoshi Akiyama, Yasushi Ichikawa, Satoshi Morita, Itaru Endo Jun Watanabe, Kenji Tatsumi, Mitsuyoshi Ota, Yusuke Suwa, Shinsuke Suzuki, Akira Watanabe, Atsushi Ishibe, Kazuteru Watanabe, Hirotoshi Akiyama, Yasushi Ichikawa, Satoshi Morita, Itaru Endo Jun Watanabe, Kenji Tatsumi, Mitsuyoshi Ota, Yusuke Suwa, Shinsuke Suzuki, Akira Watanabe, Atsushi Ishibe, Kazuteru Watanabe, Hirotoshi Akiyama, Yasushi Ichikawa, Satoshi Morita, Itaru Endo The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29, 3, 343-351 INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29, 3, 343-351 INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29, 3, 343-351 2014/03 英語 研究論文(学術雑誌) 公開
Toru Aoyama, Takaki Yoshikawa, Satoshi Morita, Junya Shirai, Hirohito Fujikawa, Kenichi Iwasaki, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Norio Yukawa, Takashi Oshima, Yasushi Rino, Munetaka Masuda, Akira Tsuburaya Toru Aoyama, Takaki Yoshikawa, Satoshi Morita, Junya Shirai, Hirohito Fujikawa, Kenichi Iwasaki, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Norio Yukawa, Takashi Oshima, Yasushi Rino, Munetaka Masuda, Akira Tsuburaya Toru Aoyama, Takaki Yoshikawa, Satoshi Morita, Junya Shirai, Hirohito Fujikawa, Kenichi Iwasaki, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Norio Yukawa, Takashi Oshima, Yasushi Rino, Munetaka Masuda, Akira Tsuburaya Methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective randomized phase III study Methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective randomized phase III study Methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective randomized phase III study BMC CANCER, 14, 155 BMC CANCER, 14, 155 BMC CANCER, 14, 155 2014/03 英語 研究論文(学術雑誌) 公開
Masakatsu Numata, Teni Godai, Junya Shirai, Kazuteru Watanabe, Daisuke Inagaki, Shinichi Hasegawa, Tsutomu Sato, Takashi Oshima, Shoichi Fujii, Chikara Kunisaki, Norio Yukawa, Yasushi Rino, Masataka Taguri, Satoshi Morita, Munetaka Masuda Masakatsu Numata, Teni Godai, Junya Shirai, Kazuteru Watanabe, Daisuke Inagaki, Shinichi Hasegawa, Tsutomu Sato, Takashi Oshima, Shoichi Fujii, Chikara Kunisaki, Norio Yukawa, Yasushi Rino, Masataka Taguri, Satoshi Morita, Munetaka Masuda Masakatsu Numata, Teni Godai, Junya Shirai, Kazuteru Watanabe, Daisuke Inagaki, Shinichi Hasegawa, Tsutomu Sato, Takashi Oshima, Shoichi Fujii, Chikara Kunisaki, Norio Yukawa, Yasushi Rino, Masataka Taguri, Satoshi Morita, Munetaka Masuda A prospective randomized controlled trial of subcutaneous passive drainage for the prevention of superficial surgical site infections in open and laparoscopic colorectal surgery A prospective randomized controlled trial of subcutaneous passive drainage for the prevention of superficial surgical site infections in open and laparoscopic colorectal surgery A prospective randomized controlled trial of subcutaneous passive drainage for the prevention of superficial surgical site infections in open and laparoscopic colorectal surgery INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29, 3, 353-358 INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29, 3, 353-358 INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29, 3, 353-358 2014/03 英語 研究論文(学術雑誌) 公開
Shoichi Fujii, Atsushi Ishibe, Mitsuyoshi Ota, Shigeru Yamagishi, Kazuteru Watanabe, Jun Watanabe, Amane Kanazawa, Yasushi Ichikawa, Mari Oba, Satoshi Morita, Yojiro Hashiguchi, Chikara Kunisaki, Itaru Endo Shoichi Fujii, Atsushi Ishibe, Mitsuyoshi Ota, Shigeru Yamagishi, Kazuteru Watanabe, Jun Watanabe, Amane Kanazawa, Yasushi Ichikawa, Mari Oba, Satoshi Morita, Yojiro Hashiguchi, Chikara Kunisaki, Itaru Endo Shoichi Fujii, Atsushi Ishibe, Mitsuyoshi Ota, Shigeru Yamagishi, Kazuteru Watanabe, Jun Watanabe, Amane Kanazawa, Yasushi Ichikawa, Mari Oba, Satoshi Morita, Yojiro Hashiguchi, Chikara Kunisaki, Itaru Endo Short-term results of a randomized study between laparoscopic and open surgery in elderly colorectal cancer patients Short-term results of a randomized study between laparoscopic and open surgery in elderly colorectal cancer patients Short-term results of a randomized study between laparoscopic and open surgery in elderly colorectal cancer patients SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 28, 2, 466-476 SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 28, 2, 466-476 SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 28, 2, 466-476 2014/02 英語 研究論文(学術雑誌) 公開
Sumiyuki Nishida, Shigeo Koido, Yutaka Takeda, Sadamu Homma, Hideo Komita, Akitaka Takahara, Satoshi Morita, Toshinori Ito, Soyoko Morimoto, Kazuma Hara, Akihiro Tsuboi, Yoshihiro Oka, Satoru Yanagisawa, Yoichi Toyama, Masahiro Ikegami, Toru Kitagawa, Hidetoshi Eguchi, Hiroshi Wada, Hiroaki Nagano, Jun Nakata, Yoshiki Nakae, Naoki Hosen, Yusuke Oji, Toshio Tanaka, Ichiro Kawase, Atsushi Kumanogoh, Junichi Sakamoto, Yuichiro Doki, Masaki Mori, Toshifumi Ohkusa, Hisao Tajiri, Haruo Sugiyama Sumiyuki Nishida, Shigeo Koido, Yutaka Takeda, Sadamu Homma, Hideo Komita, Akitaka Takahara, Satoshi Morita, Toshinori Ito, Soyoko Morimoto, Kazuma Hara, Akihiro Tsuboi, Yoshihiro Oka, Satoru Yanagisawa, Yoichi Toyama, Masahiro Ikegami, Toru Kitagawa, Hidetoshi Eguchi, Hiroshi Wada, Hiroaki Nagano, Jun Nakata, Yoshiki Nakae, Naoki Hosen, Yusuke Oji, Toshio Tanaka, Ichiro Kawase, Atsushi Kumanogoh, Junichi Sakamoto, Yuichiro Doki, Masaki Mori, Toshifumi Ohkusa, Hisao Tajiri, Haruo Sugiyama Sumiyuki Nishida, Shigeo Koido, Yutaka Takeda, Sadamu Homma, Hideo Komita, Akitaka Takahara, Satoshi Morita, Toshinori Ito, Soyoko Morimoto, Kazuma Hara, Akihiro Tsuboi, Yoshihiro Oka, Satoru Yanagisawa, Yoichi Toyama, Masahiro Ikegami, Toru Kitagawa, Hidetoshi Eguchi, Hiroshi Wada, Hiroaki Nagano, Jun Nakata, Yoshiki Nakae, Naoki Hosen, Yusuke Oji, Toshio Tanaka, Ichiro Kawase, Atsushi Kumanogoh, Junichi Sakamoto, Yuichiro Doki, Masaki Mori, Toshifumi Ohkusa, Hisao Tajiri, Haruo Sugiyama Wilms Tumor Gene ( WT1) Peptide- based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer Wilms Tumor Gene ( WT1) Peptide- based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer Wilms Tumor Gene ( WT1) Peptide- based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer JOURNAL OF IMMUNOTHERAPY, 37, 2, 105-114 JOURNAL OF IMMUNOTHERAPY, 37, 2, 105-114 JOURNAL OF IMMUNOTHERAPY, 37, 2, 105-114 2014/02 英語 研究論文(学術雑誌) 公開
Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Small, Moderate, and Large Changes, and the Minimum Clinically Important Difference in the University of California, San Diego Shortness of Breath Questionnaire Small, Moderate, and Large Changes, and the Minimum Clinically Important Difference in the University of California, San Diego Shortness of Breath Questionnaire Small, Moderate, and Large Changes, and the Minimum Clinically Important Difference in the University of California, San Diego Shortness of Breath Questionnaire COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 11, 1, 26-32 COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 11, 1, 26-32 COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 11, 1, 26-32 2014/02 英語 研究論文(学術雑誌) 公開
Koji Izumi, Masataka Taguri, Hiroshi Miyamoto, Yoshinori Hara, Takeshi Kishida, Kimio Chiba, Tetsuo Murai, Kotaro Hirai, Kotaro Suzuki, Kiyoshi Fujinami, Teiichiro Ueki, Koichi Udagawa, Kazuo Kitami, Masatoshi Moriyama, Yasuhide Miyoshi, Futoshi Tsuchiya, Ichiro Ikeda, Kazuki Kobayashi, Maho Sato, Satoshi Morita, Kazumi Noguchi, Hiroji Uemura Koji Izumi, Masataka Taguri, Hiroshi Miyamoto, Yoshinori Hara, Takeshi Kishida, Kimio Chiba, Tetsuo Murai, Kotaro Hirai, Kotaro Suzuki, Kiyoshi Fujinami, Teiichiro Ueki, Koichi Udagawa, Kazuo Kitami, Masatoshi Moriyama, Yasuhide Miyoshi, Futoshi Tsuchiya, Ichiro Ikeda, Kazuki Kobayashi, Maho Sato, Satoshi Morita, Kazumi Noguchi, Hiroji Uemura Koji Izumi, Masataka Taguri, Hiroshi Miyamoto, Yoshinori Hara, Takeshi Kishida, Kimio Chiba, Tetsuo Murai, Kotaro Hirai, Kotaro Suzuki, Kiyoshi Fujinami, Teiichiro Ueki, Koichi Udagawa, Kazuo Kitami, Masatoshi Moriyama, Yasuhide Miyoshi, Futoshi Tsuchiya, Ichiro Ikeda, Kazuki Kobayashi, Maho Sato, Satoshi Morita, Kazumi Noguchi, Hiroji Uemura Androgen deprivation therapy prevents bladder cancer recurrence Androgen deprivation therapy prevents bladder cancer recurrence Androgen deprivation therapy prevents bladder cancer recurrence Oncotarget, 5, 24, 12665-12674 Oncotarget, 5, 24, 12665-12674 Oncotarget, 5, 24, 12665-12674 2014 英語 研究論文(学術雑誌) 公開
Jin Oshikawa, Yoshiyuki Toya, Satoshi Morita, Masataka Taguri, Kazushige Hanaoka, Toshio Hasegawa, Kazo Kaizu, Kouju Kamata, Shuzo Kobayashi, Takayasu Ohtake, Takeo Sato, Gen Yasuda, Kenjiro Kimura, Satoshi Umemura Jin Oshikawa, Yoshiyuki Toya, Satoshi Morita, Masataka Taguri, Kazushige Hanaoka, Toshio Hasegawa, Kazo Kaizu, Kouju Kamata, Shuzo Kobayashi, Takayasu Ohtake, Takeo Sato, Gen Yasuda, Kenjiro Kimura, Satoshi Umemura Jin Oshikawa, Yoshiyuki Toya, Satoshi Morita, Masataka Taguri, Kazushige Hanaoka, Toshio Hasegawa, Kazo Kaizu, Kouju Kamata, Shuzo Kobayashi, Takayasu Ohtake, Takeo Sato, Gen Yasuda, Kenjiro Kimura, Satoshi Umemura Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy Clinical and Experimental Hypertension, 36, 4, 244-250 Clinical and Experimental Hypertension, 36, 4, 244-250 Clinical and Experimental Hypertension, 36, 4, 244-250 2014 英語 研究論文(学術雑誌) 公開
N. Yamamoto, H. Yamaguchi, K. Ohmura, T. Yokoyama, H. Yoshifuji, N. Yukawa, D. Kawabata, T. Fujii, S. Morita, S. Nagata, T. Mimori N. Yamamoto, H. Yamaguchi, K. Ohmura, T. Yokoyama, H. Yoshifuji, N. Yukawa, D. Kawabata, T. Fujii, S. Morita, S. Nagata, T. Mimori N. Yamamoto, H. Yamaguchi, K. Ohmura, T. Yokoyama, H. Yoshifuji, N. Yukawa, D. Kawabata, T. Fujii, S. Morita, S. Nagata, T. Mimori Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets Lupus, 23, 4, 386-394 Lupus, 23, 4, 386-394 Lupus, 23, 4, 386-394 2014 英語 研究論文(学術雑誌) 公開
Tomoyuki Kakizume, Satoshi Morita Tomoyuki Kakizume, Satoshi Morita Tomoyuki Kakizume, Satoshi Morita A Continual Reassessment Method With Cohort Size Adaptation Based on Bayesian Posterior Probabilities in Phase I Dose-Finding Studies A Continual Reassessment Method With Cohort Size Adaptation Based on Bayesian Posterior Probabilities in Phase I Dose-Finding Studies A Continual Reassessment Method With Cohort Size Adaptation Based on Bayesian Posterior Probabilities in Phase I Dose-Finding Studies Therapeutic Innovation and Regulatory Science, 48, 2, 213-219 Therapeutic Innovation and Regulatory Science, 48, 2, 213-219 Therapeutic Innovation and Regulatory Science, 48, 2, 213-219 2014 英語 研究論文(学術雑誌) 公開
Masaaki Konishi, Yasushi Matsuzawa, Hiroyuki Suzuki, Eiichi Akiyama, Noriaki Iwahashi, Nobuhiko Maejima, Mitsuaki Endo, Kengo Tsukahara, Kiyoshi Hibi, Masami Kosuge, Toshiaki Ebina, Kentaro Sakamaki, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Masaaki Konishi, Yasushi Matsuzawa, Hiroyuki Suzuki, Eiichi Akiyama, Noriaki Iwahashi, Nobuhiko Maejima, Mitsuaki Endo, Kengo Tsukahara, Kiyoshi Hibi, Masami Kosuge, Toshiaki Ebina, Kentaro Sakamaki, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Masaaki Konishi, Yasushi Matsuzawa, Hiroyuki Suzuki, Eiichi Akiyama, Noriaki Iwahashi, Nobuhiko Maejima, Mitsuaki Endo, Kengo Tsukahara, Kiyoshi Hibi, Masami Kosuge, Toshiaki Ebina, Kentaro Sakamaki, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Higher level at admission and subsequent decline in hemoglobin in patients with acute pulmonary edema. Higher level at admission and subsequent decline in hemoglobin in patients with acute pulmonary edema. Higher level at admission and subsequent decline in hemoglobin in patients with acute pulmonary edema. Circulation journal : official journal of the Japanese Circulation Society, 78, 4, 896-902 Circulation journal : official journal of the Japanese Circulation Society, 78, 4, 896-902 Circulation journal : official journal of the Japanese Circulation Society, 78, 4, 896-902 2014 英語 公開
Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Tatsuya Ioka Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Tatsuya Ioka Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Tatsuya Ioka Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) JOURNAL OF CLINICAL ONCOLOGY, 32, 3, 1-7 JOURNAL OF CLINICAL ONCOLOGY, 32, 3, 1-7 JOURNAL OF CLINICAL ONCOLOGY, 32, 3, 1-7 2014/01 英語 公開
Yoshihiro Hattori, Miyako Satouchi, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Akito Hata, Yoshiko Urata, Temiko Shimada, Junji Uchida, Keisuke Tomii, Satoshi Morita, Shunichi Negoro Yoshihiro Hattori, Miyako Satouchi, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Akito Hata, Yoshiko Urata, Temiko Shimada, Junji Uchida, Keisuke Tomii, Satoshi Morita, Shunichi Negoro Yoshihiro Hattori, Miyako Satouchi, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Akito Hata, Yoshiko Urata, Temiko Shimada, Junji Uchida, Keisuke Tomii, Satoshi Morita, Shunichi Negoro A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001) A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001) A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001) CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 1, 17-23 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 1, 17-23 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 1, 17-23 2014/01 英語 研究論文(学術雑誌) 公開
Kazunari Misawa, Yoshinari Mochizuki, Norifumi Ohashi, Takanori Matsui, Hiroshi Nakayama, Kenji Tsuboi, Mitsuru Sakai, Seiji Ito, Satoshi Morita, Yasuhiro Kodera Kazunari Misawa, Yoshinari Mochizuki, Norifumi Ohashi, Takanori Matsui, Hiroshi Nakayama, Kenji Tsuboi, Mitsuru Sakai, Seiji Ito, Satoshi Morita, Yasuhiro Kodera Kazunari Misawa, Yoshinari Mochizuki, Norifumi Ohashi, Takanori Matsui, Hiroshi Nakayama, Kenji Tsuboi, Mitsuru Sakai, Seiji Ito, Satoshi Morita, Yasuhiro Kodera A Randomized Phase III Trial Exploring the Prognostic Value of Extensive Intraoperative Peritoneal Lavage in Addition to Standard Treatment for Resectable Advanced Gastric Cancer: CCOG 1102 Study A Randomized Phase III Trial Exploring the Prognostic Value of Extensive Intraoperative Peritoneal Lavage in Addition to Standard Treatment for Resectable Advanced Gastric Cancer: CCOG 1102 Study A Randomized Phase III Trial Exploring the Prognostic Value of Extensive Intraoperative Peritoneal Lavage in Addition to Standard Treatment for Resectable Advanced Gastric Cancer: CCOG 1102 Study JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 1, 101-103 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 1, 101-103 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 1, 101-103 2014/01 英語 研究論文(学術雑誌) 公開
Tae Iwasawa, Takashi Ogura, Fumikazu Sakai, Tetsu Kanauchi, Takanobu Komagata, Tomohisa Baba, Toshiyuki Gotoh, Satoshi Morita, Takuya Yazawa, Tomio Inoue Tae Iwasawa, Takashi Ogura, Fumikazu Sakai, Tetsu Kanauchi, Takanobu Komagata, Tomohisa Baba, Toshiyuki Gotoh, Satoshi Morita, Takuya Yazawa, Tomio Inoue Tae Iwasawa, Takashi Ogura, Fumikazu Sakai, Tetsu Kanauchi, Takanobu Komagata, Tomohisa Baba, Toshiyuki Gotoh, Satoshi Morita, Takuya Yazawa, Tomio Inoue CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis EUROPEAN JOURNAL OF RADIOLOGY, 83, 1, 32-38 EUROPEAN JOURNAL OF RADIOLOGY, 83, 1, 32-38 EUROPEAN JOURNAL OF RADIOLOGY, 83, 1, 32-38 2014/01 英語 研究論文(学術雑誌) 公開
Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Yutaka Kimura, Naoki Hirabayashi, Shoki Mikata, Makoto Iwahashi, Ryoji Fukushima, Nobuhiro Takiguchi, Isao Miyashiro, Satoshi Morita, Yumi Miyashita, Aakira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Yutaka Kimura, Naoki Hirabayashi, Shoki Mikata, Makoto Iwahashi, Ryoji Fukushima, Nobuhiro Takiguchi, Isao Miyashiro, Satoshi Morita, Yumi Miyashita, Aakira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Takanori Matsui, Yutaka Kimura, Naoki Hirabayashi, Shoki Mikata, Makoto Iwahashi, Ryoji Fukushima, Nobuhiro Takiguchi, Isao Miyashiro, Satoshi Morita, Yumi Miyashita, Aakira Tsuburaya, Junichi Sakamoto Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial ANNALS OF SURGICAL ONCOLOGY, 21, 1, 213-219 ANNALS OF SURGICAL ONCOLOGY, 21, 1, 213-219 ANNALS OF SURGICAL ONCOLOGY, 21, 1, 213-219 2014/01 英語 研究論文(学術雑誌) 公開
Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui, Tomohiro Nishina, Masahiro Tsuda, Takehiko Tsumura, Naotoshi Sugimoto, Hideki Shimodaira, Shinya Tokunaga, Toshikazu Moriwaki, Taito Esaki, Michitaka Nagase, Kazumasa Fujitani, Kensei Yamaguchi, Takashi Ura, Yasuo Hamamoto, Satoshi Morita, Isamu Okamoto, Narikazu Boku, Ichinosuke Hyodo Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui, Tomohiro Nishina, Masahiro Tsuda, Takehiko Tsumura, Naotoshi Sugimoto, Hideki Shimodaira, Shinya Tokunaga, Toshikazu Moriwaki, Taito Esaki, Michitaka Nagase, Kazumasa Fujitani, Kensei Yamaguchi, Takashi Ura, Yasuo Hamamoto, Satoshi Morita, Isamu Okamoto, Narikazu Boku, Ichinosuke Hyodo Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui, Tomohiro Nishina, Masahiro Tsuda, Takehiko Tsumura, Naotoshi Sugimoto, Hideki Shimodaira, Shinya Tokunaga, Toshikazu Moriwaki, Taito Esaki, Michitaka Nagase, Kazumasa Fujitani, Kensei Yamaguchi, Takashi Ura, Yasuo Hamamoto, Satoshi Morita, Isamu Okamoto, Narikazu Boku, Ichinosuke Hyodo Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial Journal of Clinical Oncology, 31, 35, 4438-4444 Journal of Clinical Oncology, 31, 35, 4438-4444 Journal of Clinical Oncology, 31, 35, 4438-4444 2013/12/10 英語 研究論文(学術雑誌) 公開
Toru Kono, Taishi Hata, Satoshi Morita, Yoshinori Munemoto, Takanori Matsui, Hiroshi Kojima, Hiroyoshi Takemoto, Mutsumi Fukunaga, Naoki Nagata, Mitsuo Shimada, Junichi Sakamoto, Hideyuki Mishima Toru Kono, Taishi Hata, Satoshi Morita, Yoshinori Munemoto, Takanori Matsui, Hiroshi Kojima, Hiroyoshi Takemoto, Mutsumi Fukunaga, Naoki Nagata, Mitsuo Shimada, Junichi Sakamoto, Hideyuki Mishima Toru Kono, Taishi Hata, Satoshi Morita, Yoshinori Munemoto, Takanori Matsui, Hiroshi Kojima, Hiroyoshi Takemoto, Mutsumi Fukunaga, Naoki Nagata, Mitsuo Shimada, Junichi Sakamoto, Hideyuki Mishima Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy CANCER CHEMOTHERAPY AND PHARMACOLOGY, 72, 6, 1283-1290 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 72, 6, 1283-1290 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 72, 6, 1283-1290 2013/12 英語 研究論文(学術雑誌) 公開
Y. Hattori, M. Iwasaku, M. Satouchi, A. Nishiyama, Y. Korogi, K. Otsuka, S. Fujita, N. Katakami, M. Mori, K. Nishino, S. Morita, S. Negoro Y. Hattori, M. Iwasaku, M. Satouchi, A. Nishiyama, Y. Korogi, K. Otsuka, S. Fujita, N. Katakami, M. Mori, K. Nishino, S. Morita, S. Negoro Yoshihiro Hattori, Masahiro Iwasaku, Miyako Satouchi, Akihiro Nishiyama, Yohei Korogi, Kojiro Otsuka, Shiro Fujita, Nobuyuki Katakami, Masahide Mori, Kazumi Nishino, Satoshi Morita, Shunichi Negoro A phase II study of pemetrexed in chemotherapy-naïve elderly patients aged ≥75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003) A phase II study of pemetrexed in chemotherapy-naïve elderly patients aged ≥75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003) A Phase II Study of Pemetrexed in Chemotherapy-nave Elderly Patients Aged 75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003) Japanese Journal of Clinical Oncology, 43, 12, 1184-1189 Japanese Journal of Clinical Oncology, 43, 12, 1184-1189 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43, 12, 1184-1189 2013/12 英語 研究論文(学術雑誌) 公開
Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto, Hideo Baba, Masato Nakamura, Kazuhiro Yoshida, Motoki Yoshida, Shigeyoshi Iwamoto, Ken Shimada, Yoshito Komatsu, Yasutsuna Sasaki, Taroh Satoh, Keiichi Takahashi, Hideyuki Mishima, Kei Muro, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto, Hideo Baba, Masato Nakamura, Kazuhiro Yoshida, Motoki Yoshida, Shigeyoshi Iwamoto, Ken Shimada, Yoshito Komatsu, Yasutsuna Sasaki, Taroh Satoh, Keiichi Takahashi, Hideyuki Mishima, Kei Muro, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto, Hideo Baba, Masato Nakamura, Kazuhiro Yoshida, Motoki Yoshida, Shigeyoshi Iwamoto, Ken Shimada, Yoshito Komatsu, Yasutsuna Sasaki, Taroh Satoh, Keiichi Takahashi, Hideyuki Mishima, Kei Muro, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial LANCET ONCOLOGY, 14, 13, 1278-1286 LANCET ONCOLOGY, 14, 13, 1278-1286 LANCET ONCOLOGY, 14, 13, 1278-1286 2013/12 英語 研究論文(学術雑誌) 公開
Xavier Paoletti, Koji Oba, Yung-Jue Bang, Harry Bleiberg, Narikazu Boku, Olivier Bouché, Paul Catalano, Nozomu Fuse, Stefan Michiels, Markus Moehler, Satoshi Morita, Yasuo Ohashi, Atsushi Ohtsu, Arnaud Roth, Philippe Rougier, Junichi Sakamoto, Daniel Sargent, Mitsuru Sasako, Kohei Shitara, Peter Thuss-Patience, Eric Van Cutsem, Tomasz Burzykowski, Marc Buyse Xavier Paoletti, Koji Oba, Yung-Jue Bang, Harry Bleiberg, Narikazu Boku, Olivier Bouché, Paul Catalano, Nozomu Fuse, Stefan Michiels, Markus Moehler, Satoshi Morita, Yasuo Ohashi, Atsushi Ohtsu, Arnaud Roth, Philippe Rougier, Junichi Sakamoto, Daniel Sargent, Mitsuru Sasako, Kohei Shitara, Peter Thuss-Patience, Eric Van Cutsem, Tomasz Burzykowski, Marc Buyse Xavier Paoletti, Koji Oba, Yung-Jue Bang, Harry Bleiberg, Narikazu Boku, Olivier Bouché, Paul Catalano, Nozomu Fuse, Stefan Michiels, Markus Moehler, Satoshi Morita, Yasuo Ohashi, Atsushi Ohtsu, Arnaud Roth, Philippe Rougier, Junichi Sakamoto, Daniel Sargent, Mitsuru Sasako, Kohei Shitara, Peter Thuss-Patience, Eric Van Cutsem, Tomasz Burzykowski, Marc Buyse Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. Journal of the National Cancer Institute, 105, 21, 1667-70 Journal of the National Cancer Institute, 105, 21, 1667-70 Journal of the National Cancer Institute, 105, 21, 1667-70 2013/11/06 英語 公開
Koji Oba, Xavier Paoletti, Steven Alberts, Yung-Jue Bang, Jacqueline Benedetti, Harry Bleiberg, Paul Catalano, Florian Lordick, Stefan Michiels, Satoshi Morita, Yasuo Ohashi, Jean-Pierre Pignon, Philippe Rougier, Mitsuru Sasako, Junichi Sakamoto, Daniel Sargent, Kohei Shitara, Eric Van Cutsem, Marc Buyse, Tomasz Burzykowski Koji Oba, Xavier Paoletti, Steven Alberts, Yung-Jue Bang, Jacqueline Benedetti, Harry Bleiberg, Paul Catalano, Florian Lordick, Stefan Michiels, Satoshi Morita, Yasuo Ohashi, Jean-Pierre Pignon, Philippe Rougier, Mitsuru Sasako, Junichi Sakamoto, Daniel Sargent, Kohei Shitara, Eric Van Cutsem, Marc Buyse, Tomasz Burzykowski Koji Oba, Xavier Paoletti, Steven Alberts, Yung-Jue Bang, Jacqueline Benedetti, Harry Bleiberg, Paul Catalano, Florian Lordick, Stefan Michiels, Satoshi Morita, Yasuo Ohashi, Jean-Pierre Pignon, Philippe Rougier, Mitsuru Sasako, Junichi Sakamoto, Daniel Sargent, Kohei Shitara, Eric Van Cutsem, Marc Buyse, Tomasz Burzykowski Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. Journal of the National Cancer Institute, 105, 21, 1600-7 Journal of the National Cancer Institute, 105, 21, 1600-7 Journal of the National Cancer Institute, 105, 21, 1600-7 2013/11/06 英語 公開
Yayoi Yamamoto, Youichiro Tasaki, Yukiko Kuwada, Yukihiko Ozawa, Atsushi Katayama, Yoshihide Kanemaki, Katsutoshi Enokido, Seigo Nakamura, Kouichi Kubouchi, Satoshi Morita, Mutsumi Noritake, Yasuo Nakajima, Tomio Inoue Yayoi Yamamoto, Youichiro Tasaki, Yukiko Kuwada, Yukihiko Ozawa, Atsushi Katayama, Yoshihide Kanemaki, Katsutoshi Enokido, Seigo Nakamura, Kouichi Kubouchi, Satoshi Morita, Mutsumi Noritake, Yasuo Nakajima, Tomio Inoue Yayoi Yamamoto, Youichiro Tasaki, Yukiko Kuwada, Yukihiko Ozawa, Atsushi Katayama, Yoshihide Kanemaki, Katsutoshi Enokido, Seigo Nakamura, Kouichi Kubouchi, Satoshi Morita, Mutsumi Noritake, Yasuo Nakajima, Tomio Inoue Positron emission mammography (PEM): reviewing standardized semiquantitative method Positron emission mammography (PEM): reviewing standardized semiquantitative method Positron emission mammography (PEM): reviewing standardized semiquantitative method ANNALS OF NUCLEAR MEDICINE, 27, 9, 795-801 ANNALS OF NUCLEAR MEDICINE, 27, 9, 795-801 ANNALS OF NUCLEAR MEDICINE, 27, 9, 795-801 2013/11 英語 公開
Yukihide Koyama, Tomio Andoh, Yoshinori Kamiya, Satoshi Morita, Tomoyuki Miyazaki, Kazuhiro Uchimoto, Takahiro Mihara, Takahisa Goto Yukihide Koyama, Tomio Andoh, Yoshinori Kamiya, Satoshi Morita, Tomoyuki Miyazaki, Kazuhiro Uchimoto, Takahiro Mihara, Takahisa Goto Yukihide Koyama, Tomio Andoh, Yoshinori Kamiya, Satoshi Morita, Tomoyuki Miyazaki, Kazuhiro Uchimoto, Takahiro Mihara, Takahisa Goto Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits ?-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits ?-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits ?-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats Anesthesiology, 119, 5, 1096-1108 Anesthesiology, 119, 5, 1096-1108 Anesthesiology, 119, 5, 1096-1108 2013/11 英語 研究論文(学術雑誌) 公開
K. Nishino, F. Imamura, S. Morita, M. Mori, K. Komuta, T. Kijima, Y. Namba, T. Kumagai, S. Yamamoto, I. Tachibana, Y. Nakazawa, J. Uchida, S. Minami, R. Takahashi, Y. Yano, T. Okuyama, A. Kumanogoh K. Nishino, F. Imamura, S. Morita, M. Mori, K. Komuta, T. Kijima, Y. Namba, T. Kumagai, S. Yamamoto, I. Tachibana, Y. Nakazawa, J. Uchida, S. Minami, R. Takahashi, Y. Yano, T. Okuyama, A. Kumanogoh K. Nishino, F. Imamura, S. Morita, M. Mori, K. Komuta, T. Kijima, Y. Namba, T. Kumagai, S. Yamamoto, I. Tachibana, Y. Nakazawa, J. Uchida, S. Minami, R. Takahashi, Y. Yano, T. Okuyama, A. Kumanogoh A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment Lung Cancer, 82, 2, 299-304 Lung Cancer, 82, 2, 299-304 Lung Cancer, 82, 2, 299-304 2013/11 英語 研究論文(学術雑誌) 公開
Yasuko Okano, Uru Nezu, Yasuaki Enokida, Ming Ta Michael Lee, Hiroko Kinoshita, Alexander Lezhava, Yoshihide Hayashizaki, Satoshi Morita, Masataka Taguri, Yasushi Ichikawa, Takeshi Kaneko, Yutaka Natsumeda, Tomoyuki Yokose, Haruhiko Nakayama, Yohei Miyagi, Toshihisa Ishikawa Yasuko Okano, Uru Nezu, Yasuaki Enokida, Ming Ta Michael Lee, Hiroko Kinoshita, Alexander Lezhava, Yoshihide Hayashizaki, Satoshi Morita, Masataka Taguri, Yasushi Ichikawa, Takeshi Kaneko, Yutaka Natsumeda, Tomoyuki Yokose, Haruhiko Nakayama, Yohei Miyagi, Toshihisa Ishikawa Yasuko Okano, Uru Nezu, Yasuaki Enokida, Ming Ta Michael Lee, Hiroko Kinoshita, Alexander Lezhava, Yoshihide Hayashizaki, Satoshi Morita, Masataka Taguri, Yasushi Ichikawa, Takeshi Kaneko, Yutaka Natsumeda, Tomoyuki Yokose, Haruhiko Nakayama, Yohei Miyagi, Toshihisa Ishikawa SNP (-617C > A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women SNP (-617C > A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women SNP (-617C > A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women PLOS ONE, 8, 9, e73794 PLOS ONE, 8, 9, e73794 PLOS ONE, 8, 9, e73794 2013/09 英語 研究論文(学術雑誌) 公開
Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Preoperative Chemotherapy Is Effective for Stage III Resectable Non-Small-Cell Lung Cancer: Metaanalysis of 16 Trials Preoperative Chemotherapy Is Effective for Stage III Resectable Non-Small-Cell Lung Cancer: Metaanalysis of 16 Trials Preoperative Chemotherapy Is Effective for Stage III Resectable Non-Small-Cell Lung Cancer: Metaanalysis of 16 Trials CLINICAL LUNG CANCER, 14, 5, 488-494 CLINICAL LUNG CANCER, 14, 5, 488-494 CLINICAL LUNG CANCER, 14, 5, 488-494 2013/09 英語 研究論文(学術雑誌) 公開
Zenko Nagashima, Kengo Tsukahara, Satoshi Morita, Tsutomu Endo, Teruyasu Sugano, Kiyoshi Hibi, Hideo Himeno, Kazuki Fukui, Satoshi Umemura, Kazuo Kimura Zenko Nagashima, Kengo Tsukahara, Satoshi Morita, Tsutomu Endo, Teruyasu Sugano, Kiyoshi Hibi, Hideo Himeno, Kazuki Fukui, Satoshi Umemura, Kazuo Kimura Zenko Nagashima, Kengo Tsukahara, Satoshi Morita, Tsutomu Endo, Teruyasu Sugano, Kiyoshi Hibi, Hideo Himeno, Kazuki Fukui, Satoshi Umemura, Kazuo Kimura Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes JOURNAL OF CARDIOLOGY, 62, 3-4, 158-164 JOURNAL OF CARDIOLOGY, 62, 3-4, 158-164 JOURNAL OF CARDIOLOGY, 62, 3-4, 158-164 2013/09 英語 研究論文(学術雑誌) 公開
Yu Shimoyama, Akito Nozaki, Manabu Morimoto, Satoshi Moriya, Masaaki Kondo, Hiroyuki Fukuda, Kazushi Numata, Eiji Miyajima, Mari S. Oba, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Yu Shimoyama, Akito Nozaki, Manabu Morimoto, Satoshi Moriya, Masaaki Kondo, Hiroyuki Fukuda, Kazushi Numata, Eiji Miyajima, Mari S. Oba, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Yu Shimoyama, Akito Nozaki, Manabu Morimoto, Satoshi Moriya, Masaaki Kondo, Hiroyuki Fukuda, Kazushi Numata, Eiji Miyajima, Mari S. Oba, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C HEPATOLOGY RESEARCH, 43, 9, 919-924 HEPATOLOGY RESEARCH, 43, 9, 919-924 HEPATOLOGY RESEARCH, 43, 9, 919-924 2013/09 英語 研究論文(学術雑誌) 公開
Hisato Kawakami, Isamu Okamoto, Hidetoshi Hayashi, Masataka Taguri, Satoshi Morita, Kazuhiko Nakagawa Hisato Kawakami, Isamu Okamoto, Hidetoshi Hayashi, Masataka Taguri, Satoshi Morita, Kazuhiko Nakagawa Hisato Kawakami, Isamu Okamoto, Hidetoshi Hayashi, Masataka Taguri, Satoshi Morita, Kazuhiko Nakagawa Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer European Journal of Cancer, 49, 14, 3003-3009 European Journal of Cancer, 49, 14, 3003-3009 European Journal of Cancer, 49, 14, 3003-3009 2013/09 英語 研究論文(学術雑誌) 公開
Kiyotaka Imoto, Keiji Uchida, Norihisa Karube, Toru Yasutsune, Tonoki Cho, Kazuo Kimura, Munetaka Masuda, Satoshi Morita Kiyotaka Imoto, Keiji Uchida, Norihisa Karube, Toru Yasutsune, Tonoki Cho, Kazuo Kimura, Munetaka Masuda, Satoshi Morita Kiyotaka Imoto, Keiji Uchida, Norihisa Karube, Toru Yasutsune, Tonoki Cho, Kazuo Kimura, Munetaka Masuda, Satoshi Morita Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 44, 3, 419-424 EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 44, 3, 419-424 EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 44, 3, 419-424 2013/09 英語 研究論文(学術雑誌) 公開
Ryonho Koh, Kingo Hirasawa, Sei Yahara, Hiroyuki Oka, Kazuya Sugimori, Manabu Morimoto, Kazushi Numata, Atsushi Kokawa, Takeshi Sasaki, Akinori Nozawa, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Ryonho Koh, Kingo Hirasawa, Sei Yahara, Hiroyuki Oka, Kazuya Sugimori, Manabu Morimoto, Kazushi Numata, Atsushi Kokawa, Takeshi Sasaki, Akinori Nozawa, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Ryonho Koh, Kingo Hirasawa, Sei Yahara, Hiroyuki Oka, Kazuya Sugimori, Manabu Morimoto, Kazushi Numata, Atsushi Kokawa, Takeshi Sasaki, Akinori Nozawa, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms GASTROINTESTINAL ENDOSCOPY, 78, 3, 476-483 GASTROINTESTINAL ENDOSCOPY, 78, 3, 476-483 GASTROINTESTINAL ENDOSCOPY, 78, 3, 476-483 2013/09 英語 研究論文(学術雑誌) 公開
S. Kako, S. Morita, H. Sakamaki, H. Iida, M. Kurokawa, K. Miyamura, H. Kanamori, M. Hara, N. Kobayashi, Y. Morishima, K. Kawa, T. Kyo, T. Sakura, I. Jinnai, J. Takeuchi, Y. Miyazaki, S. Miyawaki, K. Ohnishi, T. Naoe, Y. Kanda S. Kako, S. Morita, H. Sakamaki, H. Iida, M. Kurokawa, K. Miyamura, H. Kanamori, M. Hara, N. Kobayashi, Y. Morishima, K. Kawa, T. Kyo, T. Sakura, I. Jinnai, J. Takeuchi, Y. Miyazaki, S. Miyawaki, K. Ohnishi, T. Naoe, Y. Kanda S. Kako, S. Morita, H. Sakamaki, H. Iida, M. Kurokawa, K. Miyamura, H. Kanamori, M. Hara, N. Kobayashi, Y. Morishima, K. Kawa, T. Kyo, T. Sakura, I. Jinnai, J. Takeuchi, Y. Miyazaki, S. Miyawaki, K. Ohnishi, T. Naoe, Y. Kanda The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis Bone Marrow Transplantation, 48, 8, 1077-1083 Bone Marrow Transplantation, 48, 8, 1077-1083 Bone Marrow Transplantation, 48, 8, 1077-1083 2013/08 英語 研究論文(学術雑誌) 公開
Takahiro Mihara, Kentaro Tojo, Kazuhiro Uchimoto, Satoshi Morita, Takahisa Goto Takahiro Mihara, Kentaro Tojo, Kazuhiro Uchimoto, Satoshi Morita, Takahisa Goto Takahiro Mihara, Kentaro Tojo, Kazuhiro Uchimoto, Satoshi Morita, Takahisa Goto Reevaluation of the Effectiveness of Ramosetron for Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis Reevaluation of the Effectiveness of Ramosetron for Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis Reevaluation of the Effectiveness of Ramosetron for Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis ANESTHESIA AND ANALGESIA, 117, 2, 329-339 ANESTHESIA AND ANALGESIA, 117, 2, 329-339 ANESTHESIA AND ANALGESIA, 117, 2, 329-339 2013/08 英語 研究論文(学術雑誌) 公開
Fumihiro Asano, Naofumi Shinagawa, Takashi Ishida, Joe Shindoh, Masaki Anzai, Akifumi Tsuzuku, Satoshi Oizumi, Satoshi Morita Fumihiro Asano, Naofumi Shinagawa, Takashi Ishida, Joe Shindoh, Masaki Anzai, Akifumi Tsuzuku, Satoshi Oizumi, Satoshi Morita Fumihiro Asano, Naofumi Shinagawa, Takashi Ishida, Joe Shindoh, Masaki Anzai, Akifumi Tsuzuku, Satoshi Oizumi, Satoshi Morita Virtual Bronchoscopic Navigation Combined with Ultrathin Bronchoscopy A Randomized Clinical Trial Virtual Bronchoscopic Navigation Combined with Ultrathin Bronchoscopy A Randomized Clinical Trial Virtual Bronchoscopic Navigation Combined with Ultrathin Bronchoscopy A Randomized Clinical Trial AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 188, 3, 327-333 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 188, 3, 327-333 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 188, 3, 327-333 2013/08 英語 研究論文(学術雑誌) 公開
Shinichi Hasegawa, Chikara Kunisaki, Hidetaka Ono, Takashi Oshima, Shoichi Fujii, Masataka Taguri, Satoshi Morita, Tsutomu Sato, Roppei Yamada, Norio Yukawa, Yasushi Rino, Munetaka Masuda Shinichi Hasegawa, Chikara Kunisaki, Hidetaka Ono, Takashi Oshima, Shoichi Fujii, Masataka Taguri, Satoshi Morita, Tsutomu Sato, Roppei Yamada, Norio Yukawa, Yasushi Rino, Munetaka Masuda Shinichi Hasegawa, Chikara Kunisaki, Hidetaka Ono, Takashi Oshima, Shoichi Fujii, Masataka Taguri, Satoshi Morita, Tsutomu Sato, Roppei Yamada, Norio Yukawa, Yasushi Rino, Munetaka Masuda Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 16, 3, 383-8 Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 16, 3, 383-8 Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 16, 3, 383-8 2013/07 英語 研究論文(学術雑誌) 公開
Nobuyuki Horita, Takeshi Kaneko, Masaharu Shinkai, Makiko Yomota, Satoshi Morita, Bruce K Rubin, Yoshiaki Ishigatsubo Nobuyuki Horita, Takeshi Kaneko, Masaharu Shinkai, Makiko Yomota, Satoshi Morita, Bruce K Rubin, Yoshiaki Ishigatsubo Nobuyuki Horita, Takeshi Kaneko, Masaharu Shinkai, Makiko Yomota, Satoshi Morita, Bruce K Rubin, Yoshiaki Ishigatsubo Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study. Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study. Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study. Respiratory care, 58, 7, 1196-203 Respiratory care, 58, 7, 1196-203 Respiratory care, 58, 7, 1196-203 2013/07 英語 公開
Yoshida Kazuhiro, Tsuburaya Akira, Kobayashi Michiya, Yoshino Shigefumi, Takahashi Masazumi, Takiguchi Nobuhiro, Tanabe Kazuaki, Takahashi Naoto, Imamura Hiroshi, Tatsumoto Naokuni, Hara Akinori, Nishikawa Kazuhiro, Fukushima Ryoji, Kurita Akira, Kojima Hiroshi, Miyashita Yumi, Oba Koji, Buyse Marc E, Morita Satoshi, Sakamoto Junichi Yoshida Kazuhiro, Tsuburaya Akira, Kobayashi Michiya, Yoshino Shigefumi, Takahashi Masazumi, Takiguchi Nobuhiro, Tanabe Kazuaki, Takahashi Naoto, Imamura Hiroshi, Tatsumoto Naokuni, Hara Akinori, Nishikawa Kazuhiro, Fukushima Ryoji, Kurita Akira, Kojima Hiroshi, Miyashita Yumi, Oba Koji, Buyse Marc E, Morita Satoshi, Sakamoto Junichi Yoshida Kazuhiro, Tsuburaya Akira, Kobayashi Michiya, Yoshino Shigefumi, Takahashi Masazumi, Takiguchi Nobuhiro, Tanabe Kazuaki, Takahashi Naoto, Imamura Hiroshi, Tatsumoto Naokuni, Hara Akinori, Nishikawa Kazuhiro, Fukushima Ryoji, Kurita Akira, Kojima Hiroshi, Miyashita Yumi, Oba Koji, Buyse Marc E, Morita Satoshi, Sakamoto Junichi SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. JOURNAL OF CLINICAL ONCOLOGY, 31, 18 JOURNAL OF CLINICAL ONCOLOGY, 31, 18 JOURNAL OF CLINICAL ONCOLOGY, 31, 18 2013/06/20 公開
Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Nobuyuki Horita, Naoki Miyazawa, Satoshi Morita, Ryota Kojima, Naoko Kimura, Takeshi Kaneko, Yoshiaki Ishigatsubo Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: A propensity score matching study Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: A propensity score matching study Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: A propensity score matching study Respiratory Research, 14, 1 Respiratory Research, 14, 1 Respiratory Research, 14, 1 2013/06/03 英語 研究論文(学術雑誌) 公開
T. Kawahara, S. Morita, H. Ito, H. Terao, R. Sakata, H. Ishiguro, K. Tanaka, H. Miyamoto, J. Matsuzaki, Y. Kubota, H. Uemura T. Kawahara, S. Morita, H. Ito, H. Terao, R. Sakata, H. Ishiguro, K. Tanaka, H. Miyamoto, J. Matsuzaki, Y. Kubota, H. Uemura Takashi Kawahara, Satoshi Morita, Hiroki Ito, Hideyuki Terao, Ryoko Sakata, Hitoshi Ishiguro, Katsuyuki Tanaka, Hiroshi Miyamoto, Junichi Matsuzaki, Yoshinobu Kubota, Hiroji Uemura Ramelteon combined with an α<sub>1</sub>-blocker decreases nocturia in men with benign prostatic hyperplasia Ramelteon combined with an α<sub>1</sub>-blocker decreases nocturia in men with benign prostatic hyperplasia Ramelteon combined with an alpha(1)-blocker decreases nocturia in men with benign prostatic hyperplasia BMC Urology, 13 BMC Urology, 13 BMC UROLOGY, 13 2013/06 英語 研究論文(学術雑誌) 公開
Yoshiko Urata, Isamu Okamoto, Masayuki Takeda, Yoshihiro Hattori, Keiko Okuno, Temiko Shimada, Takayasu Kurata, Hiroyasu Kaneda, Masaki Miyazaki, Masaaki Terashima, Kaoru Tanaka, Satoshi Morita, Kazuhiko Nakagawa, Shunichi Negoro, Miyako Satouchi Yoshiko Urata, Isamu Okamoto, Masayuki Takeda, Yoshihiro Hattori, Keiko Okuno, Temiko Shimada, Takayasu Kurata, Hiroyasu Kaneda, Masaki Miyazaki, Masaaki Terashima, Kaoru Tanaka, Satoshi Morita, Kazuhiko Nakagawa, Shunichi Negoro, Miyako Satouchi Yoshiko Urata, Isamu Okamoto, Masayuki Takeda, Yoshihiro Hattori, Keiko Okuno, Temiko Shimada, Takayasu Kurata, Hiroyasu Kaneda, Masaki Miyazaki, Masaaki Terashima, Kaoru Tanaka, Satoshi Morita, Kazuhiko Nakagawa, Shunichi Negoro, Miyako Satouchi Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer CANCER, 119, 12, 2275-2281 CANCER, 119, 12, 2275-2281 CANCER, 119, 12, 2275-2281 2013/06 英語 研究論文(学術雑誌) 公開
Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 145, 6, 1577-+ JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 145, 6, 1577-+ JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 145, 6, 1577-+ 2013/06 英語 研究論文(学術雑誌) 公開
Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Takeshi Kaneko, Satoshi Morita, Hiroshi Handa, Yousuke Aoki, Yohei Oku, Etsuo Kunieda Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Takeshi Kaneko, Satoshi Morita, Hiroshi Handa, Yousuke Aoki, Yohei Oku, Etsuo Kunieda Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Takeshi Kaneko, Satoshi Morita, Hiroshi Handa, Yousuke Aoki, Yohei Oku, Etsuo Kunieda Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung Cancer Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung Cancer Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86, 2, 257-263 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86, 2, 257-263 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86, 2, 257-263 2013/06 英語 研究論文(学術雑誌) 公開
Yoshida Kazuhiro, Tsuburaya Akira, Kobayashi Michiya, Yoshino Shigefumi, Takahashi Masazumi, Takiguchi Nobuhiro, Tanabe Kazuaki, Takahashi Naoto, Imamura Hiroshi, Tatsumoto Naokuni, Hara Akinori, Nishikawa Kazuhiro, Fukushima Ryoji, Kurita Akira, Kojima Hiroshi, Miyashita Yumi, Oba Koji, Buyse Marc E, Morita Satoshi, Sakamoto Junichi Yoshida Kazuhiro, Tsuburaya Akira, Kobayashi Michiya, Yoshino Shigefumi, Takahashi Masazumi, Takiguchi Nobuhiro, Tanabe Kazuaki, Takahashi Naoto, Imamura Hiroshi, Tatsumoto Naokuni, Hara Akinori, Nishikawa Kazuhiro, Fukushima Ryoji, Kurita Akira, Kojima Hiroshi, Miyashita Yumi, Oba Koji, Buyse Marc E, Morita Satoshi, Sakamoto Junichi Yoshida Kazuhiro, Tsuburaya Akira, Kobayashi Michiya, Yoshino Shigefumi, Takahashi Masazumi, Takiguchi Nobuhiro, Tanabe Kazuaki, Takahashi Naoto, Imamura Hiroshi, Tatsumoto Naokuni, Hara Akinori, Nishikawa Kazuhiro, Fukushima Ryoji, Kurita Akira, Kojima Hiroshi, Miyashita Yumi, Oba Koji, Buyse Marc E, Morita Satoshi, Sakamoto Junichi SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 JOURNAL OF CLINICAL ONCOLOGY, 31, 15 2013/05/20 公開
Yasushi Matsuzawa, Masaaki Konishi, Eiichi Akiyama, Hiroyuki Suzuki, Naoki Nakayama, Masayoshi Kiyokuni, Shinichi Sumita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Kengo Tsukahara, Noriaki Iwahashi, Mitsuaki Endo, Nobuhiko Maejima, Kenichiro Saka, Katsutaka Hashiba, Kozo Okada, Masataka Taguri, Satoshi Morita, Seigo Sugiyama, Hisao Ogawa, Hironobu Sashika, Satoshi Umemura, Kazuo Kimura Yasushi Matsuzawa, Masaaki Konishi, Eiichi Akiyama, Hiroyuki Suzuki, Naoki Nakayama, Masayoshi Kiyokuni, Shinichi Sumita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Kengo Tsukahara, Noriaki Iwahashi, Mitsuaki Endo, Nobuhiko Maejima, Kenichiro Saka, Katsutaka Hashiba, Kozo Okada, Masataka Taguri, Satoshi Morita, Seigo Sugiyama, Hisao Ogawa, Hironobu Sashika, Satoshi Umemura, Kazuo Kimura Yasushi Matsuzawa, Masaaki Konishi, Eiichi Akiyama, Hiroyuki Suzuki, Naoki Nakayama, Masayoshi Kiyokuni, Shinichi Sumita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Kengo Tsukahara, Noriaki Iwahashi, Mitsuaki Endo, Nobuhiko Maejima, Kenichiro Saka, Katsutaka Hashiba, Kozo Okada, Masataka Taguri, Satoshi Morita, Seigo Sugiyama, Hisao Ogawa, Hironobu Sashika, Satoshi Umemura, Kazuo Kimura Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. Journal of the American College of Cardiology, 61, 19, 1964-72 Journal of the American College of Cardiology, 61, 19, 1964-72 Journal of the American College of Cardiology, 61, 19, 1964-72 2013/05/14 英語 公開
Hidetoshi Hayashi, Isamu Okamoto, Masataka Taguri, Satoshi Morita, Kazuhiko Nakagawa Hidetoshi Hayashi, Isamu Okamoto, Masataka Taguri, Satoshi Morita, Kazuhiko Nakagawa Hidetoshi Hayashi, Isamu Okamoto, Masataka Taguri, Satoshi Morita, Kazuhiko Nakagawa Postprogression Survival in Patients With Advanced Non-Small-Cell Lung Cancer Who Receive Second-Line or Third-Line Chemotherapy Postprogression Survival in Patients With Advanced Non-Small-Cell Lung Cancer Who Receive Second-Line or Third-Line Chemotherapy Postprogression Survival in Patients With Advanced Non-Small-Cell Lung Cancer Who Receive Second-Line or Third-Line Chemotherapy CLINICAL LUNG CANCER, 14, 3, 261-266 CLINICAL LUNG CANCER, 14, 3, 261-266 CLINICAL LUNG CANCER, 14, 3, 261-266 2013/05 英語 研究論文(学術雑誌) 公開
Tomoo Shiozawa, Jun-ichi Tadokoro, Toshitaka Fujiki, Koji Fujino, Koji Kakihata, Shuji Masatani, Satoshi Morita, Akihiko Gemma, Narikazu Boku Tomoo Shiozawa, Jun-ichi Tadokoro, Toshitaka Fujiki, Koji Fujino, Koji Kakihata, Shuji Masatani, Satoshi Morita, Akihiko Gemma, Narikazu Boku Tomoo Shiozawa, Jun-ichi Tadokoro, Toshitaka Fujiki, Koji Fujino, Koji Kakihata, Shuji Masatani, Satoshi Morita, Akihiko Gemma, Narikazu Boku Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43, 5, 483-491 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43, 5, 483-491 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43, 5, 483-491 2013/05 英語 研究論文(学術雑誌) 公開
H. Yoshioka, I. Okamoto, S. Morita, M. Ando, K. Takeda, T. Seto, N. Yamamoto, H. Saka, S. Atagi, T. Hirashima, S. Kudoh, M. Satouchi, N. Ikeda, Y. Iwamoto, T. Sawa, Y. Nakanishi, K. Nakagawa H. Yoshioka, I. Okamoto, S. Morita, M. Ando, K. Takeda, T. Seto, N. Yamamoto, H. Saka, S. Atagi, T. Hirashima, S. Kudoh, M. Satouchi, N. Ikeda, Y. Iwamoto, T. Sawa, Y. Nakanishi, K. Nakagawa H. Yoshioka, I. Okamoto, S. Morita, M. Ando, K. Takeda, T. Seto, N. Yamamoto, H. Saka, S. Atagi, T. Hirashima, S. Kudoh, M. Satouchi, N. Ikeda, Y. Iwamoto, T. Sawa, Y. Nakanishi, K. Nakagawa Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study ANNALS OF ONCOLOGY, 24, 5, 1326-1331 ANNALS OF ONCOLOGY, 24, 5, 1326-1331 ANNALS OF ONCOLOGY, 24, 5, 1326-1331 2013/05 英語 研究論文(学術雑誌) 公開
Yoshinobu Kanda, Junya Kanda, Yoshiko Atsuta, Yoshinobu Maeda, Tatsuo Ichinohe, Kazuteru Ohashi, Takahiro Fukuda, Koichi Miyamura, Hiroatsu Iida, Takehiko Mori, Koji Iwato, Tetsuya Eto, Keisei Kawa, Satoshi Morita, Yasuo Morishima Yoshinobu Kanda, Junya Kanda, Yoshiko Atsuta, Yoshinobu Maeda, Tatsuo Ichinohe, Kazuteru Ohashi, Takahiro Fukuda, Koichi Miyamura, Hiroatsu Iida, Takehiko Mori, Koji Iwato, Tetsuya Eto, Keisei Kawa, Satoshi Morita, Yasuo Morishima Yoshinobu Kanda, Junya Kanda, Yoshiko Atsuta, Yoshinobu Maeda, Tatsuo Ichinohe, Kazuteru Ohashi, Takahiro Fukuda, Koichi Miyamura, Hiroatsu Iida, Takehiko Mori, Koji Iwato, Tetsuya Eto, Keisei Kawa, Satoshi Morita, Yasuo Morishima Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation BRITISH JOURNAL OF HAEMATOLOGY, 161, 4, 566-577 BRITISH JOURNAL OF HAEMATOLOGY, 161, 4, 566-577 BRITISH JOURNAL OF HAEMATOLOGY, 161, 4, 566-577 2013/05 英語 研究論文(学術雑誌) 公開
Koji Oba, Xavier Paoletti, Yung-Jue Bang, Harry Bleiberg, Tomasz Burzykowski, Nozomu Fuse, Stefan Michiels, Satoshi Morita, Yasuo Ohashi, Jean-Pierre Pignon, Philippe Rougier, Junichi Sakamoto, Daniel Sargent, Mitsuru Sasako, Kohei Shitara, Akira Tsuburaya, Eric Van Cutsem, Marc Buyse Koji Oba, Xavier Paoletti, Yung-Jue Bang, Harry Bleiberg, Tomasz Burzykowski, Nozomu Fuse, Stefan Michiels, Satoshi Morita, Yasuo Ohashi, Jean-Pierre Pignon, Philippe Rougier, Junichi Sakamoto, Daniel Sargent, Mitsuru Sasako, Kohei Shitara, Akira Tsuburaya, Eric Van Cutsem, Marc Buyse Koji Oba, Xavier Paoletti, Yung-Jue Bang, Harry Bleiberg, Tomasz Burzykowski, Nozomu Fuse, Stefan Michiels, Satoshi Morita, Yasuo Ohashi, Jean-Pierre Pignon, Philippe Rougier, Junichi Sakamoto, Daniel Sargent, Mitsuru Sasako, Kohei Shitara, Akira Tsuburaya, Eric Van Cutsem, Marc Buyse Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. European journal of cancer (Oxford, England : 1990), 49, 7, 1565-77 European journal of cancer (Oxford, England : 1990), 49, 7, 1565-77 European journal of cancer (Oxford, England : 1990), 49, 7, 1565-77 2013/05 英語 公開
T. Kikuchi, H. Tan, T. Mihara, K. Uchimoto, D. Mitsushima, K. Takase, S. Morita, T. Goto, T. Andoh, Y. Kamiya T. Kikuchi, H. Tan, T. Mihara, K. Uchimoto, D. Mitsushima, K. Takase, S. Morita, T. Goto, T. Andoh, Y. Kamiya T. Kikuchi, H. Tan, T. Mihara, K. Uchimoto, D. Mitsushima, K. Takase, S. Morita, T. Goto, T. Andoh, Y. Kamiya Effects of volatile anesthetics on the circadian rhythms of rat hippocampal acetylcholine release and locomotor activity Effects of volatile anesthetics on the circadian rhythms of rat hippocampal acetylcholine release and locomotor activity Effects of volatile anesthetics on the circadian rhythms of rat hippocampal acetylcholine release and locomotor activity Neuroscience, 237, 151-160 Neuroscience, 237, 151-160 Neuroscience, 237, 151-160 2013/05/01 英語 研究論文(学術雑誌) 公開
Takako T. Ishii, Tomoko Kawate, Yoshikazu Nakatani, Satoshi Morita, Kiyoshi Ichimoto, Satoshi Masuda Takako T. Ishii, Tomoko Kawate, Yoshikazu Nakatani, Satoshi Morita, Kiyoshi Ichimoto, Satoshi Masuda Takako T. Ishii, Tomoko Kawate, Yoshikazu Nakatani, Satoshi Morita, Kiyoshi Ichimoto, Satoshi Masuda High-Speed Imaging System for Solar-Flare Research at Hida Observatory High-Speed Imaging System for Solar-Flare Research at Hida Observatory High-Speed Imaging System for Solar-Flare Research at Hida Observatory PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 65, 2 PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 65, 2 PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 65, 2 2013/04 英語 研究論文(学術雑誌) 公開
Izumi Wasada, Hisae Eguchi, Maya Kurita, Shitomi Kudo, Tomoko Shishida, Yaeko Mishima, Yuko Saito, Nobuko Ushiorozawa, Takashi Seto, Kojiro Shimozuma, Satoshi Morita, Mari Saito, Yuki Yokomizo, Kenichi Ishizawa, Yasuo Ohashi, Kenji Eguchi Izumi Wasada, Hisae Eguchi, Maya Kurita, Shitomi Kudo, Tomoko Shishida, Yaeko Mishima, Yuko Saito, Nobuko Ushiorozawa, Takashi Seto, Kojiro Shimozuma, Satoshi Morita, Mari Saito, Yuki Yokomizo, Kenichi Ishizawa, Yasuo Ohashi, Kenji Eguchi Izumi Wasada, Hisae Eguchi, Maya Kurita, Shitomi Kudo, Tomoko Shishida, Yaeko Mishima, Yuko Saito, Nobuko Ushiorozawa, Takashi Seto, Kojiro Shimozuma, Satoshi Morita, Mari Saito, Yuki Yokomizo, Kenichi Ishizawa, Yasuo Ohashi, Kenji Eguchi Anemia affects the quality of life of japanese cancer patients Anemia affects the quality of life of japanese cancer patients Anemia affects the quality of life of japanese cancer patients Tokai Journal of Experimental and Clinical Medicine, 38, 1, 7-11 Tokai Journal of Experimental and Clinical Medicine, 38, 1, 7-11 Tokai Journal of Experimental and Clinical Medicine, 38, 1, 7-11 2013/04 英語 研究論文(学術雑誌) 公開
Takao Takahashi, Yoshihisa Shibata, Yuichiro Tojima, Kenji Tsuboi, Eiji Sakamoto, Katsuyuki Kunieda, Hiroshi Matsuoka, Kazuyoshi Suzumura, Mikinori Sato, Tatsushi Naganuma, Junichi Sakamoto, Satoshi Morita, Ken Kondo Takao Takahashi, Yoshihisa Shibata, Yuichiro Tojima, Kenji Tsuboi, Eiji Sakamoto, Katsuyuki Kunieda, Hiroshi Matsuoka, Kazuyoshi Suzumura, Mikinori Sato, Tatsushi Naganuma, Junichi Sakamoto, Satoshi Morita, Ken Kondo Takao Takahashi, Yoshihisa Shibata, Yuichiro Tojima, Kenji Tsuboi, Eiji Sakamoto, Katsuyuki Kunieda, Hiroshi Matsuoka, Kazuyoshi Suzumura, Mikinori Sato, Tatsushi Naganuma, Junichi Sakamoto, Satoshi Morita, Ken Kondo Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study International Journal of Clinical Oncology, 18, 2, 335-342 International Journal of Clinical Oncology, 18, 2, 335-342 International Journal of Clinical Oncology, 18, 2, 335-342 2013/04 英語 研究論文(学術雑誌) 公開
Kazuaki Kadonosono, Akira Arakawa, Maiko Inoue, Shin Yamane, Eiichi Uchio, Tadashi Yamakawa, Masataka Taguri, Satoshi Morita, Jamison R. Ridgeley, Yasuo Yanagi Kazuaki Kadonosono, Akira Arakawa, Maiko Inoue, Shin Yamane, Eiichi Uchio, Tadashi Yamakawa, Masataka Taguri, Satoshi Morita, Jamison R. Ridgeley, Yasuo Yanagi Kazuaki Kadonosono, Akira Arakawa, Maiko Inoue, Shin Yamane, Eiichi Uchio, Tadashi Yamakawa, Masataka Taguri, Satoshi Morita, Jamison R. Ridgeley, Yasuo Yanagi INTERNAL LIMITING MEMBRANE CONTRAST AFTER STAINING WITH INDOCYANINE GREEN AND BRILLIANT BLUE G DURING MACULAR SURGERY INTERNAL LIMITING MEMBRANE CONTRAST AFTER STAINING WITH INDOCYANINE GREEN AND BRILLIANT BLUE G DURING MACULAR SURGERY INTERNAL LIMITING MEMBRANE CONTRAST AFTER STAINING WITH INDOCYANINE GREEN AND BRILLIANT BLUE G DURING MACULAR SURGERY RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 33, 4, 812-817 RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 33, 4, 812-817 RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 33, 4, 812-817 2013/04 英語 研究論文(学術雑誌) 公開
Ken-Ichi Okada, Manabu Kawai, Katsuhiko Uesaka, Yasuhiro Kodera, Hiroaki Nagano, Yoshiaki Murakami, Satoshi Morita, Junichi Sakamoto, Hiroki Yamaue Ken-Ichi Okada, Manabu Kawai, Katsuhiko Uesaka, Yasuhiro Kodera, Hiroaki Nagano, Yoshiaki Murakami, Satoshi Morita, Junichi Sakamoto, Hiroki Yamaue Ken-Ichi Okada, Manabu Kawai, Katsuhiko Uesaka, Yasuhiro Kodera, Hiroaki Nagano, Yoshiaki Murakami, Satoshi Morita, Junichi Sakamoto, Hiroki Yamaue Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, randomized, placebo-controlled phase II trial (The Japan-PD study) Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, randomized, placebo-controlled phase II trial (The Japan-PD study) Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, randomized, placebo-controlled phase II trial (The Japan-PD study) Japanese Journal of Clinical Oncology, 43, 4, 436-438 Japanese Journal of Clinical Oncology, 43, 4, 436-438 Japanese Journal of Clinical Oncology, 43, 4, 436-438 2013/04 英語 研究論文(学術雑誌) 公開
Tsutomu Hayashi, Takaki Yoshikawa, Kiran Bonam, Henry M. Sue-Ling, Masataka Taguri, Satoshi Morita, Akira Tsuburaya, Jeremy D. Hayden, Heike I. Grabsch Tsutomu Hayashi, Takaki Yoshikawa, Kiran Bonam, Henry M. Sue-Ling, Masataka Taguri, Satoshi Morita, Akira Tsuburaya, Jeremy D. Hayden, Heike I. Grabsch Tsutomu Hayashi, Takaki Yoshikawa, Kiran Bonam, Henry M. Sue-Ling, Masataka Taguri, Satoshi Morita, Akira Tsuburaya, Jeremy D. Hayden, Heike I. Grabsch The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort CANCER, 119, 7, 1330-1337 CANCER, 119, 7, 1330-1337 CANCER, 119, 7, 1330-1337 2013/04 英語 研究論文(学術雑誌) 公開
Takashi Miyatake, Yutaka Ueda, Akiko Morimoto, Takayuki Enomoto, Sumiyuki Nishida, Toshiaki Shirakata, Yoshihiro Oka, Akihiro Tsuboi, Yusuke Oji, Naoki Hosen, Shin-ichi Nakatsuka, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Tadashi Kimura Takashi Miyatake, Yutaka Ueda, Akiko Morimoto, Takayuki Enomoto, Sumiyuki Nishida, Toshiaki Shirakata, Yoshihiro Oka, Akihiro Tsuboi, Yusuke Oji, Naoki Hosen, Shin-ichi Nakatsuka, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Tadashi Kimura Takashi Miyatake, Yutaka Ueda, Akiko Morimoto, Takayuki Enomoto, Sumiyuki Nishida, Toshiaki Shirakata, Yoshihiro Oka, Akihiro Tsuboi, Yusuke Oji, Naoki Hosen, Shin-ichi Nakatsuka, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Tadashi Kimura WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 139, 3, 457-463 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 139, 3, 457-463 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 139, 3, 457-463 2013/03 英語 研究論文(学術雑誌) 公開
Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Satoshi Moriya, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Satoshi Moriya, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Satoshi Moriya, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study EUROPEAN JOURNAL OF RADIOLOGY, 82, 3, 497-503 EUROPEAN JOURNAL OF RADIOLOGY, 82, 3, 497-503 EUROPEAN JOURNAL OF RADIOLOGY, 82, 3, 497-503 2013/03 英語 研究論文(学術雑誌) 公開
Akimitsu Yamada, Takashi Ishikawa, Ikuko Ota, Mariko Kimura, Daisuke Shimizu, Mikiko Tanabe, Takashi Chishima, Takeshi Sasaki, Yasushi Ichikawa, Satoshi Morita, Koh-ichiro Yoshiura, Kazuaki Takabe, Itaru Endo Akimitsu Yamada, Takashi Ishikawa, Ikuko Ota, Mariko Kimura, Daisuke Shimizu, Mikiko Tanabe, Takashi Chishima, Takeshi Sasaki, Yasushi Ichikawa, Satoshi Morita, Koh-ichiro Yoshiura, Kazuaki Takabe, Itaru Endo Akimitsu Yamada, Takashi Ishikawa, Ikuko Ota, Mariko Kimura, Daisuke Shimizu, Mikiko Tanabe, Takashi Chishima, Takeshi Sasaki, Yasushi Ichikawa, Satoshi Morita, Koh-ichiro Yoshiura, Kazuaki Takabe, Itaru Endo High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival BREAST CANCER RESEARCH AND TREATMENT, 137, 3, 773-782 BREAST CANCER RESEARCH AND TREATMENT, 137, 3, 773-782 BREAST CANCER RESEARCH AND TREATMENT, 137, 3, 773-782 2013/02 英語 研究論文(学術雑誌) 公開
Shinichi Hasegawa, Yuji Yamamoto, Masataka Taguri, Satoshi Morita, Tsutomu Sato, Roppei Yamada, Takashi Oshima, Norio Yukawa, Takaki Yoshikawa, Yasushi Rino, Toshio Imada, Munetaka Masuda Shinichi Hasegawa, Yuji Yamamoto, Masataka Taguri, Satoshi Morita, Tsutomu Sato, Roppei Yamada, Takashi Oshima, Norio Yukawa, Takaki Yoshikawa, Yasushi Rino, Toshio Imada, Munetaka Masuda Shinichi Hasegawa, Yuji Yamamoto, Masataka Taguri, Satoshi Morita, Tsutomu Sato, Roppei Yamada, Takashi Oshima, Norio Yukawa, Takaki Yoshikawa, Yasushi Rino, Toshio Imada, Munetaka Masuda A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer. A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer. A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer. Japanese journal of clinical oncology, 43, 2, 214-6 Japanese journal of clinical oncology, 43, 2, 214-6 Japanese journal of clinical oncology, 43, 2, 214-6 2013/02 英語 研究論文(学術雑誌) 公開
Chu Matsuda, Toru Kono, Yoshinori Munemoto, Naoki Nagata, Masato Kataoka, Mitsuru Oshiro, Satoshi Morita, Junichi Sakamoto, Hideyuki Mishima Chu Matsuda, Toru Kono, Yoshinori Munemoto, Naoki Nagata, Masato Kataoka, Mitsuru Oshiro, Satoshi Morita, Junichi Sakamoto, Hideyuki Mishima Chu Matsuda, Toru Kono, Yoshinori Munemoto, Naoki Nagata, Masato Kataoka, Mitsuru Oshiro, Satoshi Morita, Junichi Sakamoto, Hideyuki Mishima Double-Blind, Placebo-Controlled, Randomized Phase II Study of TJ-14 (Hangeshashinto) for Infusional Fluorinated-Pyrimidine-based Colorectal Cancer Chemotherapy-induced Oral Mucositis Double-Blind, Placebo-Controlled, Randomized Phase II Study of TJ-14 (Hangeshashinto) for Infusional Fluorinated-Pyrimidine-based Colorectal Cancer Chemotherapy-induced Oral Mucositis Double-Blind, Placebo-Controlled, Randomized Phase II Study of TJ-14 (Hangeshashinto) for Infusional Fluorinated-Pyrimidine-based Colorectal Cancer Chemotherapy-induced Oral Mucositis Annals of Cancer Research and Therapy, 21, 1, 26-30 Annals of Cancer Research and Therapy, 21, 1, 26-30 Annals of Cancer Research and Therapy, 21, 1, 26-30 2013 英語 研究論文(学術雑誌) 公開
T. Miyahara, S. Mochinaga, S. Kimura, N. Aragane, T. Yakabe, S. Morita, K. Okudaira, H. Fujito T. Miyahara, S. Mochinaga, S. Kimura, N. Aragane, T. Yakabe, S. Morita, K. Okudaira, H. Fujito T. Miyahara, S. Mochinaga, S. Kimura, N. Aragane, T. Yakabe, S. Morita, K. Okudaira, H. Fujito Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients Cancer Chemotherapy and Pharmacology, 71, 1, 175-182 Cancer Chemotherapy and Pharmacology, 71, 1, 175-182 Cancer Chemotherapy and Pharmacology, 71, 1, 175-182 2013/01 英語 研究論文(学術雑誌) 公開
Masaaki Konishi, Seigo Sugiyama, Koichi Sugamura, Toshimitsu Nozaki, Keisuke Ohba, Junichi Matsubara, Kenji Sakamoto, Yasuhiro Nagayoshi, Hitoshi Sumida, Eiichi Akiyama, Yasushi Matsuzawa, Kentaro Sakamaki, Satoshi Morita, Kazuo Kimura, Satoshi Umemura, Hisao Ogawa Masaaki Konishi, Seigo Sugiyama, Koichi Sugamura, Toshimitsu Nozaki, Keisuke Ohba, Junichi Matsubara, Kenji Sakamoto, Yasuhiro Nagayoshi, Hitoshi Sumida, Eiichi Akiyama, Yasushi Matsuzawa, Kentaro Sakamaki, Satoshi Morita, Kazuo Kimura, Satoshi Umemura, Hisao Ogawa Masaaki Konishi, Seigo Sugiyama, Koichi Sugamura, Toshimitsu Nozaki, Keisuke Ohba, Junichi Matsubara, Kenji Sakamoto, Yasuhiro Nagayoshi, Hitoshi Sumida, Eiichi Akiyama, Yasushi Matsuzawa, Kentaro Sakamaki, Satoshi Morita, Kazuo Kimura, Satoshi Umemura, Hisao Ogawa Basal and ischemia-induced transcardiac troponin release into the coronary circulation in patients with suspected coronary artery disease. Basal and ischemia-induced transcardiac troponin release into the coronary circulation in patients with suspected coronary artery disease. Basal and ischemia-induced transcardiac troponin release into the coronary circulation in patients with suspected coronary artery disease. PloS one, 8, 4, e60163 PloS one, 8, 4, e60163 PloS one, 8, 4, e60163 2013 英語 公開
Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment BMC PUBLIC HEALTH, 13, 1 BMC PUBLIC HEALTH, 13, 1 BMC PUBLIC HEALTH, 13, 1 2013/01 英語 研究論文(学術雑誌) 公開
A. Inoue, K. Kobayashi, M. Maemondo, S. Sugawara, S. Oizumi, H. Isobe, A. Gemma, M. Harada, H. Yoshizawa, I. Kinoshita, Y. Fujita, S. Okinaga, H. Hirano, K. Yoshimori, T. Harada, Y. Saijo, K. Hagiwara, S. Morita, T. Nukiwa A. Inoue, K. Kobayashi, M. Maemondo, S. Sugawara, S. Oizumi, H. Isobe, A. Gemma, M. Harada, H. Yoshizawa, I. Kinoshita, Y. Fujita, S. Okinaga, H. Hirano, K. Yoshimori, T. Harada, Y. Saijo, K. Hagiwara, S. Morita, T. Nukiwa A. Inoue, K. Kobayashi, M. Maemondo, S. Sugawara, S. Oizumi, H. Isobe, A. Gemma, M. Harada, H. Yoshizawa, I. Kinoshita, Y. Fujita, S. Okinaga, H. Hirano, K. Yoshimori, T. Harada, Y. Saijo, K. Hagiwara, S. Morita, T. Nukiwa Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Annals of Oncology, 24, 1, 54-59 Annals of Oncology, 24, 1, 54-59 ANNALS OF ONCOLOGY, 24, 1, 54-59 2013/01 英語 研究論文(学術雑誌) 公開
N. Horita, N. Miyazawa, T. Yoshiyama, T. Sato, M. Yamamoto, K. Tomaru, M. Masuda, K. Tashiro, M. Sasaki, S. Morita, T. Kaneko, Y. Ishigatsubo N. Horita, N. Miyazawa, T. Yoshiyama, T. Sato, M. Yamamoto, K. Tomaru, M. Masuda, K. Tashiro, M. Sasaki, S. Morita, T. Kaneko, Y. Ishigatsubo N. Horita, N. Miyazawa, T. Yoshiyama, T. Sato, M. Yamamoto, K. Tomaru, M. Masuda, K. Tashiro, M. Sasaki, S. Morita, T. Kaneko, Y. Ishigatsubo Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 17, 1, 54-60 INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 17, 1, 54-60 INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 17, 1, 54-60 2013/01 英語 研究論文(学術雑誌) 公開
Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Kengo Tsukahara, Noriaki Iwahashi, Masaomi Gohbara, Yasushi Matsuzawa, Kozo Okada, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Kengo Tsukahara, Noriaki Iwahashi, Masaomi Gohbara, Yasushi Matsuzawa, Kozo Okada, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Kengo Tsukahara, Noriaki Iwahashi, Masaomi Gohbara, Yasushi Matsuzawa, Kozo Okada, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and Takotsubo cardiomyopathy. Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and Takotsubo cardiomyopathy. Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and Takotsubo cardiomyopathy. European heart journal. Acute cardiovascular care, 1, 4, 349-57 European heart journal. Acute cardiovascular care, 1, 4, 349-57 European heart journal. Acute cardiovascular care, 1, 4, 349-57 2012/12 英語 研究論文(学術雑誌) 公開
Satoko Miyatake, Hajime Touho, Noriko Miyake, Chihiro Ohba, Hiroshi Doi, Hirotomo Saitsu, Masataka Taguri, Satoshi Morita, Naomichi Matsumoto Satoko Miyatake, Hajime Touho, Noriko Miyake, Chihiro Ohba, Hiroshi Doi, Hirotomo Saitsu, Masataka Taguri, Satoshi Morita, Naomichi Matsumoto Satoko Miyatake, Hajime Touho, Noriko Miyake, Chihiro Ohba, Hiroshi Doi, Hirotomo Saitsu, Masataka Taguri, Satoshi Morita, Naomichi Matsumoto Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G &gt; A variant in RNF213 showed varying clinical course and severity Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G &gt; A variant in RNF213 showed varying clinical course and severity Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G &gt; A variant in RNF213 showed varying clinical course and severity JOURNAL OF HUMAN GENETICS, 57, 12, 804-806 JOURNAL OF HUMAN GENETICS, 57, 12, 804-806 JOURNAL OF HUMAN GENETICS, 57, 12, 804-806 2012/12 英語 研究論文(学術雑誌) 公開
Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Katsumasa Kuroi, Shozo Ohsumi, Haruhiko Makino, Noriyuki Katsumata, Masaru Kuranami, Kimito Suemasu, Toru Watanabe, Frederick H. Hausheer Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Katsumasa Kuroi, Shozo Ohsumi, Haruhiko Makino, Noriyuki Katsumata, Masaru Kuranami, Kimito Suemasu, Toru Watanabe, Frederick H. Hausheer Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Katsumasa Kuroi, Shozo Ohsumi, Haruhiko Makino, Noriyuki Katsumata, Masaru Kuranami, Kimito Suemasu, Toru Watanabe, Frederick H. Hausheer Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial SUPPORTIVE CARE IN CANCER, 20, 12, 3355-3364 SUPPORTIVE CARE IN CANCER, 20, 12, 3355-3364 SUPPORTIVE CARE IN CANCER, 20, 12, 3355-3364 2012/12 英語 研究論文(学術雑誌) 公開
Yasutsugu Takada, Yoshimi Suzukamo, Fumitaka Oike, Hiroto Egawa, Satoshi Morita, Shunichi Fukuhara, Shinji Uemoto, Koichi Tanaka Yasutsugu Takada, Yoshimi Suzukamo, Fumitaka Oike, Hiroto Egawa, Satoshi Morita, Shunichi Fukuhara, Shinji Uemoto, Koichi Tanaka Yasutsugu Takada, Yoshimi Suzukamo, Fumitaka Oike, Hiroto Egawa, Satoshi Morita, Shunichi Fukuhara, Shinji Uemoto, Koichi Tanaka Long-term quality of life of donors after living donor liver transplantation Long-term quality of life of donors after living donor liver transplantation Long-term quality of life of donors after living donor liver transplantation LIVER TRANSPLANTATION, 18, 11, 1343-1352 LIVER TRANSPLANTATION, 18, 11, 1343-1352 LIVER TRANSPLANTATION, 18, 11, 1343-1352 2012/11 英語 研究論文(学術雑誌) 公開
Hideto Yano, Kengo Tsukahara, Satoshi Morita, Tsutomu Endo, Teruyasu Sugano, Kiyoshi Hibi, Hideo Himeno, Kazuki Fukui, Satoshi Umemura, Kazuo Kimura Hideto Yano, Kengo Tsukahara, Satoshi Morita, Tsutomu Endo, Teruyasu Sugano, Kiyoshi Hibi, Hideo Himeno, Kazuki Fukui, Satoshi Umemura, Kazuo Kimura Hideto Yano, Kengo Tsukahara, Satoshi Morita, Tsutomu Endo, Teruyasu Sugano, Kiyoshi Hibi, Hideo Himeno, Kazuki Fukui, Satoshi Umemura, Kazuo Kimura Influence of Omeprazole and Famotidine on the Antiplatelet Effects of Clopidogrel in Addition to Aspirin in Patients With Acute Coronary Syndromes - A Prospective, Randomized, Multicenter Study Influence of Omeprazole and Famotidine on the Antiplatelet Effects of Clopidogrel in Addition to Aspirin in Patients With Acute Coronary Syndromes - A Prospective, Randomized, Multicenter Study Influence of Omeprazole and Famotidine on the Antiplatelet Effects of Clopidogrel in Addition to Aspirin in Patients With Acute Coronary Syndromes - A Prospective, Randomized, Multicenter Study CIRCULATION JOURNAL, 76, 11, 2673-2680 CIRCULATION JOURNAL, 76, 11, 2673-2680 CIRCULATION JOURNAL, 76, 11, 2673-2680 2012/11 英語 研究論文(学術雑誌) 公開
Kazuhiro Nishikawa, Satoshi Morita, Takanori Matsui, Michiya Kobayashi, Yoji Takeuchi, Ikuo Takahashi, Seiji Sato, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Yoshihiro Kakeji, Hideo Baba Kazuhiro Nishikawa, Satoshi Morita, Takanori Matsui, Michiya Kobayashi, Yoji Takeuchi, Ikuo Takahashi, Seiji Sato, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Yoshihiro Kakeji, Hideo Baba Kazuhiro Nishikawa, Satoshi Morita, Takanori Matsui, Michiya Kobayashi, Yoji Takeuchi, Ikuo Takahashi, Seiji Sato, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto, Yoshihiro Kakeji, Hideo Baba A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer GASTRIC CANCER, 15, 4, 363-369 GASTRIC CANCER, 15, 4, 363-369 GASTRIC CANCER, 15, 4, 363-369 2012/10 英語 研究論文(学術雑誌) 公開
Takafumi Watanabe, Takaki Yoshikawa, Yoichi Kameda, Toru Aoyama, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Akira Tsuburaya, Satoshi Morita, Yumi Miyashita, Junichi Sakamoto Takafumi Watanabe, Takaki Yoshikawa, Yoichi Kameda, Toru Aoyama, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Akira Tsuburaya, Satoshi Morita, Yumi Miyashita, Junichi Sakamoto Takafumi Watanabe, Takaki Yoshikawa, Yoichi Kameda, Toru Aoyama, Tsutomu Hayashi, Takashi Ogata, Haruhiko Cho, Akira Tsuburaya, Satoshi Morita, Yumi Miyashita, Junichi Sakamoto Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case SURGERY TODAY, 42, 10, 983-987 SURGERY TODAY, 42, 10, 983-987 SURGERY TODAY, 42, 10, 983-987 2012/10 英語 研究論文(学術雑誌) 公開
Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Satoshi Morita, Shuichiro Takanashi Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144, 4, 824-829 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144, 4, 824-829 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144, 4, 824-829 2012/10 英語 研究論文(学術雑誌) 公開
Takahiro Tsushima, Masataka Taguri, Yoshitaka Honma, Hideaki Takahashi, Shinya Ueda, Tomohiro Nishina, Hiroki Kawai, Shunsuke Kato, Mitsukuni Suenaga, Fumio Tamura, Satoshi Morita, Narikazu Boku Takahiro Tsushima, Masataka Taguri, Yoshitaka Honma, Hideaki Takahashi, Shinya Ueda, Tomohiro Nishina, Hiroki Kawai, Shunsuke Kato, Mitsukuni Suenaga, Fumio Tamura, Satoshi Morita, Narikazu Boku Takahiro Tsushima, Masataka Taguri, Yoshitaka Honma, Hideaki Takahashi, Shinya Ueda, Tomohiro Nishina, Hiroki Kawai, Shunsuke Kato, Mitsukuni Suenaga, Fumio Tamura, Satoshi Morita, Narikazu Boku Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy ONCOLOGIST, 17, 9, 1163-1170 ONCOLOGIST, 17, 9, 1163-1170 ONCOLOGIST, 17, 9, 1163-1170 2012/09 英語 研究論文(学術雑誌) 公開
Takuma Higurashi, Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Hiroshi Iida, Takashi Uchiyama, Akiko Ezuka, Shiori Uchiyama, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Shin Maeda, Satoshi Morita, Yutaka Natsumeda, Hajime Nagase, Atsushi Nakajima Takuma Higurashi, Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Hiroshi Iida, Takashi Uchiyama, Akiko Ezuka, Shiori Uchiyama, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Shin Maeda, Satoshi Morita, Yutaka Natsumeda, Hajime Nagase, Atsushi Nakajima Takuma Higurashi, Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Hiroshi Iida, Takashi Uchiyama, Akiko Ezuka, Shiori Uchiyama, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Shin Maeda, Satoshi Morita, Yutaka Natsumeda, Hajime Nagase, Atsushi Nakajima Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial BMC CANCER, 12 BMC CANCER, 12 BMC CANCER, 12 2012/09 英語 研究論文(学術雑誌) 公開
M. Morimoto, K. Numata, A. Nozaki, M. Kondo, S. Moriya, M. Taguri, S. Morita, M. Konno, A. Sugo, E. Miyajima, S. Maeda, K. Tanaka M. Morimoto, K. Numata, A. Nozaki, M. Kondo, S. Moriya, M. Taguri, S. Morita, M. Konno, A. Sugo, E. Miyajima, S. Maeda, K. Tanaka Manabu Morimoto, Kazushi Numata, Akito Nozaki, Masaaki Kondo, Satoshi Moriya, Masataka Taguri, Satoshi Morita, Miki Konno, Akie Sugo, Eiji Miyajima, Shin Maeda, Katsuaki Tanaka Novel Lens culinaris agglutinin-reactive fraction of a-fetoprotein: A biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations Novel Lens culinaris agglutinin-reactive fraction of a-fetoprotein: A biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations Novel Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low alpha-fetoprotein concentrations International Journal of Clinical Oncology, 17, 4, 373-379 International Journal of Clinical Oncology, 17, 4, 373-379 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17, 4, 373-379 2012/08 英語 研究論文(学術雑誌) 公開
Masataka Yoshimoto, Shintaro Takao, Masaru Hirata, Yasushi Okamoto, Sumio Yamashita, Yoshihiro Kawaguchi, Makoto Takami, Hidemi Furusawa, Satoshi Morita, Chigusa Abe, Junichi Sakamoto Masataka Yoshimoto, Shintaro Takao, Masaru Hirata, Yasushi Okamoto, Sumio Yamashita, Yoshihiro Kawaguchi, Makoto Takami, Hidemi Furusawa, Satoshi Morita, Chigusa Abe, Junichi Sakamoto Masataka Yoshimoto, Shintaro Takao, Masaru Hirata, Yasushi Okamoto, Sumio Yamashita, Yoshihiro Kawaguchi, Makoto Takami, Hidemi Furusawa, Satoshi Morita, Chigusa Abe, Junichi Sakamoto Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 70, 2, 331-338 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 70, 2, 331-338 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 70, 2, 331-338 2012/08 英語 研究論文(学術雑誌) 公開
Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, Michiya Kobayashi, Kohei Shitara, Kensei Yamaguchi, Takaki Yoshikawa, Kazuhiro Yoshida, Shigefumi Yoshino, Jun-ichi Sakamoto Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, Michiya Kobayashi, Kohei Shitara, Kensei Yamaguchi, Takaki Yoshikawa, Kazuhiro Yoshida, Shigefumi Yoshino, Jun-ichi Sakamoto Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, Michiya Kobayashi, Kohei Shitara, Kensei Yamaguchi, Takaki Yoshikawa, Kazuhiro Yoshida, Shigefumi Yoshino, Jun-ichi Sakamoto A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) BMC CANCER, 12 BMC CANCER, 12 BMC CANCER, 12 2012/07 英語 研究論文(学術雑誌) 公開
Kohei Shitara, Satoshi Morita, Kazumasa Fujitani, Shigenori Kadowaki, Nobuhiro Takiguchi, Naoki Hirabayashi, Masazumi Takahashi, Masakazu Takagi, Yukihiko Tokunaga, Ryoji Fukushima, Yasuhiro Munakata, Kazuhiro Nishikawa, Akinori Takagane, Takaho Tanaka, Yoshiaki Sekishita, Junichi Sakamoto, Akira Tsuburaya Kohei Shitara, Satoshi Morita, Kazumasa Fujitani, Shigenori Kadowaki, Nobuhiro Takiguchi, Naoki Hirabayashi, Masazumi Takahashi, Masakazu Takagi, Yukihiko Tokunaga, Ryoji Fukushima, Yasuhiro Munakata, Kazuhiro Nishikawa, Akinori Takagane, Takaho Tanaka, Yoshiaki Sekishita, Junichi Sakamoto, Akira Tsuburaya Kohei Shitara, Satoshi Morita, Kazumasa Fujitani, Shigenori Kadowaki, Nobuhiro Takiguchi, Naoki Hirabayashi, Masazumi Takahashi, Masakazu Takagi, Yukihiko Tokunaga, Ryoji Fukushima, Yasuhiro Munakata, Kazuhiro Nishikawa, Akinori Takagane, Takaho Tanaka, Yoshiaki Sekishita, Junichi Sakamoto, Akira Tsuburaya Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis GASTRIC CANCER, 15, 3, 245-251 GASTRIC CANCER, 15, 3, 245-251 GASTRIC CANCER, 15, 3, 245-251 2012/07 英語 研究論文(学術雑誌) 公開
Takaki Yoshikawa, Tetsu Fukunaga, Masataka Taguri, Chikara Kunisaki, Shinichi Sakuramoto, Seiji Ito, Satoshi Morita, Akira Tsuburaya Takaki Yoshikawa, Tetsu Fukunaga, Masataka Taguri, Chikara Kunisaki, Shinichi Sakuramoto, Seiji Ito, Satoshi Morita, Akira Tsuburaya Takaki Yoshikawa, Tetsu Fukunaga, Masataka Taguri, Chikara Kunisaki, Shinichi Sakuramoto, Seiji Ito, Satoshi Morita, Akira Tsuburaya Laparoscopic or Open Distal Gastrectomy After Neoadjuvant Chemotherapy for Operable Gastric Cancer, a Randomized Phase II Trial (LANDSCOPE Trial) Laparoscopic or Open Distal Gastrectomy After Neoadjuvant Chemotherapy for Operable Gastric Cancer, a Randomized Phase II Trial (LANDSCOPE Trial) Laparoscopic or Open Distal Gastrectomy After Neoadjuvant Chemotherapy for Operable Gastric Cancer, a Randomized Phase II Trial (LANDSCOPE Trial) JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 7, 654-657 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 7, 654-657 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 7, 654-657 2012/07 英語 研究論文(学術雑誌) 公開
Shunichi Fukuhara, Tadao Akizawa, Satoshi Morita, Yoshiharu Tsubakihara Shunichi Fukuhara, Tadao Akizawa, Satoshi Morita, Yoshiharu Tsubakihara Shunichi Fukuhara, Tadao Akizawa, Satoshi Morita, Yoshiharu Tsubakihara Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities PLOS ONE, 7, 7 PLOS ONE, 7, 7 PLOS ONE, 7, 7 2012/07 英語 研究論文(学術雑誌) 公開
Kazuo Yamamura, Akimasa Nakao, Tsutomu Fujii, Suguru Yamada, Hiroyuki Sugimoto, Hideki Kasuya, Shuji Nomoto, Yasuhiro Kodera, Shigeo Nakamura, Satoshi Morita, Shin Takeda Kazuo Yamamura, Akimasa Nakao, Tsutomu Fujii, Suguru Yamada, Hiroyuki Sugimoto, Hideki Kasuya, Shuji Nomoto, Yasuhiro Kodera, Shigeo Nakamura, Satoshi Morita, Shin Takeda Kazuo Yamamura, Akimasa Nakao, Tsutomu Fujii, Suguru Yamada, Hiroyuki Sugimoto, Hideki Kasuya, Shuji Nomoto, Yasuhiro Kodera, Shigeo Nakamura, Satoshi Morita, Shin Takeda Clinicopathologic Study of Intrapancreatic Cancer Spread in Carcinoma of the Body and Tail of the Pancreas Clinicopathologic Study of Intrapancreatic Cancer Spread in Carcinoma of the Body and Tail of the Pancreas Clinicopathologic Study of Intrapancreatic Cancer Spread in Carcinoma of the Body and Tail of the Pancreas PANCREAS, 41, 5, 753-758 PANCREAS, 41, 5, 753-758 PANCREAS, 41, 5, 753-758 2012/07 英語 研究論文(学術雑誌) 公開
Tatsuro Yamaguchi, Yasuo Hamamoto, Tomohiro Nishina, Kentaro Yamazaki, Takashi Ura, Nakajima Takako, Ayumu Goto, Ken Shimada, Norisuke Nakayama, Junichi Sakamoto, Satoshi Morita, Yasuhide Yamada Tatsuro Yamaguchi, Yasuo Hamamoto, Tomohiro Nishina, Kentaro Yamazaki, Takashi Ura, Nakajima Takako, Ayumu Goto, Ken Shimada, Norisuke Nakayama, Junichi Sakamoto, Satoshi Morita, Yasuhide Yamada Tatsuro Yamaguchi, Yasuo Hamamoto, Tomohiro Nishina, Kentaro Yamazaki, Takashi Ura, Nakajima Takako, Ayumu Goto, Ken Shimada, Norisuke Nakayama, Junichi Sakamoto, Satoshi Morita, Yasuhide Yamada A PHASE I/II STUDY OF TRI-WEEKLY XELIRI PLUS BEVACIZUMAB FOR JAPANESE PATIENTS WITH MCRC AS SECOND-LINE CHEMOTHERAPY (BIX STUDY) A PHASE I/II STUDY OF TRI-WEEKLY XELIRI PLUS BEVACIZUMAB FOR JAPANESE PATIENTS WITH MCRC AS SECOND-LINE CHEMOTHERAPY (BIX STUDY) A PHASE I/II STUDY OF TRI-WEEKLY XELIRI PLUS BEVACIZUMAB FOR JAPANESE PATIENTS WITH MCRC AS SECOND-LINE CHEMOTHERAPY (BIX STUDY) ANNALS OF ONCOLOGY, 23, 99-99 ANNALS OF ONCOLOGY, 23, 99-99 ANNALS OF ONCOLOGY, 23, 99-99 2012/06 英語 公開
Satoshi Oizumi, Kunihiko Kobayashi, Akira Inoue, Makoto Maemondo, Shunichi Sugawara, Hirohisa Yoshizawa, Hiroshi Isobe, Masao Harada, Ichiro Kinoshita, Shoji Okinaga, Terufumi Kato, Toshiyuki Harada, Akihiko Gemma, Yasuo Saijo, Yuki Yokomizo, Satoshi Morita, Koichi Hagiwara, Toshihiro Nukiwa Satoshi Oizumi, Kunihiko Kobayashi, Akira Inoue, Makoto Maemondo, Shunichi Sugawara, Hirohisa Yoshizawa, Hiroshi Isobe, Masao Harada, Ichiro Kinoshita, Shoji Okinaga, Terufumi Kato, Toshiyuki Harada, Akihiko Gemma, Yasuo Saijo, Yuki Yokomizo, Satoshi Morita, Koichi Hagiwara, Toshihiro Nukiwa Satoshi Oizumi, Kunihiko Kobayashi, Akira Inoue, Makoto Maemondo, Shunichi Sugawara, Hirohisa Yoshizawa, Hiroshi Isobe, Masao Harada, Ichiro Kinoshita, Shoji Okinaga, Terufumi Kato, Toshiyuki Harada, Akihiko Gemma, Yasuo Saijo, Yuki Yokomizo, Satoshi Morita, Koichi Hagiwara, Toshihiro Nukiwa Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial ONCOLOGIST, 17, 6, 863-870 ONCOLOGIST, 17, 6, 863-870 ONCOLOGIST, 17, 6, 863-870 2012/06 英語 研究論文(学術雑誌) 公開
H. Hayashi, I. Okamoto, S. Morita, M. Taguri, K. Nakagawa H. Hayashi, I. Okamoto, S. Morita, M. Taguri, K. Nakagawa H. Hayashi, I. Okamoto, S. Morita, M. Taguri, K. Nakagawa Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer ANNALS OF ONCOLOGY, 23, 6, 1537-1541 ANNALS OF ONCOLOGY, 23, 6, 1537-1541 ANNALS OF ONCOLOGY, 23, 6, 1537-1541 2012/06 英語 研究論文(学術雑誌) 公開
Hideto Yano, Kiyoshi Hibi, Naoki Nozawa, Hiroyuki Ozaki, Ikuyoshi Kusama, Toshiaki Ebina, Masami Kosuge, Kengo Tsukahara, Jun Okuda, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Hideto Yano, Kiyoshi Hibi, Naoki Nozawa, Hiroyuki Ozaki, Ikuyoshi Kusama, Toshiaki Ebina, Masami Kosuge, Kengo Tsukahara, Jun Okuda, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Hideto Yano, Kiyoshi Hibi, Naoki Nozawa, Hiroyuki Ozaki, Ikuyoshi Kusama, Toshiaki Ebina, Masami Kosuge, Kengo Tsukahara, Jun Okuda, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor CIRCULATION JOURNAL, 76, 6, 1442-1451 CIRCULATION JOURNAL, 76, 6, 1442-1451 CIRCULATION JOURNAL, 76, 6, 1442-1451 2012/06 英語 研究論文(学術雑誌) 公開
Kaneda Hiroyasu, Urata Yoshiko, Okamoto Isamu, Hattori Yoshihiro, Okuno Keiko, Shimada Temiko, Takeda Masayuki, Kurata Takayasu, Miyazaki Masaki, Terashima Masaaki, Tanaka Kaoru, Kiyota Hidemi, Hayashi Hidetoshi, Kudo Toshihiro, Okabe Takafumi, Azuma Koichi, Morita Satoshi, Nakagawa Kazuhiko, Negoro Shunichi, Satouchi Miyako Kaneda Hiroyasu, Urata Yoshiko, Okamoto Isamu, Hattori Yoshihiro, Okuno Keiko, Shimada Temiko, Takeda Masayuki, Kurata Takayasu, Miyazaki Masaki, Terashima Masaaki, Tanaka Kaoru, Kiyota Hidemi, Hayashi Hidetoshi, Kudo Toshihiro, Okabe Takafumi, Azuma Koichi, Morita Satoshi, Nakagawa Kazuhiko, Negoro Shunichi, Satouchi Miyako Kaneda Hiroyasu, Urata Yoshiko, Okamoto Isamu, Hattori Yoshihiro, Okuno Keiko, Shimada Temiko, Takeda Masayuki, Kurata Takayasu, Miyazaki Masaki, Terashima Masaaki, Tanaka Kaoru, Kiyota Hidemi, Hayashi Hidetoshi, Kudo Toshihiro, Okabe Takafumi, Azuma Koichi, Morita Satoshi, Nakagawa Kazuhiko, Negoro Shunichi, Satouchi Miyako Oral S-1 and carboplatin plus bevacizumab with maintenance S-1 and bevacizumab for chemo-naive patients (Pts) with advanced non-squamous non-small cell lung cancer (NSCLC). Oral S-1 and carboplatin plus bevacizumab with maintenance S-1 and bevacizumab for chemo-naive patients (Pts) with advanced non-squamous non-small cell lung cancer (NSCLC). Oral S-1 and carboplatin plus bevacizumab with maintenance S-1 and bevacizumab for chemo-naive patients (Pts) with advanced non-squamous non-small cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY, 30, 15 JOURNAL OF CLINICAL ONCOLOGY, 30, 15 JOURNAL OF CLINICAL ONCOLOGY, 30, 15 2012/05/20 公開
Shoichi Fujii, Kazuteru Watanabe, Mitsuyoshi Ota, Jun Watanabe, Yasushi Ichikawa, Shigeru Yamagishi, Kenji Tatsumi, Hirokazu Suwa, Chikara Kunisaki, Masataka Taguri, Satoshi Morita, Itaru Endo Shoichi Fujii, Kazuteru Watanabe, Mitsuyoshi Ota, Jun Watanabe, Yasushi Ichikawa, Shigeru Yamagishi, Kenji Tatsumi, Hirokazu Suwa, Chikara Kunisaki, Masataka Taguri, Satoshi Morita, Itaru Endo Shoichi Fujii, Kazuteru Watanabe, Mitsuyoshi Ota, Jun Watanabe, Yasushi Ichikawa, Shigeru Yamagishi, Kenji Tatsumi, Hirokazu Suwa, Chikara Kunisaki, Masataka Taguri, Satoshi Morita, Itaru Endo Single-incision laparoscopic surgery using colon-lifting technique for colorectal cancer: a matched case-control comparison with standard multiport laparoscopic surgery in terms of short-term results and access instrument cost Single-incision laparoscopic surgery using colon-lifting technique for colorectal cancer: a matched case-control comparison with standard multiport laparoscopic surgery in terms of short-term results and access instrument cost Single-incision laparoscopic surgery using colon-lifting technique for colorectal cancer: a matched case-control comparison with standard multiport laparoscopic surgery in terms of short-term results and access instrument cost SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26, 5, 1403-1411 SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26, 5, 1403-1411 SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26, 5, 1403-1411 2012/05 英語 研究論文(学術雑誌) 公開
Kenzen Kou, Michiko Aihara, Tomoko Matsunaga, Huichin Chen, Masataka Taguri, Satoshi Morita, Hiroyuki Fujita, Yukie Yamaguchi, Takeshi Kambara, Zenro Ikezawa Kenzen Kou, Michiko Aihara, Tomoko Matsunaga, Huichin Chen, Masataka Taguri, Satoshi Morita, Hiroyuki Fujita, Yukie Yamaguchi, Takeshi Kambara, Zenro Ikezawa Kenzen Kou, Michiko Aihara, Tomoko Matsunaga, Huichin Chen, Masataka Taguri, Satoshi Morita, Hiroyuki Fujita, Yukie Yamaguchi, Takeshi Kambara, Zenro Ikezawa Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis ARCHIVES OF DERMATOLOGICAL RESEARCH, 304, 4, 305-312 ARCHIVES OF DERMATOLOGICAL RESEARCH, 304, 4, 305-312 ARCHIVES OF DERMATOLOGICAL RESEARCH, 304, 4, 305-312 2012/05 英語 研究論文(学術雑誌) 公開
Takaki Yoshikawa, Naoki Hiki, Masataka Taguri, Takeshi Sano, Souya Nunobe, Hideki Taniguchi, Ryoji Fukushima, Haruhiko Cho, Satoshi Morita, Akira Tsuburaya Takaki Yoshikawa, Naoki Hiki, Masataka Taguri, Takeshi Sano, Souya Nunobe, Hideki Taniguchi, Ryoji Fukushima, Haruhiko Cho, Satoshi Morita, Akira Tsuburaya Takaki Yoshikawa, Naoki Hiki, Masataka Taguri, Takeshi Sano, Souya Nunobe, Hideki Taniguchi, Ryoji Fukushima, Haruhiko Cho, Satoshi Morita, Akira Tsuburaya A Phase III Trial to Evaluate the Effect of Perioperative Nutrition Enriched with Eicosapentaenoic Acid on Body Weight Loss after Total Gastrectomy for T2T4a Gastric Cancer A Phase III Trial to Evaluate the Effect of Perioperative Nutrition Enriched with Eicosapentaenoic Acid on Body Weight Loss after Total Gastrectomy for T2T4a Gastric Cancer A Phase III Trial to Evaluate the Effect of Perioperative Nutrition Enriched with Eicosapentaenoic Acid on Body Weight Loss after Total Gastrectomy for T2T4a Gastric Cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 5, 459-462 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 5, 459-462 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 5, 459-462 2012/05 英語 研究論文(学術雑誌) 公開
Yasuyoshi Chiba, Manabu Kinoshita, Yoshiko Okita, Akihito Tsuboi, Kayako Isohashi, Naoki Kagawa, Yasunori Fujimoto, Yusuke Oji, Yoshihiro Oka, Eku Shimosegawa, Satoshi Morita, Jun Hatazawa, Haruo Sugiyama, Naoya Hashimoto, Toshiki Yoshimine Yasuyoshi Chiba, Manabu Kinoshita, Yoshiko Okita, Akihito Tsuboi, Kayako Isohashi, Naoki Kagawa, Yasunori Fujimoto, Yusuke Oji, Yoshihiro Oka, Eku Shimosegawa, Satoshi Morita, Jun Hatazawa, Haruo Sugiyama, Naoya Hashimoto, Toshiki Yoshimine Yasuyoshi Chiba, Manabu Kinoshita, Yoshiko Okita, Akihito Tsuboi, Kayako Isohashi, Naoki Kagawa, Yasunori Fujimoto, Yusuke Oji, Yoshihiro Oka, Eku Shimosegawa, Satoshi Morita, Jun Hatazawa, Haruo Sugiyama, Naoya Hashimoto, Toshiki Yoshimine Use of C-11-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma Clinical article Use of C-11-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma Clinical article Use of C-11-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma Clinical article JOURNAL OF NEUROSURGERY, 116, 4, 835-842 JOURNAL OF NEUROSURGERY, 116, 4, 835-842 JOURNAL OF NEUROSURGERY, 116, 4, 835-842 2012/04 英語 研究論文(学術雑誌) 公開
S. Miyatake, N. Miyake, H. Touho, A. Nishimura-Tadaki, Y. Kondo, I. Okada, Y. Tsurusaki, H. Doi, H. Sakai, H. Saitsu, K. Shimojima, T. Yamamoto, M. Higurashi, N. Kawahara, H. Kawauchi, K. Nagasaka, N. Okamoto, T. Mori, S. Koyano, Y. Kuroiwa, M. Taguri, S. Morita, Y. Matsubara, S. Kure, N. Matsumoto S. Miyatake, N. Miyake, H. Touho, A. Nishimura-Tadaki, Y. Kondo, I. Okada, Y. Tsurusaki, H. Doi, H. Sakai, H. Saitsu, K. Shimojima, T. Yamamoto, M. Higurashi, N. Kawahara, H. Kawauchi, K. Nagasaka, N. Okamoto, T. Mori, S. Koyano, Y. Kuroiwa, M. Taguri, S. Morita, Y. Matsubara, S. Kure, N. Matsumoto S. Miyatake, N. Miyake, H. Touho, A. Nishimura-Tadaki, Y. Kondo, I. Okada, Y. Tsurusaki, H. Doi, H. Sakai, H. Saitsu, K. Shimojima, T. Yamamoto, M. Higurashi, N. Kawahara, H. Kawauchi, K. Nagasaka, N. Okamoto, T. Mori, S. Koyano, Y. Kuroiwa, M. Taguri, S. Morita, Y. Matsubara, S. Kure, N. Matsumoto Homozygous c.14576G &gt; A variant of RNF213 predicts early-onset and severe form of moyamoya disease Homozygous c.14576G &gt; A variant of RNF213 predicts early-onset and severe form of moyamoya disease Homozygous c.14576G &gt; A variant of RNF213 predicts early-onset and severe form of moyamoya disease NEUROLOGY, 78, 11, 803-810 NEUROLOGY, 78, 11, 803-810 NEUROLOGY, 78, 11, 803-810 2012/03 英語 研究論文(学術雑誌) 公開
Takuma Higurashi, Hirokazu Takahashi, Hiroki Endo, Kunihiro Hosono, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Takashi Uchiyama, Yasuo Hata, Nobutaka Fujisawa, Shiori Uchiyama, Akiko Ezuka, Hajime Nagase, Takaomi Kessoku, Nobuyuki Matsuhashi, Shoji Yamanaka, Yoshiaki Inayama, Satoshi Morita, Atsushi Nakajima Takuma Higurashi, Hirokazu Takahashi, Hiroki Endo, Kunihiro Hosono, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Takashi Uchiyama, Yasuo Hata, Nobutaka Fujisawa, Shiori Uchiyama, Akiko Ezuka, Hajime Nagase, Takaomi Kessoku, Nobuyuki Matsuhashi, Shoji Yamanaka, Yoshiaki Inayama, Satoshi Morita, Atsushi Nakajima Takuma Higurashi, Hirokazu Takahashi, Hiroki Endo, Kunihiro Hosono, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Takashi Uchiyama, Yasuo Hata, Nobutaka Fujisawa, Shiori Uchiyama, Akiko Ezuka, Hajime Nagase, Takaomi Kessoku, Nobuyuki Matsuhashi, Shoji Yamanaka, Yoshiaki Inayama, Satoshi Morita, Atsushi Nakajima Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial BMC CANCER, 12 BMC CANCER, 12 BMC CANCER, 12 2012/03 英語 研究論文(学術雑誌) 公開
Shinju Arata, Junichi Suzuki, Yoshihiro Moriwaki, Noriyuki Suzuki, Masayuki Iwashita, Mitsugi Sugiyama, Satoshi Morita Shinju Arata, Junichi Suzuki, Yoshihiro Moriwaki, Noriyuki Suzuki, Masayuki Iwashita, Mitsugi Sugiyama, Satoshi Morita Shinju Arata, Junichi Suzuki, Yoshihiro Moriwaki, Noriyuki Suzuki, Masayuki Iwashita, Mitsugi Sugiyama, Satoshi Morita Characteristics of high-echoic objects in the hepatic vessels of patients with cardiopulmonary arrest: a prospective cohort study Characteristics of high-echoic objects in the hepatic vessels of patients with cardiopulmonary arrest: a prospective cohort study Characteristics of high-echoic objects in the hepatic vessels of patients with cardiopulmonary arrest: a prospective cohort study EMERGENCY MEDICINE JOURNAL, 29, 3, 213-218 EMERGENCY MEDICINE JOURNAL, 29, 3, 213-218 EMERGENCY MEDICINE JOURNAL, 29, 3, 213-218 2012/03 英語 研究論文(学術雑誌) 公開
Chikara Kunisaki, Hirochika Makino, Takashi Kosaka, Takashi Oshima, Shoichi Fujii, Ryo Takagawa, Jun Kimura, Hidetaka A. Ono, Hirotoshi Akiyama, Masataka Taguri, Satoshi Morita, Itaru Endo Chikara Kunisaki, Hirochika Makino, Takashi Kosaka, Takashi Oshima, Shoichi Fujii, Ryo Takagawa, Jun Kimura, Hidetaka A. Ono, Hirotoshi Akiyama, Masataka Taguri, Satoshi Morita, Itaru Endo Chikara Kunisaki, Hirochika Makino, Takashi Kosaka, Takashi Oshima, Shoichi Fujii, Ryo Takagawa, Jun Kimura, Hidetaka A. Ono, Hirotoshi Akiyama, Masataka Taguri, Satoshi Morita, Itaru Endo Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: a case-control study Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: a case-control study Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: a case-control study SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26, 3, 804-810 SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26, 3, 804-810 SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26, 3, 804-810 2012/03 英語 研究論文(学術雑誌) 公開
Kobayashi Michiya, Tsuburaya Akira, Yoshida Kazuhiro, Yoshino Shigefumi, Miyashita Yumi, Morita Satoshi, Oba Koji, Buyse Marc E Kobayashi Michiya, Tsuburaya Akira, Yoshida Kazuhiro, Yoshino Shigefumi, Miyashita Yumi, Morita Satoshi, Oba Koji, Buyse Marc E Kobayashi Michiya, Tsuburaya Akira, Yoshida Kazuhiro, Yoshino Shigefumi, Miyashita Yumi, Morita Satoshi, Oba Koji, Buyse Marc E Adjuvant paclitaxel followed by oral fluoropyrimidines for gastric cancer: Safety data of the factorial phase III SAMIT trial. Adjuvant paclitaxel followed by oral fluoropyrimidines for gastric cancer: Safety data of the factorial phase III SAMIT trial. Adjuvant paclitaxel followed by oral fluoropyrimidines for gastric cancer: Safety data of the factorial phase III SAMIT trial. JOURNAL OF CLINICAL ONCOLOGY, 30, 4 JOURNAL OF CLINICAL ONCOLOGY, 30, 4 JOURNAL OF CLINICAL ONCOLOGY, 30, 4 2012/02/01 公開
Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Noriaki Iwahashi, Kengo Tsukahara, Mitsuaki Endo, Nobuhiko Maejima, Zenko Nagashima, Hiroyuki Suzuki, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Noriaki Iwahashi, Kengo Tsukahara, Mitsuaki Endo, Nobuhiko Maejima, Zenko Nagashima, Hiroyuki Suzuki, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Noriaki Iwahashi, Kengo Tsukahara, Mitsuaki Endo, Nobuhiko Maejima, Zenko Nagashima, Hiroyuki Suzuki, Satoshi Morita, Satoshi Umemura, Kazuo Kimura Differences in Negative T Waves Between Takotsubo Cardiomyopathy and Reperfused Anterior Acute Myocardial Infarction Differences in Negative T Waves Between Takotsubo Cardiomyopathy and Reperfused Anterior Acute Myocardial Infarction Differences in Negative T Waves Between Takotsubo Cardiomyopathy and Reperfused Anterior Acute Myocardial Infarction CIRCULATION JOURNAL, 76, 2, 462-468 CIRCULATION JOURNAL, 76, 2, 462-468 CIRCULATION JOURNAL, 76, 2, 462-468 2012/02 英語 研究論文(学術雑誌) 公開
Shoichi Fujii, Kazuteru Watanabe, Mitsuyoshi Ota, Jun Watanabe, Yasushi Ichikawa, Shigeru Yamagishi, Kenji Tatsumi, Hirokazu Suwa, Chikara Kunisaki, Masataka Taguri, Satoshi Morita, Itaru Endo Shoichi Fujii, Kazuteru Watanabe, Mitsuyoshi Ota, Jun Watanabe, Yasushi Ichikawa, Shigeru Yamagishi, Kenji Tatsumi, Hirokazu Suwa, Chikara Kunisaki, Masataka Taguri, Satoshi Morita, Itaru Endo Shoichi Fujii, Kazuteru Watanabe, Mitsuyoshi Ota, Jun Watanabe, Yasushi Ichikawa, Shigeru Yamagishi, Kenji Tatsumi, Hirokazu Suwa, Chikara Kunisaki, Masataka Taguri, Satoshi Morita, Itaru Endo Laparoscopic Colorectal Cancer Surgery by a Colon Lifting-up Technique That Decreases the Number of Access Ports: Comparison by Propensity Scoring of Short-term and Long-term Outcomes With Standard Multiport Laparoscopic Surgery Laparoscopic Colorectal Cancer Surgery by a Colon Lifting-up Technique That Decreases the Number of Access Ports: Comparison by Propensity Scoring of Short-term and Long-term Outcomes With Standard Multiport Laparoscopic Surgery Laparoscopic Colorectal Cancer Surgery by a Colon Lifting-up Technique That Decreases the Number of Access Ports: Comparison by Propensity Scoring of Short-term and Long-term Outcomes With Standard Multiport Laparoscopic Surgery SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 22, 1, 38-45 SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 22, 1, 38-45 SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 22, 1, 38-45 2012/02 英語 研究論文(学術雑誌) 公開
A. Asai, T.T. Ishii, H. Isobe, R. Kitai, K. Ichimoto, S. Ueno, S. Nagata, S. Morita, K. Nishida, D. Shiota, A. Oi, M. Akioka, K. Shibata A. Asai, T.T. Ishii, H. Isobe, R. Kitai, K. Ichimoto, S. Ueno, S. Nagata, S. Morita, K. Nishida, D. Shiota, A. Oi, M. Akioka, K. Shibata Ayumi Asai, Takako T. Ishii, Hiroaki Isobe, Reizaburo Kitai, Kiyoshi Ichimoto, Satoru UeNo, Shin'ichi Nagata, Satoshi Morita, Keisuke Nishida, Daikou Shiota, Akihito Oi, Maki Akioka, Kazunari Shibata First simultaneous observation of AN Hα Moreton wave, EUV wave, and filament/prominence oscillations First simultaneous observation of AN Hα Moreton wave, EUV wave, and filament/prominence oscillations FIRST SIMULTANEOUS OBSERVATION OF AN H alpha MORETON WAVE, EUV WAVE, AND FILAMENT/PROMINENCE OSCILLATIONS Astrophysical Journal Letters, 745, 2 Astrophysical Journal Letters, 745, 2 ASTROPHYSICAL JOURNAL LETTERS, 745, 2 2012/02 英語 研究論文(学術雑誌) 公開
Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Noriaki Iwahashi, Satoshi Morita, Mitsuaki Endo, Nobuhiki Maejima, Masaomi Gouhara, Zenkou Nagashima, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Noriaki Iwahashi, Satoshi Morita, Mitsuaki Endo, Nobuhiki Maejima, Masaomi Gouhara, Zenkou Nagashima, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Noriaki Iwahashi, Satoshi Morita, Mitsuaki Endo, Nobuhiki Maejima, Masaomi Gouhara, Zenkou Nagashima, Satoshi Umemura, Kazuo Kimura Implications of ST-Segment Elevation in Leads V-5 and V-6 in Patients With Reperfused Inferior Wall Acute Myocardial Infarction Implications of ST-Segment Elevation in Leads V-5 and V-6 in Patients With Reperfused Inferior Wall Acute Myocardial Infarction Implications of ST-Segment Elevation in Leads V-5 and V-6 in Patients With Reperfused Inferior Wall Acute Myocardial Infarction AMERICAN JOURNAL OF CARDIOLOGY, 109, 3, 314-319 AMERICAN JOURNAL OF CARDIOLOGY, 109, 3, 314-319 AMERICAN JOURNAL OF CARDIOLOGY, 109, 3, 314-319 2012/02 英語 研究論文(学術雑誌) 公開
S. Morita, K. Shibata, S. Ueno, K. Ichimoto, R. Kitai, K. Otsuji S. Morita, K. Shibata, S. Ueno, K. Ichimoto, R. Kitai, K. Otsuji S. Morita, K. Shibata, S. Ueno, K. Ichimoto, R. Kitai, K. Otsuji Chromospheric Anemone Jets Observed with Hinode/SOT and Hida Ca II Spectroheliograph Chromospheric Anemone Jets Observed with Hinode/SOT and Hida Ca II Spectroheliograph Chromospheric Anemone Jets Observed with Hinode/SOT and Hida Ca II Spectroheliograph HINODE-3: THE 3RD HINODE SCIENCE MEETING, 454, 95-98 HINODE-3: THE 3RD HINODE SCIENCE MEETING, 454, 95-98 HINODE-3: THE 3RD HINODE SCIENCE MEETING, 454, 95-98 2012 英語 研究論文(国際会議プロシーディングス) 公開
Hideyuki Nagakura, Masanori Nishikawa, Nobuko Kusano, Mari Saito, Satoshi Morita, Takeshi Kaneko, Yoshiaki Ishigatsubo Hideyuki Nagakura, Masanori Nishikawa, Nobuko Kusano, Mari Saito, Satoshi Morita, Takeshi Kaneko, Yoshiaki Ishigatsubo Hideyuki Nagakura, Masanori Nishikawa, Nobuko Kusano, Mari Saito, Satoshi Morita, Takeshi Kaneko, Yoshiaki Ishigatsubo The Impact of a Negative History of Smoking on Survival in Patients with Non-Small Cell Lung Cancer Detected with Clinic-based Screening Programs The Impact of a Negative History of Smoking on Survival in Patients with Non-Small Cell Lung Cancer Detected with Clinic-based Screening Programs The Impact of a Negative History of Smoking on Survival in Patients with Non-Small Cell Lung Cancer Detected with Clinic-based Screening Programs INTERNAL MEDICINE, 51, 22, 3115-3118 INTERNAL MEDICINE, 51, 22, 3115-3118 INTERNAL MEDICINE, 51, 22, 3115-3118 2012 英語 研究論文(学術雑誌) 公開
Takashi Ishikawa, Daisuke Shimizu, Akimitsu Yamada, Takeshi Sasaki, Satoshi Morita, Mikiko Tanabe, Kae Kawachi, Akinori Nozawa, Takashi Chishima, Mariko Kimura, Yasushi Ichikawa, Itaru Endo Takashi Ishikawa, Daisuke Shimizu, Akimitsu Yamada, Takeshi Sasaki, Satoshi Morita, Mikiko Tanabe, Kae Kawachi, Akinori Nozawa, Takashi Chishima, Mariko Kimura, Yasushi Ichikawa, Itaru Endo Takashi Ishikawa, Daisuke Shimizu, Akimitsu Yamada, Takeshi Sasaki, Satoshi Morita, Mikiko Tanabe, Kae Kawachi, Akinori Nozawa, Takashi Chishima, Mariko Kimura, Yasushi Ichikawa, Itaru Endo Impacts and Predictors of Cytotoxic Anticancer Agents in Different Breast Cancer Subtypes Impacts and Predictors of Cytotoxic Anticancer Agents in Different Breast Cancer Subtypes Impacts and Predictors of Cytotoxic Anticancer Agents in Different Breast Cancer Subtypes ONCOLOGY RESEARCH, 20, 2-3, 71-79 ONCOLOGY RESEARCH, 20, 2-3, 71-79 ONCOLOGY RESEARCH, 20, 2-3, 71-79 2012 英語 研究論文(学術雑誌) 公開
Erina Shigematsu, Tadashi Yamakawa, Masataka Taguri, Satoshi Morita, Mikiya Tokui, Kazunori Miyamoto, Osamu Funae, Yoji Takatuka, Kazuaki Kadonosono, Hiroshi Shigematsu, Yasuo Terauchi Erina Shigematsu, Tadashi Yamakawa, Masataka Taguri, Satoshi Morita, Mikiya Tokui, Kazunori Miyamoto, Osamu Funae, Yoji Takatuka, Kazuaki Kadonosono, Hiroshi Shigematsu, Yasuo Terauchi Erina Shigematsu, Tadashi Yamakawa, Masataka Taguri, Satoshi Morita, Mikiya Tokui, Kazunori Miyamoto, Osamu Funae, Yoji Takatuka, Kazuaki Kadonosono, Hiroshi Shigematsu, Yasuo Terauchi Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 19, 9, 846-853 JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 19, 9, 846-853 JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 19, 9, 846-853 2012 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Peter F. Thall, Peter Mueller Satoshi Morita, Peter F. Thall, Peter Mueller Satoshi Morita, Peter F. Thall, Peter Mueller Prior Effective Sample Size in Conditionally Independent Hierarchical Models Prior Effective Sample Size in Conditionally Independent Hierarchical Models Prior Effective Sample Size in Conditionally Independent Hierarchical Models BAYESIAN ANALYSIS, 7, 3, 591-614 BAYESIAN ANALYSIS, 7, 3, 591-614 BAYESIAN ANALYSIS, 7, 3, 591-614 2012 英語 研究論文(学術雑誌) 公開
S. Arata, Y. Moriwaki, K. Takayama, M. Morimoto, K. Numata, M. Taguri, S. Morita, H. Imanari, K. Tanaka S. Arata, Y. Moriwaki, K. Takayama, M. Morimoto, K. Numata, M. Taguri, S. Morita, H. Imanari, K. Tanaka S. Arata, Y. Moriwaki, K. Takayama, M. Morimoto, K. Numata, M. Taguri, S. Morita, H. Imanari, K. Tanaka Establishment of artificial liver support by on-line hemodiafiltration for patients with acute liver failure Establishment of artificial liver support by on-line hemodiafiltration for patients with acute liver failure Establishment of artificial liver support by on-line hemodiafiltration for patients with acute liver failure Acta Hepatologica Japonica, 53, 1, 7-17 Acta Hepatologica Japonica, 53, 1, 7-17 Acta Hepatologica Japonica, 53, 1, 7-17 2012 英語 公開
Tsutomu Fujii, Mitsuro Kanda, Yasuhiro Kodera, Shunji Nagai, Tevfik T. Sahin, Masamichi Hayashi, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Tsutomu Fujii, Mitsuro Kanda, Yasuhiro Kodera, Shunji Nagai, Tevfik T. Sahin, Masamichi Hayashi, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Tsutomu Fujii, Mitsuro Kanda, Yasuhiro Kodera, Shunji Nagai, Tevfik T. Sahin, Masamichi Hayashi, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Preservation of the Pyloric Ring Has Little Value in Surgery for Pancreatic Head Cancer: A Comparative Study Comparing Three Surgical Procedures Preservation of the Pyloric Ring Has Little Value in Surgery for Pancreatic Head Cancer: A Comparative Study Comparing Three Surgical Procedures Preservation of the Pyloric Ring Has Little Value in Surgery for Pancreatic Head Cancer: A Comparative Study Comparing Three Surgical Procedures ANNALS OF SURGICAL ONCOLOGY, 19, 1, 176-183 ANNALS OF SURGICAL ONCOLOGY, 19, 1, 176-183 ANNALS OF SURGICAL ONCOLOGY, 19, 1, 176-183 2012/01 英語 研究論文(学術雑誌) 公開
Takaki Yoshikawa, Masataka Taguri, Shinichi Sakuramoto, Chikara Kunisaki, Tetsu Fukunaga, Seiji Ito, Haruhiko Cho, Kazuaki Tanabe, Kazuhiro Nishikawa, Takanori Matsui, Satoshi Morita, Akira Tsuburaya Takaki Yoshikawa, Masataka Taguri, Shinichi Sakuramoto, Chikara Kunisaki, Tetsu Fukunaga, Seiji Ito, Haruhiko Cho, Kazuaki Tanabe, Kazuhiro Nishikawa, Takanori Matsui, Satoshi Morita, Akira Tsuburaya Takaki Yoshikawa, Masataka Taguri, Shinichi Sakuramoto, Chikara Kunisaki, Tetsu Fukunaga, Seiji Ito, Haruhiko Cho, Kazuaki Tanabe, Kazuhiro Nishikawa, Takanori Matsui, Satoshi Morita, Akira Tsuburaya A Comparison of Multimodality Treatment: Two and Four Courses of Neoadjuvant Chemotherapy Using S-1/CDDP or S-1/CDDP/Docetaxel Followed by Surgery and S-1 Adjuvant Chemotherapy for Macroscopically Resectable Serosa-positive Gastric Cancer: A Randomized Phase II Trial (COMPASS-D Trial) A Comparison of Multimodality Treatment: Two and Four Courses of Neoadjuvant Chemotherapy Using S-1/CDDP or S-1/CDDP/Docetaxel Followed by Surgery and S-1 Adjuvant Chemotherapy for Macroscopically Resectable Serosa-positive Gastric Cancer: A Randomized Phase II Trial (COMPASS-D Trial) A Comparison of Multimodality Treatment: Two and Four Courses of Neoadjuvant Chemotherapy Using S-1/CDDP or S-1/CDDP/Docetaxel Followed by Surgery and S-1 Adjuvant Chemotherapy for Macroscopically Resectable Serosa-positive Gastric Cancer: A Randomized Phase II Trial (COMPASS-D Trial) JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 1, 74-77 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 1, 74-77 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 1, 74-77 2012/01 英語 研究論文(学術雑誌) 公開
Akimasa Nakao, Akiyuki Kanzaki, Tsutomu Fujii, Yasuhiro Kodera, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shigeo Nakamura, Satoshi Morita, Shin Takeda Akimasa Nakao, Akiyuki Kanzaki, Tsutomu Fujii, Yasuhiro Kodera, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shigeo Nakamura, Satoshi Morita, Shin Takeda Akimasa Nakao, Akiyuki Kanzaki, Tsutomu Fujii, Yasuhiro Kodera, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shigeo Nakamura, Satoshi Morita, Shin Takeda Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer ANNALS OF SURGERY, 255, 1, 103-108 ANNALS OF SURGERY, 255, 1, 103-108 ANNALS OF SURGERY, 255, 1, 103-108 2012/01 英語 研究論文(学術雑誌) 公開
Masakatsu Yanagimachi, Hiroaki Goto, Takako Miyamae, Keisuke Kadota, Tomoyuki Imagawa, Masaaki Mori, Hidenori Sato, Ryu Yanagisawa, Tetsuji Kaneko, Satoshi Morita, Eiichi Ishii, Shumpei Yokota Masakatsu Yanagimachi, Hiroaki Goto, Takako Miyamae, Keisuke Kadota, Tomoyuki Imagawa, Masaaki Mori, Hidenori Sato, Ryu Yanagisawa, Tetsuji Kaneko, Satoshi Morita, Eiichi Ishii, Shumpei Yokota Masakatsu Yanagimachi, Hiroaki Goto, Takako Miyamae, Keisuke Kadota, Tomoyuki Imagawa, Masaaki Mori, Hidenori Sato, Ryu Yanagisawa, Tetsuji Kaneko, Satoshi Morita, Eiichi Ishii, Shumpei Yokota Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. J. Clin. Immunol., 31, 6, 946-951 J. Clin. Immunol., 31, 6, 946-951 J. Clin. Immunol., 31, 6, 946-951 2011/12 英語 研究論文(学術雑誌) 公開
Minoru Kubota, Makoto Hiramatsu, Masato Yamakawa, Shunichi Fukuhara, Satoshi Morita, Manabu Iwasaki, Tadao Akizawa Minoru Kubota, Makoto Hiramatsu, Masato Yamakawa, Shunichi Fukuhara, Satoshi Morita, Manabu Iwasaki, Tadao Akizawa Minoru Kubota, Makoto Hiramatsu, Masato Yamakawa, Shunichi Fukuhara, Satoshi Morita, Manabu Iwasaki, Tadao Akizawa Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan CLINICAL AND EXPERIMENTAL NEPHROLOGY, 15, 6, 884-892 CLINICAL AND EXPERIMENTAL NEPHROLOGY, 15, 6, 884-892 CLINICAL AND EXPERIMENTAL NEPHROLOGY, 15, 6, 884-892 2011/12 英語 研究論文(学術雑誌) 公開
Masakatsu Yanagimachi, Hiroaki Goto, Takako Miyamae, Keisuke Kadota, Tomoyuki Imagawa, Masaaki Mori, Hidenori Sato, Ryu Yanagisawa, Tetsuji Kaneko, Satoshi Morita, Eiichi Ishii, Shumpei Yokota Masakatsu Yanagimachi, Hiroaki Goto, Takako Miyamae, Keisuke Kadota, Tomoyuki Imagawa, Masaaki Mori, Hidenori Sato, Ryu Yanagisawa, Tetsuji Kaneko, Satoshi Morita, Eiichi Ishii, Shumpei Yokota Masakatsu Yanagimachi, Hiroaki Goto, Takako Miyamae, Keisuke Kadota, Tomoyuki Imagawa, Masaaki Mori, Hidenori Sato, Ryu Yanagisawa, Tetsuji Kaneko, Satoshi Morita, Eiichi Ishii, Shumpei Yokota Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children JOURNAL OF CLINICAL IMMUNOLOGY, 31, 6, 946-951 JOURNAL OF CLINICAL IMMUNOLOGY, 31, 6, 946-951 JOURNAL OF CLINICAL IMMUNOLOGY, 31, 6, 946-951 2011/12 英語 研究論文(学術雑誌) 公開
Masaru Ito, Takeshi Kaneko, Hideto Goto, Nobuhiro Yamaguchi, Shin Fujisawa, Shigeru Ono, Satoshi Morita, Naoki Miyazawa, Heiwa Kanamori, Yuji Watanuki, Yoshiaki Ishigatsubo Masaru Ito, Takeshi Kaneko, Hideto Goto, Nobuhiro Yamaguchi, Shin Fujisawa, Shigeru Ono, Satoshi Morita, Naoki Miyazawa, Heiwa Kanamori, Yuji Watanuki, Yoshiaki Ishigatsubo Masaru Ito, Takeshi Kaneko, Hideto Goto, Nobuhiro Yamaguchi, Shin Fujisawa, Shigeru Ono, Satoshi Morita, Naoki Miyazawa, Heiwa Kanamori, Yuji Watanuki, Yoshiaki Ishigatsubo Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP JOURNAL OF INFECTION AND CHEMOTHERAPY, 17, 6, 770-775 JOURNAL OF INFECTION AND CHEMOTHERAPY, 17, 6, 770-775 JOURNAL OF INFECTION AND CHEMOTHERAPY, 17, 6, 770-775 2011/12 英語 研究論文(学術雑誌) 公開
Xiaoying Wang, Ryogo Akasaka, Chie Takemoto, Satoshi Morita, Machiko Yamaguchi, Takaho Terada, Mikako Shirozu, Shigeyuki Yokoyama, Shilin Chen, Shuyi Si, Yong Xie Xiaoying Wang, Ryogo Akasaka, Chie Takemoto, Satoshi Morita, Machiko Yamaguchi, Takaho Terada, Mikako Shirozu, Shigeyuki Yokoyama, Shilin Chen, Shuyi Si, Yong Xie Xiaoying Wang, Ryogo Akasaka, Chie Takemoto, Satoshi Morita, Machiko Yamaguchi, Takaho Terada, Mikako Shirozu, Shigeyuki Yokoyama, Shilin Chen, Shuyi Si, Yong Xie Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3 Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3 Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3 ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS, 67, 12, 1551-1555 ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS, 67, 12, 1551-1555 ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS, 67, 12, 1551-1555 2011/12 英語 研究論文(学術雑誌) 公開
Kingo Hirasawa, Atsushi Kokawa, Hiroyuki Oka, Sei Yahara, Takeshi Sasaki, Akinori Nozawa, Manabu Morimoto, Kazushi Numata, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Kingo Hirasawa, Atsushi Kokawa, Hiroyuki Oka, Sei Yahara, Takeshi Sasaki, Akinori Nozawa, Manabu Morimoto, Kazushi Numata, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Kingo Hirasawa, Atsushi Kokawa, Hiroyuki Oka, Sei Yahara, Takeshi Sasaki, Akinori Nozawa, Manabu Morimoto, Kazushi Numata, Masataka Taguri, Satoshi Morita, Shin Maeda, Katsuaki Tanaka Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection GASTROINTESTINAL ENDOSCOPY, 74, 6, 1268-1275 GASTROINTESTINAL ENDOSCOPY, 74, 6, 1268-1275 GASTROINTESTINAL ENDOSCOPY, 74, 6, 1268-1275 2011/12 英語 研究論文(学術雑誌) 公開
K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 2011/11 英語 研究論文(学術雑誌) 公開
Shingo Kato, Kensuke Kubota, Takeshi Shimamura, Yoshiyasu Shinohara, Noritoshi Kobayashi, Seitaro Watanabe, Masato Yoneda, Masahiko Inamori, Fumio Nakamura, Hitoshi Ishiguro, Noboru Nakaigawa, Yoji Nagashima, Masataka Taguri, Yoshinobu Kubota, Yoshio Goshima, Satoshi Morita, Itaru Endo, Shin Maeda, Atsushi Nakajima, Hitoshi Nakagama Shingo Kato, Kensuke Kubota, Takeshi Shimamura, Yoshiyasu Shinohara, Noritoshi Kobayashi, Seitaro Watanabe, Masato Yoneda, Masahiko Inamori, Fumio Nakamura, Hitoshi Ishiguro, Noboru Nakaigawa, Yoji Nagashima, Masataka Taguri, Yoshinobu Kubota, Yoshio Goshima, Satoshi Morita, Itaru Endo, Shin Maeda, Atsushi Nakajima, Hitoshi Nakagama Shingo Kato, Kensuke Kubota, Takeshi Shimamura, Yoshiyasu Shinohara, Noritoshi Kobayashi, Seitaro Watanabe, Masato Yoneda, Masahiko Inamori, Fumio Nakamura, Hitoshi Ishiguro, Noboru Nakaigawa, Yoji Nagashima, Masataka Taguri, Yoshinobu Kubota, Yoshio Goshima, Satoshi Morita, Itaru Endo, Shin Maeda, Atsushi Nakajima, Hitoshi Nakagama Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer CANCER SCIENCE, 102, 11, 2029-2037 CANCER SCIENCE, 102, 11, 2029-2037 CANCER SCIENCE, 102, 11, 2029-2037 2011/11 英語 研究論文(学術雑誌) 公開
Tsutomu Fujii, Mitsuro Kanda, Yasuhiro Kodera, Shunji Nagai, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Satoshi Morita, Shin Takeda, Akimasa Nakao Tsutomu Fujii, Mitsuro Kanda, Yasuhiro Kodera, Shunji Nagai, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Satoshi Morita, Shin Takeda, Akimasa Nakao Tsutomu Fujii, Mitsuro Kanda, Yasuhiro Kodera, Shunji Nagai, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Satoshi Morita, Shin Takeda, Akimasa Nakao Comparison of Pancreatic Head Resection With Segmental Duodenectomy and Pylorus-Preserving Pancreatoduodenectomy for Benign and Low-Grade Malignant Neoplasms of the Pancreatic Head Comparison of Pancreatic Head Resection With Segmental Duodenectomy and Pylorus-Preserving Pancreatoduodenectomy for Benign and Low-Grade Malignant Neoplasms of the Pancreatic Head Comparison of Pancreatic Head Resection With Segmental Duodenectomy and Pylorus-Preserving Pancreatoduodenectomy for Benign and Low-Grade Malignant Neoplasms of the Pancreatic Head PANCREAS, 40, 8, 1258-1263 PANCREAS, 40, 8, 1258-1263 PANCREAS, 40, 8, 1258-1263 2011/11 英語 研究論文(学術雑誌) 公開
Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Shiro Fujita, Kei Kunimasa, Shigeki Nanjo, Kyoko Otsuka, Reiko Kaji, Keisuke Tomii, Masahiro Iwasaku, Akihiro Nishiyama, Hidetoshi Hayashi, Satoshi Morita, Tadashi Ishida Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Shiro Fujita, Kei Kunimasa, Shigeki Nanjo, Kyoko Otsuka, Reiko Kaji, Keisuke Tomii, Masahiro Iwasaku, Akihiro Nishiyama, Hidetoshi Hayashi, Satoshi Morita, Tadashi Ishida Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Shiro Fujita, Kei Kunimasa, Shigeki Nanjo, Kyoko Otsuka, Reiko Kaji, Keisuke Tomii, Masahiro Iwasaku, Akihiro Nishiyama, Hidetoshi Hayashi, Satoshi Morita, Tadashi Ishida Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection LUNG CANCER, 74, 2, 268-273 LUNG CANCER, 74, 2, 268-273 LUNG CANCER, 74, 2, 268-273 2011/11 英語 研究論文(学術雑誌) 公開
Tadao Akizawa, Fumitake Gejyo, Shinichi Nishi, Yasuhiko Iino, Yuzou Watanabe, Masashi Suzuki, Akira Saito, Takashi Akiba, Hideki Hirakata, Shunichi Fukuhara, Satoshi Morita, Michiaki Hiroe, Yoshiyuki Hada, Makoto Suzuki, Makoto Akaishi, Manabu Iwasaki, Yoshiharu Tsubakihara Tadao Akizawa, Fumitake Gejyo, Shinichi Nishi, Yasuhiko Iino, Yuzou Watanabe, Masashi Suzuki, Akira Saito, Takashi Akiba, Hideki Hirakata, Shunichi Fukuhara, Satoshi Morita, Michiaki Hiroe, Yoshiyuki Hada, Makoto Suzuki, Makoto Akaishi, Manabu Iwasaki, Yoshiharu Tsubakihara Tadao Akizawa, Fumitake Gejyo, Shinichi Nishi, Yasuhiko Iino, Yuzou Watanabe, Masashi Suzuki, Akira Saito, Takashi Akiba, Hideki Hirakata, Shunichi Fukuhara, Satoshi Morita, Michiaki Hiroe, Yoshiyuki Hada, Makoto Suzuki, Makoto Akaishi, Manabu Iwasaki, Yoshiharu Tsubakihara Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study THERAPEUTIC APHERESIS AND DIALYSIS, 15, 5, 431-440 THERAPEUTIC APHERESIS AND DIALYSIS, 15, 5, 431-440 THERAPEUTIC APHERESIS AND DIALYSIS, 15, 5, 431-440 2011/10 英語 研究論文(学術雑誌) 公開
Tevfik T. Sahin, Tsutomu Fujii, Mitsuro Kanda, Shunji Nagai, Yasuhiro Kodera, Akiyuki Kanzaki, Kazuo Yamamura, Hiroyuki Sugimoto, Hideki Kasuya, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Tevfik T. Sahin, Tsutomu Fujii, Mitsuro Kanda, Shunji Nagai, Yasuhiro Kodera, Akiyuki Kanzaki, Kazuo Yamamura, Hiroyuki Sugimoto, Hideki Kasuya, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Tevfik T. Sahin, Tsutomu Fujii, Mitsuro Kanda, Shunji Nagai, Yasuhiro Kodera, Akiyuki Kanzaki, Kazuo Yamamura, Hiroyuki Sugimoto, Hideki Kasuya, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Prognostic Implications of Lymph Node Metastases in Carcinoma of the Body and Tail of the Pancreas Prognostic Implications of Lymph Node Metastases in Carcinoma of the Body and Tail of the Pancreas Prognostic Implications of Lymph Node Metastases in Carcinoma of the Body and Tail of the Pancreas PANCREAS, 40, 7, 1029-1033 PANCREAS, 40, 7, 1029-1033 PANCREAS, 40, 7, 1029-1033 2011/10 英語 研究論文(学術雑誌) 公開
Yasunori Sakuma, Junichi Ishitoya, Masanori Komatsu, Osamu Shiono, Mariko Hirama, Yukiko Yamashita, Tetsuji Kaneko, Satoshi Morita, Mamoru Tsukuda Yasunori Sakuma, Junichi Ishitoya, Masanori Komatsu, Osamu Shiono, Mariko Hirama, Yukiko Yamashita, Tetsuji Kaneko, Satoshi Morita, Mamoru Tsukuda Yasunori Sakuma, Junichi Ishitoya, Masanori Komatsu, Osamu Shiono, Mariko Hirama, Yukiko Yamashita, Tetsuji Kaneko, Satoshi Morita, Mamoru Tsukuda New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis AURIS NASUS LARYNX, 38, 5, 583-588 AURIS NASUS LARYNX, 38, 5, 583-588 AURIS NASUS LARYNX, 38, 5, 583-588 2011/10 英語 研究論文(学術雑誌) 公開
Takahiro Nakayama, Satoshi Morita, Tsutomu Takashima, Shunji Kamigaki, Katsuhide Yoshidome, Toshikazu Ito, Tetsuya Taguchi, Junichi Sakamoto, Shinzaburo Noguchi Takahiro Nakayama, Satoshi Morita, Tsutomu Takashima, Shunji Kamigaki, Katsuhide Yoshidome, Toshikazu Ito, Tetsuya Taguchi, Junichi Sakamoto, Shinzaburo Noguchi Takahiro Nakayama, Satoshi Morita, Tsutomu Takashima, Shunji Kamigaki, Katsuhide Yoshidome, Toshikazu Ito, Tetsuya Taguchi, Junichi Sakamoto, Shinzaburo Noguchi Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer ANTICANCER RESEARCH, 31, 9, 3035-3039 ANTICANCER RESEARCH, 31, 9, 3035-3039 ANTICANCER RESEARCH, 31, 9, 3035-3039 2011/09 英語 研究論文(学術雑誌) 公開
Takashi Hirama, Takefumi Yamaguchi, Hitoshi Miyazawa, Tomoaki Tanaka, Giichi Hashikita, Etsuko Kishi, Yoshimi Tachi, Shun Takahashi, Keiji Kodama, Hiroshi Egashira, Akemi Yokote, Kunihiko Kobayashi, Makoto Nagata, Toshiaki Ishii, Manabu Nemoto, Masahiko Tanaka, Koichi Fukunaga, Satoshi Morita, Minoru Kanazawa, Koichi Hagiwara Takashi Hirama, Takefumi Yamaguchi, Hitoshi Miyazawa, Tomoaki Tanaka, Giichi Hashikita, Etsuko Kishi, Yoshimi Tachi, Shun Takahashi, Keiji Kodama, Hiroshi Egashira, Akemi Yokote, Kunihiko Kobayashi, Makoto Nagata, Toshiaki Ishii, Manabu Nemoto, Masahiko Tanaka, Koichi Fukunaga, Satoshi Morita, Minoru Kanazawa, Koichi Hagiwara Takashi Hirama, Takefumi Yamaguchi, Hitoshi Miyazawa, Tomoaki Tanaka, Giichi Hashikita, Etsuko Kishi, Yoshimi Tachi, Shun Takahashi, Keiji Kodama, Hiroshi Egashira, Akemi Yokote, Kunihiko Kobayashi, Makoto Nagata, Toshiaki Ishii, Manabu Nemoto, Masahiko Tanaka, Koichi Fukunaga, Satoshi Morita, Minoru Kanazawa, Koichi Hagiwara Prediction of the Pathogens That Are the Cause of Pneumonia by the Battlefield Hypothesis Prediction of the Pathogens That Are the Cause of Pneumonia by the Battlefield Hypothesis Prediction of the Pathogens That Are the Cause of Pneumonia by the Battlefield Hypothesis PLOS ONE, 6, 9 PLOS ONE, 6, 9 PLOS ONE, 6, 9 2011/09 英語 研究論文(学術雑誌) 公開
Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Masamichi Hayashi, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Masamichi Hayashi, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Masamichi Hayashi, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Recurrence Pattern and Prognosis of Pancreatic Cancer After Pancreatic Fistula Recurrence Pattern and Prognosis of Pancreatic Cancer After Pancreatic Fistula Recurrence Pattern and Prognosis of Pancreatic Cancer After Pancreatic Fistula ANNALS OF SURGICAL ONCOLOGY, 18, 8, 2329-2337 ANNALS OF SURGICAL ONCOLOGY, 18, 8, 2329-2337 ANNALS OF SURGICAL ONCOLOGY, 18, 8, 2329-2337 2011/08 英語 研究論文(学術雑誌) 公開
Mitsuro Kanda, Tsutomu Fujii, Shunji Nagai, Yasuhiro Kodera, Akiyuki Kanzaki, Tevfik T. Sahin, Masamichi Hayashi, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Mitsuro Kanda, Tsutomu Fujii, Shunji Nagai, Yasuhiro Kodera, Akiyuki Kanzaki, Tevfik T. Sahin, Masamichi Hayashi, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Mitsuro Kanda, Tsutomu Fujii, Shunji Nagai, Yasuhiro Kodera, Akiyuki Kanzaki, Tevfik T. Sahin, Masamichi Hayashi, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer PANCREAS, 40, 6, 951-955 PANCREAS, 40, 6, 951-955 PANCREAS, 40, 6, 951-955 2011/08 英語 研究論文(学術雑誌) 公開
Maiko Inoue, Satoshi Morita, Yoichiro Watanabe, Tetsuji Kaneko, Shin Yamane, Satoshi Kobayashi, Akira Arakawa, Kazuaki Kadonosono Maiko Inoue, Satoshi Morita, Yoichiro Watanabe, Tetsuji Kaneko, Shin Yamane, Satoshi Kobayashi, Akira Arakawa, Kazuaki Kadonosono Maiko Inoue, Satoshi Morita, Yoichiro Watanabe, Tetsuji Kaneko, Shin Yamane, Satoshi Kobayashi, Akira Arakawa, Kazuaki Kadonosono PREOPERATIVE INNER SEGMENT/OUTER SEGMENT JUNCTION IN SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS A PROGNOSTIC FACTOR IN EPIRETINAL MEMBRANE SURGERY PREOPERATIVE INNER SEGMENT/OUTER SEGMENT JUNCTION IN SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS A PROGNOSTIC FACTOR IN EPIRETINAL MEMBRANE SURGERY PREOPERATIVE INNER SEGMENT/OUTER SEGMENT JUNCTION IN SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS A PROGNOSTIC FACTOR IN EPIRETINAL MEMBRANE SURGERY RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 31, 7, 1366-1372 RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 31, 7, 1366-1372 RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 31, 7, 1366-1372 2011/07 英語 研究論文(学術雑誌) 公開
Paul Mathew, Sijin Wen, Satoshi Morita, Peter F. Thall Paul Mathew, Sijin Wen, Satoshi Morita, Peter F. Thall Paul Mathew, Sijin Wen, Satoshi Morita, Peter F. Thall Placental Growth Factor and Soluble c-Kit Receptor Dynamics Characterize the Cytokine Signature of Imatinib in Prostate Cancer and Bone Metastases Placental Growth Factor and Soluble c-Kit Receptor Dynamics Characterize the Cytokine Signature of Imatinib in Prostate Cancer and Bone Metastases Placental Growth Factor and Soluble c-Kit Receptor Dynamics Characterize the Cytokine Signature of Imatinib in Prostate Cancer and Bone Metastases JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 31, 7, 539-544 JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 31, 7, 539-544 JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 31, 7, 539-544 2011/07 英語 研究論文(学術雑誌) 公開
H. Makino, C. Kunisaki, T. Kosaka, H. Akiyama, S. Morita, I. Endo H. Makino, C. Kunisaki, T. Kosaka, H. Akiyama, S. Morita, I. Endo H. Makino, C. Kunisaki, T. Kosaka, H. Akiyama, S. Morita, I. Endo Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer BRITISH JOURNAL OF SURGERY, 98, 7, 975-982 BRITISH JOURNAL OF SURGERY, 98, 7, 975-982 BRITISH JOURNAL OF SURGERY, 98, 7, 975-982 2011/07 英語 研究論文(学術雑誌) 公開
Satoshi Morita Satoshi Morita Satoshi Morita Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West STATISTICS IN MEDICINE, 30, 17, 2090-2097 STATISTICS IN MEDICINE, 30, 17, 2090-2097 STATISTICS IN MEDICINE, 30, 17, 2090-2097 2011/07 英語 研究論文(学術雑誌) 公開
Chikara Kunisaki, Masazumi Takahashi, Hirochika Makino, Takashi Oshima, Shoichi Fujii, Ryo Takagawa, Jun Kimura, Takashi Kosaka, Hidetaka A. Ono, Hirotoshi Akiyama, Kunio Kameda, Fumihiko Kito, Satoshi Morita, Itaru Endo Chikara Kunisaki, Masazumi Takahashi, Hirochika Makino, Takashi Oshima, Shoichi Fujii, Ryo Takagawa, Jun Kimura, Takashi Kosaka, Hidetaka A. Ono, Hirotoshi Akiyama, Kunio Kameda, Fumihiko Kito, Satoshi Morita, Itaru Endo Chikara Kunisaki, Masazumi Takahashi, Hirochika Makino, Takashi Oshima, Shoichi Fujii, Ryo Takagawa, Jun Kimura, Takashi Kosaka, Hidetaka A. Ono, Hirotoshi Akiyama, Kunio Kameda, Fumihiko Kito, Satoshi Morita, Itaru Endo Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1363-1368 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1363-1368 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1363-1368 2011/06 英語 研究論文(学術雑誌) 公開
Makiko Nakagawa, Chiaki Kawanishi, Tomoki Yamada, Kanna Sugiura, Yoko Iwamoto, Ryoko Sato, Satoshi Morita, Toshinari Odawara, Yoshio Hirayasu Makiko Nakagawa, Chiaki Kawanishi, Tomoki Yamada, Kanna Sugiura, Yoko Iwamoto, Ryoko Sato, Satoshi Morita, Toshinari Odawara, Yoshio Hirayasu Makiko Nakagawa, Chiaki Kawanishi, Tomoki Yamada, Kanna Sugiura, Yoko Iwamoto, Ryoko Sato, Satoshi Morita, Toshinari Odawara, Yoshio Hirayasu Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan PSYCHIATRY RESEARCH, 188, 1, 78-82 PSYCHIATRY RESEARCH, 188, 1, 78-82 PSYCHIATRY RESEARCH, 188, 1, 78-82 2011/06 英語 研究論文(学術雑誌) 公開
Kengo Tsukahara, Kazuo Kimura, Satoshi Morita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Noriaki Iwahashi, Mitsuaki Endo, Nobuhiko Maejima, Teruyasu Sugano, Satoshi Umemura Kengo Tsukahara, Kazuo Kimura, Satoshi Morita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Noriaki Iwahashi, Mitsuaki Endo, Nobuhiko Maejima, Teruyasu Sugano, Satoshi Umemura Kengo Tsukahara, Kazuo Kimura, Satoshi Morita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Noriaki Iwahashi, Mitsuaki Endo, Nobuhiko Maejima, Teruyasu Sugano, Satoshi Umemura Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects JOURNAL OF CARDIOLOGY, 57, 3, 275-282 JOURNAL OF CARDIOLOGY, 57, 3, 275-282 JOURNAL OF CARDIOLOGY, 57, 3, 275-282 2011/05 英語 研究論文(学術雑誌) 公開
Takashi Ishikawa, Daisuke Shimizu, Takashi Sasaki, Satoshi Morita, Mikiko Tanabe, Ikuko Ota, Kae Kawachi, Takashi Chishima, Yasushi Ichikawa, Itaru Endo Takashi Ishikawa, Daisuke Shimizu, Takashi Sasaki, Satoshi Morita, Mikiko Tanabe, Ikuko Ota, Kae Kawachi, Takashi Chishima, Yasushi Ichikawa, Itaru Endo Takashi Ishikawa, Daisuke Shimizu, Takashi Sasaki, Satoshi Morita, Mikiko Tanabe, Ikuko Ota, Kae Kawachi, Takashi Chishima, Yasushi Ichikawa, Itaru Endo Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer CANCER RESEARCH, 71 CANCER RESEARCH, 71 CANCER RESEARCH, 71 2011/04 英語 公開
Takayuki Mitsuhashi, Kiyoshi Hibi, Masami Kosuge, Satoshi Morita, Naohiro Komura, Ikuyoshi Kusama, Fumiyuki Otsuka, Mitsuaki Endo, Noriaki Iwahashi, Jun Okuda, Kengo Tsukahara, Toshiaki Ebina, Satoshi Umemura, Kazuo Kimura Takayuki Mitsuhashi, Kiyoshi Hibi, Masami Kosuge, Satoshi Morita, Naohiro Komura, Ikuyoshi Kusama, Fumiyuki Otsuka, Mitsuaki Endo, Noriaki Iwahashi, Jun Okuda, Kengo Tsukahara, Toshiaki Ebina, Satoshi Umemura, Kazuo Kimura Takayuki Mitsuhashi, Kiyoshi Hibi, Masami Kosuge, Satoshi Morita, Naohiro Komura, Ikuyoshi Kusama, Fumiyuki Otsuka, Mitsuaki Endo, Noriaki Iwahashi, Jun Okuda, Kengo Tsukahara, Toshiaki Ebina, Satoshi Umemura, Kazuo Kimura Relation Between Hyperinsulinemia and Nonculprit Plaque Characteristics in Nondiabetic Patients With Acute Coronary Syndromes Relation Between Hyperinsulinemia and Nonculprit Plaque Characteristics in Nondiabetic Patients With Acute Coronary Syndromes Relation Between Hyperinsulinemia and Nonculprit Plaque Characteristics in Nondiabetic Patients With Acute Coronary Syndromes JACC-CARDIOVASCULAR IMAGING, 4, 4, 392-401 JACC-CARDIOVASCULAR IMAGING, 4, 4, 392-401 JACC-CARDIOVASCULAR IMAGING, 4, 4, 392-401 2011/04 英語 研究論文(学術雑誌) 公開
C. Kunisaki, H. Makino, T. Oshima, S. Fujii, J. Kimura, R. Takagawa, T. Kosaka, H. Akiyama, S. Morita, I. Endo C. Kunisaki, H. Makino, T. Oshima, S. Fujii, J. Kimura, R. Takagawa, T. Kosaka, H. Akiyama, S. Morita, I. Endo Chikara Kunisaki, Hirochika Makino, Takashi Oshima, Shoichi Fujii, Jun Kimura, Ryo Takagawa, Takashi Kosaka, Hirotoshi Akiyama, Satoshi Morita, Itaru Endo Application of the transorally inserted anvil (OrVil™) after laparoscopy-assisted total gastrectomy Application of the transorally inserted anvil (OrVil™) after laparoscopy-assisted total gastrectomy Application of the transorally inserted anvil (OrVil (TM)) after laparoscopy-assisted total gastrectomy Surgical Endoscopy and Other Interventional Techniques, 25, 4, 1300-1305 Surgical Endoscopy and Other Interventional Techniques, 25, 4, 1300-1305 SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 25, 4, 1300-1305 2011/04 英語 研究論文(学術雑誌) 公開
Chigusa Morizane, Takuji Okusaka, Satoshi Morita, Katsuaki Tanaka, Hideki Ueno, Shunsuke Kondo, Masafumi Ikeda, Kohei Nakachi, Shuichi Mitsunaga Chigusa Morizane, Takuji Okusaka, Satoshi Morita, Katsuaki Tanaka, Hideki Ueno, Shunsuke Kondo, Masafumi Ikeda, Kohei Nakachi, Shuichi Mitsunaga Chigusa Morizane, Takuji Okusaka, Satoshi Morita, Katsuaki Tanaka, Hideki Ueno, Shunsuke Kondo, Masafumi Ikeda, Kohei Nakachi, Shuichi Mitsunaga Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma PANCREAS, 40, 3, 415-421 PANCREAS, 40, 3, 415-421 PANCREAS, 40, 3, 415-421 2011/04 英語 研究論文(学術雑誌) 公開
Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Hisashi Hidaka, Juichi Takada, Akitaka Shibuya, Satoshi Kobayashi, Shinichi Ohkawa, Chiaki Okuse, Satoshi Morita, Masataka Taguri, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Hisashi Hidaka, Juichi Takada, Akitaka Shibuya, Satoshi Kobayashi, Shinichi Ohkawa, Chiaki Okuse, Satoshi Morita, Masataka Taguri, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondo, Hisashi Hidaka, Juichi Takada, Akitaka Shibuya, Satoshi Kobayashi, Shinichi Ohkawa, Chiaki Okuse, Satoshi Morita, Masataka Taguri, Katsuaki Tanaka Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib HEPATOLOGY RESEARCH, 41, 4, 296-302 HEPATOLOGY RESEARCH, 41, 4, 296-302 HEPATOLOGY RESEARCH, 41, 4, 296-302 2011/04 英語 研究論文(学術雑誌) 公開
Masakatsu Yanagimachi, Takako Miyamae, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Hiroaki Goto, Satoshi Morita, Nobuhisa Mizuki, Akinori Kimura, Shumpei Yokota Masakatsu Yanagimachi, Takako Miyamae, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Hiroaki Goto, Satoshi Morita, Nobuhisa Mizuki, Akinori Kimura, Shumpei Yokota Masakatsu Yanagimachi, Takako Miyamae, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Hiroaki Goto, Satoshi Morita, Nobuhisa Mizuki, Akinori Kimura, Shumpei Yokota Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis. Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis. Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis. J. Hum. Genet., 56, 3, 196-199 J. Hum. Genet., 56, 3, 196-199 J. Hum. Genet., 56, 3, 196-199 2011/03 英語 研究論文(学術雑誌) 公開
Tadashi Yamakawa, Takeshi Kaneko, Erina Shigematu, Junko Kawaguchi, Kazuaki Kadonosono, Satoshi Morita, Yasuo Terauchi Tadashi Yamakawa, Takeshi Kaneko, Erina Shigematu, Junko Kawaguchi, Kazuaki Kadonosono, Satoshi Morita, Yasuo Terauchi Tadashi Yamakawa, Takeshi Kaneko, Erina Shigematu, Junko Kawaguchi, Kazuaki Kadonosono, Satoshi Morita, Yasuo Terauchi Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia ENDOCRINE JOURNAL, 58, 3, 185-191 ENDOCRINE JOURNAL, 58, 3, 185-191 ENDOCRINE JOURNAL, 58, 3, 185-191 2011/03 英語 研究論文(学術雑誌) 公開
Masakatsu Yanagimachi, Takako Miyamae, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Hiroaki Goto, Satoshi Morita, Nobuhisa Mizuki, Akinori Kimura, Shumpei Yokota Masakatsu Yanagimachi, Takako Miyamae, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Hiroaki Goto, Satoshi Morita, Nobuhisa Mizuki, Akinori Kimura, Shumpei Yokota Masakatsu Yanagimachi, Takako Miyamae, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Hiroaki Goto, Satoshi Morita, Nobuhisa Mizuki, Akinori Kimura, Shumpei Yokota Association of HLA- A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis Association of HLA- A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis Association of HLA- A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis JOURNAL OF HUMAN GENETICS, 56, 3, 196-199 JOURNAL OF HUMAN GENETICS, 56, 3, 196-199 JOURNAL OF HUMAN GENETICS, 56, 3, 196-199 2011/03 英語 研究論文(学術雑誌) 公開
Ichiro Ogino, Tetsuji Kaneko, Ryoko Suzuki, Tonika Matsui, Shigeo Takebayashi, Tomio Inoue, Satoshi Morita Ichiro Ogino, Tetsuji Kaneko, Ryoko Suzuki, Tonika Matsui, Shigeo Takebayashi, Tomio Inoue, Satoshi Morita Ichiro Ogino, Tetsuji Kaneko, Ryoko Suzuki, Tonika Matsui, Shigeo Takebayashi, Tomio Inoue, Satoshi Morita Rectal Content and Intrafractional Prostate Gland Motion Assessed by Magnetic Resonance Imaging Rectal Content and Intrafractional Prostate Gland Motion Assessed by Magnetic Resonance Imaging Rectal Content and Intrafractional Prostate Gland Motion Assessed by Magnetic Resonance Imaging JOURNAL OF RADIATION RESEARCH, 52, 2, 199-207 JOURNAL OF RADIATION RESEARCH, 52, 2, 199-207 JOURNAL OF RADIATION RESEARCH, 52, 2, 199-207 2011/03 英語 研究論文(学術雑誌) 公開
Haruhiko Imamoto, Koji Oba, Junichi Sakamoto, Hiroyasu Iishi, Hiroyuki Narahara, Takeyoshi Yumiba, Takashi Morimoto, Masaki Nakamura, Noboru Oriuchi, Chieko Kakutani, Satoshi Morita, Hitoshi Shiozaki Haruhiko Imamoto, Koji Oba, Junichi Sakamoto, Hiroyasu Iishi, Hiroyuki Narahara, Takeyoshi Yumiba, Takashi Morimoto, Masaki Nakamura, Noboru Oriuchi, Chieko Kakutani, Satoshi Morita, Hitoshi Shiozaki Haruhiko Imamoto, Koji Oba, Junichi Sakamoto, Hiroyasu Iishi, Hiroyuki Narahara, Takeyoshi Yumiba, Takashi Morimoto, Masaki Nakamura, Noboru Oriuchi, Chieko Kakutani, Satoshi Morita, Hitoshi Shiozaki Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 14, 1, 81-90 Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 14, 1, 81-90 Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 14, 1, 81-90 2011/03 英語 公開
Masakatsu Yanagimachi, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Takako Miyamae, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Satoshi Morita, Hiroaki Goto, Shumpei Yokota Masakatsu Yanagimachi, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Takako Miyamae, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Satoshi Morita, Hiroaki Goto, Shumpei Yokota Masakatsu Yanagimachi, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Takako Miyamae, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Satoshi Morita, Hiroaki Goto, Shumpei Yokota Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Br J Clin Pharmacol, 71, 2, 237-243 Br J Clin Pharmacol, 71, 2, 237-243 Br J Clin Pharmacol, 71, 2, 237-243 2011/02 英語 研究論文(学術雑誌) 公開
S. Kako, S. Morita, H. Sakamaki, H. Ogawa, T. Fukuda, S. Takahashi, H. Kanamori, M. Onizuka, K. Iwato, R. Suzuki, Y. Atsuta, T. Kyo, T. Sakura, I. Jinnai, J. Takeuchi, Y. Miyazaki, S. Miyawaki, K. Ohnishi, T. Naoe, Y. Kanda S. Kako, S. Morita, H. Sakamaki, H. Ogawa, T. Fukuda, S. Takahashi, H. Kanamori, M. Onizuka, K. Iwato, R. Suzuki, Y. Atsuta, T. Kyo, T. Sakura, I. Jinnai, J. Takeuchi, Y. Miyazaki, S. Miyawaki, K. Ohnishi, T. Naoe, Y. Kanda S. Kako, S. Morita, H. Sakamaki, H. Ogawa, T. Fukuda, S. Takahashi, H. Kanamori, M. Onizuka, K. Iwato, R. Suzuki, Y. Atsuta, T. Kyo, T. Sakura, I. Jinnai, J. Takeuchi, Y. Miyazaki, S. Miyawaki, K. Ohnishi, T. Naoe, Y. Kanda A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor LEUKEMIA, 25, 2, 259-265 LEUKEMIA, 25, 2, 259-265 LEUKEMIA, 25, 2, 259-265 2011/02 英語 研究論文(学術雑誌) 公開
Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Mitsuaki Endo, Nobuhiki Maejima, Noriaki Iwahashi, Kozo Okada, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Mitsuaki Endo, Nobuhiki Maejima, Noriaki Iwahashi, Kozo Okada, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Mitsuaki Endo, Nobuhiki Maejima, Noriaki Iwahashi, Kozo Okada, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura An Early and Simple Predictor of Severe Left Main and/or Three-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome An Early and Simple Predictor of Severe Left Main and/or Three-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome An Early and Simple Predictor of Severe Left Main and/or Three-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome AMERICAN JOURNAL OF CARDIOLOGY, 107, 4, 495-500 AMERICAN JOURNAL OF CARDIOLOGY, 107, 4, 495-500 AMERICAN JOURNAL OF CARDIOLOGY, 107, 4, 495-500 2011/02 英語 研究論文(学術雑誌) 公開
Yasuhiro Kodera, Motohiro Imano, Takaki Yoshikawa, Naoto Takahashi, Akira Tsuburaya, Yumi Miyashita, Satoshi Morita, Akimasa Nakao, Junichi Sakamoto, Mitsuru Sasako Yasuhiro Kodera, Motohiro Imano, Takaki Yoshikawa, Naoto Takahashi, Akira Tsuburaya, Yumi Miyashita, Satoshi Morita, Akimasa Nakao, Junichi Sakamoto, Mitsuru Sasako Yasuhiro Kodera, Motohiro Imano, Takaki Yoshikawa, Naoto Takahashi, Akira Tsuburaya, Yumi Miyashita, Satoshi Morita, Akimasa Nakao, Junichi Sakamoto, Mitsuru Sasako A Randomized Phase II Trial to Test the Efficacy of Intra-peritoneal Paclitaxel for Gastric Cancer with High Risk for the Peritoneal Metastasis (INPACT Trial) A Randomized Phase II Trial to Test the Efficacy of Intra-peritoneal Paclitaxel for Gastric Cancer with High Risk for the Peritoneal Metastasis (INPACT Trial) A Randomized Phase II Trial to Test the Efficacy of Intra-peritoneal Paclitaxel for Gastric Cancer with High Risk for the Peritoneal Metastasis (INPACT Trial) JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 2, 283-286 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 2, 283-286 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 2, 283-286 2011/02 英語 研究論文(学術雑誌) 公開
Masaaki Shakudo, Misa Takegami, Ai Shibata, Miki Kuzumaki, Takahiro Higashi, Yasuaki Hayashino, Yoshimi Suzukamo, Satoshi Morita, Michio Katsuki, Shunichi Fukuhara Masaaki Shakudo, Misa Takegami, Ai Shibata, Miki Kuzumaki, Takahiro Higashi, Yasuaki Hayashino, Yoshimi Suzukamo, Satoshi Morita, Michio Katsuki, Shunichi Fukuhara Masaaki Shakudo, Misa Takegami, Ai Shibata, Miki Kuzumaki, Takahiro Higashi, Yasuaki Hayashino, Yoshimi Suzukamo, Satoshi Morita, Michio Katsuki, Shunichi Fukuhara Effect of feedback in promoting adherence to an exercise programme: a randomized controlled trial Effect of feedback in promoting adherence to an exercise programme: a randomized controlled trial Effect of feedback in promoting adherence to an exercise programme: a randomized controlled trial JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 17, 1, 7-11 JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 17, 1, 7-11 JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 17, 1, 7-11 2011/02 英語 研究論文(学術雑誌) 公開
Toshihiro Fukui, Minoru Tabata, Masataka Taguri, Susumu Manabe, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Masataka Taguri, Susumu Manabe, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Masataka Taguri, Susumu Manabe, Satoshi Morita, Shuichiro Takanashi Extensive Reconstruction of the Left Anterior Descending Coronary Artery With an Internal Thoracic Artery Graft Extensive Reconstruction of the Left Anterior Descending Coronary Artery With an Internal Thoracic Artery Graft Extensive Reconstruction of the Left Anterior Descending Coronary Artery With an Internal Thoracic Artery Graft ANNALS OF THORACIC SURGERY, 91, 2, 445-451 ANNALS OF THORACIC SURGERY, 91, 2, 445-451 ANNALS OF THORACIC SURGERY, 91, 2, 445-451 2011/02 英語 研究論文(学術雑誌) 公開
T. Kariya, G. Inagawa, K. Nakamura, J. Fujimoto, Y. Aoi, S. Morita, T. Goto T. Kariya, G. Inagawa, K. Nakamura, J. Fujimoto, Y. Aoi, S. Morita, T. Goto T. Kariya, G. Inagawa, K. Nakamura, J. Fujimoto, Y. Aoi, S. Morita, T. Goto Evaluation of the Pentax-AWS <sup>®</sup> and the Macintosh laryngoscope in difficult intubation: A manikin study Evaluation of the Pentax-AWS <sup>®</sup> and the Macintosh laryngoscope in difficult intubation: A manikin study Evaluation of the Pentax-AWS (R) and the Macintosh laryngoscope in difficult intubation: a manikin study Acta Anaesthesiologica Scandinavica, 55, 2, 223-227 Acta Anaesthesiologica Scandinavica, 55, 2, 223-227 ACTA ANAESTHESIOLOGICA SCANDINAVICA, 55, 2, 223-227 2011/02 英語 研究論文(学術雑誌) 公開
Masakatsu Yanagimachi, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Takako Miyamae, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Satoshi Morita, Hiroaki Goto, Shumpei Yokota Masakatsu Yanagimachi, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Takako Miyamae, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Satoshi Morita, Hiroaki Goto, Shumpei Yokota Masakatsu Yanagimachi, Takuya Naruto, Takuma Hara, Masako Kikuchi, Ryoki Hara, Takako Miyamae, Tomoyuki Imagawa, Masaaki Mori, Tetsuji Kaneko, Satoshi Morita, Hiroaki Goto, Shumpei Yokota Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 71, 2, 237-243 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 71, 2, 237-243 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 71, 2, 237-243 2011/02 英語 研究論文(学術雑誌) 公開
Satoshi Inoue, Yuji Watanuki, Tetsuji Kaneko, Takashi Sato, Naoki Miyazawa, Takeshi Kaneko, Yoshiaki Ishigatsubo, Satoshi Morita, Yutaka Natsumeda, Shunsaku Mizushima Satoshi Inoue, Yuji Watanuki, Tetsuji Kaneko, Takashi Sato, Naoki Miyazawa, Takeshi Kaneko, Yoshiaki Ishigatsubo, Satoshi Morita, Yutaka Natsumeda, Shunsaku Mizushima Satoshi Inoue, Yuji Watanuki, Tetsuji Kaneko, Takashi Sato, Naoki Miyazawa, Takeshi Kaneko, Yoshiaki Ishigatsubo, Satoshi Morita, Yutaka Natsumeda, Shunsaku Mizushima Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study BMJ OPEN, 1, 1, e000105 BMJ OPEN, 1, 1, e000105 BMJ OPEN, 1, 1, e000105 2011 英語 研究論文(学術雑誌) 公開
H. Kuwabara, H. Takahashi, Y. Hattori, R. Ohshima, M. Hagihara, R. Sakai, T. Kaneko, S. Morita, Y. Ishigatsubo, S. Fujisawa H. Kuwabara, H. Takahashi, Y. Hattori, R. Ohshima, M. Hagihara, R. Sakai, T. Kaneko, S. Morita, Y. Ishigatsubo, S. Fujisawa H. Kuwabara, H. Takahashi, Y. Hattori, R. Ohshima, M. Hagihara, R. Sakai, T. Kaneko, S. Morita, Y. Ishigatsubo, S. Fujisawa Assessment of adherence to imatinib therapy by questionnaire survey in patients with chronic myeloid leukemia Assessment of adherence to imatinib therapy by questionnaire survey in patients with chronic myeloid leukemia Assessment of adherence to imatinib therapy by questionnaire survey in patients with chronic myeloid leukemia Yokohama Medical Journal, 62, 4, 495-500 Yokohama Medical Journal, 62, 4, 495-500 Yokohama Medical Journal, 62, 4, 495-500 2011 英語 公開
Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Prognostic Implications of Intraoperative Radiotherapy for Unresectable Pancreatic Cancer Prognostic Implications of Intraoperative Radiotherapy for Unresectable Pancreatic Cancer Prognostic Implications of Intraoperative Radiotherapy for Unresectable Pancreatic Cancer PANCREATOLOGY, 11, 1, 68-75 PANCREATOLOGY, 11, 1, 68-75 PANCREATOLOGY, 11, 1, 68-75 2011 英語 研究論文(学術雑誌) 公開
Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Shunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, Mitsuro Kanda, Tevfik T. Sahin, Akiyuki Kanzaki, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Akimasa Nakao Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas PANCREAS, 40, 1, 3-9 PANCREAS, 40, 1, 3-9 PANCREAS, 40, 1, 3-9 2011/01 英語 研究論文(学術雑誌) 公開
Ikuko Ota, Aki Sakurai, Yu Toyoda, Satoshi Morita, Takeshi Sasaki, Takashi Chishima, Minoru Yamakado, Yuki Kawai, Takefumi Ishidao, Alexander Lezhava, Koh-Ichiro Yoshiura, Shinji Togo, Yoshihide Hayashizaki, Takashi Ishikawa, Toshihisa Ishikawa, Itaru Endo, Hiroshi Shimada Ikuko Ota, Aki Sakurai, Yu Toyoda, Satoshi Morita, Takeshi Sasaki, Takashi Chishima, Minoru Yamakado, Yuki Kawai, Takefumi Ishidao, Alexander Lezhava, Koh-Ichiro Yoshiura, Shinji Togo, Yoshihide Hayashizaki, Takashi Ishikawa, Toshihisa Ishikawa, Itaru Endo, Hiroshi Shimada Ikuko Ota, Aki Sakurai, Yu Toyoda, Satoshi Morita, Takeshi Sasaki, Takashi Chishima, Minoru Yamakado, Yuki Kawai, Takefumi Ishidao, Alexander Lezhava, Koh-Ichiro Yoshiura, Shinji Togo, Yoshihide Hayashizaki, Takashi Ishikawa, Toshihisa Ishikawa, Itaru Endo, Hiroshi Shimada Association between Breast Cancer Risk and the Wild-type Allele of Human ABC Transporter ABCC11 Association between Breast Cancer Risk and the Wild-type Allele of Human ABC Transporter ABCC11 Association between Breast Cancer Risk and the Wild-type Allele of Human ABC Transporter ABCC11 ANTICANCER RESEARCH, 30, 12, 5189-5194 ANTICANCER RESEARCH, 30, 12, 5189-5194 ANTICANCER RESEARCH, 30, 12, 5189-5194 2010/12 英語 研究論文(学術雑誌) 公開
I. Okamoto, H. Yoshioka, S. Morita, M. Ando, K. Takeda, T. Seto, N. Yamamoto, H. Saka, K. Asami, T. Hirashima, S. Kudoh, M. Satouchi, N. Ikeda, Y. Iwamoto, T. Sawa, M. Miyazaki, K. Tamura, T. Kurata, M. Fukuoka, K. Nakagawa I. Okamoto, H. Yoshioka, S. Morita, M. Ando, K. Takeda, T. Seto, N. Yamamoto, H. Saka, K. Asami, T. Hirashima, S. Kudoh, M. Satouchi, N. Ikeda, Y. Iwamoto, T. Sawa, M. Miyazaki, K. Tamura, T. Kurata, M. Fukuoka, K. Nakagawa Isamu Okamoto, Hiroshige Yoshioka, Satoshi Morita, Masahiko Ando, Koji Takeda, Takashi Seto, Nobuyuki Yamamoto, Hideo Saka, Kazuhiro Asami, Tomonori Hirashima, Shinzoh Kudoh, Miyako Satouchi, Norihiko Ikeda, Yasuo Iwamoto, Toshiyuki Sawa, Masaki Miyazaki, Kenji Tamura, Takayasu Kurata, Masahiro Fukuoka, Kazuhiko Nakagawa Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: Results of a west Japan oncology group study Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: Results of a west Japan oncology group study Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Oncology Group Study Journal of Clinical Oncology, 28, 36, 5240-5246 Journal of Clinical Oncology, 28, 36, 5240-5246 JOURNAL OF CLINICAL ONCOLOGY, 28, 36, 5240-5246 2010/12 英語 研究論文(学術雑誌) 公開
Manabu Morimoto, Kazushi Numata, Masaaki Kondou, Akito Nozaki, Satoshi Morita, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondou, Akito Nozaki, Satoshi Morita, Katsuaki Tanaka Manabu Morimoto, Kazushi Numata, Masaaki Kondou, Akito Nozaki, Satoshi Morita, Katsuaki Tanaka Midterm Outcomes in Patients With Intermediate-Sized Hepatocellular Carcinoma Midterm Outcomes in Patients With Intermediate-Sized Hepatocellular Carcinoma Midterm Outcomes in Patients With Intermediate-Sized Hepatocellular Carcinoma CANCER, 116, 23, 5452-5460 CANCER, 116, 23, 5452-5460 CANCER, 116, 23, 5452-5460 2010/12 英語 研究論文(学術雑誌) 公開
Maiko Inoue, Satoshi Morita, Yoichiro Watanabe, Tetsuji Kaneko, Shin Yamane, Satoshi Kobayashi, Akira Arakawa, Kazuaki Kadonosono Maiko Inoue, Satoshi Morita, Yoichiro Watanabe, Tetsuji Kaneko, Shin Yamane, Satoshi Kobayashi, Akira Arakawa, Kazuaki Kadonosono Maiko Inoue, Satoshi Morita, Yoichiro Watanabe, Tetsuji Kaneko, Shin Yamane, Satoshi Kobayashi, Akira Arakawa, Kazuaki Kadonosono Inner Segment/Outer Segment Junction Assessed by Spectral-Domain Optical Coherence Tomography in Patients with Idiopathic Epiretinal Membrane Inner Segment/Outer Segment Junction Assessed by Spectral-Domain Optical Coherence Tomography in Patients with Idiopathic Epiretinal Membrane Inner Segment/Outer Segment Junction Assessed by Spectral-Domain Optical Coherence Tomography in Patients with Idiopathic Epiretinal Membrane AMERICAN JOURNAL OF OPHTHALMOLOGY, 150, 6, 834-839 AMERICAN JOURNAL OF OPHTHALMOLOGY, 150, 6, 834-839 AMERICAN JOURNAL OF OPHTHALMOLOGY, 150, 6, 834-839 2010/12 英語 研究論文(学術雑誌) 公開
Susumu Manabe, Toshihiro Fukui, Minoru Tabata, Tomoki Shimokawa, Satoshi Morita, Shuichiro Takanashi Susumu Manabe, Toshihiro Fukui, Minoru Tabata, Tomoki Shimokawa, Satoshi Morita, Shuichiro Takanashi Susumu Manabe, Toshihiro Fukui, Minoru Tabata, Tomoki Shimokawa, Satoshi Morita, Shuichiro Takanashi Arterial graft deterioration one year after coronary artery bypass grafting Arterial graft deterioration one year after coronary artery bypass grafting Arterial graft deterioration one year after coronary artery bypass grafting JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140, 6, 1306-1311 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140, 6, 1306-1311 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140, 6, 1306-1311 2010/12 英語 研究論文(学術雑誌) 公開
Ishimoto Osamu, Kunihiko Kobayashi, Akira Inoue, Makoto Maemondo, Shunichi Sugawara, Satoshi Oizumi, Yasuo Saijo, Akihiko Gemma, Satoshi Morita, Koichi Hagiwara, Toshihiro Nukiwa Ishimoto Osamu, Kunihiko Kobayashi, Akira Inoue, Makoto Maemondo, Shunichi Sugawara, Satoshi Oizumi, Yasuo Saijo, Akihiko Gemma, Satoshi Morita, Koichi Hagiwara, Toshihiro Nukiwa Ishimoto Osamu, Kunihiko Kobayashi, Akira Inoue, Makoto Maemondo, Shunichi Sugawara, Satoshi Oizumi, Yasuo Saijo, Akihiko Gemma, Satoshi Morita, Koichi Hagiwara, Toshihiro Nukiwa FIRST-LINE GEFITINIB VS CARBOPLATIN/PACLITAXEL IN NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION: PHASE III STUDY NEJ002 FIRST-LINE GEFITINIB VS CARBOPLATIN/PACLITAXEL IN NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION: PHASE III STUDY NEJ002 FIRST-LINE GEFITINIB VS CARBOPLATIN/PACLITAXEL IN NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION: PHASE III STUDY NEJ002 ANNALS OF ONCOLOGY, 21, 11-11 ANNALS OF ONCOLOGY, 21, 11-11 ANNALS OF ONCOLOGY, 21, 11-11 2010/11 英語 公開
Yasuhiro Kodera, Michitaka Fujiwara, Norifumi Ohashi, Goro Nakayama, Masahiko Koike, Satoshi Morita, Akimasa Nakao Yasuhiro Kodera, Michitaka Fujiwara, Norifumi Ohashi, Goro Nakayama, Masahiko Koike, Satoshi Morita, Akimasa Nakao Yasuhiro Kodera, Michitaka Fujiwara, Norifumi Ohashi, Goro Nakayama, Masahiko Koike, Satoshi Morita, Akimasa Nakao Laparoscopic Surgery for Gastric Cancer: A Collective Review with Meta-Analysis of Randomized Trials Laparoscopic Surgery for Gastric Cancer: A Collective Review with Meta-Analysis of Randomized Trials Laparoscopic Surgery for Gastric Cancer: A Collective Review with Meta-Analysis of Randomized Trials JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 211, 5, 677-686 JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 211, 5, 677-686 JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 211, 5, 677-686 2010/11 英語 公開
Toshihiro Fukui, Minoru Tabata, Susumu Manabe, Tomoki Shimokawa, Jun Shimizu, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Susumu Manabe, Tomoki Shimokawa, Jun Shimizu, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Susumu Manabe, Tomoki Shimokawa, Jun Shimizu, Satoshi Morita, Shuichiro Takanashi Off-pump bilateral internal thoracic artery grafting in patients with left main disease Off-pump bilateral internal thoracic artery grafting in patients with left main disease Off-pump bilateral internal thoracic artery grafting in patients with left main disease JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140, 5, 1040-1045 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140, 5, 1040-1045 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 140, 5, 1040-1045 2010/11 英語 研究論文(学術雑誌) 公開
Go Miyashita, Tetsuya Higuchi, Noboru Oriuchi, Yukiko Arisaka, Hirofumi Hanaoka, Hideyuki Tominaga, Satoshi Morita, Mitsuyuki Miyakubo, Tomohiro Ishikita, Yoshiki Nakasone, Akihide Negishi, Satoshi Yokoo, Keigo Endo Go Miyashita, Tetsuya Higuchi, Noboru Oriuchi, Yukiko Arisaka, Hirofumi Hanaoka, Hideyuki Tominaga, Satoshi Morita, Mitsuyuki Miyakubo, Tomohiro Ishikita, Yoshiki Nakasone, Akihide Negishi, Satoshi Yokoo, Keigo Endo Go Miyashita, Tetsuya Higuchi, Noboru Oriuchi, Yukiko Arisaka, Hirofumi Hanaoka, Hideyuki Tominaga, Satoshi Morita, Mitsuyuki Miyakubo, Tomohiro Ishikita, Yoshiki Nakasone, Akihide Negishi, Satoshi Yokoo, Keigo Endo 18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with 18F-FDG PET and immunohistochemistry 18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with 18F-FDG PET and immunohistochemistry 18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with 18F-FDG PET and immunohistochemistry Annals of Nuclear Medicine, 24, 8, 579-584 Annals of Nuclear Medicine, 24, 8, 579-584 Annals of Nuclear Medicine, 24, 8, 579-584 2010/10 英語 研究論文(学術雑誌) 公開
G. Miyashita, T. Higuchi, N. Oriuch, Y. Arisaka, T. Ishikita, H. Hanaoka, H. Tominaga, M. Miyakubo, A. Negishi, S. Yokoo, K. Endo G. Miyashita, T. Higuchi, N. Oriuch, Y. Arisaka, T. Ishikita, H. Hanaoka, H. Tominaga, M. Miyakubo, A. Negishi, S. Yokoo, K. Endo G. Miyashita, T. Higuchi, N. Oriuch, Y. Arisaka, T. Ishikita, H. Hanaoka, H. Tominaga, M. Miyakubo, A. Negishi, S. Yokoo, K. Endo F-18-FAMT uptake correlates tumor proliferative activity in oral squamous cell carcinoma; Comparative study with F-18-FDG PET and immunohistochemistry F-18-FAMT uptake correlates tumor proliferative activity in oral squamous cell carcinoma; Comparative study with F-18-FDG PET and immunohistochemistry F-18-FAMT uptake correlates tumor proliferative activity in oral squamous cell carcinoma; Comparative study with F-18-FDG PET and immunohistochemistry EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 37, 8, S408-S408 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 37, 8, S408-S408 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 37, 8, S408-S408 2010/10 英語 公開
Yusuke Oji, Yoshihiro Oka, Sumiyuki Nishida, Akihiro Tsuboi, Manabu Kawakami, Toshiaki Shirakata, Kazuko Takahashi, Ayako Murao, Hiroko Nakajima, Miwako Narita, Masuhiro Takahashi, Satoshi Morita, Junichi Sakamoto, Toshio Tanaka, Ichiro Kawase, Naoki Hosen, Haruo Sugiyama Yusuke Oji, Yoshihiro Oka, Sumiyuki Nishida, Akihiro Tsuboi, Manabu Kawakami, Toshiaki Shirakata, Kazuko Takahashi, Ayako Murao, Hiroko Nakajima, Miwako Narita, Masuhiro Takahashi, Satoshi Morita, Junichi Sakamoto, Toshio Tanaka, Ichiro Kawase, Naoki Hosen, Haruo Sugiyama Yusuke Oji, Yoshihiro Oka, Sumiyuki Nishida, Akihiro Tsuboi, Manabu Kawakami, Toshiaki Shirakata, Kazuko Takahashi, Ayako Murao, Hiroko Nakajima, Miwako Narita, Masuhiro Takahashi, Satoshi Morita, Junichi Sakamoto, Toshio Tanaka, Ichiro Kawase, Naoki Hosen, Haruo Sugiyama WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient EUROPEAN JOURNAL OF HAEMATOLOGY, 85, 4, 358-360 EUROPEAN JOURNAL OF HAEMATOLOGY, 85, 4, 358-360 EUROPEAN JOURNAL OF HAEMATOLOGY, 85, 4, 358-360 2010/10 英語 研究論文(学術雑誌) 公開
Mayumi Kobayashi, Nobuhito Hirawa, Satoshi Morita, Keisuke Yatsu, Yusuke Kobayashi, Yuichiro Yamamoto, Sanae Saka, Yoshiyuki Toya, Gen Yasuda, Satoshi Umemura Mayumi Kobayashi, Nobuhito Hirawa, Satoshi Morita, Keisuke Yatsu, Yusuke Kobayashi, Yuichiro Yamamoto, Sanae Saka, Yoshiyuki Toya, Gen Yasuda, Satoshi Umemura Mayumi Kobayashi, Nobuhito Hirawa, Satoshi Morita, Keisuke Yatsu, Yusuke Kobayashi, Yuichiro Yamamoto, Sanae Saka, Yoshiyuki Toya, Gen Yasuda, Satoshi Umemura Silent Brain Infarction and Rapid Decline of Kidney Function in Patients With CKD: A Prospective Cohort Study Silent Brain Infarction and Rapid Decline of Kidney Function in Patients With CKD: A Prospective Cohort Study Silent Brain Infarction and Rapid Decline of Kidney Function in Patients With CKD: A Prospective Cohort Study AMERICAN JOURNAL OF KIDNEY DISEASES, 56, 3, 468-476 AMERICAN JOURNAL OF KIDNEY DISEASES, 56, 3, 468-476 AMERICAN JOURNAL OF KIDNEY DISEASES, 56, 3, 468-476 2010/09 英語 研究論文(学術雑誌) 公開
Kei Muro, Narikazu Boku, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hideo Baba, Taroh Satoh, Tadamichi Denda, Kenji Ina, Tomohiro Nishina, Kensei Yamaguchi, Hiroya Takiuchi, Taito Esaki, Shinya Tokunaga, Hiroyuki Kuwano, Yoshito Komatsu, Masahiko Watanabe, Ichinosuke Hyodo, Satoshi Morita, Kenichi Sugihara Kei Muro, Narikazu Boku, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hideo Baba, Taroh Satoh, Tadamichi Denda, Kenji Ina, Tomohiro Nishina, Kensei Yamaguchi, Hiroya Takiuchi, Taito Esaki, Shinya Tokunaga, Hiroyuki Kuwano, Yoshito Komatsu, Masahiko Watanabe, Ichinosuke Hyodo, Satoshi Morita, Kenichi Sugihara Kei Muro, Narikazu Boku, Yasuhiro Shimada, Akihito Tsuji, Shinichi Sameshima, Hideo Baba, Taroh Satoh, Tadamichi Denda, Kenji Ina, Tomohiro Nishina, Kensei Yamaguchi, Hiroya Takiuchi, Taito Esaki, Shinya Tokunaga, Hiroyuki Kuwano, Yoshito Komatsu, Masahiko Watanabe, Ichinosuke Hyodo, Satoshi Morita, Kenichi Sugihara Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study) Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study) Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study) LANCET ONCOLOGY, 11, 9, 853-860 LANCET ONCOLOGY, 11, 9, 853-860 LANCET ONCOLOGY, 11, 9, 853-860 2010/09 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Kazunari Shibata, Satoru UeNo, Kiyoshi Ichimoto, Reizaburo Kitai, Ken-ichi Otsuji Satoshi Morita, Kazunari Shibata, Satoru UeNo, Kiyoshi Ichimoto, Reizaburo Kitai, Ken-ichi Otsuji Satoshi Morita, Kazunari Shibata, Satoru UeNo, Kiyoshi Ichimoto, Reizaburo Kitai, Ken-ichi Otsuji Observations of Chromospheric Anemone Jets with Hinode Ca II Broadband Filtergraph and Hida Ca II Spectroheliograph Observations of Chromospheric Anemone Jets with Hinode Ca II Broadband Filtergraph and Hida Ca II Spectroheliograph Observations of Chromospheric Anemone Jets with Hinode Ca II Broadband Filtergraph and Hida Ca II Spectroheliograph PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 62, 4, 901-920 PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 62, 4, 901-920 PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 62, 4, 901-920 2010/08 英語 研究論文(学術雑誌) 公開
Ukihide Tateishi, Satoshi Morita, Masataka Taguri, Kazuya Shizukuishi, Ryogo Minamimoto, Masashi Kawaguchi, Takeshi Murano, Takashi Terauchi, Tomio Inoue, E. Edmund Kim Ukihide Tateishi, Satoshi Morita, Masataka Taguri, Kazuya Shizukuishi, Ryogo Minamimoto, Masashi Kawaguchi, Takeshi Murano, Takashi Terauchi, Tomio Inoue, E. Edmund Kim Ukihide Tateishi, Satoshi Morita, Masataka Taguri, Kazuya Shizukuishi, Ryogo Minamimoto, Masashi Kawaguchi, Takeshi Murano, Takashi Terauchi, Tomio Inoue, E. Edmund Kim A meta-analysis of F-18-Fluoride positron emission tomography for assessment of metastatic bone tumor A meta-analysis of F-18-Fluoride positron emission tomography for assessment of metastatic bone tumor A meta-analysis of F-18-Fluoride positron emission tomography for assessment of metastatic bone tumor ANNALS OF NUCLEAR MEDICINE, 24, 7, 523-531 ANNALS OF NUCLEAR MEDICINE, 24, 7, 523-531 ANNALS OF NUCLEAR MEDICINE, 24, 7, 523-531 2010/08 英語 研究論文(学術雑誌) 公開
Yuji Ueda, Hisakazu Yamagishi, Daisuke Ichikawa, Kazuma Okamoto, Eigo Otsuji, Jun Morii, Kinya Koizumi, Naoki Kakihara, Masataka Shimotsuma, Tetsuro Yamashita, Fumihiro Taniguchi, Hideki Aragane, Hiroshi Nishi, Yoshiki Itokawa, Satoshi Morita, Junichi Sakamoto Yuji Ueda, Hisakazu Yamagishi, Daisuke Ichikawa, Kazuma Okamoto, Eigo Otsuji, Jun Morii, Kinya Koizumi, Naoki Kakihara, Masataka Shimotsuma, Tetsuro Yamashita, Fumihiro Taniguchi, Hideki Aragane, Hiroshi Nishi, Yoshiki Itokawa, Satoshi Morita, Junichi Sakamoto Yuji Ueda, Hisakazu Yamagishi, Daisuke Ichikawa, Kazuma Okamoto, Eigo Otsuji, Jun Morii, Kinya Koizumi, Naoki Kakihara, Masataka Shimotsuma, Tetsuro Yamashita, Fumihiro Taniguchi, Hideki Aragane, Hiroshi Nishi, Yoshiki Itokawa, Satoshi Morita, Junichi Sakamoto Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer GASTRIC CANCER, 13, 3, 149-154 GASTRIC CANCER, 13, 3, 149-154 GASTRIC CANCER, 13, 3, 149-154 2010/08 英語 研究論文(学術雑誌) 公開
Tsutomu Fujii, Koichi Kato, Yasuhiro Kodera, Mitsuro Kanda, Shunji Nagai, Suguru Yamada, Akiyuki Kanzaki, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Shigeo Nakamura, Akimasa Nakao Tsutomu Fujii, Koichi Kato, Yasuhiro Kodera, Mitsuro Kanda, Shunji Nagai, Suguru Yamada, Akiyuki Kanzaki, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Shigeo Nakamura, Akimasa Nakao Tsutomu Fujii, Koichi Kato, Yasuhiro Kodera, Mitsuro Kanda, Shunji Nagai, Suguru Yamada, Akiyuki Kanzaki, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Satoshi Morita, Shigeo Nakamura, Akimasa Nakao Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas SURGERY, 148, 2, 285-290 SURGERY, 148, 2, 285-290 SURGERY, 148, 2, 285-290 2010/08 英語 研究論文(学術雑誌) 公開
Takashi Ishikawa, Daisuke Shimizu, Takeshi Sasaki, Satoshi Morita, Mikiko Tanabe, Ikuko Ota, Kae Kawachi, Akinori Nozawa, Takashi Chishima, Yasushi Ichikawa, Itaru Endo, Hiroshi Shimada Takashi Ishikawa, Daisuke Shimizu, Takeshi Sasaki, Satoshi Morita, Mikiko Tanabe, Ikuko Ota, Kae Kawachi, Akinori Nozawa, Takashi Chishima, Yasushi Ichikawa, Itaru Endo, Hiroshi Shimada Takashi Ishikawa, Daisuke Shimizu, Takeshi Sasaki, Satoshi Morita, Mikiko Tanabe, Ikuko Ota, Kae Kawachi, Akinori Nozawa, Takashi Chishima, Yasushi Ichikawa, Itaru Endo, Hiroshi Shimada A Human Epidermal Growth Factor Receptor 2 Expression-based Approach to Neoadjuvant Chemotherapy for Operable Breast Cancer A Human Epidermal Growth Factor Receptor 2 Expression-based Approach to Neoadjuvant Chemotherapy for Operable Breast Cancer A Human Epidermal Growth Factor Receptor 2 Expression-based Approach to Neoadjuvant Chemotherapy for Operable Breast Cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, 7, 620-626 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, 7, 620-626 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, 7, 620-626 2010/07 英語 研究論文(学術雑誌) 公開
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita, Yuka Fujita, Shoji Okinaga, Haruto Hirano, Kozo Yoshimori, Toshiyuki Harada, Takashi Ogura, Masahiro Ando, Hitoshi Miyazawa, Tomoaki Tanaka, Yasuo Saijo, Koichi Hagiwara, Satoshi Morita, Toshihiro Nukiwa Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita, Yuka Fujita, Shoji Okinaga, Haruto Hirano, Kozo Yoshimori, Toshiyuki Harada, Takashi Ogura, Masahiro Ando, Hitoshi Miyazawa, Tomoaki Tanaka, Yasuo Saijo, Koichi Hagiwara, Satoshi Morita, Toshihiro Nukiwa Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita, Yuka Fujita, Shoji Okinaga, Haruto Hirano, Kozo Yoshimori, Toshiyuki Harada, Takashi Ogura, Masahiro Ando, Hitoshi Miyazawa, Tomoaki Tanaka, Yasuo Saijo, Koichi Hagiwara, Satoshi Morita, Toshihiro Nukiwa Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR. Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR. Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR. NEW ENGLAND JOURNAL OF MEDICINE, 362, 25, 2380-2388 NEW ENGLAND JOURNAL OF MEDICINE, 362, 25, 2380-2388 NEW ENGLAND JOURNAL OF MEDICINE, 362, 25, 2380-2388 2010/06 英語 研究論文(学術雑誌) 公開
Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Jun Okuda, Noriaki Iwahashi, Kengo Tsukahara, Tatsuya Nakachi, Masayoshi Kiyokuni, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Jun Okuda, Noriaki Iwahashi, Kengo Tsukahara, Tatsuya Nakachi, Masayoshi Kiyokuni, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Jun Okuda, Noriaki Iwahashi, Kengo Tsukahara, Tatsuya Nakachi, Masayoshi Kiyokuni, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura Simple and Accurate Electrocardiographic Criteria to Differentiate Takotsubo Cardiomyopathy From Anterior Acute Myocardial Infarction Simple and Accurate Electrocardiographic Criteria to Differentiate Takotsubo Cardiomyopathy From Anterior Acute Myocardial Infarction Simple and Accurate Electrocardiographic Criteria to Differentiate Takotsubo Cardiomyopathy From Anterior Acute Myocardial Infarction JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55, 22, 2514-2516 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55, 22, 2514-2516 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55, 22, 2514-2516 2010/06 英語 公開
Wen Luo, Kazushi Numata, Manabu Morimoto, Akito Nozaki, Michio Ueda, Masaaki Kondo, Satoshi Morita, Katsuaki Tanaka Wen Luo, Kazushi Numata, Manabu Morimoto, Akito Nozaki, Michio Ueda, Masaaki Kondo, Satoshi Morita, Katsuaki Tanaka Wen Luo, Kazushi Numata, Manabu Morimoto, Akito Nozaki, Michio Ueda, Masaaki Kondo, Satoshi Morita, Katsuaki Tanaka Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies WORLD JOURNAL OF GASTROENTEROLOGY, 16, 17, 2109-2119 WORLD JOURNAL OF GASTROENTEROLOGY, 16, 17, 2109-2119 WORLD JOURNAL OF GASTROENTEROLOGY, 16, 17, 2109-2119 2010/05 英語 研究論文(学術雑誌) 公開
Kenji Tsushima, Shusuke Sone, Keisaku Fujimoto, Keishi Kubo, Satoshi Morita, Misa Takegami, Shunichi Fukuhara Kenji Tsushima, Shusuke Sone, Keisaku Fujimoto, Keishi Kubo, Satoshi Morita, Misa Takegami, Shunichi Fukuhara Kenji Tsushima, Shusuke Sone, Keisaku Fujimoto, Keishi Kubo, Satoshi Morita, Misa Takegami, Shunichi Fukuhara Identification of Occult Parechymal Disease Such as Emphysema or Airway Disease Using Screening Computed Tomography Identification of Occult Parechymal Disease Such as Emphysema or Airway Disease Using Screening Computed Tomography Identification of Occult Parechymal Disease Such as Emphysema or Airway Disease Using Screening Computed Tomography COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 7, 2, 117-125 COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 7, 2, 117-125 COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 7, 2, 117-125 2010/04 英語 研究論文(学術雑誌) 公開
Takaki Yoshikawa, Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, Seiji Ito, Haruhiko Cho, Yumi Miyashita, Junichi Sakamoto Takaki Yoshikawa, Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, Seiji Ito, Haruhiko Cho, Yumi Miyashita, Junichi Sakamoto Takaki Yoshikawa, Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, Seiji Ito, Haruhiko Cho, Yumi Miyashita, Junichi Sakamoto A Comparison of Multimodality Treatment: Two or Four Courses of Paclitaxel plus Cisplatin or S-1 plus Cisplatin Followed by Surgery for Locally Advanced Gastric Cancer, a Randomized Phase II Trial (COMPASS) A Comparison of Multimodality Treatment: Two or Four Courses of Paclitaxel plus Cisplatin or S-1 plus Cisplatin Followed by Surgery for Locally Advanced Gastric Cancer, a Randomized Phase II Trial (COMPASS) A Comparison of Multimodality Treatment: Two or Four Courses of Paclitaxel plus Cisplatin or S-1 plus Cisplatin Followed by Surgery for Locally Advanced Gastric Cancer, a Randomized Phase II Trial (COMPASS) JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, 4, 369-372 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, 4, 369-372 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, 4, 369-372 2010/04 英語 研究論文(学術雑誌) 公開
Kengo Tsukahara, Kazuo Kimura, Satoshi Morita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Jun Okuda, Noriaki Iwahashi, Nobuhiko Maejima, Tatsuya Nakachi, Fumiyuki Ohtsuka, Katsutaka Hashiba, Yoshio Tahara, Teruyasu Sugano, Satoshi Umemura Kengo Tsukahara, Kazuo Kimura, Satoshi Morita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Jun Okuda, Noriaki Iwahashi, Nobuhiko Maejima, Tatsuya Nakachi, Fumiyuki Ohtsuka, Katsutaka Hashiba, Yoshio Tahara, Teruyasu Sugano, Satoshi Umemura Kengo Tsukahara, Kazuo Kimura, Satoshi Morita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Jun Okuda, Noriaki Iwahashi, Nobuhiko Maejima, Tatsuya Nakachi, Fumiyuki Ohtsuka, Katsutaka Hashiba, Yoshio Tahara, Teruyasu Sugano, Satoshi Umemura Impact of High-Responsiveness to Dual Antiplatelet Therapy on Bleeding Complications in Patients Receiving Drug-Eluting Stents Impact of High-Responsiveness to Dual Antiplatelet Therapy on Bleeding Complications in Patients Receiving Drug-Eluting Stents Impact of High-Responsiveness to Dual Antiplatelet Therapy on Bleeding Complications in Patients Receiving Drug-Eluting Stents CIRCULATION JOURNAL, 74, 4, 679-685 CIRCULATION JOURNAL, 74, 4, 679-685 CIRCULATION JOURNAL, 74, 4, 679-685 2010/04 英語 研究論文(学術雑誌) 公開
Akito Nozaki, Manabu Morimoto, Masaaki Kondo, Takashi Oshima, Kazushi Numata, Shin Fujisawa, Takeshi Kaneko, Eiji Miyajima, Satoshi Morita, Kyoko Mori, Masanori Ikeda, Nobuyuki Kato, Katsuaki Tanaka Akito Nozaki, Manabu Morimoto, Masaaki Kondo, Takashi Oshima, Kazushi Numata, Shin Fujisawa, Takeshi Kaneko, Eiji Miyajima, Satoshi Morita, Kyoko Mori, Masanori Ikeda, Nobuyuki Kato, Katsuaki Tanaka Akito Nozaki, Manabu Morimoto, Masaaki Kondo, Takashi Oshima, Kazushi Numata, Shin Fujisawa, Takeshi Kaneko, Eiji Miyajima, Satoshi Morita, Kyoko Mori, Masanori Ikeda, Nobuyuki Kato, Katsuaki Tanaka Hydroxyurea as an inhibitor of hepatitis C virus RNA replication Hydroxyurea as an inhibitor of hepatitis C virus RNA replication Hydroxyurea as an inhibitor of hepatitis C virus RNA replication ARCHIVES OF VIROLOGY, 155, 4, 601-605 ARCHIVES OF VIROLOGY, 155, 4, 601-605 ARCHIVES OF VIROLOGY, 155, 4, 601-605 2010/04 英語 研究論文(学術雑誌) 公開
Toshihiro Fukui, Minoru Tabata, Susumu Manabe, Tomoki Shimokawa, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Susumu Manabe, Tomoki Shimokawa, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Minoru Tabata, Susumu Manabe, Tomoki Shimokawa, Satoshi Morita, Shuichiro Takanashi Angiographic outcomes of right internal thoracic artery grafts in situ or as free grafts in coronary artery bypass grafting Angiographic outcomes of right internal thoracic artery grafts in situ or as free grafts in coronary artery bypass grafting Angiographic outcomes of right internal thoracic artery grafts in situ or as free grafts in coronary artery bypass grafting JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 139, 4, 868-873 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 139, 4, 868-873 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 139, 4, 868-873 2010/04 英語 研究論文(学術雑誌) 公開
Mitsuro Kanda, Tsutomu Fujii, Tevfik T. Sahin, Akiyuki Kanzaki, Shunji Nagai, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao Mitsuro Kanda, Tsutomu Fujii, Tevfik T. Sahin, Akiyuki Kanzaki, Shunji Nagai, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao Mitsuro Kanda, Tsutomu Fujii, Tevfik T. Sahin, Akiyuki Kanzaki, Shunji Nagai, Suguru Yamada, Hiroyuki Sugimoto, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas ANNALS OF SURGERY, 251, 3, 483-487 ANNALS OF SURGERY, 251, 3, 483-487 ANNALS OF SURGERY, 251, 3, 483-487 2010/03 英語 研究論文(学術雑誌) 公開
Susumu Manabe, Toshihiro Fukui, Tomoki Shimokawa, Minoru Tabata, Yuzo Katayama, Satoshi Morita, Shuichiro Takanashi Susumu Manabe, Toshihiro Fukui, Tomoki Shimokawa, Minoru Tabata, Yuzo Katayama, Satoshi Morita, Shuichiro Takanashi Susumu Manabe, Toshihiro Fukui, Tomoki Shimokawa, Minoru Tabata, Yuzo Katayama, Satoshi Morita, Shuichiro Takanashi Increased Graft Occlusion or String Sign in Composite Arterial Grafting for Mildly Stenosed Target Vessels Increased Graft Occlusion or String Sign in Composite Arterial Grafting for Mildly Stenosed Target Vessels Increased Graft Occlusion or String Sign in Composite Arterial Grafting for Mildly Stenosed Target Vessels ANNALS OF THORACIC SURGERY, 89, 3, 683-688 ANNALS OF THORACIC SURGERY, 89, 3, 683-688 ANNALS OF THORACIC SURGERY, 89, 3, 683-688 2010/03 英語 研究論文(学術雑誌) 公開
Hideki Hirakata, Yoshiharu Tsubakihara, Fumitake Gejyo, Shinichi Nishi, Yasuhiko Iino, Yuzou Watanabe, Masashi Suzuki, Akira Saito, Takashi Akiba, Daijo Inaguma, Shunichi Fukuhara, Satoshi Morita, Michiaki Hiroe, Yoshiyuki Hada, Makoto Suzuki, Makoto Akaishi, Kazutaka Aonuma, Tadao Akizawa Hideki Hirakata, Yoshiharu Tsubakihara, Fumitake Gejyo, Shinichi Nishi, Yasuhiko Iino, Yuzou Watanabe, Masashi Suzuki, Akira Saito, Takashi Akiba, Daijo Inaguma, Shunichi Fukuhara, Satoshi Morita, Michiaki Hiroe, Yoshiyuki Hada, Makoto Suzuki, Makoto Akaishi, Kazutaka Aonuma, Tadao Akizawa Hideki Hirakata, Yoshiharu Tsubakihara, Fumitake Gejyo, Shinichi Nishi, Yasuhiko Iino, Yuzou Watanabe, Masashi Suzuki, Akira Saito, Takashi Akiba, Daijo Inaguma, Shunichi Fukuhara, Satoshi Morita, Michiaki Hiroe, Yoshiyuki Hada, Makoto Suzuki, Makoto Akaishi, Kazutaka Aonuma, Tadao Akizawa Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients CLINICAL AND EXPERIMENTAL NEPHROLOGY, 14, 1, 28-35 CLINICAL AND EXPERIMENTAL NEPHROLOGY, 14, 1, 28-35 CLINICAL AND EXPERIMENTAL NEPHROLOGY, 14, 1, 28-35 2010/02 英語 研究論文(学術雑誌) 公開
Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer BMC CANCER, 10 BMC CANCER, 10 BMC CANCER, 10 2010/02 英語 研究論文(学術雑誌) 公開
Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Junji Tsurutani, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Hiroshige Yoshioka, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Junji Tsurutani, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Hiroshige Yoshioka, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Junji Tsurutani, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Hiroshige Yoshioka, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial LANCET ONCOLOGY, 11, 2, 121-128 LANCET ONCOLOGY, 11, 2, 121-128 LANCET ONCOLOGY, 11, 2, 121-128 2010/02 英語 研究論文(学術雑誌) 公開
Tomoaki Tanaka, Masaru Matsuoka, Akihisa Sutani, Akihiko Gemma, Makoto Maemondo, Akira Inoue, Shoji Okinaga, Makoto Nagashima, Satoshi Oizumi, Kazutsugu Uematsu, Yoshiaki Nagai, Gaku Moriyama, Hitoshi Miyazawa, Kenji Ikebuchi, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara Tomoaki Tanaka, Masaru Matsuoka, Akihisa Sutani, Akihiko Gemma, Makoto Maemondo, Akira Inoue, Shoji Okinaga, Makoto Nagashima, Satoshi Oizumi, Kazutsugu Uematsu, Yoshiaki Nagai, Gaku Moriyama, Hitoshi Miyazawa, Kenji Ikebuchi, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara Tomoaki Tanaka, Masaru Matsuoka, Akihisa Sutani, Akihiko Gemma, Makoto Maemondo, Akira Inoue, Shoji Okinaga, Makoto Nagashima, Satoshi Oizumi, Kazutsugu Uematsu, Yoshiaki Nagai, Gaku Moriyama, Hitoshi Miyazawa, Kenji Ikebuchi, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara Frequency of and variables associated with the EGFR mutation and its subtypes Frequency of and variables associated with the EGFR mutation and its subtypes Frequency of and variables associated with the EGFR mutation and its subtypes INTERNATIONAL JOURNAL OF CANCER, 126, 3, 651-655 INTERNATIONAL JOURNAL OF CANCER, 126, 3, 651-655 INTERNATIONAL JOURNAL OF CANCER, 126, 3, 651-655 2010/02 英語 研究論文(学術雑誌) 公開
Bunzo Nakata, Akihito Tsuji, Yasushi Mitachi, Naoyuki Taenaka, Toshiki Kamano, Keisuke Oikawa, Naoyoshi Onoda, Mariko Kambe, Masahiro Takahashi, Tetsuhiko Shirasaka, Satoshi Morita, Junichi Sakamoto, Yukari Tanaka, Shigetoyo Saji, Kosei Hirakawa Bunzo Nakata, Akihito Tsuji, Yasushi Mitachi, Naoyuki Taenaka, Toshiki Kamano, Keisuke Oikawa, Naoyoshi Onoda, Mariko Kambe, Masahiro Takahashi, Tetsuhiko Shirasaka, Satoshi Morita, Junichi Sakamoto, Yukari Tanaka, Shigetoyo Saji, Kosei Hirakawa Bunzo Nakata, Akihito Tsuji, Yasushi Mitachi, Naoyuki Taenaka, Toshiki Kamano, Keisuke Oikawa, Naoyoshi Onoda, Mariko Kambe, Masahiro Takahashi, Tetsuhiko Shirasaka, Satoshi Morita, Junichi Sakamoto, Yukari Tanaka, Shigetoyo Saji, Kosei Hirakawa Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2) Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2) Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2) ONCOLOGY, 79, 5-6, 337-342 ONCOLOGY, 79, 5-6, 337-342 ONCOLOGY, 79, 5-6, 337-342 2010 英語 研究論文(学術雑誌) 公開
Akito Nozaki, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Kazuya Sugimori, Satoshi Morita, Eiji Miyajima, Masanori Ikeda, Nobuyuki Kato, Shin Maeda, Katsuaki Tanaka Akito Nozaki, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Kazuya Sugimori, Satoshi Morita, Eiji Miyajima, Masanori Ikeda, Nobuyuki Kato, Shin Maeda, Katsuaki Tanaka Akito Nozaki, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Kazuya Sugimori, Satoshi Morita, Eiji Miyajima, Masanori Ikeda, Nobuyuki Kato, Shin Maeda, Katsuaki Tanaka Hydroxyurea suppresses HCV replication in humans: a Phase I trial of oral hydroxyurea in chronic hepatitis C patients Hydroxyurea suppresses HCV replication in humans: a Phase I trial of oral hydroxyurea in chronic hepatitis C patients Hydroxyurea suppresses HCV replication in humans: a Phase I trial of oral hydroxyurea in chronic hepatitis C patients ANTIVIRAL THERAPY, 15, 8, 1179-1183 ANTIVIRAL THERAPY, 15, 8, 1179-1183 ANTIVIRAL THERAPY, 15, 8, 1179-1183 2010 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Peter F. Thall, Peter Müller Satoshi Morita, Peter F. Thall, Peter Müller Satoshi Morita, Peter F. Thall, Peter Müller Evaluating the impact of prior assumptions in Bayesian biostatistics Evaluating the impact of prior assumptions in Bayesian biostatistics Evaluating the impact of prior assumptions in Bayesian biostatistics Statistics in Biosciences, 2, 1, 1-17 Statistics in Biosciences, 2, 1, 1-17 Statistics in Biosciences, 2, 1, 1-17 2010 英語 研究論文(学術雑誌) 公開
Lon Say Heng, Hiroshi Yatsuya, Satoshi Morita, Junichi Sakamoto Lon Say Heng, Hiroshi Yatsuya, Satoshi Morita, Junichi Sakamoto Lon Say Heng, Hiroshi Yatsuya, Satoshi Morita, Junichi Sakamoto Vaginal Douching in Cambodian Women: Its Prevalence and Association With Vaginal Candidiasis Vaginal Douching in Cambodian Women: Its Prevalence and Association With Vaginal Candidiasis Vaginal Douching in Cambodian Women: Its Prevalence and Association With Vaginal Candidiasis JOURNAL OF EPIDEMIOLOGY, 20, 1, 70-76 JOURNAL OF EPIDEMIOLOGY, 20, 1, 70-76 JOURNAL OF EPIDEMIOLOGY, 20, 1, 70-76 2010/01 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Peter F. Thall, B. Nebiyou Bekele, Paul Mathew Satoshi Morita, Peter F. Thall, B. Nebiyou Bekele, Paul Mathew Satoshi Morita, Peter F. Thall, B. Nebiyou Bekele, Paul Mathew A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 59, 1, 19-34 JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 59, 1, 19-34 JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 59, 1, 19-34 2010 英語 研究論文(学術雑誌) 公開
Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Katsumasa Kuroi, Shozo Ohsumi, Haruhiko Makino, Hirohumi Mukai, Noriyuki Katsumata, Yoshihide Sunada, Toru Watanabe, Frederick H. Hausheer Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Katsumasa Kuroi, Shozo Ohsumi, Haruhiko Makino, Hirohumi Mukai, Noriyuki Katsumata, Yoshihide Sunada, Toru Watanabe, Frederick H. Hausheer Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Katsumasa Kuroi, Shozo Ohsumi, Haruhiko Makino, Hirohumi Mukai, Noriyuki Katsumata, Yoshihide Sunada, Toru Watanabe, Frederick H. Hausheer Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02 Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02 Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02 SUPPORTIVE CARE IN CANCER, 17, 12, 1483-1491 SUPPORTIVE CARE IN CANCER, 17, 12, 1483-1491 SUPPORTIVE CARE IN CANCER, 17, 12, 1483-1491 2009/12 英語 研究論文(学術雑誌) 公開
Toru Kono, Hideyuki Mishima, Mitsuo Shimada, Satoshi Morita, Junichi Sakamoto Toru Kono, Hideyuki Mishima, Mitsuo Shimada, Satoshi Morita, Junichi Sakamoto Toru Kono, Hideyuki Mishima, Mitsuo Shimada, Satoshi Morita, Junichi Sakamoto Preventive Effect of Goshajinkigan on Peripheral Neurotoxicity of FOLFOX Therapy: A Placebo-controlled Double-blind Randomized Phase II Study (the GONE Study) Preventive Effect of Goshajinkigan on Peripheral Neurotoxicity of FOLFOX Therapy: A Placebo-controlled Double-blind Randomized Phase II Study (the GONE Study) Preventive Effect of Goshajinkigan on Peripheral Neurotoxicity of FOLFOX Therapy: A Placebo-controlled Double-blind Randomized Phase II Study (the GONE Study) JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 12, 847-849 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 12, 847-849 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 12, 847-849 2009/12 英語 研究論文(学術雑誌) 公開
Masami Kosuge, Toshiyuki Ishikawa, Satoshi Morita, Toshiaki Ebina, Kiyoshi Hibi, Nobuhiko Maejima, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiyuki Ishikawa, Satoshi Morita, Toshiaki Ebina, Kiyoshi Hibi, Nobuhiko Maejima, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiyuki Ishikawa, Satoshi Morita, Toshiaki Ebina, Kiyoshi Hibi, Nobuhiko Maejima, Satoshi Umemura, Kazuo Kimura Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardial infarction Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardial infarction Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardial infarction JOURNAL OF CARDIOLOGY, 54, 3, 386-393 JOURNAL OF CARDIOLOGY, 54, 3, 386-393 JOURNAL OF CARDIOLOGY, 54, 3, 386-393 2009/12 英語 研究論文(学術雑誌) 公開
Satoshi Ohno, Satoru Kyo, Subaru Myojo, Satoshi Dohi, Junko Ishizaki, Ken-Ichi Miyamoto, Satoshi Morita, Jun-Ichi Sakamoto, Takayuki Enomoto, Tadashi Kimura, Yoshihiro Oka, Akihiro Tsuboi, Haruo Sugiyama, Masaki Inoue Satoshi Ohno, Satoru Kyo, Subaru Myojo, Satoshi Dohi, Junko Ishizaki, Ken-Ichi Miyamoto, Satoshi Morita, Jun-Ichi Sakamoto, Takayuki Enomoto, Tadashi Kimura, Yoshihiro Oka, Akihiro Tsuboi, Haruo Sugiyama, Masaki Inoue Satoshi Ohno, Satoru Kyo, Subaru Myojo, Satoshi Dohi, Junko Ishizaki, Ken-Ichi Miyamoto, Satoshi Morita, Jun-Ichi Sakamoto, Takayuki Enomoto, Tadashi Kimura, Yoshihiro Oka, Akihiro Tsuboi, Haruo Sugiyama, Masaki Inoue Wilms&apos; Tumor 1 (WT1) Peptide Immunotherapy for Gynecological Malignancy Wilms&apos; Tumor 1 (WT1) Peptide Immunotherapy for Gynecological Malignancy Wilms&apos; Tumor 1 (WT1) Peptide Immunotherapy for Gynecological Malignancy ANTICANCER RESEARCH, 29, 11, 4779-4784 ANTICANCER RESEARCH, 29, 11, 4779-4784 ANTICANCER RESEARCH, 29, 11, 4779-4784 2009/11 英語 研究論文(学術雑誌) 公開
Tadao Akizawa, Yasushi Asano, Satoshi Morita, Takafumi Wakita, Yoshihiro Onishi, Shunichi Fukuhara, Fumitake Gejyo, Seiichi Matsuo, Noriaki Yorioka, Kiyoshi Kurokawa Tadao Akizawa, Yasushi Asano, Satoshi Morita, Takafumi Wakita, Yoshihiro Onishi, Shunichi Fukuhara, Fumitake Gejyo, Seiichi Matsuo, Noriaki Yorioka, Kiyoshi Kurokawa Tadao Akizawa, Yasushi Asano, Satoshi Morita, Takafumi Wakita, Yoshihiro Onishi, Shunichi Fukuhara, Fumitake Gejyo, Seiichi Matsuo, Noriaki Yorioka, Kiyoshi Kurokawa Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial AMERICAN JOURNAL OF KIDNEY DISEASES, 54, 3, 459-467 AMERICAN JOURNAL OF KIDNEY DISEASES, 54, 3, 459-467 AMERICAN JOURNAL OF KIDNEY DISEASES, 54, 3, 459-467 2009/09 英語 研究論文(学術雑誌) 公開
Tomoki Shimokawa, Hitoshi Kasegawa, Shigefumi Matsuyama, Hiroshi Seki, Susumu Manabe, Toshihiro Fukui, Satoshi Morita, Shuichiro Takanashi Tomoki Shimokawa, Hitoshi Kasegawa, Shigefumi Matsuyama, Hiroshi Seki, Susumu Manabe, Toshihiro Fukui, Satoshi Morita, Shuichiro Takanashi Tomoki Shimokawa, Hitoshi Kasegawa, Shigefumi Matsuyama, Hiroshi Seki, Susumu Manabe, Toshihiro Fukui, Satoshi Morita, Shuichiro Takanashi Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis ANNALS OF THORACIC SURGERY, 88, 3, 733-739 ANNALS OF THORACIC SURGERY, 88, 3, 733-739 ANNALS OF THORACIC SURGERY, 88, 3, 733-739 2009/09 英語 研究論文(学術雑誌) 公開
Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, Kazufumi Hisamatsu, Norikazu Masuda, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Shozo Ohsumi, Frederick H. Hausheer Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, Kazufumi Hisamatsu, Norikazu Masuda, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Shozo Ohsumi, Frederick H. Hausheer Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, Kazufumi Hisamatsu, Norikazu Masuda, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Shozo Ohsumi, Frederick H. Hausheer Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study) Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study) Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study) SUPPORTIVE CARE IN CANCER, 17, 8, 1071-1080 SUPPORTIVE CARE IN CANCER, 17, 8, 1071-1080 SUPPORTIVE CARE IN CANCER, 17, 8, 1071-1080 2009/08 英語 研究論文(学術雑誌) 公開
M. Kanai, S. Morita, S. Matsumoto, T. Nishimura, E. Hatano, S. Yazumi, T. Sasaki, H. Yasuda, T. Kitano, A. Misawa, H. Ishiguro, K. Yanagihara, I. Ikai, R. Doi, M. Fukushima M. Kanai, S. Morita, S. Matsumoto, T. Nishimura, E. Hatano, S. Yazumi, T. Sasaki, H. Yasuda, T. Kitano, A. Misawa, H. Ishiguro, K. Yanagihara, I. Ikai, R. Doi, M. Fukushima M. Kanai, S. Morita, S. Matsumoto, T. Nishimura, E. Hatano, S. Yazumi, T. Sasaki, H. Yasuda, T. Kitano, A. Misawa, H. Ishiguro, K. Yanagihara, I. Ikai, R. Doi, M. Fukushima A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia ANNALS OF ONCOLOGY, 20, 8, 1397-1401 ANNALS OF ONCOLOGY, 20, 8, 1397-1401 ANNALS OF ONCOLOGY, 20, 8, 1397-1401 2009/08 英語 研究論文(学術雑誌) 公開
Koichi Kato, Suguru Yamada, Hiroyuki Sugimoto, Naohito Kanazumi, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao Koichi Kato, Suguru Yamada, Hiroyuki Sugimoto, Naohito Kanazumi, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao Koichi Kato, Suguru Yamada, Hiroyuki Sugimoto, Naohito Kanazumi, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Satoshi Morita, Akimasa Nakao Prognostic Factors for Survival After Extended Pancreatectomy for Pancreatic Head Cancer Influence of Resection Margin Status on Survival Prognostic Factors for Survival After Extended Pancreatectomy for Pancreatic Head Cancer Influence of Resection Margin Status on Survival Prognostic Factors for Survival After Extended Pancreatectomy for Pancreatic Head Cancer Influence of Resection Margin Status on Survival PANCREAS, 38, 6, 605-612 PANCREAS, 38, 6, 605-612 PANCREAS, 38, 6, 605-612 2009/08 英語 研究論文(学術雑誌) 公開
Shozo Ohsumi, Kojiro Shimozuma, Satoshi Morita, Fumikata Hara, Daisuke Takabatake, Seiki Takashima, Naruto Taira, Kenjiro Aogi, Shigemitsu Takashima Shozo Ohsumi, Kojiro Shimozuma, Satoshi Morita, Fumikata Hara, Daisuke Takabatake, Seiki Takashima, Naruto Taira, Kenjiro Aogi, Shigemitsu Takashima Shozo Ohsumi, Kojiro Shimozuma, Satoshi Morita, Fumikata Hara, Daisuke Takabatake, Seiki Takashima, Naruto Taira, Kenjiro Aogi, Shigemitsu Takashima Factors Associated with Health-related Quality-of-life in Breast Cancer Survivors: Influence of the Type of Surgery Factors Associated with Health-related Quality-of-life in Breast Cancer Survivors: Influence of the Type of Surgery Factors Associated with Health-related Quality-of-life in Breast Cancer Survivors: Influence of the Type of Surgery JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 8, 491-496 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 8, 491-496 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 8, 491-496 2009/08 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, Koichi Yamazaki, Hajime Asahina, Akira Inoue, Koichi Hagiwara, Noriaki Sunaga, Noriko Yanagitani, Toyoaki Hida, Kimihide Yoshida, Tomonori Hirashima, Kosei Yasumoto, Kenji Sugio, Tetsuya Mitsudomi, Masahiro Fukuoka, Toshihiro Nukiwa Satoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, Koichi Yamazaki, Hajime Asahina, Akira Inoue, Koichi Hagiwara, Noriaki Sunaga, Noriko Yanagitani, Toyoaki Hida, Kimihide Yoshida, Tomonori Hirashima, Kosei Yasumoto, Kenji Sugio, Tetsuya Mitsudomi, Masahiro Fukuoka, Toshihiro Nukiwa Satoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, Koichi Yamazaki, Hajime Asahina, Akira Inoue, Koichi Hagiwara, Noriaki Sunaga, Noriko Yanagitani, Toyoaki Hida, Kimihide Yoshida, Tomonori Hirashima, Kosei Yasumoto, Kenji Sugio, Tetsuya Mitsudomi, Masahiro Fukuoka, Toshihiro Nukiwa Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations CLINICAL CANCER RESEARCH, 15, 13, 4493-4498 CLINICAL CANCER RESEARCH, 15, 13, 4493-4498 CLINICAL CANCER RESEARCH, 15, 13, 4493-4498 2009/07 英語 研究論文(学術雑誌) 公開
Makiko Nakagawa, Chiaki Kawanishi, Tomoki Yamada, Yoko Iwamoto, Ryoko Sato, Hana Hasegawa, Satoshi Morita, Toshinari Odawara, Yoshio Hirayasu Makiko Nakagawa, Chiaki Kawanishi, Tomoki Yamada, Yoko Iwamoto, Ryoko Sato, Hana Hasegawa, Satoshi Morita, Toshinari Odawara, Yoshio Hirayasu Makiko Nakagawa, Chiaki Kawanishi, Tomoki Yamada, Yoko Iwamoto, Ryoko Sato, Hana Hasegawa, Satoshi Morita, Toshinari Odawara, Yoshio Hirayasu Characteristics of suicide attempters with family history of suicide attempt: a retrospective chart review Characteristics of suicide attempters with family history of suicide attempt: a retrospective chart review Characteristics of suicide attempters with family history of suicide attempt: a retrospective chart review BMC PSYCHIATRY, 9 BMC PSYCHIATRY, 9 BMC PSYCHIATRY, 9 2009/06 英語 研究論文(学術雑誌) 公開
Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Naohiro Komura, Katsutaka Hashiba, Masayoshi Kiyokuni, Naoki Nakayama, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Naohiro Komura, Katsutaka Hashiba, Masayoshi Kiyokuni, Naoki Nakayama, Satoshi Umemura, Kazuo Kimura Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, Naohiro Komura, Katsutaka Hashiba, Masayoshi Kiyokuni, Naoki Nakayama, Satoshi Umemura, Kazuo Kimura Early, Accurate, Non-Invasive Predictors of Left Main or 3-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Early, Accurate, Non-Invasive Predictors of Left Main or 3-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Early, Accurate, Non-Invasive Predictors of Left Main or 3-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome CIRCULATION JOURNAL, 73, 6, 1105-1110 CIRCULATION JOURNAL, 73, 6, 1105-1110 CIRCULATION JOURNAL, 73, 6, 1105-1110 2009/06 英語 研究論文(学術雑誌) 公開
Takashi Ishikawa, Satoru Shimizu, Kiyofumi Katayama, Takashi Chishima, Yohei Hamaguchi, Takako Doi, Mikiko Tanabe, Akio Kasahara, Naotaka Yamaguchi, Kazutaka Narui, Ikuko Ohta, Chizuru Matsumoto, Daisuke Shimizu, Ayako Kito, Takashi Suda, Masaaki Inaba, Taro Asaga, Nobuyoshi Momiyama, Yasushi Ichikawa, Masataka Yoshimoto, Satoshi Morita, Hiroshi Shimada Takashi Ishikawa, Satoru Shimizu, Kiyofumi Katayama, Takashi Chishima, Yohei Hamaguchi, Takako Doi, Mikiko Tanabe, Akio Kasahara, Naotaka Yamaguchi, Kazutaka Narui, Ikuko Ohta, Chizuru Matsumoto, Daisuke Shimizu, Ayako Kito, Takashi Suda, Masaaki Inaba, Taro Asaga, Nobuyoshi Momiyama, Yasushi Ichikawa, Masataka Yoshimoto, Satoshi Morita, Hiroshi Shimada Takashi Ishikawa, Satoru Shimizu, Kiyofumi Katayama, Takashi Chishima, Yohei Hamaguchi, Takako Doi, Mikiko Tanabe, Akio Kasahara, Naotaka Yamaguchi, Kazutaka Narui, Ikuko Ohta, Chizuru Matsumoto, Daisuke Shimizu, Ayako Kito, Takashi Suda, Masaaki Inaba, Taro Asaga, Nobuyoshi Momiyama, Yasushi Ichikawa, Masataka Yoshimoto, Satoshi Morita, Hiroshi Shimada Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan ANTICANCER RESEARCH, 29, 5, 1515-1520 ANTICANCER RESEARCH, 29, 5, 1515-1520 ANTICANCER RESEARCH, 29, 5, 1515-1520 2009/05 英語 研究論文(学術雑誌) 公開
Yoshinori Kamiya, Tatsuaki Kikuchi, Gaku Inagawa, Hiroshi Miyazaki, Masashi Miura, Satoshi Morita, Takahisa Goto Yoshinori Kamiya, Tatsuaki Kikuchi, Gaku Inagawa, Hiroshi Miyazaki, Masashi Miura, Satoshi Morita, Takahisa Goto Yoshinori Kamiya, Tatsuaki Kikuchi, Gaku Inagawa, Hiroshi Miyazaki, Masashi Miura, Satoshi Morita, Takahisa Goto Lidocaine Concentration in Cerebrospinal Fluid after Epidural Administration A Comparison between Epidural and Combined Spinal-Epidural Anesthesia Lidocaine Concentration in Cerebrospinal Fluid after Epidural Administration A Comparison between Epidural and Combined Spinal-Epidural Anesthesia Lidocaine Concentration in Cerebrospinal Fluid after Epidural Administration A Comparison between Epidural and Combined Spinal-Epidural Anesthesia ANESTHESIOLOGY, 110, 5, 1127-1132 ANESTHESIOLOGY, 110, 5, 1127-1132 ANESTHESIOLOGY, 110, 5, 1127-1132 2009/05 英語 研究論文(学術雑誌) 公開
Yasushige Shingu, Norihiko Shiiya, Tomonori Ooka, Tsuyoshi Tachibana, Suguru Kubota, Satoshi Morita, Yoshiro Matsui Yasushige Shingu, Norihiko Shiiya, Tomonori Ooka, Tsuyoshi Tachibana, Suguru Kubota, Satoshi Morita, Yoshiro Matsui Yasushige Shingu, Norihiko Shiiya, Tomonori Ooka, Tsuyoshi Tachibana, Suguru Kubota, Satoshi Morita, Yoshiro Matsui Augmentation Index Is Elevated in Aortic Aneurysm and Dissection Augmentation Index Is Elevated in Aortic Aneurysm and Dissection Augmentation Index Is Elevated in Aortic Aneurysm and Dissection ANNALS OF THORACIC SURGERY, 87, 5, 1373-1378 ANNALS OF THORACIC SURGERY, 87, 5, 1373-1378 ANNALS OF THORACIC SURGERY, 87, 5, 1373-1378 2009/05 英語 研究論文(学術雑誌) 公開
Wen Luo, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Shigeo Takebayashi, Masahiro Okada, Satoshi Morita, Katsuaki Tanaka Wen Luo, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Shigeo Takebayashi, Masahiro Okada, Satoshi Morita, Katsuaki Tanaka Wen Luo, Kazushi Numata, Manabu Morimoto, Masaaki Kondo, Shigeo Takebayashi, Masahiro Okada, Satoshi Morita, Katsuaki Tanaka Focal Liver Tumors: Characterization with 3D Perflubutane Microbubble Contrast Agent-enhanced US versus 3D Contrast-enhanced Multidetector CT Focal Liver Tumors: Characterization with 3D Perflubutane Microbubble Contrast Agent-enhanced US versus 3D Contrast-enhanced Multidetector CT Focal Liver Tumors: Characterization with 3D Perflubutane Microbubble Contrast Agent-enhanced US versus 3D Contrast-enhanced Multidetector CT RADIOLOGY, 251, 1, 287-295 RADIOLOGY, 251, 1, 287-295 RADIOLOGY, 251, 1, 287-295 2009/04 英語 研究論文(学術雑誌) 公開
S. Ueno, K. Shibata, R. Kitai, K. Ichimoto, S. Nagata, H. Isobe, G. Kimura, Y. Nakatani, M. Kadota, H. Komori, T. T. Ishii, S. Morita, K. Otsuji S. Ueno, K. Shibata, R. Kitai, K. Ichimoto, S. Nagata, H. Isobe, G. Kimura, Y. Nakatani, M. Kadota, H. Komori, T. T. Ishii, S. Morita, K. Otsuji S. Ueno, K. Shibata, R. Kitai, K. Ichimoto, S. Nagata, H. Isobe, G. Kimura, Y. Nakatani, M. Kadota, H. Komori, T. T. Ishii, S. Morita, K. Otsuji The CHAIN-project and installation of flare monitoring telescopes in developing countries The CHAIN-project and installation of flare monitoring telescopes in developing countries The CHAIN-project and installation of flare monitoring telescopes in developing countries Data Science Journal, 8, S51-S58 Data Science Journal, 8, S51-S58 Data Science Journal, 8, S51-S58 2009/03/30 英語 研究論文(学術雑誌) 公開
Inoue Akira, Kobayashi Kunihiko, Usui Kazuhiro, Maemondo Makoto, Okinaga Shoji, Mikami Iwao, Ando Masahiro, Yamazaki Koichi, Saijo Yasuo, Gemma Akihiko, Miyazawa Hitoshi, Tanaka Tomoaki, Ikebuchi Kenji, Nukiwa Toshihiro, Morita Satoshi, Hagiwara Koichi Inoue Akira, Kobayashi Kunihiko, Usui Kazuhiro, Maemondo Makoto, Okinaga Shoji, Mikami Iwao, Ando Masahiro, Yamazaki Koichi, Saijo Yasuo, Gemma Akihiko, Miyazawa Hitoshi, Tanaka Tomoaki, Ikebuchi Kenji, Nukiwa Toshihiro, Morita Satoshi, Hagiwara Koichi Inoue Akira, Kobayashi Kunihiko, Usui Kazuhiro, Maemondo Makoto, Okinaga Shoji, Mikami Iwao, Ando Masahiro, Yamazaki Koichi, Saijo Yasuo, Gemma Akihiko, Miyazawa Hitoshi, Tanaka Tomoaki, Ikebuchi Kenji, Nukiwa Toshihiro, Morita Satoshi, Hagiwara Koichi First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. J Clin Oncol, 27, 9, 1394-1400 J Clin Oncol, 27, 9, 1394-1400 J Clin Oncol, 27, 9, 1394-1400 2009/03/20 英語 研究論文(学術雑誌) 公開
Md Harun-Or-Rashid, Uh Farida Khatun, Yoshitoku Yoshida, Satoshi Morita, Nuruddin Chowdhury, Junichi Sakamoto Md Harun-Or-Rashid, Uh Farida Khatun, Yoshitoku Yoshida, Satoshi Morita, Nuruddin Chowdhury, Junichi Sakamoto Md Harun-Or-Rashid, Uh Farida Khatun, Yoshitoku Yoshida, Satoshi Morita, Nuruddin Chowdhury, Junichi Sakamoto IRON AND IODINE DEFICIENCIES AMONG UNDER-2 CHILDREN, ADOLESCENT GIRLS, AND PREGNANT WOMEN OF BANGLADESH: ASSOCIATION WITH COMMON DISEASES IRON AND IODINE DEFICIENCIES AMONG UNDER-2 CHILDREN, ADOLESCENT GIRLS, AND PREGNANT WOMEN OF BANGLADESH: ASSOCIATION WITH COMMON DISEASES IRON AND IODINE DEFICIENCIES AMONG UNDER-2 CHILDREN, ADOLESCENT GIRLS, AND PREGNANT WOMEN OF BANGLADESH: ASSOCIATION WITH COMMON DISEASES NAGOYA JOURNAL OF MEDICAL SCIENCE, 71, 1-2, 39-49 NAGOYA JOURNAL OF MEDICAL SCIENCE, 71, 1-2, 39-49 NAGOYA JOURNAL OF MEDICAL SCIENCE, 71, 1-2, 39-49 2009/02 英語 研究論文(学術雑誌) 公開
Soodsada Nalongsack, Yoshitoku Yoshida, Satoshi Morita, Keo Sosouphanh, Junichi Sakamoto Soodsada Nalongsack, Yoshitoku Yoshida, Satoshi Morita, Keo Sosouphanh, Junichi Sakamoto Soodsada Nalongsack, Yoshitoku Yoshida, Satoshi Morita, Keo Sosouphanh, Junichi Sakamoto KNOWLEDGE, ATTITUDE AND PRACTICE REGARDING DENGUE AMONG PEOPLE IN PAKSE, LAOS KNOWLEDGE, ATTITUDE AND PRACTICE REGARDING DENGUE AMONG PEOPLE IN PAKSE, LAOS KNOWLEDGE, ATTITUDE AND PRACTICE REGARDING DENGUE AMONG PEOPLE IN PAKSE, LAOS NAGOYA JOURNAL OF MEDICAL SCIENCE, 71, 1-2, 29-37 NAGOYA JOURNAL OF MEDICAL SCIENCE, 71, 1-2, 29-37 NAGOYA JOURNAL OF MEDICAL SCIENCE, 71, 1-2, 29-37 2009/02 英語 研究論文(学術雑誌) 公開
Masami Kosuge, Kazuo Kimura, Satoshi Morita, Sunao Kojima, Tomohiro Sakamoto, Masaharu Ishihara, Yujiro Asada, Chuwa Tei, Shunichi Miyazaki, Masahiro Sonoda, Kazufumi Tsuchihashi, Masakazu Yamagishi, Mutsunori Shirai, Hisatoyo Hiraoka, Takashi Honda, Yasuhiro Ogata, Hisao Ogawa Masami Kosuge, Kazuo Kimura, Satoshi Morita, Sunao Kojima, Tomohiro Sakamoto, Masaharu Ishihara, Yujiro Asada, Chuwa Tei, Shunichi Miyazaki, Masahiro Sonoda, Kazufumi Tsuchihashi, Masakazu Yamagishi, Mutsunori Shirai, Hisatoyo Hiraoka, Takashi Honda, Yasuhiro Ogata, Hisao Ogawa Masami Kosuge, Kazuo Kimura, Satoshi Morita, Sunao Kojima, Tomohiro Sakamoto, Masaharu Ishihara, Yujiro Asada, Chuwa Tei, Shunichi Miyazaki, Masahiro Sonoda, Kazufumi Tsuchihashi, Masakazu Yamagishi, Mutsunori Shirai, Hisatoyo Hiraoka, Takashi Honda, Yasuhiro Ogata, Hisao Ogawa Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction AMERICAN JOURNAL OF CARDIOLOGY, 103, 3, 322-327 AMERICAN JOURNAL OF CARDIOLOGY, 103, 3, 322-327 AMERICAN JOURNAL OF CARDIOLOGY, 103, 3, 322-327 2009/02 英語 研究論文(学術雑誌) 公開
Toshihiro Fukui, Tomoki Shimokawa, Susumu Manabe, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Tomoki Shimokawa, Susumu Manabe, Satoshi Morita, Shuichiro Takanashi Toshihiro Fukui, Tomoki Shimokawa, Susumu Manabe, Satoshi Morita, Shuichiro Takanashi Prior Inferior Myocardial Infarction Has Worse Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Than Prior Anterior Myocardial Infarction Prior Inferior Myocardial Infarction Has Worse Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Than Prior Anterior Myocardial Infarction Prior Inferior Myocardial Infarction Has Worse Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Than Prior Anterior Myocardial Infarction ANNALS OF THORACIC SURGERY, 87, 2, 475-480 ANNALS OF THORACIC SURGERY, 87, 2, 475-480 ANNALS OF THORACIC SURGERY, 87, 2, 475-480 2009/02 英語 研究論文(学術雑誌) 公開
J. Sakamoto, Y. Kodera, M. Kobayashi, K. Kondo, M. Ninomiya, N. Nagata, Y. Ueda, T. Matsui, S. Morita, A. Tsuburaya J. Sakamoto, Y. Kodera, M. Kobayashi, K. Kondo, M. Ninomiya, N. Nagata, Y. Ueda, T. Matsui, S. Morita, A. Tsuburaya J. Sakamoto, Y. Kodera, M. Kobayashi, K. Kondo, M. Ninomiya, N. Nagata, Y. Ueda, T. Matsui, S. Morita, A. Tsuburaya Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer - ECRIN group studies Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer - ECRIN group studies Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer - ECRIN group studies IGCC: PROCEEDINGS OF THE 8TH INTERNATIONAL GASTRIC CANCER CONGRESS, 115-+ IGCC: PROCEEDINGS OF THE 8TH INTERNATIONAL GASTRIC CANCER CONGRESS, 115-+ IGCC: PROCEEDINGS OF THE 8TH INTERNATIONAL GASTRIC CANCER CONGRESS, 115-+ 2009 英語 研究論文(国際会議プロシーディングス) 公開
S. Nagata, K. Otsuji, T.T. Ishii, K. Ichimoto, S. UeNo, R. Kitai, G. Kimura, K. Shibata, Y. Nakatani, S. Morita S. Nagata, K. Otsuji, T.T. Ishii, K. Ichimoto, S. UeNo, R. Kitai, G. Kimura, K. Shibata, Y. Nakatani, S. Morita S. Nagata, K. Otsuji, T.T. Ishii, K. Ichimoto, S. UeNo, R. Kitai, G. Kimura, K. Shibata, Y. Nakatani, S. Morita The tandem fabry-perot filter imagaing spectro-polarimeter for the Solar Magnetic Activity Research Telescope(SMART) The tandem fabry-perot filter imagaing spectro-polarimeter for the Solar Magnetic Activity Research Telescope(SMART) The tandem fabry-perot filter imagaing spectro-polarimeter for the Solar Magnetic Activity Research Telescope(SMART) Proceedings of SPIE - The International Society for Optical Engineering, 7438 Proceedings of SPIE - The International Society for Optical Engineering, 7438 Proceedings of SPIE - The International Society for Optical Engineering, 7438 2009 英語 公開
K. Nakao, H. Makino, S. Morita, Y. Takahashi, T. Akizawa, A. Saito, Y. Asano, K. Kurokawa, S. Fukuhara, T. Akiba K. Nakao, H. Makino, S. Morita, Y. Takahashi, T. Akizawa, A. Saito, Y. Asano, K. Kurokawa, S. Fukuhara, T. Akiba Kazushi Nakao, Hirofumi Makino, Satoshi Morita, Yoshimitsu Takahashi, Tadao Akizawa, Akira Saito, Yasushi Asano, Kiyoshi Kurokawa, Shunichi Fukuhara, Takashi Akiba β-Blocker prescription and outcomes in hemodialysis patients from the japan dialysis outcomes and practice patterns study β-Blocker prescription and outcomes in hemodialysis patients from the japan dialysis outcomes and practice patterns study beta-Blocker Prescription and Outcomes in Hemodialysis Patients from The Japan Dialysis Outcomes and Practice Patterns Study Nephron - Clinical Practice, 113, 3, C132-C139 Nephron - Clinical Practice, 113, 3, C132-C139 NEPHRON CLINICAL PRACTICE, 113, 3, C132-C139 2009 英語 研究論文(学術雑誌) 公開
Shimozuma K, Yamaguchi T, Fujita K, Yuzawa M, Suzukamo Y, Takahashi N, Takahashi K, Morita S, Fukuhara S Shimozuma K, Yamaguchi T, Fujita K, Yuzawa M, Suzukamo Y, Takahashi N, Takahashi K, Morita S, Fukuhara S Shimozuma K, Yamaguchi T, Fujita K, Yuzawa M, Suzukamo Y, Takahashi N, Takahashi K, Morita S, Fukuhara S Response shift in a randomized controlled trial of low vision care for patients with age-related maculopathy. Response shift in a randomized controlled trial of low vision care for patients with age-related maculopathy. Response shift in a randomized controlled trial of low vision care for patients with age-related maculopathy. Value in Health, 11, 6, A621-A622 Value in Health, 11, 6, A621-A622 Value in Health, 11, 6, A621-A622 2008/11 英語 研究論文(学術雑誌) 公開
Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Shozo Ohsumi, Toru Watanabe, Stacey Bain, Frederick H. Hausheer Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Shozo Ohsumi, Toru Watanabe, Stacey Bain, Frederick H. Hausheer Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, Toshihiko Aranishi, Satoshi Morita, Shozo Ohsumi, Toru Watanabe, Stacey Bain, Frederick H. Hausheer A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 38, 11, 748-754 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 38, 11, 748-754 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 38, 11, 748-754 2008/11 英語 研究論文(学術雑誌) 公開
Akihiro Nakajo, Shuichi Hokita, Sumiya Ishigami, Futoshi Miyazono, Tadaaki Etoh, Masahiro Hamanoue, Shigeho Maenohara, Toshimitsu Iwashita, Hideaki Komatsu, Kiyoharu Satoh, Kuniaki Aridome, Satoshi Morita, Shoji Natsugoe, Hiroya Takiuchi, Shyuji Nakano, Yoshihiko Maehara, Junichi Sakamoto, Takashi Aikou, Kyushu Taxol Akihiro Nakajo, Shuichi Hokita, Sumiya Ishigami, Futoshi Miyazono, Tadaaki Etoh, Masahiro Hamanoue, Shigeho Maenohara, Toshimitsu Iwashita, Hideaki Komatsu, Kiyoharu Satoh, Kuniaki Aridome, Satoshi Morita, Shoji Natsugoe, Hiroya Takiuchi, Shyuji Nakano, Yoshihiko Maehara, Junichi Sakamoto, Takashi Aikou, Kyushu Taxol Akihiro Nakajo, Shuichi Hokita, Sumiya Ishigami, Futoshi Miyazono, Tadaaki Etoh, Masahiro Hamanoue, Shigeho Maenohara, Toshimitsu Iwashita, Hideaki Komatsu, Kiyoharu Satoh, Kuniaki Aridome, Satoshi Morita, Shoji Natsugoe, Hiroya Takiuchi, Shyuji Nakano, Yoshihiko Maehara, Junichi Sakamoto, Takashi Aikou, Kyushu Taxol A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 62, 6, 1103-1109 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 62, 6, 1103-1109 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 62, 6, 1103-1109 2008/11 英語 研究論文(学術雑誌) 公開
Ken-ichi Takahashi, Kazuo Chin, Takashi Akamizu, Satoshi Morita, Kensuke Sumi, Toru Oga, Hisako Matsumoto, Akio Niimi, Tomomasa Tsuboi, Shunichi Fukuhara, Kenji Kangawa, Michiaki Mishima Ken-ichi Takahashi, Kazuo Chin, Takashi Akamizu, Satoshi Morita, Kensuke Sumi, Toru Oga, Hisako Matsumoto, Akio Niimi, Tomomasa Tsuboi, Shunichi Fukuhara, Kenji Kangawa, Michiaki Mishima Ken-ichi Takahashi, Kazuo Chin, Takashi Akamizu, Satoshi Morita, Kensuke Sumi, Toru Oga, Hisako Matsumoto, Akio Niimi, Tomomasa Tsuboi, Shunichi Fukuhara, Kenji Kangawa, Michiaki Mishima Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment RESPIROLOGY, 13, 6, 810-816 RESPIROLOGY, 13, 6, 810-816 RESPIROLOGY, 13, 6, 810-816 2008/09 英語 研究論文(学術雑誌) 公開
Nguyen Thi Lien Huong, Nguyen Thi Hong Tu, Satoshi Morita, Junichi Sakamoto Nguyen Thi Lien Huong, Nguyen Thi Hong Tu, Satoshi Morita, Junichi Sakamoto Nguyen Thi Lien Huong, Nguyen Thi Hong Tu, Satoshi Morita, Junichi Sakamoto Injury and pre-hospital trauma care in Hanoi, Vietnam Injury and pre-hospital trauma care in Hanoi, Vietnam Injury and pre-hospital trauma care in Hanoi, Vietnam INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 39, 9, 1026-1033 INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 39, 9, 1026-1033 INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 39, 9, 1026-1033 2008/09 英語 研究論文(学術雑誌) 公開
Noriko Handa, Eiichi Mizohata, Seiichiro Kishishita, Mitsutoshi Toyama, Satoshi Morita, Tomomi Uchikubo-Kamo, Ryogo Akasaka, Kenji Omori, Jun Kotera, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Noriko Handa, Eiichi Mizohata, Seiichiro Kishishita, Mitsutoshi Toyama, Satoshi Morita, Tomomi Uchikubo-Kamo, Ryogo Akasaka, Kenji Omori, Jun Kotera, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Noriko Handa, Eiichi Mizohata, Seiichiro Kishishita, Mitsutoshi Toyama, Satoshi Morita, Tomomi Uchikubo-Kamo, Ryogo Akasaka, Kenji Omori, Jun Kotera, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP Journal of Biological Chemistry, 283, 28, 19657-19664 Journal of Biological Chemistry, 283, 28, 19657-19664 Journal of Biological Chemistry, 283, 28, 19657-19664 2008/07/11 英語 研究論文(学術雑誌) 公開
K. Kobayashi, S. Morita, M. Shimonagayoshi, M. Kobayashi, Y. Fujiki, Y. Uchida, K. Yamaguchi K. Kobayashi, S. Morita, M. Shimonagayoshi, M. Kobayashi, Y. Fujiki, Y. Uchida, K. Yamaguchi K. Kobayashi, S. Morita, M. Shimonagayoshi, M. Kobayashi, Y. Fujiki, Y. Uchida, K. Yamaguchi Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan PSYCHO-ONCOLOGY, 17, 6, 606-611 PSYCHO-ONCOLOGY, 17, 6, 606-611 PSYCHO-ONCOLOGY, 17, 6, 606-611 2008/06 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Peter F. Thall, Peter Mueller Satoshi Morita, Peter F. Thall, Peter Mueller Satoshi Morita, Peter F. Thall, Peter Mueller Determining the effective sample size of a parametric prior Determining the effective sample size of a parametric prior Determining the effective sample size of a parametric prior BIOMETRICS, 64, 2, 595-602 BIOMETRICS, 64, 2, 595-602 BIOMETRICS, 64, 2, 595-602 2008/06 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Adrian A Kaptein, Koji Oba, Junichi Sakamoto Satoshi Morita, Adrian A Kaptein, Koji Oba, Junichi Sakamoto Satoshi Morita, Adrian A Kaptein, Koji Oba, Junichi Sakamoto The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. Psycho-oncology, 17, 5, 474-9 Psycho-oncology, 17, 5, 474-9 Psycho-oncology, 17, 5, 474-9 2008/05 英語 公開
Shuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, Tsuyoshi Suzuki, Tetsuo Hashiba, Naoki Kagawa, Naoya Hashimoto, Motohiko Maruno, Olga A. Elisseeva, Toshiaki Shirakata, Manabu Kawakami, Yusuke Oji, Sumiyuki Nishida, Satoshi Ohno, Ichiro Kawase, Jun Hatazawa, Shin-icih Nakatsuka, Katsuyuki Aozasa, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Toshiki Yosihmine Shuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, Tsuyoshi Suzuki, Tetsuo Hashiba, Naoki Kagawa, Naoya Hashimoto, Motohiko Maruno, Olga A. Elisseeva, Toshiaki Shirakata, Manabu Kawakami, Yusuke Oji, Sumiyuki Nishida, Satoshi Ohno, Ichiro Kawase, Jun Hatazawa, Shin-icih Nakatsuka, Katsuyuki Aozasa, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Toshiki Yosihmine Shuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, Tsuyoshi Suzuki, Tetsuo Hashiba, Naoki Kagawa, Naoya Hashimoto, Motohiko Maruno, Olga A. Elisseeva, Toshiaki Shirakata, Manabu Kawakami, Yusuke Oji, Sumiyuki Nishida, Satoshi Ohno, Ichiro Kawase, Jun Hatazawa, Shin-icih Nakatsuka, Katsuyuki Aozasa, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Toshiki Yosihmine Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme JOURNAL OF NEUROSURGERY, 108, 5, 963-971 JOURNAL OF NEUROSURGERY, 108, 5, 963-971 JOURNAL OF NEUROSURGERY, 108, 5, 963-971 2008/05 英語 研究論文(学術雑誌) 公開
Ken-Ichi Takahashi, Kazuo Chin, Hajime Nakamura, Satoshi Morita, Kensuke Sumi, Toru Oga, Hisako Matsumoto, Akio Niimi, Shunichi Fukuhara, Junji Yodoi, Michiaki Mishima Ken-Ichi Takahashi, Kazuo Chin, Hajime Nakamura, Satoshi Morita, Kensuke Sumi, Toru Oga, Hisako Matsumoto, Akio Niimi, Shunichi Fukuhara, Junji Yodoi, Michiaki Mishima Ken-Ichi Takahashi, Kazuo Chin, Hajime Nakamura, Satoshi Morita, Kensuke Sumi, Toru Oga, Hisako Matsumoto, Akio Niimi, Shunichi Fukuhara, Junji Yodoi, Michiaki Mishima Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure ANTIOXIDANTS & REDOX SIGNALING, 10, 4, 715-726 ANTIOXIDANTS & REDOX SIGNALING, 10, 4, 715-726 ANTIOXIDANTS & REDOX SIGNALING, 10, 4, 715-726 2008/04 英語 研究論文(学術雑誌) 公開
Shunichi Fukuhara, Tadao Akizawa, Satoshi Morita, Shozo Koshikawa Shunichi Fukuhara, Tadao Akizawa, Satoshi Morita, Shozo Koshikawa Shunichi Fukuhara, Tadao Akizawa, Satoshi Morita, Shozo Koshikawa Quality of life improvements in dialysis patients receiving darbepoetin alfa Quality of life improvements in dialysis patients receiving darbepoetin alfa Quality of life improvements in dialysis patients receiving darbepoetin alfa THERAPEUTIC APHERESIS AND DIALYSIS, 12, 1, 72-77 THERAPEUTIC APHERESIS AND DIALYSIS, 12, 1, 72-77 THERAPEUTIC APHERESIS AND DIALYSIS, 12, 1, 72-77 2008/02 英語 研究論文(学術雑誌) 公開
Y. Asano, T. Akizawa, S. Fukuhara, F. Gejyo, S. Matsuo, N. Yorioka, S. Morita, T. Wakita, Y. Onishi, K. Kurokawa Y. Asano, T. Akizawa, S. Fukuhara, F. Gejyo, S. Matsuo, N. Yorioka, S. Morita, T. Wakita, Y. Onishi, K. Kurokawa Y. Asano, T. Akizawa, S. Fukuhara, F. Gejyo, S. Matsuo, N. Yorioka, S. Morita, T. Wakita, Y. Onishi, K. Kurokawa Summary of CAP-KD study from the 37th western/eastern regional meeting, JSN Summary of CAP-KD study from the 37th western/eastern regional meeting, JSN Summary of CAP-KD study from the 37th western/eastern regional meeting, JSN Japanese Journal of Nephrology, 50, 5, 528-531 Japanese Journal of Nephrology, 50, 5, 528-531 Japanese Journal of Nephrology, 50, 5, 528-531 2008 英語 公開
Haruhiko Cho, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita, Koji Oba, Takaki Yoshikawa, Naomi Miyajima Haruhiko Cho, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita, Koji Oba, Takaki Yoshikawa, Naomi Miyajima Haruhiko Cho, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita, Koji Oba, Takaki Yoshikawa, Naomi Miyajima A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group. A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group. A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group. Japanese journal of clinical oncology, 38, 1, 71-3 Japanese journal of clinical oncology, 38, 1, 71-3 Japanese journal of clinical oncology, 38, 1, 71-3 2008/01 英語 公開
Satoshi Morita, Bunzo Nakata, Akihito Tsuji, Yasushi Mitachi, Tetsuhiko Shirasaka, Shigetoyo Saji, Yasuo Ohashi, Junichi Sakamoto, Kosei Hirakawa Satoshi Morita, Bunzo Nakata, Akihito Tsuji, Yasushi Mitachi, Tetsuhiko Shirasaka, Shigetoyo Saji, Yasuo Ohashi, Junichi Sakamoto, Kosei Hirakawa Satoshi Morita, Bunzo Nakata, Akihito Tsuji, Yasushi Mitachi, Tetsuhiko Shirasaka, Shigetoyo Saji, Yasuo Ohashi, Junichi Sakamoto, Kosei Hirakawa A phase I study of combination therapy of the oral fluorinated pyrimidine compound s-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 step2) in patients with advanced gastric cancer using a continual reassessment method A phase I study of combination therapy of the oral fluorinated pyrimidine compound s-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 step2) in patients with advanced gastric cancer using a continual reassessment method A phase I study of combination therapy of the oral fluorinated pyrimidine compound s-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 step2) in patients with advanced gastric cancer using a continual reassessment method JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 37, 12, 924-929 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 37, 12, 924-929 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 37, 12, 924-929 2007/12 英語 研究論文(学術雑誌) 公開
Akihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, Yoko Fukuda, Olga A. Elisseeva, Satoshi Yoshihara, Naoki Hosen, Atsushi Ogata, Katsuyuki Kito, Fumihiro Fujiki, Sumiyuki Nishida, Toshiaki Shirakata, Satoshi Ohno, Masaki Yasukawa, Yusuke Oji, Manabu Kawakami, Satoshi Morita, Junichi Sakamoto, Keiko Udaka, Ichiro Kawase, Haruo Sugiyama Akihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, Yoko Fukuda, Olga A. Elisseeva, Satoshi Yoshihara, Naoki Hosen, Atsushi Ogata, Katsuyuki Kito, Fumihiro Fujiki, Sumiyuki Nishida, Toshiaki Shirakata, Satoshi Ohno, Masaki Yasukawa, Yusuke Oji, Manabu Kawakami, Satoshi Morita, Junichi Sakamoto, Keiko Udaka, Ichiro Kawase, Haruo Sugiyama Akihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, Yoko Fukuda, Olga A. Elisseeva, Satoshi Yoshihara, Naoki Hosen, Atsushi Ogata, Katsuyuki Kito, Fumihiro Fujiki, Sumiyuki Nishida, Toshiaki Shirakata, Satoshi Ohno, Masaki Yasukawa, Yusuke Oji, Manabu Kawakami, Satoshi Morita, Junichi Sakamoto, Keiko Udaka, Ichiro Kawase, Haruo Sugiyama Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 5, 414-417 INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 5, 414-417 INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 5, 414-417 2007/12 英語 研究論文(学術雑誌) 公開
Noriko Handa, Seiichiro Kishishita, Satoshi Morita, Ryogo Akasaka, Zhongmin Jin, John Chrzas, Lirong Chen, Zhi-Jie Liu, Bi-Cheng Wang, Sumio Sugano, Akiko Tanaka, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Noriko Handa, Seiichiro Kishishita, Satoshi Morita, Ryogo Akasaka, Zhongmin Jin, John Chrzas, Lirong Chen, Zhi-Jie Liu, Bi-Cheng Wang, Sumio Sugano, Akiko Tanaka, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Noriko Handa, Seiichiro Kishishita, Satoshi Morita, Ryogo Akasaka, Zhongmin Jin, John Chrzas, Lirong Chen, Zhi-Jie Liu, Bi-Cheng Wang, Sumio Sugano, Akiko Tanaka, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Structure of the human Tim44 C-terminal domain in complex with pentaethylene glycol: Ligand-bound form Structure of the human Tim44 C-terminal domain in complex with pentaethylene glycol: Ligand-bound form Structure of the human Tim44 C-terminal domain in complex with pentaethylene glycol: Ligand-bound form Acta Crystallographica Section D: Biological Crystallography, 63, 12, 1225-1234 Acta Crystallographica Section D: Biological Crystallography, 63, 12, 1225-1234 Acta Crystallographica Section D: Biological Crystallography, 63, 12, 1225-1234 2007/11/16 英語 研究論文(学術雑誌) 公開
M. Ninomiya, K. Kondo, K. Matsuo, N. Hirabayashi, H. Kojima, M. Kobayashi, S. Kawamura, T. Ando, N. Musha, H. Konno, N. Nagata, H. Usuki, Y. Miyashita, K. Oba, S. Morita, J. Sakamoto M. Ninomiya, K. Kondo, K. Matsuo, N. Hirabayashi, H. Kojima, M. Kobayashi, S. Kawamura, T. Ando, N. Musha, H. Konno, N. Nagata, H. Usuki, Y. Miyashita, K. Oba, S. Morita, J. Sakamoto M. Ninomiya, K. Kondo, K. Matsuo, N. Hirabayashi, H. Kojima, M. Kobayashi, S. Kawamura, T. Ando, N. Musha, H. Konno, N. Nagata, H. Usuki, Y. Miyashita, K. Oba, S. Morita, J. Sakamoto Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma JOURNAL OF CHEMOTHERAPY, 19, 4, 444-450 JOURNAL OF CHEMOTHERAPY, 19, 4, 444-450 JOURNAL OF CHEMOTHERAPY, 19, 4, 444-450 2007/08 英語 研究論文(学術雑誌) 公開
Suguru Yamada, Shin Takeda, Tsutomu Fujii, Shuji Nomoto, Naohito Kanazumi, Hiroyuki Sugimoto, Hideki Kasuya, Yasuhiro Kodera, Tetsuro Nagasaka, Satoshi Morita, Akimasa Nakao Suguru Yamada, Shin Takeda, Tsutomu Fujii, Shuji Nomoto, Naohito Kanazumi, Hiroyuki Sugimoto, Hideki Kasuya, Yasuhiro Kodera, Tetsuro Nagasaka, Satoshi Morita, Akimasa Nakao Suguru Yamada, Shin Takeda, Tsutomu Fujii, Shuji Nomoto, Naohito Kanazumi, Hiroyuki Sugimoto, Hideki Kasuya, Yasuhiro Kodera, Tetsuro Nagasaka, Satoshi Morita, Akimasa Nakao Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer - Positive peritoneal cytology may not confer an adverse prognosis Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer - Positive peritoneal cytology may not confer an adverse prognosis Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer - Positive peritoneal cytology may not confer an adverse prognosis ANNALS OF SURGERY, 246, 2, 254-258 ANNALS OF SURGERY, 246, 2, 254-258 ANNALS OF SURGERY, 246, 2, 254-258 2007/08 英語 研究論文(学術雑誌) 公開
Hisashi Urushihara, Shunichi Fukuhara, Shigeru Tai, Satoshi Morita, Kazuo Chihara Hisashi Urushihara, Shunichi Fukuhara, Shigeru Tai, Satoshi Morita, Kazuo Chihara Hisashi Urushihara, Shunichi Fukuhara, Shigeru Tai, Satoshi Morita, Kazuo Chihara Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement EUROPEAN JOURNAL OF ENDOCRINOLOGY, 156, 6, 637-645 EUROPEAN JOURNAL OF ENDOCRINOLOGY, 156, 6, 637-645 EUROPEAN JOURNAL OF ENDOCRINOLOGY, 156, 6, 637-645 2007/06 英語 研究論文(学術雑誌) 公開
Yamazaki S, Fukuhara S, Suzukamo Y, Morita S, Okamura T, Tanaka T, Ueshima H Yamazaki S, Fukuhara S, Suzukamo Y, Morita S, Okamura T, Tanaka T, Ueshima H Yamazaki S, Fukuhara S, Suzukamo Y, Morita S, Okamura T, Tanaka T, Ueshima H Lifestyle and work predictors of fatigue in Japanese manufacturing workers. Lifestyle and work predictors of fatigue in Japanese manufacturing workers. Lifestyle and work predictors of fatigue in Japanese manufacturing workers. Occup Med (Lond), 57, 4, 262-269 Occup Med (Lond), 57, 4, 262-269 Occup Med (Lond), 57, 4, 262-269 2007/06 英語 研究論文(学術雑誌) 公開
M. Kawakami, Y. Oka, A. Tsuboi, Y. Harada, O.A. Elisseeva, Y. Furukawa, M. Tsukaguchi, T. Shirakata, S. Nishida, H. Nakajima, S. Morita, J. Sakamoto, I. Kawase, Y. Oji, H. Sugiyama M. Kawakami, Y. Oka, A. Tsuboi, Y. Harada, O.A. Elisseeva, Y. Furukawa, M. Tsukaguchi, T. Shirakata, S. Nishida, H. Nakajima, S. Morita, J. Sakamoto, I. Kawase, Y. Oji, H. Sugiyama Manabu Kawakami, Yoshihiro Oka, Akihiro Tsuboi, Yukie Harada, Olga A. Elisseeva, Yoshio Furukawa, Machiko Tsukaguchi, Toshiaki Shirakata, Sumiyuki Nishida, Hiroko Nakajima, Satoshi Morita, Junichi Sakamoto, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 μg/body) in a patient with chronic myelomonocytic leukemia Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 μg/body) in a patient with chronic myelomonocytic leukemia Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 mu g/body) in a patient with chronic myelomonocytic leukemia International Journal of Hematology, 85, 5, 426-429 International Journal of Hematology, 85, 5, 426-429 INTERNATIONAL JOURNAL OF HEMATOLOGY, 85, 5, 426-429 2007/06 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Hideo Baba, Akira Tsuburaya, Hiroya Takiuchi, Takanori Matsui, Yoshihiko Maehara, Junichi Sakamoto Satoshi Morita, Hideo Baba, Akira Tsuburaya, Hiroya Takiuchi, Takanori Matsui, Yoshihiko Maehara, Junichi Sakamoto Satoshi Morita, Hideo Baba, Akira Tsuburaya, Hiroya Takiuchi, Takanori Matsui, Yoshihiko Maehara, Junichi Sakamoto A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC) A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC) A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC) JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 37, 6, 469-472 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 37, 6, 469-472 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 37, 6, 469-472 2007/06 英語 研究論文(学術雑誌) 公開
Yoshihiro Nakamura, Takashi Umehara, Kazumi Nakano, Kyoo Jang Moon, Mikako Shirouzu, Satoshi Morita, Hiroko Uda-Tochio, Hiroaki Hamana, Takaho Terada, Naruhiko Adachi, Takehisa Matsumoto, Akiko Tanaka, Masami Horikoshi, Keiko Ozato, Balasundaram Padmanabhan, Shigeyuki Yokoyama Yoshihiro Nakamura, Takashi Umehara, Kazumi Nakano, Kyoo Jang Moon, Mikako Shirouzu, Satoshi Morita, Hiroko Uda-Tochio, Hiroaki Hamana, Takaho Terada, Naruhiko Adachi, Takehisa Matsumoto, Akiko Tanaka, Masami Horikoshi, Keiko Ozato, Balasundaram Padmanabhan, Shigeyuki Yokoyama Yoshihiro Nakamura, Takashi Umehara, Kazumi Nakano, Kyoo Jang Moon, Mikako Shirouzu, Satoshi Morita, Hiroko Uda-Tochio, Hiroaki Hamana, Takaho Terada, Naruhiko Adachi, Takehisa Matsumoto, Akiko Tanaka, Masami Horikoshi, Keiko Ozato, Balasundaram Padmanabhan, Shigeyuki Yokoyama Crystal structure of the human BRD2 bromodomain: Insights into dimerization and recognition of acetylated histone H4 Crystal structure of the human BRD2 bromodomain: Insights into dimerization and recognition of acetylated histone H4 Crystal structure of the human BRD2 bromodomain: Insights into dimerization and recognition of acetylated histone H4 Journal of Biological Chemistry, 282, 6, 4193-4201 Journal of Biological Chemistry, 282, 6, 4193-4201 Journal of Biological Chemistry, 282, 6, 4193-4201 2007/01/09 英語 研究論文(学術雑誌) 公開
Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer ONCOLOGY, 72, 5-6, 330-337 ONCOLOGY, 72, 5-6, 330-337 ONCOLOGY, 72, 5-6, 330-337 2007 英語 研究論文(学術雑誌) 公開
S. Enkhbold, S. Tugsdelger, S. Morita, J. Sakamoto, N. Hamajima S. Enkhbold, S. Tugsdelger, S. Morita, J. Sakamoto, N. Hamajima S. Enkhbold, S. Tugsdelger, S. Morita, J. Sakamoto, N. Hamajima HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. Nagoya journal of medical science, 69, 3-4, 157-165 Nagoya journal of medical science, 69, 3-4, 157-165 Nagoya journal of medical science, 69, 3-4, 157-165 2007 英語 公開
Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer DRUG INFORMATION JOURNAL, 41, 6, 691-700 DRUG INFORMATION JOURNAL, 41, 6, 691-700 DRUG INFORMATION JOURNAL, 41, 6, 691-700 2007 英語 研究論文(学術雑誌) 公開
J. Sakamoto, S. Morita J. Sakamoto, S. Morita J. Sakamoto, S. Morita From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside. Nagoya journal of medical science, 69, 1-2, 9-16 Nagoya journal of medical science, 69, 1-2, 9-16 Nagoya journal of medical science, 69, 1-2, 9-16 2007 英語 公開
Maya Kurita, Kojiro Shimozuma, Satoshi Morita, Yuki Fujiki, Kenichi Ishizawa, Hisae Eguchi, Yuko Saito, Nobuko Ushirozawa, Izumi Wasada, Yasuo Ohashi, Kenji Eguchi Maya Kurita, Kojiro Shimozuma, Satoshi Morita, Yuki Fujiki, Kenichi Ishizawa, Hisae Eguchi, Yuko Saito, Nobuko Ushirozawa, Izumi Wasada, Yasuo Ohashi, Kenji Eguchi Maya Kurita, Kojiro Shimozuma, Satoshi Morita, Yuki Fujiki, Kenichi Ishizawa, Hisae Eguchi, Yuko Saito, Nobuko Ushirozawa, Izumi Wasada, Yasuo Ohashi, Kenji Eguchi Clinical validity of the japanese version of the functional assessment of cancer therapy-anemia scale Clinical validity of the japanese version of the functional assessment of cancer therapy-anemia scale Clinical validity of the japanese version of the functional assessment of cancer therapy-anemia scale SUPPORTIVE CARE IN CANCER, 15, 1, 1-6 SUPPORTIVE CARE IN CANCER, 15, 1, 1-6 SUPPORTIVE CARE IN CANCER, 15, 1, 1-6 2007/01 英語 研究論文(学術雑誌) 公開
Kiyoshi Ando, Satoshi Morita, Takahiro Higashi, Shunichi Fukuhara, Shigeki Watanabe, Jaeon Park, Masao Kikuchi, Koichi Kawano, Izumi Wasada, Tomomitsu Hotta Kiyoshi Ando, Satoshi Morita, Takahiro Higashi, Shunichi Fukuhara, Shigeki Watanabe, Jaeon Park, Masao Kikuchi, Koichi Kawano, Izumi Wasada, Tomomitsu Hotta Kiyoshi Ando, Satoshi Morita, Takahiro Higashi, Shunichi Fukuhara, Shigeki Watanabe, Jaeon Park, Masao Kikuchi, Koichi Kawano, Izumi Wasada, Tomomitsu Hotta Health-related quality of life among Japanese women with iron-deficiency anemia Health-related quality of life among Japanese women with iron-deficiency anemia Health-related quality of life among Japanese women with iron-deficiency anemia QUALITY OF LIFE RESEARCH, 15, 10, 1559-1563 QUALITY OF LIFE RESEARCH, 15, 10, 1559-1563 QUALITY OF LIFE RESEARCH, 15, 10, 1559-1563 2006/12 英語 研究論文(学術雑誌) 公開
Takanori Matsui, Kenji Omura, Kazuyuki Kawakami, Satoshi Morita, Junichi Sakamoto Takanori Matsui, Kenji Omura, Kazuyuki Kawakami, Satoshi Morita, Junichi Sakamoto Takanori Matsui, Kenji Omura, Kazuyuki Kawakami, Satoshi Morita, Junichi Sakamoto Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer ONCOLOGY REPORTS, 16, 5, 1111-1115 ONCOLOGY REPORTS, 16, 5, 1111-1115 ONCOLOGY REPORTS, 16, 5, 1111-1115 2006/11 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Adrian A. Kaptein, Akira Tsuburaya, Yasuhiro Kodera, Takanori Matsui, Junichi Sakamoto Satoshi Morita, Adrian A. Kaptein, Akira Tsuburaya, Yasuhiro Kodera, Takanori Matsui, Junichi Sakamoto Satoshi Morita, Adrian A. Kaptein, Akira Tsuburaya, Yasuhiro Kodera, Takanori Matsui, Junichi Sakamoto Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Gastric Cancer, 9, 4, 254-261 Gastric Cancer, 9, 4, 254-261 Gastric Cancer, 9, 4, 254-261 2006/11 英語 公開
Koji Oba, Satoshi Morita, Mahbubur Rahman, Junichi Sakamoto Koji Oba, Satoshi Morita, Mahbubur Rahman, Junichi Sakamoto Koji Oba, Satoshi Morita, Mahbubur Rahman, Junichi Sakamoto Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial. Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial. Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial. Trials, 7, 26-26 Trials, 7, 26-26 Trials, 7, 26-26 2006/08/21 英語 公開
Tsuguya Fukui, Mahbubur Rahman, Satoshi Morita, Junichi Sakamoto Tsuguya Fukui, Mahbubur Rahman, Satoshi Morita, Junichi Sakamoto Tsuguya Fukui, Mahbubur Rahman, Satoshi Morita, Junichi Sakamoto Informed consent in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial: A survey of collaborating physicians Informed consent in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial: A survey of collaborating physicians Informed consent in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial: A survey of collaborating physicians HYPERTENSION RESEARCH, 29, 7, 471-474 HYPERTENSION RESEARCH, 29, 7, 471-474 HYPERTENSION RESEARCH, 29, 7, 471-474 2006/07 英語 研究論文(学術雑誌) 公開
Masataka Kamei, Satoshi Morita, Yukio Hayashi, Yuichi Kanmura, Masakazu Kuro Masataka Kamei, Satoshi Morita, Yukio Hayashi, Yuichi Kanmura, Masakazu Kuro Masataka Kamei, Satoshi Morita, Yukio Hayashi, Yuichi Kanmura, Masakazu Kuro Carvedilol versus metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: Rationale and design of the carvedilol or metoprolol post-revascularization atrial fibrillation controlled trial (COMPACT) Carvedilol versus metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: Rationale and design of the carvedilol or metoprolol post-revascularization atrial fibrillation controlled trial (COMPACT) Carvedilol versus metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: Rationale and design of the carvedilol or metoprolol post-revascularization atrial fibrillation controlled trial (COMPACT) Cardiovascular Drugs and Therapy, 20, 3, 219-227 Cardiovascular Drugs and Therapy, 20, 3, 219-227 Cardiovascular Drugs and Therapy, 20, 3, 219-227 2006/06 英語 研究論文(学術雑誌) 公開
K. Oba, S. Morita, A. Tsuburaya, Y. Kodera, M. Kobayashi, J. Sakamoto K. Oba, S. Morita, A. Tsuburaya, Y. Kodera, M. Kobayashi, J. Sakamoto K. Oba, S. Morita, A. Tsuburaya, Y. Kodera, M. Kobayashi, J. Sakamoto Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials in Japan Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials in Japan Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials in Japan JOURNAL OF CHEMOTHERAPY, 18, 3, 311-317 JOURNAL OF CHEMOTHERAPY, 18, 3, 311-317 JOURNAL OF CHEMOTHERAPY, 18, 3, 311-317 2006/06 英語 研究論文(学術雑誌) 公開
K Kobayashi, A Tsuji, S Morita, T Horimi, T Shirasaka, T Kanematsu K Kobayashi, A Tsuji, S Morita, T Horimi, T Shirasaka, T Kanematsu K Kobayashi, A Tsuji, S Morita, T Horimi, T Shirasaka, T Kanematsu A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma BMC CANCER, 6, 121 BMC CANCER, 6, 121 BMC CANCER, 6, 121 2006/05 英語 研究論文(学術雑誌) 公開
S Morita, Y Oka, A Tsuboi, M Kawakami, M Maruno, S Izumoto, T Osaki, T Taguchi, T Ueda, A Myoui, S Nishida, T Shirakata, S Ohno, Y Oji, K Aozasa, J Hatazawa, K Udaka, H Yoshikawa, T Yoshimine, S Noguchi, Kawase, I, SI Nakatsuka, H Sugiyama, J Sakamoto S Morita, Y Oka, A Tsuboi, M Kawakami, M Maruno, S Izumoto, T Osaki, T Taguchi, T Ueda, A Myoui, S Nishida, T Shirakata, S Ohno, Y Oji, K Aozasa, J Hatazawa, K Udaka, H Yoshikawa, T Yoshimine, S Noguchi, Kawase, I, SI Nakatsuka, H Sugiyama, J Sakamoto S Morita, Y Oka, A Tsuboi, M Kawakami, M Maruno, S Izumoto, T Osaki, T Taguchi, T Ueda, A Myoui, S Nishida, T Shirakata, S Ohno, Y Oji, K Aozasa, J Hatazawa, K Udaka, H Yoshikawa, T Yoshimine, S Noguchi, Kawase, I, SI Nakatsuka, H Sugiyama, J Sakamoto A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 36, 4, 231-236 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 36, 4, 231-236 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 36, 4, 231-236 2006/04 英語 研究論文(学術雑誌) 公開
S Morita, J Sakamoto S Morita, J Sakamoto S Morita, J Sakamoto Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design PHARMACEUTICAL STATISTICS, 5, 2, 109-118 PHARMACEUTICAL STATISTICS, 5, 2, 109-118 PHARMACEUTICAL STATISTICS, 5, 2, 109-118 2006/04 英語 研究論文(学術雑誌) 公開
N Takahashi, S Kikuchi, S Konno, S Morita, Y Suzukamo, J Green, S Fukuhara N Takahashi, S Kikuchi, S Konno, S Morita, Y Suzukamo, J Green, S Fukuhara N Takahashi, S Kikuchi, S Konno, S Morita, Y Suzukamo, J Green, S Fukuhara Discrepancy between disability and the severity of low back pain: Demographic, psychologic, and employment-related factors Discrepancy between disability and the severity of low back pain: Demographic, psychologic, and employment-related factors Discrepancy between disability and the severity of low back pain: Demographic, psychologic, and employment-related factors SPINE, 31, 8, 931-939 SPINE, 31, 8, 931-939 SPINE, 31, 8, 931-939 2006/04 英語 研究論文(学術雑誌) 公開
Junichi Sakamoto, Satoshi Morita, Koji Oba, Takanori Matsui, Michiya Kobayashi, Hiroaki Nakazato, Yasuo Ohashi Junichi Sakamoto, Satoshi Morita, Koji Oba, Takanori Matsui, Michiya Kobayashi, Hiroaki Nakazato, Yasuo Ohashi Junichi Sakamoto, Satoshi Morita, Koji Oba, Takanori Matsui, Michiya Kobayashi, Hiroaki Nakazato, Yasuo Ohashi Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer immunology, immunotherapy : CII, 55, 4, 404-11 Cancer immunology, immunotherapy : CII, 55, 4, 404-11 Cancer immunology, immunotherapy : CII, 55, 4, 404-11 2006/04 英語 公開
S Morita, S Fukuhara, T Akizawa, Y Asano, S Koshikawa, K Koide, K Kurokawa S Morita, S Fukuhara, T Akizawa, Y Asano, S Koshikawa, K Koide, K Kurokawa S Morita, S Fukuhara, T Akizawa, Y Asano, S Koshikawa, K Koide, K Kurokawa Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease THERAPEUTIC APHERESIS AND DIALYSIS, 10, 1, 72-77 THERAPEUTIC APHERESIS AND DIALYSIS, 10, 1, 72-77 THERAPEUTIC APHERESIS AND DIALYSIS, 10, 1, 72-77 2006/02 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Michiya Kobayashi, Koji Oba, Toru Ichihara, Akimasa Nakao, Junichi Sakamoto Satoshi Morita, Michiya Kobayashi, Koji Oba, Toru Ichihara, Akimasa Nakao, Junichi Sakamoto Satoshi Morita, Michiya Kobayashi, Koji Oba, Toru Ichihara, Akimasa Nakao, Junichi Sakamoto Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals, and private general practitioners in Japan Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals, and private general practitioners in Japan Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals, and private general practitioners in Japan Annals of Cancer Research and Therapy, 14, 1, 1-11 Annals of Cancer Research and Therapy, 14, 1, 1-11 Annals of Cancer Research and Therapy, 14, 1, 1-11 2006 英語 研究論文(学術雑誌) 公開
Tsuguya Fukui, Mahbubur Rahman, Takuro Shimbo, Satoshi Morita, Junichi Sakamoto Tsuguya Fukui, Mahbubur Rahman, Takuro Shimbo, Satoshi Morita, Junichi Sakamoto Tsuguya Fukui, Mahbubur Rahman, Takuro Shimbo, Satoshi Morita, Junichi Sakamoto Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side INTERNAL MEDICINE, 45, 8, 511-514 INTERNAL MEDICINE, 45, 8, 511-514 INTERNAL MEDICINE, 45, 8, 511-514 2006 英語 研究論文(学術雑誌) 公開
Y Matsuyama, S Morita Y Matsuyama, S Morita Y Matsuyama, S Morita Estimation of the average causal effect among subgroups defined by post-treatment variables Estimation of the average causal effect among subgroups defined by post-treatment variables Estimation of the average causal effect among subgroups defined by post-treatment variables CLINICAL TRIALS, 3, 1, 1-9 CLINICAL TRIALS, 3, 1, 1-9 CLINICAL TRIALS, 3, 1, 1-9 2006 英語 研究論文(学術雑誌) 公開
W Noguchi, S Morita, T Ohno, O Aihara, H Tsujii, K Shimozuma, E Matsushima W Noguchi, S Morita, T Ohno, O Aihara, H Tsujii, K Shimozuma, E Matsushima W Noguchi, S Morita, T Ohno, O Aihara, H Tsujii, K Shimozuma, E Matsushima Spiritual needs in cancer patients and spiritual care based on logotherapy Spiritual needs in cancer patients and spiritual care based on logotherapy Spiritual needs in cancer patients and spiritual care based on logotherapy SUPPORTIVE CARE IN CANCER, 14, 1, 65-70 SUPPORTIVE CARE IN CANCER, 14, 1, 65-70 SUPPORTIVE CARE IN CANCER, 14, 1, 65-70 2006/01 英語 研究論文(学術雑誌) 公開
Hiroyuki Komatsu, Shouichi Fujimoto, Yuji Sato, Seiichiro Hara, Kazuhiro Yamada, Satoshi Morita, Tanenao Eto Hiroyuki Komatsu, Shouichi Fujimoto, Yuji Sato, Seiichiro Hara, Kazuhiro Yamada, Satoshi Morita, Tanenao Eto Hiroyuki Komatsu, Shouichi Fujimoto, Yuji Sato, Seiichiro Hara, Kazuhiro Yamada, Satoshi Morita, Tanenao Eto "Point of no return (PNR)" in progressive IgA nephropathy: Significance of blood pressure and proteinuria management up to PNR "Point of no return (PNR)" in progressive IgA nephropathy: Significance of blood pressure and proteinuria management up to PNR "Point of no return (PNR)" in progressive IgA nephropathy: Significance of blood pressure and proteinuria management up to PNR Journal of Nephrology, 18, 6, 690-695 Journal of Nephrology, 18, 6, 690-695 Journal of Nephrology, 18, 6, 690-695 2005/11 英語 研究論文(学術雑誌) 公開
A Tsuburaya, J Sakamoto, S Morita, Y Kodera, M Kobayashi, Y Miyashita, JS Macdonald A Tsuburaya, J Sakamoto, S Morita, Y Kodera, M Kobayashi, Y Miyashita, JS Macdonald A Tsuburaya, J Sakamoto, S Morita, Y Kodera, M Kobayashi, Y Miyashita, JS Macdonald A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 11, 672-675 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 11, 672-675 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 11, 672-675 2005/11 英語 研究論文(学術雑誌) 公開
Satoshi Morita, Shunichi Fukuhara, Tadao Akizawa, Yasushi Asano, Kiyoshi Kurokawa Satoshi Morita, Shunichi Fukuhara, Tadao Akizawa, Yasushi Asano, Kiyoshi Kurokawa Satoshi Morita, Shunichi Fukuhara, Tadao Akizawa, Yasushi Asano, Kiyoshi Kurokawa Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD) Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD) Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD) Clinical and Experimental Nephrology, 9, 3, 219-227 Clinical and Experimental Nephrology, 9, 3, 219-227 Clinical and Experimental Nephrology, 9, 3, 219-227 2005/09 英語 研究論文(学術雑誌) 公開
S Morita, K Kobayashi, K Eguchi, T Matsumoto, M Shibuya, Y Yamaji, Y Ohashi S Morita, K Kobayashi, K Eguchi, T Matsumoto, M Shibuya, Y Yamaji, Y Ohashi S Morita, K Kobayashi, K Eguchi, T Matsumoto, M Shibuya, Y Yamaji, Y Ohashi Analysis of incomplete quality of life data in advanced stage cancer: A practical application of multiple imputation Analysis of incomplete quality of life data in advanced stage cancer: A practical application of multiple imputation Analysis of incomplete quality of life data in advanced stage cancer: A practical application of multiple imputation QUALITY OF LIFE RESEARCH, 14, 6, 1533-1544 QUALITY OF LIFE RESEARCH, 14, 6, 1533-1544 QUALITY OF LIFE RESEARCH, 14, 6, 1533-1544 2005/08 英語 研究論文(学術雑誌) 公開
Ryoichi Arai, Mutsuko Kukimoto-Niino, Hiroko Uda-Tochio, Satoshi Morita, Tomomi Uchikubo-Kamo, Ryogo Akasaka, Yuuka Etou, Yoshihide Hayashizaki, Takanori Kigawa, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Ryoichi Arai, Mutsuko Kukimoto-Niino, Hiroko Uda-Tochio, Satoshi Morita, Tomomi Uchikubo-Kamo, Ryogo Akasaka, Yuuka Etou, Yoshihide Hayashizaki, Takanori Kigawa, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Ryoichi Arai, Mutsuko Kukimoto-Niino, Hiroko Uda-Tochio, Satoshi Morita, Tomomi Uchikubo-Kamo, Ryogo Akasaka, Yuuka Etou, Yoshihide Hayashizaki, Takanori Kigawa, Takaho Terada, Mikako Shirouzu, Shigeyuki Yokoyama Crystal structure of an enhancer of rudimentary homolog (ERH) at 2.1 Å resolution Crystal structure of an enhancer of rudimentary homolog (ERH) at 2.1 Å resolution Crystal structure of an enhancer of rudimentary homolog (ERH) at 2.1 Å resolution Protein Science, 14, 7, 1888-1893 Protein Science, 14, 7, 1888-1893 Protein Science, 14, 7, 1888-1893 2005/07 英語 研究論文(学術雑誌) 公開
Ad A. Kaptein, Satoshi Morita, Junichi Sakamoto Ad A. Kaptein, Satoshi Morita, Junichi Sakamoto Ad A. Kaptein, Satoshi Morita, Junichi Sakamoto Quality of life in gastric cancer Quality of life in gastric cancer Quality of life in gastric cancer WORLD JOURNAL OF GASTROENTEROLOGY, 11, 21, 3189-3196 WORLD JOURNAL OF GASTROENTEROLOGY, 11, 21, 3189-3196 WORLD JOURNAL OF GASTROENTEROLOGY, 11, 21, 3189-3196 2005/06 英語 研究論文(学術雑誌) 公開
H Matsumoto, A Niimi, M Takemura, T Ueda, M Minakuchi, R Tabuena, K Chin, T Mio, Y Ito, S Muro, T Hirai, S Morita, S Fukuhara, M Mishima H Matsumoto, A Niimi, M Takemura, T Ueda, M Minakuchi, R Tabuena, K Chin, T Mio, Y Ito, S Muro, T Hirai, S Morita, S Fukuhara, M Mishima H Matsumoto, A Niimi, M Takemura, T Ueda, M Minakuchi, R Tabuena, K Chin, T Mio, Y Ito, S Muro, T Hirai, S Morita, S Fukuhara, M Mishima Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma THORAX, 60, 4, 277-281 THORAX, 60, 4, 277-281 THORAX, 60, 4, 277-281 2005/04 英語 研究論文(学術雑誌) 公開
M Rahman, S Morita, T Fukui, J Sakamoto M Rahman, S Morita, T Fukui, J Sakamoto M Rahman, S Morita, T Fukui, J Sakamoto Physicians' attitudes towards and reasons for participation in the Candesartan Anti Hypertensive Survival Evaluation in Japan (CASE-J) trial Physicians' attitudes towards and reasons for participation in the Candesartan Anti Hypertensive Survival Evaluation in Japan (CASE-J) trial Physicians' attitudes towards and reasons for participation in the Candesartan Anti Hypertensive Survival Evaluation in Japan (CASE-J) trial JOURNAL OF EPIDEMIOLOGY, 15, 2, 38-40 JOURNAL OF EPIDEMIOLOGY, 15, 2, 38-40 JOURNAL OF EPIDEMIOLOGY, 15, 2, 38-40 2005/03 英語 研究論文(学術雑誌) 公開
Y Ueda, H Yamagishi, D Ichikawa, J Morii, K Koizumi, N Kakihara, M Shimotsuma, A Takenaka, T Yamashita, H Kurioka, M Nishiyama, S Morita, K Nakamura, J Sakamoto Y Ueda, H Yamagishi, D Ichikawa, J Morii, K Koizumi, N Kakihara, M Shimotsuma, A Takenaka, T Yamashita, H Kurioka, M Nishiyama, S Morita, K Nakamura, J Sakamoto Y Ueda, H Yamagishi, D Ichikawa, J Morii, K Koizumi, N Kakihara, M Shimotsuma, A Takenaka, T Yamashita, H Kurioka, M Nishiyama, S Morita, K Nakamura, J Sakamoto Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer ONCOLOGY, 69, 3, 261-268 ONCOLOGY, 69, 3, 261-268 ONCOLOGY, 69, 3, 261-268 2005 英語 研究論文(学術雑誌) 公開
J Sakamoto, S Morita, Y Kodera, M Rahman, A Nakao J Sakamoto, S Morita, Y Kodera, M Rahman, A Nakao J Sakamoto, S Morita, Y Kodera, M Rahman, A Nakao Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives CANCER CHEMOTHERAPY AND PHARMACOLOGY, 54, SUPPL. 1, S25-S31 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 54, SUPPL. 1, S25-S31 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 54, SUPPL. 1, S25-S31 2004/09 英語 研究論文(学術雑誌) 公開
M Rahman, S Morita, T Fukui, J Sakamoto M Rahman, S Morita, T Fukui, J Sakamoto M Rahman, S Morita, T Fukui, J Sakamoto Physicians' reasons for not entering their patients in a randomized controlled trial in Japan Physicians' reasons for not entering their patients in a randomized controlled trial in Japan Physicians' reasons for not entering their patients in a randomized controlled trial in Japan TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 203, 2, 105-109 TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 203, 2, 105-109 TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 203, 2, 105-109 2004/06 英語 研究論文(学術雑誌) 公開
W Noguchi, T Ohno, S Morita, O Aihara, H Tsujii, K Shimozuma, E Matsushima W Noguchi, T Ohno, S Morita, O Aihara, H Tsujii, K Shimozuma, E Matsushima W Noguchi, T Ohno, S Morita, O Aihara, H Tsujii, K Shimozuma, E Matsushima Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer SUPPORTIVE CARE IN CANCER, 12, 4, 240-245 SUPPORTIVE CARE IN CANCER, 12, 4, 240-245 SUPPORTIVE CARE IN CANCER, 12, 4, 240-245 2004/04 英語 研究論文(学術雑誌) 公開
高橋奈津子, 菊地臣一, 福原俊一, 鈴鴨よしみ, 紺野愼一, 森田智視, 岩本幸英, 中村孝志 高橋奈津子, 菊地臣一, 福原俊一, 鈴鴨よしみ, 紺野愼一, 森田智視, 岩本幸英, 中村孝志 高橋奈津子, 菊地臣一, 福原俊一, 鈴鴨よしみ, 紺野愼一, 森田智視, 岩本幸英, 中村孝志 腰痛特異的QOL尺度 Roland-Morris Disability Questionnaireの性・年齢階層別基準値の測定 腰痛特異的QOL尺度 Roland-Morris Disability Questionnaireの性・年齢階層別基準値の測定 腰痛特異的QOL尺度 Roland-Morris Disability Questionnaireの性・年齢階層別基準値の測定 臨床整形外科, 39, 3, 315-320 臨床整形外科, 39, 3, 315-320 臨床整形外科, 39, 3, 315-320 2004/03 日本語 研究論文(学術雑誌) 公開
S Morita, Y Ohashi, K Hirakawa, B Nakata, S Saji, J Sakamoto S Morita, Y Ohashi, K Hirakawa, B Nakata, S Saji, J Sakamoto S Morita, Y Ohashi, K Hirakawa, B Nakata, S Saji, J Sakamoto Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 3, 159-161 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 3, 159-161 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 3, 159-161 2004/03 英語 研究論文(学術雑誌) 公開
S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 2004/02 英語 研究論文(学術雑誌) 公開
S. Morita, K. Kobayashi, Y. Ohashi, K. Eguchi, M. Shibuya, T. Matsumoto, Y. Yamaji, K. Nagao, J. Sakamoto, H. Niitani S. Morita, K. Kobayashi, Y. Ohashi, K. Eguchi, M. Shibuya, T. Matsumoto, Y. Yamaji, K. Nagao, J. Sakamoto, H. Niitani S. Morita, K. Kobayashi, Y. Ohashi, K. Eguchi, M. Shibuya, T. Matsumoto, Y. Yamaji, K. Nagao, J. Sakamoto, H. Niitani Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial Annals of Cancer Research and Therapy, 12, 1-2, 105-117 Annals of Cancer Research and Therapy, 12, 1-2, 105-117 Annals of Cancer Research and Therapy, 12, 1-2, 105-117 2004 英語 公開
S. Morita, K. Shimozuma, A. Sato, M. Nakamachi, J. Blazeby, K. West, S. Fukuhara, J. Sakamoto S. Morita, K. Shimozuma, A. Sato, M. Nakamachi, J. Blazeby, K. West, S. Fukuhara, J. Sakamoto Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module Gan to kagaku ryoho. Cancer & chemotherapy, 31, 8, 1195-1199 Gan to kagaku ryoho. Cancer & chemotherapy, 31, 8, 1195-1199 , 31, 8, 1195-1199 2004 日本語 公開
Junichi Sakamoto, Satoshi Morita Junichi Sakamoto, Satoshi Morita Junichi Sakamoto, Satoshi Morita Planning, administration, and management of the clinical trial based on EBM - What are key points to generate valid evidence? Planning, administration, and management of the clinical trial based on EBM - What are key points to generate valid evidence? Planning, administration, and management of the clinical trial based on EBM - What are key points to generate valid evidence? Japanese Journal of Allergology, 53, 4, 413-416 Japanese Journal of Allergology, 53, 4, 413-416 Japanese Journal of Allergology, 53, 4, 413-416 2004 日本語 公開
M Rahman, S Morita, T Fukui, J Sakamoto M Rahman, S Morita, T Fukui, J Sakamoto M Rahman, S Morita, T Fukui, J Sakamoto Physicians' choice in using internet and fax for patient recruitment and follow-up in a randomized controlled trial Physicians' choice in using internet and fax for patient recruitment and follow-up in a randomized controlled trial Physicians' choice in using internet and fax for patient recruitment and follow-up in a randomized controlled trial METHODS OF INFORMATION IN MEDICINE, 43, 3, 268-272 METHODS OF INFORMATION IN MEDICINE, 43, 3, 268-272 METHODS OF INFORMATION IN MEDICINE, 43, 3, 268-272 2004 英語 研究論文(学術雑誌) 公開
T Fukui, M Rahman, K Hayashi, K Takeda, J Higaki, T Sato, M Fukushima, J Sakamoto, S Morita, T Ogihara, K Fukiyama T Fukui, M Rahman, K Hayashi, K Takeda, J Higaki, T Sato, M Fukushima, J Sakamoto, S Morita, T Ogihara, K Fukiyama T Fukui, M Rahman, K Hayashi, K Takeda, J Higaki, T Sato, M Fukushima, J Sakamoto, S Morita, T Ogihara, K Fukiyama Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods HYPERTENSION RESEARCH, 26, 12, 979-990 HYPERTENSION RESEARCH, 26, 12, 979-990 HYPERTENSION RESEARCH, 26, 12, 979-990 2003/12 英語 研究論文(学術雑誌) 公開
S Morita, K Kobayashi, K Eguchi, T Matsumoto, M Shibuya, Y Yamaji, J Sakamoto, Y Ohashi S Morita, K Kobayashi, K Eguchi, T Matsumoto, M Shibuya, Y Yamaji, J Sakamoto, Y Ohashi S Morita, K Kobayashi, K Eguchi, T Matsumoto, M Shibuya, Y Yamaji, J Sakamoto, Y Ohashi Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 33, 9, 470-476 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 33, 9, 470-476 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 33, 9, 470-476 2003/09 英語 研究論文(学術雑誌) 公開
S Morita, Y Ohashi, K Kobayashi, T Matsumoto, K Eguchi, M Shibuya, Y Yamaji, M Fukuoka, K Nagao, H Niitani S Morita, Y Ohashi, K Kobayashi, T Matsumoto, K Eguchi, M Shibuya, Y Yamaji, M Fukuoka, K Nagao, H Niitani S Morita, Y Ohashi, K Kobayashi, T Matsumoto, K Eguchi, M Shibuya, Y Yamaji, M Fukuoka, K Nagao, H Niitani Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer JOURNAL OF CLINICAL EPIDEMIOLOGY, 56, 8, 744-751 JOURNAL OF CLINICAL EPIDEMIOLOGY, 56, 8, 744-751 JOURNAL OF CLINICAL EPIDEMIOLOGY, 56, 8, 744-751 2003/08 英語 研究論文(学術雑誌) 公開
J Sakamoto, S Morita, T Yumiba, H Narahara, K Kinoshita, Y Nakane, H Imamoto, H Shiozaki J Sakamoto, S Morita, T Yumiba, H Narahara, K Kinoshita, Y Nakane, H Imamoto, H Shiozaki J Sakamoto, S Morita, T Yumiba, H Narahara, K Kinoshita, Y Nakane, H Imamoto, H Shiozaki A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: A new concept of clinical benefit response for non-measurable type of gastric cancer A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: A new concept of clinical benefit response for non-measurable type of gastric cancer A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: A new concept of clinical benefit response for non-measurable type of gastric cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 33, 5, 238-240 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 33, 5, 238-240 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 33, 5, 238-240 2003/05 英語 研究論文(学術雑誌) 公開
T Matsumoto, Y Ohashi, S Morita, K Kobayashi, M Shibuya, Y Yamaji, K Eguchi, M Fukuoka, K Nagao, Y Nishiwaki, H Niitani T Matsumoto, Y Ohashi, S Morita, K Kobayashi, M Shibuya, Y Yamaji, K Eguchi, M Fukuoka, K Nagao, Y Nishiwaki, H Niitani T Matsumoto, Y Ohashi, S Morita, K Kobayashi, M Shibuya, Y Yamaji, K Eguchi, M Fukuoka, K Nagao, Y Nishiwaki, H Niitani The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer QUALITY OF LIFE RESEARCH, 11, 5, 483-493 QUALITY OF LIFE RESEARCH, 11, 5, 483-493 QUALITY OF LIFE RESEARCH, 11, 5, 483-493 2002/08 英語 研究論文(学術雑誌) 公開
Y Suzuki, T Nakano, T Ohno, A Abe, S Morita, H Tsujii Y Suzuki, T Nakano, T Ohno, A Abe, S Morita, H Tsujii Y Suzuki, T Nakano, T Ohno, A Abe, S Morita, H Tsujii Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 126, 6, 332-336 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 126, 6, 332-336 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 126, 6, 332-336 2000/06 英語 研究論文(学術雑誌) 公開
A Terahara, T Nakano, A Ishikawa, S Morita, H Tsujii A Terahara, T Nakano, A Ishikawa, S Morita, H Tsujii A Terahara, T Nakano, A Ishikawa, S Morita, H Tsujii Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 35, 3, 549-554 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 35, 3, 549-554 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 35, 3, 549-554 1996/06 英語 研究論文(学術雑誌) 公開
M Masuda, Y Kawachi, S Inaba, K Matsuzaki, F Fukumura, S Morita, R Tominaga, H Yasui M Masuda, Y Kawachi, S Inaba, K Matsuzaki, F Fukumura, S Morita, R Tominaga, H Yasui M Masuda, Y Kawachi, S Inaba, K Matsuzaki, F Fukumura, S Morita, R Tominaga, H Yasui Preoperative autologous blood donations in pediatric cardiac surgery Preoperative autologous blood donations in pediatric cardiac surgery Preoperative autologous blood donations in pediatric cardiac surgery ANNALS OF THORACIC SURGERY, 60, 6, 1694-1697 ANNALS OF THORACIC SURGERY, 60, 6, 1694-1697 ANNALS OF THORACIC SURGERY, 60, 6, 1694-1697 1995/12 英語 研究論文(学術雑誌) 公開
S. Morita, S. Matsumoto, R. Odani S. Morita, S. Matsumoto, R. Odani S. Morita, S. Matsumoto, R. Odani Hepatic arterial infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II for the treatment of malignant liver tumors Hepatic arterial infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II for the treatment of malignant liver tumors Hepatic arterial infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II for the treatment of malignant liver tumors Japanese Journal of Cancer and Chemotherapy, 15, 4, 689-695 Japanese Journal of Cancer and Chemotherapy, 15, 4, 689-695 Japanese Journal of Cancer and Chemotherapy, 15, 4, 689-695 1988 日本語 研究論文(学術雑誌) 公開
S MATSUMOTO, S MORITA S MATSUMOTO, S MORITA S MATSUMOTO, S MORITA BOUNDED COHOMOLOGY OF CERTAIN GROUPS OF HOMEOMORPHISMS BOUNDED COHOMOLOGY OF CERTAIN GROUPS OF HOMEOMORPHISMS BOUNDED COHOMOLOGY OF CERTAIN GROUPS OF HOMEOMORPHISMS PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY, 94, 3, 539-544 PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY, 94, 3, 539-544 PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY, 94, 3, 539-544 1985 英語 研究論文(学術雑誌) 公開
Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) San Antonio Breast Cancer Symposium 2013 San Antonio Breast Cancer Symposium 2013 San Antonio Breast Cancer Symposium 2013 英語 公開

  • <<
  • >>
  • 表示
タイトル言語:
Misc
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Nahomi Tokudome, Yasuhiro Koh, Hiroaki Akamatsu, Daichi Fujimoto, Isamu Okamoto, Kazuhiko Nakagawa, Toyoaki Hida, Fumio Imamura, Satoshi Morita, Nobuyuki Yamamoto Nahomi Tokudome, Yasuhiro Koh, Hiroaki Akamatsu, Daichi Fujimoto, Isamu Okamoto, Kazuhiko Nakagawa, Toyoaki Hida, Fumio Imamura, Satoshi Morita, Nobuyuki Yamamoto Nahomi Tokudome, Yasuhiro Koh, Hiroaki Akamatsu, Daichi Fujimoto, Isamu Okamoto, Kazuhiko Nakagawa, Toyoaki Hida, Fumio Imamura, Satoshi Morita, Nobuyuki Yamamoto Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy. Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy. Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy. BMC cancer, 20, 1, 103-103 BMC cancer, 20, 1, 103-103 BMC cancer, 20, 1, 103-103 2020/02/06 英語 公開
Masahiro Takada, Michio Yoshimura, Kosuke Kawaguchi, Takeshi Kotake, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji, Hiroyasu Yamashiro, Tatsuki Kataoka, Hiroshi Ishiguro, Reitaro Tokumasu, Maya Honda, Rikiya Yamashita, Atsushi Yonezawa, Yuki Himoto, Natsuko Onishi, Laxmi Parida, Satoshi Morita, Masakazu Toi Masahiro Takada, Michio Yoshimura, Kosuke Kawaguchi, Takeshi Kotake, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji, Hiroyasu Yamashiro, Tatsuki Kataoka, Hiroshi Ishiguro, Reitaro Tokumasu, Maya Honda, Rikiya Yamashita, Atsushi Yonezawa, Yuki Himoto, Natsuko Onishi, Laxmi Parida, Satoshi Morita, Masakazu Toi Masahiro Takada, Michio Yoshimura, Kosuke Kawaguchi, Takeshi Kotake, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji, Hiroyasu Yamashiro, Tatsuki Kataoka, Hiroshi Ishiguro, Reitaro Tokumasu, Maya Honda, Rikiya Yamashita, Atsushi Yonezawa, Yuki Himoto, Natsuko Onishi, Laxmi Parida, Satoshi Morita, Masakazu Toi A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial) A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial) A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial) CANCER RESEARCH, 80, 4 CANCER RESEARCH, 80, 4 CANCER RESEARCH, 80, 4 2020/02 英語 研究発表ペーパー・要旨(国際会議) 公開
Keiko Imamura, Yuishin Izumi, Haruhiko Banno, Ryuji Uozumi, Satoshi Morita, Naohiro Egawa, Takashi Ayaki, Makiko Nagai, Kazutoshi Nishiyama, Yasuhiro Watanabe, Ritsuko Hanajima, Ryosuke Oki, Koji Fujita, Naoto Takahashi, Takafumi Ikeda, Akira Shimizu, Akiko Morinaga, Tomoko Hirohashi, Yosuke Fujii, Ryosuke Takahashi, Haruhisa Inoue Keiko Imamura, Yuishin Izumi, Haruhiko Banno, Ryuji Uozumi, Satoshi Morita, Naohiro Egawa, Takashi Ayaki, Makiko Nagai, Kazutoshi Nishiyama, Yasuhiro Watanabe, Ritsuko Hanajima, Ryosuke Oki, Koji Fujita, Naoto Takahashi, Takafumi Ikeda, Akira Shimizu, Akiko Morinaga, Tomoko Hirohashi, Yosuke Fujii, Ryosuke Takahashi, Haruhisa Inoue Keiko Imamura, Yuishin Izumi, Haruhiko Banno, Ryuji Uozumi, Satoshi Morita, Naohiro Egawa, Takashi Ayaki, Makiko Nagai, Kazutoshi Nishiyama, Yasuhiro Watanabe, Ritsuko Hanajima, Ryosuke Oki, Koji Fujita, Naoto Takahashi, Takafumi Ikeda, Akira Shimizu, Akiko Morinaga, Tomoko Hirohashi, Yosuke Fujii, Ryosuke Takahashi, Haruhisa Inoue Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. BMJ open, 9, 12, e033131 BMJ open, 9, 12, e033131 BMJ open, 9, 12, e033131 2019/12/02 英語 公開
西田 純幸, 白方 俊章, 森本 創世子, 榎本 隆之, 吉野 潔, 冨松 拓治, 藤木 文博, 尾路 祐介, 上田 豊, 坪井 昭博, 森田 智視, 岡 芳弘, 熊ノ郷 淳, 木村 正, 杉山 治夫 西田 純幸, 白方 俊章, 森本 創世子, 榎本 隆之, 吉野 潔, 冨松 拓治, 藤木 文博, 尾路 祐介, 上田 豊, 坪井 昭博, 森田 智視, 岡 芳弘, 熊ノ郷 淳, 木村 正, 杉山 治夫 西田 純幸, 白方 俊章, 森本 創世子, 榎本 隆之, 吉野 潔, 冨松 拓治, 藤木 文博, 尾路 祐介, 上田 豊, 坪井 昭博, 森田 智視, 岡 芳弘, 熊ノ郷 淳, 木村 正, 杉山 治夫 進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer) 進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer) 進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer) 日本がん免疫学会総会プログラム・抄録集, 23回, 159-159 日本がん免疫学会総会プログラム・抄録集, 23回, 159-159 日本がん免疫学会総会プログラム・抄録集, 23回, 159-159 2019/07 英語 公開
Takaki Yoshikawa, Toru Aoyama, Kentaro Sakamaki, Takasi Oshima, Joyce Lin, Shenli Zhang, Nur Sabrina Sapari, Richie Soong, Iain Tan, Xiu Bin Chan, Dan Bottomley, Lindsay C Hewitt, Tomio Arai, Bin Tean Teh, David Epstein, Takashi Ogata, Yoichi Kameda, Yohei Miyagi, Akira Tsuburaya, Satoshi Morita, Heike I Grabsch, Patrick Tan Takaki Yoshikawa, Toru Aoyama, Kentaro Sakamaki, Takasi Oshima, Joyce Lin, Shenli Zhang, Nur Sabrina Sapari, Richie Soong, Iain Tan, Xiu Bin Chan, Dan Bottomley, Lindsay C Hewitt, Tomio Arai, Bin Tean Teh, David Epstein, Takashi Ogata, Yoichi Kameda, Yohei Miyagi, Akira Tsuburaya, Satoshi Morita, Heike I Grabsch, Patrick Tan Takaki Yoshikawa, Toru Aoyama, Kentaro Sakamaki, Takasi Oshima, Joyce Lin, Shenli Zhang, Nur Sabrina Sapari, Richie Soong, Iain Tan, Xiu Bin Chan, Dan Bottomley, Lindsay C Hewitt, Tomio Arai, Bin Tean Teh, David Epstein, Takashi Ogata, Yoichi Kameda, Yohei Miyagi, Akira Tsuburaya, Satoshi Morita, Heike I Grabsch, Patrick Tan Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. Journal of Cancer, 10, 21, 5130-5138 Journal of Cancer, 10, 21, 5130-5138 Journal of Cancer, 10, 21, 5130-5138 2019 英語 公開
Takeshi Kato, Yoshinori Kagawa, Mitsuyoshi Ota, Akitaka Makiyama, Tadamichi Denda, Chu Matsuda, Yasuhide Yamada, Satoru Iwasa, Tae Won Kim, Rui-hua Xu, Young Suk Park, Satoshi Morita, Junichi Sakamoto, Kei Muro Takeshi Kato, Yoshinori Kagawa, Mitsuyoshi Ota, Akitaka Makiyama, Tadamichi Denda, Chu Matsuda, Yasuhide Yamada, Satoru Iwasa, Tae Won Kim, Rui-hua Xu, Young Suk Park, Satoshi Morita, Junichi Sakamoto, Kei Muro Takeshi Kato, Yoshinori Kagawa, Mitsuyoshi Ota, Akitaka Makiyama, Tadamichi Denda, Chu Matsuda, Yasuhide Yamada, Satoru Iwasa, Tae Won Kim, Rui-hua Xu, Young Suk Park, Satoshi Morita, Junichi Sakamoto, Kei Muro Global phase III trial of comparing mXELIRI plus BV vs FOLFIRI+Bmab for 2nd line mCRC (AXEPT) Japanese population analysis Global phase III trial of comparing mXELIRI plus BV vs FOLFIRI+Bmab for 2nd line mCRC (AXEPT) Japanese population analysis Global phase III trial of comparing mXELIRI plus BV vs FOLFIRI+Bmab for 2nd line mCRC (AXEPT) Japanese population analysis ANNALS OF ONCOLOGY, 29, 65-65 ANNALS OF ONCOLOGY, 29, 65-65 ANNALS OF ONCOLOGY, 29, 65-65 2018/10 英語 研究発表ペーパー・要旨(国際会議) 公開
Shuichi Mizuta, Masashi Sawa, Hisashi Tsurumi, Kana Matsumoto, Kotaro Miyao, Takeshi Hara, Takeshi Takahashi, Reona Sakemura, Hiroshi Kojima, Akio Kohno, Mari S Oba, Satoshi Morita, Junichi Sakamoto, Nobuhiko Emi Shuichi Mizuta, Masashi Sawa, Hisashi Tsurumi, Kana Matsumoto, Kotaro Miyao, Takeshi Hara, Takeshi Takahashi, Reona Sakemura, Hiroshi Kojima, Akio Kohno, Mari S Oba, Satoshi Morita, Junichi Sakamoto, Nobuhiko Emi Shuichi Mizuta, Masashi Sawa, Hisashi Tsurumi, Kana Matsumoto, Kotaro Miyao, Takeshi Hara, Takeshi Takahashi, Reona Sakemura, Hiroshi Kojima, Akio Kohno, Mari S Oba, Satoshi Morita, Junichi Sakamoto, Nobuhiko Emi Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study. Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study. Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study. International journal of clinical oncology, 23, 5, 980-988 International journal of clinical oncology, 23, 5, 980-988 International journal of clinical oncology, 23, 5, 980-988 2018/10 英語 公開
服部 正也, 相良 安昭, 高田 正泰, 大井 恭代, 黒住 昌史, 大谷 彰一郎, 井上 賢一, 高尾 信太郎, 佐藤 信昭, 山下 年成, 小坂 愉賢, 黒住 献, 森田 智視, 岩田 広治, 戸井 雅和 服部 正也, 相良 安昭, 高田 正泰, 大井 恭代, 黒住 昌史, 大谷 彰一郎, 井上 賢一, 高尾 信太郎, 佐藤 信昭, 山下 年成, 小坂 愉賢, 黒住 献, 森田 智視, 岩田 広治, 戸井 雅和 服部 正也, 相良 安昭, 高田 正泰, 大井 恭代, 黒住 昌史, 大谷 彰一郎, 井上 賢一, 高尾 信太郎, 佐藤 信昭, 山下 年成, 小坂 愉賢, 黒住 献, 森田 智視, 岩田 広治, 戸井 雅和 HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究 HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究 HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究 日本乳癌学会総会プログラム抄録集, 26回, 273-273 日本乳癌学会総会プログラム抄録集, 26回, 273-273 日本乳癌学会総会プログラム抄録集, 26回, 273-273 2018/05 日本語 公開
村瀬公彦, 谷澤公伸, 津田徹, 大井元晴, 赤星俊樹, 成井浩司, 名嘉村博, 大平徹郎, 吉嶺裕之, 坪井知正, 山城義広, 安藤眞一, 葛西隆敏, 北英夫, 巽浩一郎, 鰤岡直人, 富井啓介, 近藤康博, 小賀徹, 酒巻哲夫, 森田智視, 平井豊博, 黒田知宏, 陳和夫 村瀬公彦, 谷澤公伸, 津田徹, 大井元晴, 赤星俊樹, 成井浩司, 名嘉村博, 大平徹郎, 吉嶺裕之, 坪井知正, 山城義広, 安藤眞一, 葛西隆敏, 北英夫, 巽浩一郎, 鰤岡直人, 富井啓介, 近藤康博, 小賀徹, 酒巻哲夫, 森田智視, 平井豊博, 黒田知宏, 陳和夫 村瀬公彦, 谷澤公伸, 津田徹, 大井元晴, 赤星俊樹, 成井浩司, 名嘉村博, 大平徹郎, 吉嶺裕之, 坪井知正, 山城義広, 安藤眞一, 葛西隆敏, 北英夫, 巽浩一郎, 鰤岡直人, 富井啓介, 近藤康博, 小賀徹, 酒巻哲夫, 森田智視, 平井豊博, 黒田知宏, 陳和夫 遠隔モニタリングシステム導入によるCPAPアドヒアランスの変化:多施設共同無作為化比較試験 遠隔モニタリングシステム導入によるCPAPアドヒアランスの変化:多施設共同無作為化比較試験 遠隔モニタリングシステム導入によるCPAPアドヒアランスの変化:多施設共同無作為化比較試験 日本呼吸器学会誌(Web), 7, 増刊, 265-265 日本呼吸器学会誌(Web), 7, 増刊, 265-265 日本呼吸器学会誌(Web), 7, 増刊, 265-265 2018/03/10 日本語 公開
江口直樹, 多田春江, 上山華栄, 青山正典, 森田智視 江口直樹, 多田春江, 上山華栄, 青山正典, 森田智視 CDISC標準導入の経験から CDISC標準導入の経験から 日本臨床試験学会第9回学術集会総会 日本臨床試験学会第9回学術集会総会 2018/02 公開
上山華栄, 多田春江, 江口直樹, 青山正典, 竹川遼子, 森田智視 上山華栄, 多田春江, 江口直樹, 青山正典, 竹川遼子, 森田智視 CDISC標準導入のメリットと効率化の検討 CDISC標準導入のメリットと効率化の検討 日本臨床試験学会第9回学術集会総会 日本臨床試験学会第9回学術集会総会 2018/02 公開
多田春江, 上山華栄, 木下明美, 白川知佐, 徳田彩華, 森麻子, 船越千尋, 川口恭子, 榎本佳代子, 渡邊美惠子, 前尾裕子, 塚田紗佑里, 森田智視 多田春江, 上山華栄, 木下明美, 白川知佐, 徳田彩華, 森麻子, 船越千尋, 川口恭子, 榎本佳代子, 渡邊美惠子, 前尾裕子, 塚田紗佑里, 森田智視 データレビュー情報を品質管理活動の指標として定量化するためのツールの開発と運用 データレビュー情報を品質管理活動の指標として定量化するためのツールの開発と運用 日本臨床試験学会第9回学術集会総会 日本臨床試験学会第9回学術集会総会 2018/02 公開
藤澤 知巳, 川口 英俊, 増田 慎三, 中山 貴寛, 青儀 健二郎, 伊藤 良則, 大谷 彰一郎, 佐治 重衛, 長谷川 善枝, 服部 正也, 山下 年成, 山本 豊, 森田 智視, 戸井 雅和, 大野 真司 藤澤 知巳, 川口 英俊, 増田 慎三, 中山 貴寛, 青儀 健二郎, 伊藤 良則, 大谷 彰一郎, 佐治 重衛, 長谷川 善枝, 服部 正也, 山下 年成, 山本 豊, 森田 智視, 戸井 雅和, 大野 真司 藤澤 知巳, 川口 英俊, 増田 慎三, 中山 貴寛, 青儀 健二郎, 伊藤 良則, 大谷 彰一郎, 佐治 重衛, 長谷川 善枝, 服部 正也, 山下 年成, 山本 豊, 森田 智視, 戸井 雅和, 大野 真司 「それぞれの癌」難治性癌に対する治療戦略 乳腺 閉経後進行再発乳癌におけるフルベストラントの長期TTFに関わる検討 Safari試験 「それぞれの癌」難治性癌に対する治療戦略 乳腺 閉経後進行再発乳癌におけるフルベストラントの長期TTFに関わる検討 Safari試験 「それぞれの癌」難治性癌に対する治療戦略 乳腺 閉経後進行再発乳癌におけるフルベストラントの長期TTFに関わる検討 Safari試験 日本癌治療学会学術集会抄録集, 55回, WS13-4 日本癌治療学会学術集会抄録集, 55回, WS13-4 日本癌治療学会学術集会抄録集, 55回, WS13-4 2017/10 日本語 公開
肥田侯矢, 岡村亮輔, 西崎大輔, 坂井義治, 小西 毅, 赤木智徳, 山口智弘, 秋吉高志, 福田 明輝, 山本聖一郎, 山本倫生, 森田智視, 有薗茂樹, 田村 寛, 渡邊昌彦, 腹腔鏡下大腸切除研究会 肥田侯矢, 岡村亮輔, 西崎大輔, 坂井義治, 小西 毅, 赤木智徳, 山口智弘, 秋吉高志, 福田 明輝, 山本聖一郎, 山本倫生, 森田智視, 有薗茂樹, 田村 寛, 渡邊昌彦, 腹腔鏡下大腸切除研究会 「それぞれの癌」難治性癌に対する治療戦略 大腸・虫垂 進行下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同研究結果と追加調査 「それぞれの癌」難治性癌に対する治療戦略 大腸・虫垂 進行下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同研究結果と追加調査 第55回日本癌治療学会学術集会抄録集, WS8-1-WS8-1 第55回日本癌治療学会学術集会抄録集, WS8-1-WS8-1 , WS8-1-WS8-1 2017/10 日本語 研究発表ペーパー・要旨(全国大会、その他学術会議) 公開
Y. Komatsu, A. Takashima, T. Denda, M. Gamoh, I. Iwanaga, H. Shimodaira, M. Nakamura, T. Yamaguchi, H. Takahashi, K. Kobayashi, M. Tsuda, Y. Kobayashi, H. Baba, M. Kotake, C. Ishioka, A. Sato, S. Yuki, S. Morita, S. Takahashi, K. Shimada Y. Komatsu, A. Takashima, T. Denda, M. Gamoh, I. Iwanaga, H. Shimodaira, M. Nakamura, T. Yamaguchi, H. Takahashi, K. Kobayashi, M. Tsuda, Y. Kobayashi, H. Baba, M. Kotake, C. Ishioka, A. Sato, S. Yuki, S. Morita, S. Takahashi, K. Shimada Y. Komatsu, A. Takashima, T. Denda, M. Gamoh, I. Iwanaga, H. Shimodaira, M. Nakamura, T. Yamaguchi, H. Takahashi, K. Kobayashi, M. Tsuda, Y. Kobayashi, H. Baba, M. Kotake, C. Ishioka, A. Sato, S. Yuki, S. Morita, S. Takahashi, K. Shimada Treatment outcome according to tumor RAS mutation status in TRICOLORE trial: A randomized phase 3 trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer Treatment outcome according to tumor RAS mutation status in TRICOLORE trial: A randomized phase 3 trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer Treatment outcome according to tumor RAS mutation status in TRICOLORE trial: A randomized phase 3 trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 2017/09 英語 研究発表ペーパー・要旨(国際会議) 公開
N. Masuda, S. Ohtani, T. Takano, K. Inoue, E. Suzuki, R. Nakamura, H. Bando, Y. Ito, K. Ishida, T. Yamanaka, K. Kuroi, H. Yasojima, H. Kasai, T. Takasuka, T. Sakurai, T. R. Kataoka, S. Morita, S. Ohno, M. Toi N. Masuda, S. Ohtani, T. Takano, K. Inoue, E. Suzuki, R. Nakamura, H. Bando, Y. Ito, K. Ishida, T. Yamanaka, K. Kuroi, H. Yasojima, H. Kasai, T. Takasuka, T. Sakurai, T. R. Kataoka, S. Morita, S. Ohno, M. Toi N. Masuda, S. Ohtani, T. Takano, K. Inoue, E. Suzuki, R. Nakamura, H. Bando, Y. Ito, K. Ishida, T. Yamanaka, K. Kuroi, H. Yasojima, H. Kasai, T. Takasuka, T. Sakurai, T. R. Kataoka, S. Morita, S. Ohno, M. Toi Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20) Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20) Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20) ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 ANNALS OF ONCOLOGY, 28 2017/09 英語 研究発表ペーパー・要旨(国際会議) 公開
Naoki Sakane, Yoshitake Oshima, Shinsuke Nirengi, Kazuhiko Kotani, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Yoshitake Oshima, Shinsuke Nirengi, Kazuhiko Kotani, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Yoshitake Oshima, Shinsuke Nirengi, Kazuhiko Kotani, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Frequent Self-Weighing Delays or Prevents the Development of Type 2 Diabetes in a Real-World Setting: A Subanalysis of Japan Diabetes Outcome Trial-1 Frequent Self-Weighing Delays or Prevents the Development of Type 2 Diabetes in a Real-World Setting: A Subanalysis of Japan Diabetes Outcome Trial-1 Frequent Self-Weighing Delays or Prevents the Development of Type 2 Diabetes in a Real-World Setting: A Subanalysis of Japan Diabetes Outcome Trial-1 DIABETES, 66, A43-A43 DIABETES, 66, A43-A43 DIABETES, 66, A43-A43 2017/06 英語 研究発表ペーパー・要旨(国際会議) 公開
Kohei Otsubo, Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Daichi Fujimoto, Akihiro Bessho, Koichi Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto Kohei Otsubo, Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Daichi Fujimoto, Akihiro Bessho, Koichi Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto Kohei Otsubo, Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Daichi Fujimoto, Akihiro Bessho, Koichi Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto Predictive impact of complete molecular response in plasma: A phase II, liquid biopsy study in EGFR mutated NSCLC patients treated with afatinib (WJOG 8114LTR). Predictive impact of complete molecular response in plasma: A phase II, liquid biopsy study in EGFR mutated NSCLC patients treated with afatinib (WJOG 8114LTR). Predictive impact of complete molecular response in plasma: A phase II, liquid biopsy study in EGFR mutated NSCLC patients treated with afatinib (WJOG 8114LTR). JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Akito Hata, Nobuyuki Katakami, Reiko Kaji, Toshihide Yokoyama, Toshihiko Kaneda, Motohiro Tamiya, Takako Inoue, Hiromi Kimura, Yukihiro Yano, Daisuke Tamura, Satoshi Morita, Shunichi Negoro Akito Hata, Nobuyuki Katakami, Reiko Kaji, Toshihide Yokoyama, Toshihiko Kaneda, Motohiro Tamiya, Takako Inoue, Hiromi Kimura, Yukihiro Yano, Daisuke Tamura, Satoshi Morita, Shunichi Negoro Akito Hata, Nobuyuki Katakami, Reiko Kaji, Toshihide Yokoyama, Toshihiko Kaneda, Motohiro Tamiya, Takako Inoue, Hiromi Kimura, Yukihiro Yano, Daisuke Tamura, Satoshi Morita, Shunichi Negoro Afatinib (Afa) plus bevacizumab (Bev) combination after acquired resistance (AR) to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR-mutant non-small cell lung cancer (NSCLC): Multicenter single arm phase II trial (ABC-study). Afatinib (Afa) plus bevacizumab (Bev) combination after acquired resistance (AR) to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR-mutant non-small cell lung cancer (NSCLC): Multicenter single arm phase II trial (ABC-study). Afatinib (Afa) plus bevacizumab (Bev) combination after acquired resistance (AR) to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR-mutant non-small cell lung cancer (NSCLC): Multicenter single arm phase II trial (ABC-study). JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Kazutaka Narui, Toshinari Yamashita, Masahiro Kitada, Hidetoshi Kawaguchi, Masaya Hattori, Tetsuhiro Yoshinami, Nobuki Matsunami, Kazuhiro Yanagihara, Teru Kawasoe, Takeshi Nagashima, Hiroko Bando, Hiroshi Yano, Yoshie Hasegawa, Rikiya Nakamura, Masahiro Kashiwaba, Norikazu Masuda, Satoshi Morita, Shinji Ohno, Masakazu Toi Kazutaka Narui, Toshinari Yamashita, Masahiro Kitada, Hidetoshi Kawaguchi, Masaya Hattori, Tetsuhiro Yoshinami, Nobuki Matsunami, Kazuhiro Yanagihara, Teru Kawasoe, Takeshi Nagashima, Hiroko Bando, Hiroshi Yano, Yoshie Hasegawa, Rikiya Nakamura, Masahiro Kashiwaba, Norikazu Masuda, Satoshi Morita, Shinji Ohno, Masakazu Toi Kazutaka Narui, Toshinari Yamashita, Masahiro Kitada, Hidetoshi Kawaguchi, Masaya Hattori, Tetsuhiro Yoshinami, Nobuki Matsunami, Kazuhiro Yanagihara, Teru Kawasoe, Takeshi Nagashima, Hiroko Bando, Hiroshi Yano, Yoshie Hasegawa, Rikiya Nakamura, Masahiro Kashiwaba, Norikazu Masuda, Satoshi Morita, Shinji Ohno, Masakazu Toi Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03). Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03). Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03). JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Shigeru Imoto, Shinji Nagamine, Toshikazu Ito, Hitoshi Tsuda, Mitsuhiro Tozaki, Satoshi Morita, Takayuki Ueno Shigeru Imoto, Shinji Nagamine, Toshikazu Ito, Hitoshi Tsuda, Mitsuhiro Tozaki, Satoshi Morita, Takayuki Ueno Shigeru Imoto, Shinji Nagamine, Toshikazu Ito, Hitoshi Tsuda, Mitsuhiro Tozaki, Satoshi Morita, Takayuki Ueno Phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal components. Phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal components. Phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal components. JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Shunichi Sugawara, Koichi Azuma, Makoto Nishio, Hidetoshi Hayashi, Katsuyuki Kiura, Miyako Satouchi, Toyoaki Hida, Atsushi Nakamura, Yasuo Iwamoto, Akira Inoue, Koji Takeda, Satoshi Ikeda, Tomoki Nakagawa, Seitaro Asahina, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Shunichi Sugawara, Koichi Azuma, Makoto Nishio, Hidetoshi Hayashi, Katsuyuki Kiura, Miyako Satouchi, Toyoaki Hida, Atsushi Nakamura, Yasuo Iwamoto, Akira Inoue, Koji Takeda, Satoshi Ikeda, Tomoki Nakagawa, Seitaro Asahina, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Shunichi Sugawara, Koichi Azuma, Makoto Nishio, Hidetoshi Hayashi, Katsuyuki Kiura, Miyako Satouchi, Toyoaki Hida, Atsushi Nakamura, Yasuo Iwamoto, Akira Inoue, Koji Takeda, Satoshi Ikeda, Tomoki Nakagawa, Seitaro Asahina, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Tolerability and antitumor activity of ASP8273 in TKI-naive Japanese subjects with EGFR mutation positive non-small cell lung cancer. Tolerability and antitumor activity of ASP8273 in TKI-naive Japanese subjects with EGFR mutation positive non-small cell lung cancer. Tolerability and antitumor activity of ASP8273 in TKI-naive Japanese subjects with EGFR mutation positive non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 JOURNAL OF CLINICAL ONCOLOGY, 35 2017/05 英語 研究発表ペーパー・要旨(国際会議) 公開
M. Tsuda, H. Ishiguro, N. Toriguchi, N. Masuda, H. Bando, M. Ohgami, M. Homma, S. Morita, N. Yamamoto, K. Kuroi, T. Takano, S. Shimizu, M. Toi M. Tsuda, H. Ishiguro, N. Toriguchi, N. Masuda, H. Bando, M. Ohgami, M. Homma, S. Morita, N. Yamamoto, K. Kuroi, T. Takano, S. Shimizu, M. Toi M. Tsuda, H. Ishiguro, N. Toriguchi, N. Masuda, H. Bando, M. Ohgami, M. Homma, S. Morita, N. Yamamoto, K. Kuroi, T. Takano, S. Shimizu, M. Toi Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH CANCER RESEARCH, 77 CANCER RESEARCH, 77 CANCER RESEARCH, 77 2017/02 英語 研究発表ペーパー・要旨(国際会議) 公開
Kazushi Yoshida, Yuichiro Ohe, Akira Inoue, Toru Kumagai, Masayuki Takeda, Nobuyuki Yamamoto, Takashi Seto, Isamu Okamoto, Naoki Tashiro, Satoshi Morita, Masahiro Fukuoka Kazushi Yoshida, Yuichiro Ohe, Akira Inoue, Toru Kumagai, Masayuki Takeda, Nobuyuki Yamamoto, Takashi Seto, Isamu Okamoto, Naoki Tashiro, Satoshi Morita, Masahiro Fukuoka Kazushi Yoshida, Yuichiro Ohe, Akira Inoue, Toru Kumagai, Masayuki Takeda, Nobuyuki Yamamoto, Takashi Seto, Isamu Okamoto, Naoki Tashiro, Satoshi Morita, Masahiro Fukuoka Overall Survival (OS) of EGFR Mutation Positive Non-Small Cell Lung Cancer Patients: Real-World Treatment Patterns of 1,660 Japanese Patients Overall Survival (OS) of EGFR Mutation Positive Non-Small Cell Lung Cancer Patients: Real-World Treatment Patterns of 1,660 Japanese Patients Overall Survival (OS) of EGFR Mutation Positive Non-Small Cell Lung Cancer Patients: Real-World Treatment Patterns of 1,660 Japanese Patients JOURNAL OF THORACIC ONCOLOGY, 12, 1, S336-S337 JOURNAL OF THORACIC ONCOLOGY, 12, 1, S336-S337 JOURNAL OF THORACIC ONCOLOGY, 12, 1, S336-S337 2017/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Makoto Nishio, Koichi Azuma, Hidetoshi Hayashi, Toyoaki Hida, Akira Inoue, Yasuo Iwamoto, Satoshi Ikeda, Katsuyuki Kiura, Miyako Satouchi, Shunichi Sugawara, Koji Takeda, Desai Bhardwaj, Anne Keating, Kanji Komatsu, Maiko Morishita, Kentaro Takeda, Satoshi Morita, Masahiro Fulmoka, Kazuhiko Nakagawa Makoto Nishio, Koichi Azuma, Hidetoshi Hayashi, Toyoaki Hida, Akira Inoue, Yasuo Iwamoto, Satoshi Ikeda, Katsuyuki Kiura, Miyako Satouchi, Shunichi Sugawara, Koji Takeda, Desai Bhardwaj, Anne Keating, Kanji Komatsu, Maiko Morishita, Kentaro Takeda, Satoshi Morita, Masahiro Fulmoka, Kazuhiko Nakagawa Makoto Nishio, Koichi Azuma, Hidetoshi Hayashi, Toyoaki Hida, Akira Inoue, Yasuo Iwamoto, Satoshi Ikeda, Katsuyuki Kiura, Miyako Satouchi, Shunichi Sugawara, Koji Takeda, Desai Bhardwaj, Anne Keating, Kanji Komatsu, Maiko Morishita, Kentaro Takeda, Satoshi Morita, Masahiro Fulmoka, Kazuhiko Nakagawa ASP8273 Tolerability and Antitumor Activity in TKI-Naive Japanese Subjects with EGFRmut plus NSCLC: Preliminary Results ASP8273 Tolerability and Antitumor Activity in TKI-Naive Japanese Subjects with EGFRmut plus NSCLC: Preliminary Results ASP8273 Tolerability and Antitumor Activity in TKI-Naive Japanese Subjects with EGFRmut plus NSCLC: Preliminary Results JOURNAL OF THORACIC ONCOLOGY, 12, 1, S1243-S1244 JOURNAL OF THORACIC ONCOLOGY, 12, 1, S1243-S1244 JOURNAL OF THORACIC ONCOLOGY, 12, 1, S1243-S1244 2017/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Daichi Fujimoto, Isamu Okamoto, Akihiro Bessho, Koichi Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Daichi Fujimoto, Isamu Okamoto, Akihiro Bessho, Koichi Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Daichi Fujimoto, Isamu Okamoto, Akihiro Bessho, Koichi Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto A Phase II, Liquid Biopsy Study Using Digital PCR in EGFR Mutated, Lung Cancer Patients Treated with Afatinib (WJOG 8114LTR) A Phase II, Liquid Biopsy Study Using Digital PCR in EGFR Mutated, Lung Cancer Patients Treated with Afatinib (WJOG 8114LTR) A Phase II, Liquid Biopsy Study Using Digital PCR in EGFR Mutated, Lung Cancer Patients Treated with Afatinib (WJOG 8114LTR) JOURNAL OF THORACIC ONCOLOGY, 12, 1, S1234-S1234 JOURNAL OF THORACIC ONCOLOGY, 12, 1, S1234-S1234 JOURNAL OF THORACIC ONCOLOGY, 12, 1, S1234-S1234 2017/01 英語 研究発表ペーパー・要旨(国際会議) 公開
蒲生真紀夫, 沖田南都子, 傳田忠道, 岩永一郎, 小松嘉人, 下平秀樹, 中村将人, 山口達郎, 大堀久詔, 小林功治, 飛松和俊, 宮城島拓人, 馬場秀夫, 小竹優範, 嶋田顕, 佐藤温, 結城敏志, 森田智視, 高橋信, 石岡千加史 蒲生真紀夫, 沖田南都子, 傳田忠道, 岩永一郎, 小松嘉人, 下平秀樹, 中村将人, 山口達郎, 大堀久詔, 小林功治, 飛松和俊, 宮城島拓人, 馬場秀夫, 小竹優範, 嶋田顕, 佐藤温, 結城敏志, 森田智視, 高橋信, 石岡千加史 切除不能大腸癌に対するmFOLFOX6/CapeOX+BmabとS‐1/CPT‐11+Bmabとの第3相試験:TRICOLORE試験 切除不能大腸癌に対するmFOLFOX6/CapeOX+BmabとS‐1/CPT‐11+Bmabとの第3相試験:TRICOLORE試験 日本臨床腫瘍学会学術集会(CD-ROM), 15th, ROMBUNNO.PS‐1 日本臨床腫瘍学会学術集会(CD-ROM), 15th, ROMBUNNO.PS‐1 , 15th, ROMBUNNO.PS‐1 2017 日本語 公開
Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Kosei Matsue, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi Discontinuation of Dasatinib after Deep Molecular Response for over 2 Years in Patients with Chronic Myelogenous Leukemia and the Unique Profiles of Lymphocyte Subsets for Successful Discontinuation: A Prospective, Multicenter Japanese Trial (D-STOP Trial) Discontinuation of Dasatinib after Deep Molecular Response for over 2 Years in Patients with Chronic Myelogenous Leukemia and the Unique Profiles of Lymphocyte Subsets for Successful Discontinuation: A Prospective, Multicenter Japanese Trial (D-STOP Trial) Discontinuation of Dasatinib after Deep Molecular Response for over 2 Years in Patients with Chronic Myelogenous Leukemia and the Unique Profiles of Lymphocyte Subsets for Successful Discontinuation: A Prospective, Multicenter Japanese Trial (D-STOP Trial) BLOOD, 128, 22 BLOOD, 128, 22 BLOOD, 128, 22 2016/12 英語 研究発表ペーパー・要旨(国際会議) 公開
K. Tanabe, T. Yoshikawa, T. Oshima, Y. Miyagi, S. Morita, K. Nishikawa, Y. Ito, T. Matsui, Y. Kimura, T. Aoyama, T. Hayashi, T. Ogata, H. Cho, A. Tuburaya, J. Sakamoto K. Tanabe, T. Yoshikawa, T. Oshima, Y. Miyagi, S. Morita, K. Nishikawa, Y. Ito, T. Matsui, Y. Kimura, T. Aoyama, T. Hayashi, T. Ogata, H. Cho, A. Tuburaya, J. Sakamoto K. Tanabe, T. Yoshikawa, T. Oshima, Y. Miyagi, S. Morita, K. Nishikawa, Y. Ito, T. Matsui, Y. Kimura, T. Aoyama, T. Hayashi, T. Ogata, H. Cho, A. Tuburaya, J. Sakamoto Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: an exploratory study of the randomized phase II COMPASS trial Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: an exploratory study of the randomized phase II COMPASS trial Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: an exploratory study of the randomized phase II COMPASS trial ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/10 英語 研究発表ペーパー・要旨(国際会議) 公開
小井戸 薫雄, 西田 純幸, 石川 剛, 江川 新一, 石井 淳, 菅野 良秀, 柳本 泰明, 古倉 聡, 森本 創世子, 大庭 真梨, 江口 英利, 島田 英昭, 本間 定, 森田 智視, 杉山 治夫 小井戸 薫雄, 西田 純幸, 石川 剛, 江川 新一, 石井 淳, 菅野 良秀, 柳本 泰明, 古倉 聡, 森本 創世子, 大庭 真梨, 江口 英利, 島田 英昭, 本間 定, 森田 智視, 杉山 治夫 小井戸薫雄, 西田純幸, 石川剛, 江川新一, 石井淳, 菅野良秀, 柳本泰明, 古倉聡, 森本創世子, 大庭真梨, 江口英利, 島田英昭, 本間定, 森田智視, 杉山治夫 膵臓 進行膵がんに対する治療戦略 進行膵癌に対するゲムシタビン併用WT1ペプチドワクチン療法ランダム化第II相臨床試験 膵臓 進行膵がんに対する治療戦略 進行膵癌に対するゲムシタビン併用WT1ペプチドワクチン療法ランダム化第II相臨床試験 進行膵癌に対するゲムシタビン併用WT1ペプチドワクチン療法ランダム化第II相臨床試験 日本癌治療学会学術集会抄録集, 54回, MS14-4 日本癌治療学会学術集会抄録集, 54回, MS14-4 日本癌治療学会学術集会(Web), 54回, MS14-4 2016/10 日本語 公開
濱西 潤三, 万代 昌紀, 池田 隆文, 南 学, 川口 淳, 村山 敏典, 金井 雅史, 森 由希子, 松本 繁, 松村 謙臣, 森田 智視, 清水 章, 本庶 佑, 小西 郁生 濱西 潤三, 万代 昌紀, 池田 隆文, 南 学, 川口 淳, 村山 敏典, 金井 雅史, 森 由希子, 松本 繁, 松村 謙臣, 森田 智視, 清水 章, 本庶 佑, 小西 郁生 濱西 潤三, 万代 昌紀, 池田 隆文, 南 学, 川口 淳, 村山 敏典, 金井 雅史, 森 由希子, 松本 繁, 松村 謙臣, 森田 智視, 清水 章, 本庶 佑, 小西 郁生 Best of Cancer Investigation(Clinical Research)from Japan '15-'16 卵巣がんに対する抗PD-1抗体(ニボルマブ)免疫療法の安全性と有効性(Best of Cancer Investigation (Clinical Research) from Japan '15-'16) Best of Cancer Investigation(Clinical Research)from Japan '15-'16 卵巣がんに対する抗PD-1抗体(ニボルマブ)免疫療法の安全性と有効性(Best of Cancer Investigation (Clinical Research) from Japan '15-'16) Best of Cancer Investigation(Clinical Research)from Japan '15-'16 卵巣がんに対する抗PD-1抗体(ニボルマブ)免疫療法の安全性と有効性(Best of Cancer Investigation (Clinical Research) from Japan '15-'16) 日本癌治療学会学術集会抄録集, 54回, S21-4 日本癌治療学会学術集会抄録集, 54回, S21-4 日本癌治療学会学術集会抄録集, 54回, S21-4 2016/10 日本語 公開
肥田 侯矢, 岡村 亮輔, 坂井 義治, 小西 毅, 赤木 智徳, 山口 智弘, 秋吉 高志, 福田 明輝, 山本 聖一郎, 山本 倫生, 森田 智視, 長谷川 順一, 堀江 久永, 山口 高史, 渡邊 昌彦, 腹腔鏡下大腸切除研究会 肥田 侯矢, 岡村 亮輔, 坂井 義治, 小西 毅, 赤木 智徳, 山口 智弘, 秋吉 高志, 福田 明輝, 山本 聖一郎, 山本 倫生, 森田 智視, 長谷川 順一, 堀江 久永, 山口 高史, 渡邊 昌彦, 腹腔鏡下大腸切除研究会 Stage II/III下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同観察研究結果 Stage II/III下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同観察研究結果 日本癌治療学会学術集会抄録集, 54回, SR-3 日本癌治療学会学術集会抄録集, 54回, SR-3 , 54回, SR-3 2016/10 日本語 公開
肥田 侯矢, 岡村 亮輔, 坂井 義治, 小西 毅, 赤木 智徳, 山口 智弘, 秋吉 高志, 福田 明輝, 山本 聖一郎, 山本 倫生, 森田 智視, 長谷川 順一, 堀江 久永, 山口 高史, 渡邊 昌彦, 腹腔鏡下大腸切除研究会 肥田 侯矢, 岡村 亮輔, 坂井 義治, 小西 毅, 赤木 智徳, 山口 智弘, 秋吉 高志, 福田 明輝, 山本 聖一郎, 山本 倫生, 森田 智視, 長谷川 順一, 堀江 久永, 山口 高史, 渡邊 昌彦, 腹腔鏡下大腸切除研究会 肥田 侯矢, 岡村 亮輔, 坂井 義治, 小西 毅, 赤木 智徳, 山口 智弘, 秋吉 高志, 福田 明輝, 山本 聖一郎, 山本 倫生, 森田 智視, 長谷川 順一, 堀江 久永, 山口 高史, 渡邊 昌彦, 腹腔鏡下大腸切除研究会 Stage II/III下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同観察研究結果 Stage II/III下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同観察研究結果 Stage II/III下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同観察研究結果 日本癌治療学会学術集会抄録集, 54回, SR-3 日本癌治療学会学術集会抄録集, 54回, SR-3 日本癌治療学会学術集会抄録集, 54回, SR-3 2016/10 日本語 公開
Satoshi Matsusaka, Atsushi Nashimoto, Kazuhiro Nishikawa, Akira Miki, Hiroto Miwa, Kazuya Yamaguchi, Takaki Yoshikawa, Atsushi Ochiai, Satoshi Morita, Takeshi Sano, Yasuhiro Kodera, Yoshihiro Kakeji, Junichi Sakamoto, Shigetoyo Saji, Kazuhiro Yoshida Satoshi Matsusaka, Atsushi Nashimoto, Kazuhiro Nishikawa, Akira Miki, Hiroto Miwa, Kazuya Yamaguchi, Takaki Yoshikawa, Atsushi Ochiai, Satoshi Morita, Takeshi Sano, Yasuhiro Kodera, Yoshihiro Kakeji, Junichi Sakamoto, Shigetoyo Saji, Kazuhiro Yoshida Satoshi Matsusaka, Atsushi Nashimoto, Kazuhiro Nishikawa, Akira Miki, Hiroto Miwa, Kazuya Yamaguchi, Takaki Yoshikawa, Atsushi Ochiai, Satoshi Morita, Takeshi Sano, Yasuhiro Kodera, Yoshihiro Kakeji, Junichi Sakamoto, Shigetoyo Saji, Kazuhiro Yoshida Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) (vol 19, pg 839, 2016) Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) (vol 19, pg 839, 2016) Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) (vol 19, pg 839, 2016) GASTRIC CANCER, 19, 3, 1026-1026 GASTRIC CANCER, 19, 3, 1026-1026 GASTRIC CANCER, 19, 3, 1026-1026 2016/07 英語 その他記事 公開
Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Nobuyuki Yamamoto, Kazuhiko Nakagawa Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Nobuyuki Yamamoto, Kazuhiko Nakagawa Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Nobuyuki Yamamoto, Kazuhiko Nakagawa A prospective biomarker study using digital PCR method in EGFR-mutated, advanced lung adenocarcinoma patients treated with afatinib (West Japan Oncology Group 8114LTR) A prospective biomarker study using digital PCR method in EGFR-mutated, advanced lung adenocarcinoma patients treated with afatinib (West Japan Oncology Group 8114LTR) A prospective biomarker study using digital PCR method in EGFR-mutated, advanced lung adenocarcinoma patients treated with afatinib (West Japan Oncology Group 8114LTR) CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 英語 研究発表ペーパー・要旨(国際会議) 公開
Hiroshige Yoshioka, Shunichi Sugawara, Kazushi Yoshida, Shuji Murakami, Young Hak Kim, Shinji Atagi, Fumio Imamura, Koji Takeda, Takashi Seto, Satoshi Morita, Yuichiro Ohe Hiroshige Yoshioka, Shunichi Sugawara, Kazushi Yoshida, Shuji Murakami, Young Hak Kim, Shinji Atagi, Fumio Imamura, Koji Takeda, Takashi Seto, Satoshi Morita, Yuichiro Ohe Hiroshige Yoshioka, Shunichi Sugawara, Kazushi Yoshida, Shuji Murakami, Young Hak Kim, Shinji Atagi, Fumio Imamura, Koji Takeda, Takashi Seto, Satoshi Morita, Yuichiro Ohe Overall survival (OS) of EGFR mutation-positive nonsmall cell lung cancer (NSCLC): 1,660 Japanese patients (pts) Overall survival (OS) of EGFR mutation-positive nonsmall cell lung cancer (NSCLC): 1,660 Japanese patients (pts) Overall survival (OS) of EGFR mutation-positive nonsmall cell lung cancer (NSCLC): 1,660 Japanese patients (pts) ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 ANNALS OF ONCOLOGY, 27 2016/07 英語 研究発表ペーパー・要旨(国際会議) 公開
H. Maeda, M. Sato, M. Kobayashi, N. Takiguchi, T. Yoshikawa, S. Yoshino, K. Yoshida, A. Tsuburaya, J. Sakamoto, S. Morita H. Maeda, M. Sato, M. Kobayashi, N. Takiguchi, T. Yoshikawa, S. Yoshino, K. Yoshida, A. Tsuburaya, J. Sakamoto, S. Morita H. Maeda, M. Sato, M. Kobayashi, N. Takiguchi, T. Yoshikawa, S. Yoshino, K. Yoshida, A. Tsuburaya, J. Sakamoto, S. Morita Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials ANNALS OF ONCOLOGY, 27, 27-27 ANNALS OF ONCOLOGY, 27, 27-27 ANNALS OF ONCOLOGY, 27, 27-27 2016/06 英語 研究発表ペーパー・要旨(国際会議) 公開
西田 純幸, 石川 剛, 江川 新一, 小井戸 薫雄, 森本 創世子, 石井 淳, 菅野 良秀, 柳本 泰明, 大庭 真梨, 古倉 聡, 本間 定, 島田 英昭, 森田 智視, 岡 芳弘, 杉山 治夫 西田 純幸, 石川 剛, 江川 新一, 小井戸 薫雄, 森本 創世子, 石井 淳, 菅野 良秀, 柳本 泰明, 大庭 真梨, 古倉 聡, 本間 定, 島田 英昭, 森田 智視, 岡 芳弘, 杉山 治夫 西田 純幸, 石川 剛, 江川 新一, 小井戸 薫雄, 森本 創世子, 石井 淳, 菅野 良秀, 柳本 泰明, 大庭 真梨, 古倉 聡, 本間 定, 島田 英昭, 森田 智視, 岡 芳弘, 杉山 治夫 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験 臨床効果と抗原特異的免疫反応の評価 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験 臨床効果と抗原特異的免疫反応の評価 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験 臨床効果と抗原特異的免疫反応の評価 日本がん免疫学会総会プログラム・抄録集, 20回, 164-164 日本がん免疫学会総会プログラム・抄録集, 20回, 164-164 日本がん免疫学会総会プログラム・抄録集, 20回, 164-164 2016/06 日本語 公開
西田 純幸, 石川 剛, 江川 新一, 小井戸 薫雄, 森本 創世子, 石井 淳, 菅野 良秀, 柳本 泰明, 大庭 真梨, 古倉 聡, 本間 定, 島田 英昭, 森田 智視, 岡 芳弘, 杉山 治夫 西田 純幸, 石川 剛, 江川 新一, 小井戸 薫雄, 森本 創世子, 石井 淳, 菅野 良秀, 柳本 泰明, 大庭 真梨, 古倉 聡, 本間 定, 島田 英昭, 森田 智視, 岡 芳弘, 杉山 治夫 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験 臨床効果と抗原特異的免疫反応の評価 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験 臨床効果と抗原特異的免疫反応の評価 日本がん免疫学会総会プログラム・抄録集, 20回, 164-164 日本がん免疫学会総会プログラム・抄録集, 20回, 164-164 , 20回, 164-164 2016/06 日本語 公開
Takuya Miura, Eiji Sunami, Tetsuya Kusumoto, Mitsuyoshi Ota, Kazuhiro Yoshida, Naohiro Tomita, Atsuyuki Maeda, Izumi Mochizuki, Michio Okabe, Katsuyuki Kunieda, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Kenichi Sugihara Takuya Miura, Eiji Sunami, Tetsuya Kusumoto, Mitsuyoshi Ota, Kazuhiro Yoshida, Naohiro Tomita, Atsuyuki Maeda, Izumi Mochizuki, Michio Okabe, Katsuyuki Kunieda, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Kenichi Sugihara Takuya Miura, Eiji Sunami, Tetsuya Kusumoto, Mitsuyoshi Ota, Kazuhiro Yoshida, Naohiro Tomita, Atsuyuki Maeda, Izumi Mochizuki, Michio Okabe, Katsuyuki Kunieda, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Kenichi Sugihara Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-lioxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-lioxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-lioxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Shunichiro Iwasawa, Ryo Ko, Takehito Shukuya, Satoshi Watanabe, Yoko Tsukita, Hironori Ashinuma, Taku Nakagawa, Ryo Ito, Kazutsugu Uematsu, Mika Nakao, Yoshiaki Mori, Kyoichi Kaira, Atsuto Moun, Takao Miyabayashi, Hiroyuki Sakashita, Yoko Matsumoto, Tomoyuki Tanigawa, Satoshi Morita, Kazuhisa Takahashi Shunichiro Iwasawa, Ryo Ko, Takehito Shukuya, Satoshi Watanabe, Yoko Tsukita, Hironori Ashinuma, Taku Nakagawa, Ryo Ito, Kazutsugu Uematsu, Mika Nakao, Yoshiaki Mori, Kyoichi Kaira, Atsuto Moun, Takao Miyabayashi, Hiroyuki Sakashita, Yoko Matsumoto, Tomoyuki Tanigawa, Satoshi Morita, Kazuhisa Takahashi Shunichiro Iwasawa, Ryo Ko, Takehito Shukuya, Satoshi Watanabe, Yoko Tsukita, Hironori Ashinuma, Taku Nakagawa, Ryo Ito, Kazutsugu Uematsu, Mika Nakao, Yoshiaki Mori, Kyoichi Kaira, Atsuto Moun, Takao Miyabayashi, Hiroyuki Sakashita, Yoko Matsumoto, Tomoyuki Tanigawa, Satoshi Morita, Kazuhisa Takahashi Second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma: A retrospective analysis of 192 patients from NEJ023 Study. Second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma: A retrospective analysis of 192 patients from NEJ023 Study. Second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma: A retrospective analysis of 192 patients from NEJ023 Study. JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Masahiro Kashiwaba, Naruto Taira, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Masahiro Kashiwaba, Naruto Taira, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Masahiro Kashiwaba, Naruto Taira, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy. PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy. PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy. JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Koya Hida, Ryosuke Okamura, Yoshiharu Sakai, Tsuyoshi Konishi, Tomonori Akagi, Tomohiro Yamaguchi, Takashi Akiyoshi, Meiki Fukuda, Seiichiro Yamamoto, Michio Yamamoto, Tatsuto Nishigori, Kenji Kawada, Suguru Hasegawa, Satoshi Morita, Masahiko Watanabe Koya Hida, Ryosuke Okamura, Yoshiharu Sakai, Tsuyoshi Konishi, Tomonori Akagi, Tomohiro Yamaguchi, Takashi Akiyoshi, Meiki Fukuda, Seiichiro Yamamoto, Michio Yamamoto, Tatsuto Nishigori, Kenji Kawada, Suguru Hasegawa, Satoshi Morita, Masahiko Watanabe Koya Hida, Ryosuke Okamura, Yoshiharu Sakai, Tsuyoshi Konishi, Tomonori Akagi, Tomohiro Yamaguchi, Takashi Akiyoshi, Meiki Fukuda, Seiichiro Yamamoto, Michio Yamamoto, Tatsuto Nishigori, Kenji Kawada, Suguru Hasegawa, Satoshi Morita, Masahiko Watanabe Open versus laparoscopic surgery for low rectal cancer: a large multicenter cohort study in Japan Open versus laparoscopic surgery for low rectal cancer: a large multicenter cohort study in Japan Open versus laparoscopic surgery for low rectal cancer: a large multicenter cohort study in Japan JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Katsunori Shinozaki, Kanehisa Fukumoto, Toshio Otsuji, Takeshi Kambara, Satoshi Morita, Yuichi Ando, Miyuki Arai, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Katsunori Shinozaki, Kanehisa Fukumoto, Toshio Otsuji, Takeshi Kambara, Satoshi Morita, Yuichi Ando, Miyuki Arai, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Katsunori Shinozaki, Kanehisa Fukumoto, Toshio Otsuji, Takeshi Kambara, Satoshi Morita, Yuichi Ando, Miyuki Arai, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Impact of UGT1A1 genotype on overall survival in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens. Impact of UGT1A1 genotype on overall survival in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens. Impact of UGT1A1 genotype on overall survival in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens. JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Yoshida Kazushi, Akira Inoue, Shunichi Sugawara, Shuji Murakami, Hideo Saka, Satoshi Morita, Young Hak Kim, Fumio Imamura, Koji Takeda, Kazuhiko Nakagawa, Masayuki Takeda, Shinji Atagi, Yoshikazu Hasegawa, Nobuyuki Yamamoto, Nobuyuki Katakami, Hiroshige Yoshioka, Yasuo Iwamoto, Isamu Okamoto, Takashi Seto, Yuichiro Ohe Yoshida Kazushi, Akira Inoue, Shunichi Sugawara, Shuji Murakami, Hideo Saka, Satoshi Morita, Young Hak Kim, Fumio Imamura, Koji Takeda, Kazuhiko Nakagawa, Masayuki Takeda, Shinji Atagi, Yoshikazu Hasegawa, Nobuyuki Yamamoto, Nobuyuki Katakami, Hiroshige Yoshioka, Yasuo Iwamoto, Isamu Okamoto, Takashi Seto, Yuichiro Ohe Yoshida Kazushi, Akira Inoue, Shunichi Sugawara, Shuji Murakami, Hideo Saka, Satoshi Morita, Young Hak Kim, Fumio Imamura, Koji Takeda, Kazuhiko Nakagawa, Masayuki Takeda, Shinji Atagi, Yoshikazu Hasegawa, Nobuyuki Yamamoto, Nobuyuki Katakami, Hiroshige Yoshioka, Yasuo Iwamoto, Isamu Okamoto, Takashi Seto, Yuichiro Ohe Overall survival (OS) of EGFR mutation-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns of 1,660 Japanese patients (pts). Overall survival (OS) of EGFR mutation-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns of 1,660 Japanese patients (pts). Overall survival (OS) of EGFR mutation-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns of 1,660 Japanese patients (pts). JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Naoto Kondo, Yoshinori Ito, Ippei Fukada, Shoichiro Ohtani, Masaya Hattori, Eriko Tokunaga, Nobuki Matsunami, Kohjiro Mashino, Taijiro Kosaka, Masahiko Tanabe, Daisuke Yotsumoto, Kosho Yamanouchi, Masataka Sawaki, Masahiro Kashiwaba, Hidetaka Kawabata, Katsumasa Kuroi, Satoshi Morita, Shinji Ohno, Masakazu Toi, Norikazu Masuda Naoto Kondo, Yoshinori Ito, Ippei Fukada, Shoichiro Ohtani, Masaya Hattori, Eriko Tokunaga, Nobuki Matsunami, Kohjiro Mashino, Taijiro Kosaka, Masahiko Tanabe, Daisuke Yotsumoto, Kosho Yamanouchi, Masataka Sawaki, Masahiro Kashiwaba, Hidetaka Kawabata, Katsumasa Kuroi, Satoshi Morita, Shinji Ohno, Masakazu Toi, Norikazu Masuda Naoto Kondo, Yoshinori Ito, Ippei Fukada, Shoichiro Ohtani, Masaya Hattori, Eriko Tokunaga, Nobuki Matsunami, Kohjiro Mashino, Taijiro Kosaka, Masahiko Tanabe, Daisuke Yotsumoto, Kosho Yamanouchi, Masataka Sawaki, Masahiro Kashiwaba, Hidetaka Kawabata, Katsumasa Kuroi, Satoshi Morita, Shinji Ohno, Masakazu Toi, Norikazu Masuda Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17). Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17). Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17). JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Shigeru Imoto, Takayuki Ueno, Hirotsugu Isaka, Hiroki Ito, Kaisuke Miyamoto, Satoshi Morita Shigeru Imoto, Takayuki Ueno, Hirotsugu Isaka, Hiroki Ito, Kaisuke Miyamoto, Satoshi Morita Shigeru Imoto, Takayuki Ueno, Hirotsugu Isaka, Hiroki Ito, Kaisuke Miyamoto, Satoshi Morita Phase II study on radiofrequency ablation in early breast cancer Phase II study on radiofrequency ablation in early breast cancer Phase II study on radiofrequency ablation in early breast cancer JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Sumiyuki Nishida, Takeshi Ishikawa, Satoshi Kokura, Shinichi Egawa, Shigeo Koido, Hiroaki Yasuda, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Mari Saito Oba, Maho Sato, Soyoko Morimoto, Hidetoshi Eguchi, Hiroaki Nagano, Sadamu Homma, Yoshihiro Oka, Satoshi Morita, Haruo Sugiyama Sumiyuki Nishida, Takeshi Ishikawa, Satoshi Kokura, Shinichi Egawa, Shigeo Koido, Hiroaki Yasuda, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Mari Saito Oba, Maho Sato, Soyoko Morimoto, Hidetoshi Eguchi, Hiroaki Nagano, Sadamu Homma, Yoshihiro Oka, Satoshi Morita, Haruo Sugiyama Sumiyuki Nishida, Takeshi Ishikawa, Satoshi Kokura, Shinichi Egawa, Shigeo Koido, Hiroaki Yasuda, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Mari Saito Oba, Maho Sato, Soyoko Morimoto, Hidetoshi Eguchi, Hiroaki Nagano, Sadamu Homma, Yoshihiro Oka, Satoshi Morita, Haruo Sugiyama Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 英語 研究発表ペーパー・要旨(国際会議) 公開
N. Kondo, Y. Yamamoto, H. Yamashiro, M. Kashiwaba, R. Nakamura, M. Takahashi, U. Toh, K. Tsugawa, K. Narui, K. Tamaki, T. Yoshinami, S. Ohtani, Y. Kai, T. Takano, Y. Yanagita, S. Morita, M. Toi, S. Ohno N. Kondo, Y. Yamamoto, H. Yamashiro, M. Kashiwaba, R. Nakamura, M. Takahashi, U. Toh, K. Tsugawa, K. Narui, K. Tamaki, T. Yoshinami, S. Ohtani, Y. Kai, T. Takano, Y. Yanagita, S. Morita, M. Toi, S. Ohno N. Kondo, Y. Yamamoto, H. Yamashiro, M. Kashiwaba, R. Nakamura, M. Takahashi, U. Toh, K. Tsugawa, K. Narui, K. Tamaki, T. Yoshinami, S. Ohtani, Y. Kai, T. Takano, Y. Yanagita, S. Morita, M. Toi, S. Ohno Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE) Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE) Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE) EUROPEAN JOURNAL OF CANCER, 57, S92-S92 EUROPEAN JOURNAL OF CANCER, 57, S92-S92 EUROPEAN JOURNAL OF CANCER, 57, S92-S92 2016/04 英語 研究発表ペーパー・要旨(国際会議) 公開
Kei Muro, Tae Won Kim, Young Suk Park, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Keun-Wook Lee, Yanhong Deng, Marc E. Buyse, Taroh Satoh, Baek-Yeol Ryoo, Lin Shen, Satoru Iwasa, Satoshi Morita, Junichi Sakamoto, Rui-hua Xu Kei Muro, Tae Won Kim, Young Suk Park, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Keun-Wook Lee, Yanhong Deng, Marc E. Buyse, Taroh Satoh, Baek-Yeol Ryoo, Lin Shen, Satoru Iwasa, Satoshi Morita, Junichi Sakamoto, Rui-hua Xu Kei Muro, Tae Won Kim, Young Suk Park, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Keun-Wook Lee, Yanhong Deng, Marc E. Buyse, Taroh Satoh, Baek-Yeol Ryoo, Lin Shen, Satoru Iwasa, Satoshi Morita, Junichi Sakamoto, Rui-hua Xu A multinational, randomized, phase III trial of XELIRI ( plus bevacizumab) versus FOLFIRI ( plus bevacizumab) as the second-line chemotherapy for metastatic colorectal cancer: Asian XELIRI project (AXEPT). A multinational, randomized, phase III trial of XELIRI ( plus bevacizumab) versus FOLFIRI ( plus bevacizumab) as the second-line chemotherapy for metastatic colorectal cancer: Asian XELIRI project (AXEPT). A multinational, randomized, phase III trial of XELIRI ( plus bevacizumab) versus FOLFIRI ( plus bevacizumab) as the second-line chemotherapy for metastatic colorectal cancer: Asian XELIRI project (AXEPT). JOURNAL OF CLINICAL ONCOLOGY, 34, 4 JOURNAL OF CLINICAL ONCOLOGY, 34, 4 JOURNAL OF CLINICAL ONCOLOGY, 34, 4 2016/02 英語 研究発表ペーパー・要旨(国際会議) 公開
A. Tsuburaya, K. Nishikawa, M. Kobayashi, J. Kawada, T. Namikawa, R. Fukushima, H. Kojima, K. Tanabe, K. Yamaguchi, S. Yoshino, M. Takahashi, N. Hirabayashi, S. Sato, H. Nemoto, Y. Rino, T. Yoshikawa, J. Nakajima, P. Tan, S. Morita, J. Sakamoto A. Tsuburaya, K. Nishikawa, M. Kobayashi, J. Kawada, T. Namikawa, R. Fukushima, H. Kojima, K. Tanabe, K. Yamaguchi, S. Yoshino, M. Takahashi, N. Hirabayashi, S. Sato, H. Nemoto, Y. Rino, T. Yoshikawa, J. Nakajima, P. Tan, S. Morita, J. Sakamoto A. Tsuburaya, K. Nishikawa, M. Kobayashi, J. Kawada, T. Namikawa, R. Fukushima, H. Kojima, K. Tanabe, K. Yamaguchi, S. Yoshino, M. Takahashi, N. Hirabayashi, S. Sato, H. Nemoto, Y. Rino, T. Yoshikawa, J. Nakajima, P. Tan, S. Morita, J. Sakamoto Molecular biomarker study in randomized phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: XParTS IIb Molecular biomarker study in randomized phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: XParTS IIb Molecular biomarker study in randomized phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: XParTS IIb ANNALS OF ONCOLOGY, 26, 59-60 ANNALS OF ONCOLOGY, 26, 59-60 ANNALS OF ONCOLOGY, 26, 59-60 2015/12 英語 研究発表ペーパー・要旨(国際会議) 公開
Masatsugu Hamaji, Fengshi Chen, Atsushi Kawaguchi, Satoshi Morita, Hiroshi Date Masatsugu Hamaji, Fengshi Chen, Atsushi Kawaguchi, Satoshi Morita, Hiroshi Date Masatsugu Hamaji, Fengshi Chen, Atsushi Kawaguchi, Satoshi Morita, Hiroshi Date Reply Reply Reply Annals of Thoracic Surgery, 100, 5, 1968-1969 Annals of Thoracic Surgery, 100, 5, 1968-1969 Annals of Thoracic Surgery, 100, 5, 1968-1969 2015/11/01 英語 速報、短報、研究ノート等(学術雑誌) 公開
Masatsugu Hamaji, Fengshi Chen, Atsushi Kawaguchi, Satoshi Morita, Hiroshi Date Masatsugu Hamaji, Fengshi Chen, Atsushi Kawaguchi, Satoshi Morita, Hiroshi Date Masatsugu Hamaji, Fengshi Chen, Atsushi Kawaguchi, Satoshi Morita, Hiroshi Date Surgery Versus Radiation Therapy in Stage I Lung Cancer Reply Surgery Versus Radiation Therapy in Stage I Lung Cancer Reply Surgery Versus Radiation Therapy in Stage I Lung Cancer Reply ANNALS OF THORACIC SURGERY, 100, 5, 1968-1969 ANNALS OF THORACIC SURGERY, 100, 5, 1968-1969 ANNALS OF THORACIC SURGERY, 100, 5, 1968-1969 2015/11 英語 速報、短報、研究ノート等(学術雑誌) 公開
Akito Hata, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Jumpei Takeshita, Satoshi Morita, Daichi Fujimoto, Kazuma Nagata, Kojiro Otsuka, Keisuke Tomii Akito Hata, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Jumpei Takeshita, Satoshi Morita, Daichi Fujimoto, Kazuma Nagata, Kojiro Otsuka, Keisuke Tomii Akito Hata, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Jumpei Takeshita, Satoshi Morita, Daichi Fujimoto, Kazuma Nagata, Kojiro Otsuka, Keisuke Tomii Garenoxacin (GRNX) for secondary prophylaxis against febrile neutropenia (FN) in chemotherapies for advanced lung cancer Garenoxacin (GRNX) for secondary prophylaxis against febrile neutropenia (FN) in chemotherapies for advanced lung cancer Garenoxacin (GRNX) for secondary prophylaxis against febrile neutropenia (FN) in chemotherapies for advanced lung cancer ANNALS OF ONCOLOGY, 26, 93-93 ANNALS OF ONCOLOGY, 26, 93-93 ANNALS OF ONCOLOGY, 26, 93-93 2015/11 英語 研究発表ペーパー・要旨(国際会議) 公開
Toshio Shimizu, Hiroshi Nokihara, Haruyasu Murakami, Takashi Seto, Makoto Nishio, Koji Takeda, Akira Inoue, Katsuyuki Kiura, Koichi Azuma, Anne Keating, Andrew Krivoshik, Koichi Uegaki, Kentaro Takeda, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Toshio Shimizu, Hiroshi Nokihara, Haruyasu Murakami, Takashi Seto, Makoto Nishio, Koji Takeda, Akira Inoue, Katsuyuki Kiura, Koichi Azuma, Anne Keating, Andrew Krivoshik, Koichi Uegaki, Kentaro Takeda, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Toshio Shimizu, Hiroshi Nokihara, Haruyasu Murakami, Takashi Seto, Makoto Nishio, Koji Takeda, Akira Inoue, Katsuyuki Kiura, Koichi Azuma, Anne Keating, Andrew Krivoshik, Koichi Uegaki, Kentaro Takeda, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Phase I/II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations Phase I/II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations Phase I/II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations ANNALS OF ONCOLOGY, 26, 82-82 ANNALS OF ONCOLOGY, 26, 82-82 ANNALS OF ONCOLOGY, 26, 82-82 2015/11 英語 研究発表ペーパー・要旨(国際会議) 公開
N. Takiguchi, Y. Kodera, N. Takahashi, T. Yoshikawa, K. Fujitani, S. Ito, K. Miyamoto, O. Takayama, M. Imano, D. Kobayashi, Y. Miyashita, S. Morita, J. Sakamoto N. Takiguchi, Y. Kodera, N. Takahashi, T. Yoshikawa, K. Fujitani, S. Ito, K. Miyamoto, O. Takayama, M. Imano, D. Kobayashi, Y. Miyashita, S. Morita, J. Sakamoto N. Takiguchi, Y. Kodera, N. Takahashi, T. Yoshikawa, K. Fujitani, S. Ito, K. Miyamoto, O. Takayama, M. Imano, D. Kobayashi, Y. Miyashita, S. Morita, J. Sakamoto Feasibility of weekly intraperitoneal versus intravenous paclitaxel delivered from the day of radical surgery for gastric cancer: A preliminary safety analysis of INPACT study, a randomized controlled trial Feasibility of weekly intraperitoneal versus intravenous paclitaxel delivered from the day of radical surgery for gastric cancer: A preliminary safety analysis of INPACT study, a randomized controlled trial Feasibility of weekly intraperitoneal versus intravenous paclitaxel delivered from the day of radical surgery for gastric cancer: A preliminary safety analysis of INPACT study, a randomized controlled trial EUROPEAN JOURNAL OF CANCER, 51, S408-S408 EUROPEAN JOURNAL OF CANCER, 51, S408-S408 EUROPEAN JOURNAL OF CANCER, 51, S408-S408 2015/09 英語 研究発表ペーパー・要旨(国際会議) 公開
Motoko Tachihara, Kazumi Nishino, Daisuke Tamura, Toru Kumagai, Fumio Imamura, Chiyuki Okuda, Akito Hata, Nobuyuki Katakami, Yoshiko Urata, Yoshihiro Hattori, Miyako Satouchi, Tsutomu Yoneda, Soichiro Yokota, Takashi Nishimura, Toshihiko Kaneda, Yoshihiro Nishimura, Satoshi Morita, Shunichi Negoro Motoko Tachihara, Kazumi Nishino, Daisuke Tamura, Toru Kumagai, Fumio Imamura, Chiyuki Okuda, Akito Hata, Nobuyuki Katakami, Yoshiko Urata, Yoshihiro Hattori, Miyako Satouchi, Tsutomu Yoneda, Soichiro Yokota, Takashi Nishimura, Toshihiko Kaneda, Yoshihiro Nishimura, Satoshi Morita, Shunichi Negoro Motoko Tachihara, Kazumi Nishino, Daisuke Tamura, Toru Kumagai, Fumio Imamura, Chiyuki Okuda, Akito Hata, Nobuyuki Katakami, Yoshiko Urata, Yoshihiro Hattori, Miyako Satouchi, Tsutomu Yoneda, Soichiro Yokota, Takashi Nishimura, Toshihiko Kaneda, Yoshihiro Nishimura, Satoshi Morita, Shunichi Negoro Bevacizumab with Docetaxel or S-1 in Non-Squamous NSCLC (HANSHIN 0110) Bevacizumab with Docetaxel or S-1 in Non-Squamous NSCLC (HANSHIN 0110) Bevacizumab with Docetaxel or S-1 in Non-Squamous NSCLC (HANSHIN 0110) JOURNAL OF THORACIC ONCOLOGY, 10, 9, S547-S547 JOURNAL OF THORACIC ONCOLOGY, 10, 9, S547-S547 JOURNAL OF THORACIC ONCOLOGY, 10, 9, S547-S547 2015/09 英語 研究発表ペーパー・要旨(国際会議) 公開
肥田 侯矢, 岡村 亮輔, 林 佑里子, 森田 智視, 小西 毅, 秋吉 高志, 山口 智弘, 福田 明輝, 山本 聖一郎, 坂井 義治, 渡邊 昌彦 肥田 侯矢, 岡村 亮輔, 林 佑里子, 森田 智視, 小西 毅, 秋吉 高志, 山口 智弘, 福田 明輝, 山本 聖一郎, 坂井 義治, 渡邊 昌彦 肥田 侯矢, 岡村 亮輔, 林 佑里子, 森田 智視, 小西 毅, 秋吉 高志, 山口 智弘, 福田 明輝, 山本 聖一郎, 坂井 義治, 渡邊 昌彦 下部進行直腸癌に対する腹腔鏡下手術の意義 下部進行直腸癌に対する腹腔鏡下手術の意義 下部進行直腸癌に対する腹腔鏡下手術の意義 日本癌治療学会誌, 50, 3, 2052-2052 日本癌治療学会誌, 50, 3, 2052-2052 日本癌治療学会誌, 50, 3, 2052-2052 2015/09 日本語 公開
金井 雅史, 佐久間 朋寛, 柳澤 宏次, 松島 健太郎, 小柳 智義, 松本 繁巳, 黒田 知宏, 森田 智視, 小杉 眞司, 奥野 恭史, 武藤 学 金井 雅史, 佐久間 朋寛, 柳澤 宏次, 松島 健太郎, 小柳 智義, 松本 繁巳, 黒田 知宏, 森田 智視, 小杉 眞司, 奥野 恭史, 武藤 学 基礎研究 基礎研究の臨床応用 わが国初の網羅的遺伝子変異パネルを用いたクリニカルシーケンスの臨床導入 基礎研究 基礎研究の臨床応用 わが国初の網羅的遺伝子変異パネルを用いたクリニカルシーケンスの臨床導入 日本癌治療学会誌, 50, 3, 392-392 日本癌治療学会誌, 50, 3, 392-392 , 50, 3, 392-392 2015/09 日本語 公開
武藤 学, 金井 雅史, 森 由希子, 松本 繁巳, 佐久間 朋寛, 小柳 智義, 岡本 和也, 加藤 源太, 黒田 知宏, 森田 智視, 小杉 眞司, 多門 啓子, 種石 慶, 奥野 恭史, 高折 晃史 武藤 学, 金井 雅史, 森 由希子, 松本 繁巳, 佐久間 朋寛, 小柳 智義, 岡本 和也, 加藤 源太, 黒田 知宏, 森田 智視, 小杉 眞司, 多門 啓子, 種石 慶, 奥野 恭史, 高折 晃史 京大病院におけるバイオバンク、クリニカルシークエンス、ビッグデータ解析の取組 京大病院におけるバイオバンク、クリニカルシークエンス、ビッグデータ解析の取組 日本癌治療学会誌, 50, 3, 865-865 日本癌治療学会誌, 50, 3, 865-865 , 50, 3, 865-865 2015/09 日本語 公開
Toru Hifumi, Ippei Jinbo, Ichiro Okada, Nobuaki Kiriu, Hiroshi Kato, Yuichi Koido, Junichi Inoue, Kenya Kawakita, Satoshi Morita, Yasuhiro Kuroda Toru Hifumi, Ippei Jinbo, Ichiro Okada, Nobuaki Kiriu, Hiroshi Kato, Yuichi Koido, Junichi Inoue, Kenya Kawakita, Satoshi Morita, Yasuhiro Kuroda Toru Hifumi, Ippei Jinbo, Ichiro Okada, Nobuaki Kiriu, Hiroshi Kato, Yuichi Koido, Junichi Inoue, Kenya Kawakita, Satoshi Morita, Yasuhiro Kuroda The authors respond The authors respond The authors respond American Journal of Emergency Medicine, 33, 8, 1107 American Journal of Emergency Medicine, 33, 8, 1107 American Journal of Emergency Medicine, 33, 8, 1107 2015/08/01 英語 速報、短報、研究ノート等(学術雑誌) 公開
山本 尚人, 増田 慎三, 近藤 直人, 坂東 裕子, 黒井 克昌, 大野 真司, 宮本 健志, 檜垣 健二, 高野 利実, 井上 賢一, 中村 力也, 清水 哲, 石黒 洋, 青儀 健二郎, 天野 定雄, 山城 大泰, 笠井 宏委, 森田 智視, 桜井 孝規, 戸井 雅和 山本 尚人, 増田 慎三, 近藤 直人, 坂東 裕子, 黒井 克昌, 大野 真司, 宮本 健志, 檜垣 健二, 高野 利実, 井上 賢一, 中村 力也, 清水 哲, 石黒 洋, 青儀 健二郎, 天野 定雄, 山城 大泰, 笠井 宏委, 森田 智視, 桜井 孝規, 戸井 雅和 pCRの意義を問う HER2陽性乳癌における術前Dual-HER2 blockage療法±ホルモン療法の検討(Neo-LaTH、JBCRG-16試験) pCRの意義を問う HER2陽性乳癌における術前Dual-HER2 blockage療法±ホルモン療法の検討(Neo-LaTH、JBCRG-16試験) 日本乳癌学会総会プログラム抄録集23回 シンポジウムSY-2-11-04, 49 日本乳癌学会総会プログラム抄録集23回 シンポジウムSY-2-11-04, 49 , 49 2015/07 公開
Tomoya Yokota, Tetsuhito Konishi, Hiroyuki Tachibana, Takashi Yurikusa, Satoshi Hamauchi, Kensuke Sakai, Masaya Nishikawa, Maho Sato, Masataka Taguri, Satoshi Morita, Toru Eguchi, Kaoru Kubota, Sadamoto Zenda Tomoya Yokota, Tetsuhito Konishi, Hiroyuki Tachibana, Takashi Yurikusa, Satoshi Hamauchi, Kensuke Sakai, Masaya Nishikawa, Maho Sato, Masataka Taguri, Satoshi Morita, Toru Eguchi, Kaoru Kubota, Sadamoto Zenda Tomoya Yokota, Tetsuhito Konishi, Hiroyuki Tachibana, Takashi Yurikusa, Satoshi Hamauchi, Kensuke Sakai, Masaya Nishikawa, Maho Sato, Masataka Taguri, Satoshi Morita, Toru Eguchi, Kaoru Kubota, Sadamoto Zenda Multicenter phase II study of oral care program for head and neck cancer patients treated with chemoradiotherapy. Multicenter phase II study of oral care program for head and neck cancer patients treated with chemoradiotherapy. Multicenter phase II study of oral care program for head and neck cancer patients treated with chemoradiotherapy. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Tetsuhiro Yoshinami, Norikazu Masuda, Takahiro Nakayama, Fumikata Hara, Yasuaki Sagara, Hidetoshi Kawaguchi, Ken-ichi Watanabe, Masako Sato, Kenjiro Aogi, Kenji Higaki, Takashi Morimoto, Yasushi Shigeoka, Shinya Tokunaga, Hirotaka Morishima, Yasuhiro Yanagita, Junji Tsurutani, Shinichi Baba, Kazuhisa Katayama, Satoshi Morita, Shoichiro Ohtani Tetsuhiro Yoshinami, Norikazu Masuda, Takahiro Nakayama, Fumikata Hara, Yasuaki Sagara, Hidetoshi Kawaguchi, Ken-ichi Watanabe, Masako Sato, Kenjiro Aogi, Kenji Higaki, Takashi Morimoto, Yasushi Shigeoka, Shinya Tokunaga, Hirotaka Morishima, Yasuhiro Yanagita, Junji Tsurutani, Shinichi Baba, Kazuhisa Katayama, Satoshi Morita, Shoichiro Ohtani Tetsuhiro Yoshinami, Norikazu Masuda, Takahiro Nakayama, Fumikata Hara, Yasuaki Sagara, Hidetoshi Kawaguchi, Ken-ichi Watanabe, Masako Sato, Kenjiro Aogi, Kenji Higaki, Takashi Morimoto, Yasushi Shigeoka, Shinya Tokunaga, Hirotaka Morishima, Yasuhiro Yanagita, Junji Tsurutani, Shinichi Baba, Kazuhisa Katayama, Satoshi Morita, Shoichiro Ohtani The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY) The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY) The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY) JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Takaki Yoshikawa, Kazuaki Tanabe, Yuichi Ito, Kazuhiro Nishikawa, Kazumasa Fujitani, Takanori Matsui, Tsutomu Hayashi, Toru Aoyama, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Yuichi Ito, Kazuhiro Nishikawa, Kazumasa Fujitani, Takanori Matsui, Tsutomu Hayashi, Toru Aoyama, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Yuichi Ito, Kazuhiro Nishikawa, Kazumasa Fujitani, Takanori Matsui, Tsutomu Hayashi, Toru Aoyama, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Subset analysis of COMPASS: A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally advanced gastric cancer. Subset analysis of COMPASS: A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally advanced gastric cancer. Subset analysis of COMPASS: A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally advanced gastric cancer. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Katsunori Shinozaki, Kanehisa Fukumoto, Toshio Otsuji, Takeshi Kambara, Satoshi Morita, Yuichi Ando, Yukihiro Okutani, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Katsunori Shinozaki, Kanehisa Fukumoto, Toshio Otsuji, Takeshi Kambara, Satoshi Morita, Yuichi Ando, Yukihiro Okutani, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Wataru Ichikawa, Keisuke Uehara, Keisuke Minamimura, Chihiro Tanaka, Yasumasa Takii, Hideaki Miyauchi, Sotaro Sadahiro, Katsunori Shinozaki, Kanehisa Fukumoto, Toshio Otsuji, Takeshi Kambara, Satoshi Morita, Yuichi Ando, Yukihiro Okutani, Masahiro Sugihara, Toru Sugiyama, Yasuo Ohashi, Yuh Sakata Impact of UGT1A1 genotype on prognosis in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens. Impact of UGT1A1 genotype on prognosis in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens. Impact of UGT1A1 genotype on prognosis in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Yasushi Goto, Hiroshi Nokihara, Haruyasu Murakami, Toshio Shimizu, Takashi Seto, Andrew P. Krivoshik, Anne Therese Keating, Koichi Uegaki, Kentaro Takeda, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Yasushi Goto, Hiroshi Nokihara, Haruyasu Murakami, Toshio Shimizu, Takashi Seto, Andrew P. Krivoshik, Anne Therese Keating, Koichi Uegaki, Kentaro Takeda, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa Yasushi Goto, Hiroshi Nokihara, Haruyasu Murakami, Toshio Shimizu, Takashi Seto, Andrew P. Krivoshik, Anne Therese Keating, Koichi Uegaki, Kentaro Takeda, Kanji Komatsu, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa ASP8273, a mutant-selective irreversible EGFR inhibitor in patients (pts) with NSCLC harboring EGFR activating mutations: Preliminary results of first-in-human phase I study in Japan. ASP8273, a mutant-selective irreversible EGFR inhibitor in patients (pts) with NSCLC harboring EGFR activating mutations: Preliminary results of first-in-human phase I study in Japan. ASP8273, a mutant-selective irreversible EGFR inhibitor in patients (pts) with NSCLC harboring EGFR activating mutations: Preliminary results of first-in-human phase I study in Japan. JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 JOURNAL OF CLINICAL ONCOLOGY, 33, 15 2015/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Koji Izumi, Mastaka Taguri, Hiroshi Miyamoto, Yusuke Ito, Yasuhide Miyoshi, Masatoshi Moriyama, Tetsuo Murai, Hiroyuki Hayashi, Yoshiaki Inayama, Yoji Nagashima, Satoshi Morita, Hiroji Uemura Koji Izumi, Mastaka Taguri, Hiroshi Miyamoto, Yusuke Ito, Yasuhide Miyoshi, Masatoshi Moriyama, Tetsuo Murai, Hiroyuki Hayashi, Yoshiaki Inayama, Yoji Nagashima, Satoshi Morita, Hiroji Uemura Koji Izumi, Mastaka Taguri, Hiroshi Miyamoto, Yusuke Ito, Yasuhide Miyoshi, Masatoshi Moriyama, Tetsuo Murai, Hiroyuki Hayashi, Yoshiaki Inayama, Yoji Nagashima, Satoshi Morita, Hiroji Uemura ANDROGEN DEPRIVATION THERAPY PREVENTS RECURRENCE OF BLADDER CANCER ANDROGEN DEPRIVATION THERAPY PREVENTS RECURRENCE OF BLADDER CANCER ANDROGEN DEPRIVATION THERAPY PREVENTS RECURRENCE OF BLADDER CANCER JOURNAL OF UROLOGY, 193, 4, E536-E536 JOURNAL OF UROLOGY, 193, 4, E536-E536 JOURNAL OF UROLOGY, 193, 4, E536-E536 2015/04 英語 研究発表ペーパー・要旨(国際会議) 公開
Hiroji Uemura, Koji Izumi, Masataka Taguri, Hiroshi Miyamoto, Satoshi Morita, Yasuhide Miyoshi, Yoshinori Hara, Takeshi Kishida, Kimio Chiba, Tetsuo Murai, Kotaro Hirai, Kotaro Suzuki, Kiyoshi Fujinami, Teiichiro Ueki, Koichi Udagawa, Kazuo Kitami, Masatoshi Moriyama, Futoshi Tsuchiya, Ichiro Ikeda, Kazuki Kobayashi Hiroji Uemura, Koji Izumi, Masataka Taguri, Hiroshi Miyamoto, Satoshi Morita, Yasuhide Miyoshi, Yoshinori Hara, Takeshi Kishida, Kimio Chiba, Tetsuo Murai, Kotaro Hirai, Kotaro Suzuki, Kiyoshi Fujinami, Teiichiro Ueki, Koichi Udagawa, Kazuo Kitami, Masatoshi Moriyama, Futoshi Tsuchiya, Ichiro Ikeda, Kazuki Kobayashi Hiroji Uemura, Koji Izumi, Masataka Taguri, Hiroshi Miyamoto, Satoshi Morita, Yasuhide Miyoshi, Yoshinori Hara, Takeshi Kishida, Kimio Chiba, Tetsuo Murai, Kotaro Hirai, Kotaro Suzuki, Kiyoshi Fujinami, Teiichiro Ueki, Koichi Udagawa, Kazuo Kitami, Masatoshi Moriyama, Futoshi Tsuchiya, Ichiro Ikeda, Kazuki Kobayashi Androgen deprivation therapy to prevent bladder cancer recurrence. Androgen deprivation therapy to prevent bladder cancer recurrence. Androgen deprivation therapy to prevent bladder cancer recurrence. JOURNAL OF CLINICAL ONCOLOGY, 33, 7 JOURNAL OF CLINICAL ONCOLOGY, 33, 7 JOURNAL OF CLINICAL ONCOLOGY, 33, 7 2015/03 英語 研究発表ペーパー・要旨(国際会議) 公開
H. Iwata, N. Yamamoto, N. Masuda, H. Bando, K. Kuroi, S. Ohno, H. Kasai, S. Morita, T. Sakurai, M. Toi H. Iwata, N. Yamamoto, N. Masuda, H. Bando, K. Kuroi, S. Ohno, H. Kasai, S. Morita, T. Sakurai, M. Toi H. Iwata, N. Yamamoto, N. Masuda, H. Bando, K. Kuroi, S. Ohno, H. Kasai, S. Morita, T. Sakurai, M. Toi Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer BREAST, 24, S95-S95 BREAST, 24, S95-S95 BREAST, 24, S95-S95 2015/03 英語 研究発表ペーパー・要旨(国際会議) 公開
森田智視, 多田春江, 渡邊美恵子, 山本倫生, 上山華栄, 柏木直子, 川口淳, 町田優子, 榎本佳代子 森田智視, 多田春江, 渡邊美恵子, 山本倫生, 上山華栄, 柏木直子, 川口淳, 町田優子, 榎本佳代子 医師主導型の介入および侵襲を伴う臨床研究のデータの質保証体制の構築に向けた京大病院での取り組み 医師主導型の介入および侵襲を伴う臨床研究のデータの質保証体制の構築に向けた京大病院での取り組み 日本臨床試験学会第6回学術集会総会 日本臨床試験学会第6回学術集会総会 2015/02 公開
Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Kazumasa Fujitani, Yuichi Ito, Takanori Matsui, Tsutomu Hayashi, Toru Aoyama, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Kazumasa Fujitani, Yuichi Ito, Takanori Matsui, Tsutomu Hayashi, Toru Aoyama, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, Kazumasa Fujitani, Yuichi Ito, Takanori Matsui, Tsutomu Hayashi, Toru Aoyama, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally resectable advanced gastric cancer: Survival results of COMPASS. A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally resectable advanced gastric cancer: Survival results of COMPASS. A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally resectable advanced gastric cancer: Survival results of COMPASS. JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 2015/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Michiya Kobayashi, Akira Tsuburaya, Kazuhiro Nishikawa, Junji Kawada, Tsutomu Namikawa, Ryoji Fukushima, Hiroshi Kojima, Kazuaki Tanabe, Kazuya Yamaguchi, Shigefumi Yoshino, Masazumi x Takahashi, Naoki Hirabayashi, Seiji Sato, Hiroshi Nemoto, Yasushi Rino, Takaki Yoshikawa, Junta Nakajima, Satoshi Morita, Junichi Sakamoto Michiya Kobayashi, Akira Tsuburaya, Kazuhiro Nishikawa, Junji Kawada, Tsutomu Namikawa, Ryoji Fukushima, Hiroshi Kojima, Kazuaki Tanabe, Kazuya Yamaguchi, Shigefumi Yoshino, Masazumi x Takahashi, Naoki Hirabayashi, Seiji Sato, Hiroshi Nemoto, Yasushi Rino, Takaki Yoshikawa, Junta Nakajima, Satoshi Morita, Junichi Sakamoto Michiya Kobayashi, Akira Tsuburaya, Kazuhiro Nishikawa, Junji Kawada, Tsutomu Namikawa, Ryoji Fukushima, Hiroshi Kojima, Kazuaki Tanabe, Kazuya Yamaguchi, Shigefumi Yoshino, Masazumi x Takahashi, Naoki Hirabayashi, Seiji Sato, Hiroshi Nemoto, Yasushi Rino, Takaki Yoshikawa, Junta Nakajima, Satoshi Morita, Junichi Sakamoto A randomized phase II trial of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment versus SP randomized PII trial (XParTS II). A randomized phase II trial of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment versus SP randomized PII trial (XParTS II). A randomized phase II trial of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment versus SP randomized PII trial (XParTS II). JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 2015/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Michitaka Nagase, Kentaro Yamazaki, Hiroshi Tamagawa, Shinya Ueda, Takao Tamura, Kohei Murata, Takashi Tsuda, Eishi Baba, Masahiro Tsuda, Toshikazu Moriwaki, Taito Esaki, Yasushi Tsuji, Kei Muro, Koichi Taira, Tadamichi Denda, Masahiko Ando, Satoshi Morita, Narikazu Boku, Ichinosuke Hyodo Michitaka Nagase, Kentaro Yamazaki, Hiroshi Tamagawa, Shinya Ueda, Takao Tamura, Kohei Murata, Takashi Tsuda, Eishi Baba, Masahiro Tsuda, Toshikazu Moriwaki, Taito Esaki, Yasushi Tsuji, Kei Muro, Koichi Taira, Tadamichi Denda, Masahiko Ando, Satoshi Morita, Narikazu Boku, Ichinosuke Hyodo Michitaka Nagase, Kentaro Yamazaki, Hiroshi Tamagawa, Shinya Ueda, Takao Tamura, Kohei Murata, Takashi Tsuda, Eishi Baba, Masahiro Tsuda, Toshikazu Moriwaki, Taito Esaki, Yasushi Tsuji, Kei Muro, Koichi Taira, Tadamichi Denda, Masahiko Ando, Satoshi Morita, Narikazu Boku, Ichinosuke Hyodo The impact of early tumor shrinkage on survival in WJOG4407G trial, a randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab in first-line treatment for metastatic colorectal cancer. The impact of early tumor shrinkage on survival in WJOG4407G trial, a randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab in first-line treatment for metastatic colorectal cancer. The impact of early tumor shrinkage on survival in WJOG4407G trial, a randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab in first-line treatment for metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 JOURNAL OF CLINICAL ONCOLOGY, 33, 3 2015/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Ichiro Tateya, Shuko Morita, Manabu Muto, Shin'Ichi Miyamoto, Tomomasa Hayashi, Makiko Funakoshi, Ikuo Aoyama, Shigeru Hirano, Morimasa Kitamura, Seiji Ishikawa, Yo Kishimoto, Mami Morita, Patnarin Mahattanasakul, Satoshi Morita, Juichi Ito Ichiro Tateya, Shuko Morita, Manabu Muto, Shin'Ichi Miyamoto, Tomomasa Hayashi, Makiko Funakoshi, Ikuo Aoyama, Shigeru Hirano, Morimasa Kitamura, Seiji Ishikawa, Yo Kishimoto, Mami Morita, Patnarin Mahattanasakul, Satoshi Morita, Juichi Ito Ichiro Tateya, Shuko Morita, Manabu Muto, Shin'Ichi Miyamoto, Tomomasa Hayashi, Makiko Funakoshi, Ikuo Aoyama, Shigeru Hirano, Morimasa Kitamura, Seiji Ishikawa, Yo Kishimoto, Mami Morita, Patnarin Mahattanasakul, Satoshi Morita, Juichi Ito Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer Laryngoscope, 125, 1124-1129 Laryngoscope, 125, 1124-1129 Laryngoscope, 125, 1124-1129 2015/01/01 公開
金井雅史, 佐久間朋寛, 柳澤宏次, 小柳智義, 松本繁巳, 黒田知宏, 森田智視, 小杉眞司, 奥野恭史 金井雅史, 佐久間朋寛, 柳澤宏次, 小柳智義, 松本繁巳, 黒田知宏, 森田智視, 小杉眞司, 奥野恭史 金井雅史, 佐久間朋寛, 柳澤宏次, 小柳智義, 松本繁巳, 黒田知宏, 森田智視, 小杉眞司, 奥野恭史 網羅的がん関連遺伝子変異パネル(OncoPrime)を用いたクリニカルシークエンスの臨床導入 網羅的がん関連遺伝子変異パネル(OncoPrime)を用いたクリニカルシークエンスの臨床導入 網羅的がん関連遺伝子変異パネル(OncoPrime)を用いたクリニカルシークエンスの臨床導入 日本臨床腫瘍学会学術集会(CD-ROM), 13th, ROMBUNNO.O1-13-6 日本臨床腫瘍学会学術集会(CD-ROM), 13th, ROMBUNNO.O1-13-6 日本臨床腫瘍学会学術集会(CD-ROM), 13th, ROMBUNNO.O1-13-6 2015 日本語 公開
武藤学, 釆野優, 西川佳孝, 森由希子, 金井雅史, 松本繁巳, 加藤源太, 黒田知宏, 森田智視, 奥野恭史 武藤学, 釆野優, 西川佳孝, 森由希子, 金井雅史, 松本繁巳, 加藤源太, 黒田知宏, 森田智視, 奥野恭史 武藤学, 釆野優, 西川佳孝, 森由希子, 金井雅史, 松本繁巳, 加藤源太, 黒田知宏, 森田智視, 奥野恭史 京大病院がんセンターにおけるバイオバンクとメディカルバイオインフォマティクスプロジェクト 京大病院がんセンターにおけるバイオバンクとメディカルバイオインフォマティクスプロジェクト 京大病院がんセンターにおけるバイオバンクとメディカルバイオインフォマティクスプロジェクト 日本臨床腫瘍学会学術集会(CD-ROM), 13th, ROMBUNNO.O1-19-5 日本臨床腫瘍学会学術集会(CD-ROM), 13th, ROMBUNNO.O1-19-5 日本臨床腫瘍学会学術集会(CD-ROM), 13th, ROMBUNNO.O1-19-5 2015 日本語 公開
Y. Matsuo, F. Chen, M. Hamaji, A. Kawaguchi, N. Ueki, Y. Nagata, M. Sonobe, S. Morita, H. Date, M. Hiraoka Y. Matsuo, F. Chen, M. Hamaji, A. Kawaguchi, N. Ueki, Y. Nagata, M. Sonobe, S. Morita, H. Date, M. Hiraoka Y. Matsuo, F. Chen, M. Hamaji, A. Kawaguchi, N. Ueki, Y. Nagata, M. Sonobe, S. Morita, H. Date, M. Hiraoka Comparison of Long-term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score-Match Analysis Comparison of Long-term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score-Match Analysis Comparison of Long-term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score-Match Analysis INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S16-S16 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S16-S16 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S16-S16 2014/11 英語 研究発表ペーパー・要旨(国際会議) 公開
Hiroyasu Kaneda, Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Koichi Takayama, Keisuke Tomii, Tadashi Maeda, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Hiroyasu Kaneda, Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Koichi Takayama, Keisuke Tomii, Tadashi Maeda, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Hiroyasu Kaneda, Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Koichi Takayama, Keisuke Tomii, Tadashi Maeda, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio TUMOR GENOMIC PROFILING OF NSCLC FROM THE PHASE III TRIAL OF FIRST-LINE S-1/CBDCA VERSUS PACLITAXEL/CBDCA (WJOG6611LTR) TUMOR GENOMIC PROFILING OF NSCLC FROM THE PHASE III TRIAL OF FIRST-LINE S-1/CBDCA VERSUS PACLITAXEL/CBDCA (WJOG6611LTR) TUMOR GENOMIC PROFILING OF NSCLC FROM THE PHASE III TRIAL OF FIRST-LINE S-1/CBDCA VERSUS PACLITAXEL/CBDCA (WJOG6611LTR) ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 2014/10 英語 研究発表ペーパー・要旨(国際会議) 公開
Yasuhide Miyoshi, Hiroji Uemura, Susumu Umemoto, Kentaro Sakamaki, Satoshi Morita, Kazuhiro Suzuki, Yasuhiro Shibata, Naoya Masumori, Tomohiko Ichikawa, Atsushi Mizokami, Yoshiki Sugimura, Norio Nonomura, Hideki Sakai, Seijiro Honma, Masaoki Harada, Yoshinobu Kubota Yasuhide Miyoshi, Hiroji Uemura, Susumu Umemoto, Kentaro Sakamaki, Satoshi Morita, Kazuhiro Suzuki, Yasuhiro Shibata, Naoya Masumori, Tomohiko Ichikawa, Atsushi Mizokami, Yoshiki Sugimura, Norio Nonomura, Hideki Sakai, Seijiro Honma, Masaoki Harada, Yoshinobu Kubota Yasuhide Miyoshi, Hiroji Uemura, Susumu Umemoto, Kentaro Sakamaki, Satoshi Morita, Kazuhiro Suzuki, Yasuhiro Shibata, Naoya Masumori, Tomohiko Ichikawa, Atsushi Mizokami, Yoshiki Sugimura, Norio Nonomura, Hideki Sakai, Seijiro Honma, Masaoki Harada, Yoshinobu Kubota High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients. High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients. High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients. BMC cancer, 14, 717-717 BMC cancer, 14, 717-717 BMC cancer, 14, 717-717 2014/09/26 英語 公開
Y. Matsuo, F. Chen, M. Hamaji, A. Kawaguchi, N. Ueki, Y. Nagata, M. Sonobe, S. Morita, H. Date, M. Hiraoka Y. Matsuo, F. Chen, M. Hamaji, A. Kawaguchi, N. Ueki, Y. Nagata, M. Sonobe, S. Morita, H. Date, M. Hiraoka Y. Matsuo, F. Chen, M. Hamaji, A. Kawaguchi, N. Ueki, Y. Nagata, M. Sonobe, S. Morita, H. Date, M. Hiraoka Comparison of Long-Term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sub lobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score Match Analysis Comparison of Long-Term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sub lobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score Match Analysis Comparison of Long-Term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sub lobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score Match Analysis INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S620-S620 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S620-S620 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S620-S620 2014/09 英語 研究発表ペーパー・要旨(国際会議) 公開
渡邊美惠子, 多田春江, 山本倫生, 上山華栄, 川口淳, 町田優子, 榎本佳代子, 森田智視 渡邊美惠子, 多田春江, 山本倫生, 上山華栄, 川口淳, 町田優子, 榎本佳代子, 森田智視 医師主導型介入臨床試験のデータの質保証体制の構築に向けた京大病院での取り組み 医師主導型介入臨床試験のデータの質保証体制の構築に向けた京大病院での取り組み ARO協議会第2回学術集会 ARO協議会第2回学術集会 2014/09 公開
Tamagawa Hiroshi, Yamazaki Kentaro, Suyama Koichi, Okabe Michio, Suzuki Kazuya, Seki Nobuhiko, Kawakami Kentaro, Sato Mikio, Takahashi Yasuo, Hirashima Tomonori, Ebi Masahide, Taku Keisei, Otsuji Toshio, Tamura Fumio, Shinozaki Eiji, Nakashima Koji, Yamaguchi Kensei, Ando Masahiko, Morita Satoshi, Boku Narikazu, Hyodo Ichinosuke Tamagawa Hiroshi, Yamazaki Kentaro, Suyama Koichi, Okabe Michio, Suzuki Kazuya, Seki Nobuhiko, Kawakami Kentaro, Sato Mikio, Takahashi Yasuo, Hirashima Tomonori, Ebi Masahide, Taku Keisei, Otsuji Toshio, Tamura Fumio, Shinozaki Eiji, Nakashima Koji, Yamaguchi Kensei, Ando Masahiko, Morita Satoshi, Boku Narikazu, Hyodo Ichinosuke Tamagawa Hiroshi, Yamazaki Kentaro, Suyama Koichi, Okabe Michio, Suzuki Kazuya, Seki Nobuhiko, Kawakami Kentaro, Sato Mikio, Takahashi Yasuo, Hirashima Tomonori, Ebi Masahide, Taku Keisei, Otsuji Toshio, Tamura Fumio, Shinozaki Eiji, Nakashima Koji, Yamaguchi Kensei, Ando Masahiko, Morita Satoshi, Boku Narikazu, Hyodo Ichinosuke PRESPECIFIED SUBGROUP ANALYSES IN WJOG4407G TRIAL, A RANDOMIZED PHASE III TRIAL OF MFOLFOX6 PLUS BEVACIZUMAB VERSUS FOLFIRI PLUS BEVACIZUMAB IN FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER PRESPECIFIED SUBGROUP ANALYSES IN WJOG4407G TRIAL, A RANDOMIZED PHASE III TRIAL OF MFOLFOX6 PLUS BEVACIZUMAB VERSUS FOLFIRI PLUS BEVACIZUMAB IN FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER PRESPECIFIED SUBGROUP ANALYSES IN WJOG4407G TRIAL, A RANDOMIZED PHASE III TRIAL OF MFOLFOX6 PLUS BEVACIZUMAB VERSUS FOLFIRI PLUS BEVACIZUMAB IN FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 2014/06 英語 研究発表ペーパー・要旨(国際会議) 公開
Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Yoshitake Oshima, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Yoshitake Oshima, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki, Kentaro Okazaki, Juichi Sato, Sadao Suzuki, Satoshi Morita, Yoshitake Oshima, Kazuo Izumi, Masayuki Kato, Naoki Ishizuka, Mitsuhiko Noda, Hideshi Kuzuya Effects of Telephone-delivered Lifestyle Support on the Development of Diabetes in Subjects at High Risk of Type 2 Diabetes: J-DOIT1, a Pragmatic Cluster Randomized Trial in the Primary Health Care Setting Effects of Telephone-delivered Lifestyle Support on the Development of Diabetes in Subjects at High Risk of Type 2 Diabetes: J-DOIT1, a Pragmatic Cluster Randomized Trial in the Primary Health Care Setting Effects of Telephone-delivered Lifestyle Support on the Development of Diabetes in Subjects at High Risk of Type 2 Diabetes: J-DOIT1, a Pragmatic Cluster Randomized Trial in the Primary Health Care Setting DIABETES, 63, A202-A202 DIABETES, 63, A202-A202 DIABETES, 63, A202-A202 2014/06 英語 研究発表ペーパー・要旨(国際会議) 公開
西田 純幸, 小井戸 薫雄, 本間 定, 武田 裕, 石川 剛, 古倉 聡, 江川 新一, 森本 創世子, 江口 英利, 森田 智視, 岡 芳弘, 杉山 治夫 西田 純幸, 小井戸 薫雄, 本間 定, 武田 裕, 石川 剛, 古倉 聡, 江川 新一, 森本 創世子, 江口 英利, 森田 智視, 岡 芳弘, 杉山 治夫 西田 純幸, 小井戸 薫雄, 本間 定, 武田 裕, 石川 剛, 古倉 聡, 江川 新一, 森本 創世子, 江口 英利, 森田 智視, 岡 芳弘, 杉山 治夫 進行性膵癌に対するgemcitabine療法と併用したWT1ペプチドを用いる癌ワクチン療法(WT1 peptide-based cancer vaccine in combination with gemcitabine for advanced pancreatic cancer) 進行性膵癌に対するgemcitabine療法と併用したWT1ペプチドを用いる癌ワクチン療法(WT1 peptide-based cancer vaccine in combination with gemcitabine for advanced pancreatic cancer) 進行性膵癌に対するgemcitabine療法と併用したWT1ペプチドを用いる癌ワクチン療法(WT1 peptide-based cancer vaccine in combination with gemcitabine for advanced pancreatic cancer) 日本がん免疫学会総会プログラム・抄録集, 18回, 74-74 日本がん免疫学会総会プログラム・抄録集, 18回, 74-74 日本がん免疫学会総会プログラム・抄録集, 18回, 74-74 2014/06 英語 公開
Nobuyuki Katakami, Satoshi Morita, Hiroshige Yoshioka, Takashi Seto, Yoshiko Urata, Miyako Satouchi, Yasuo Iwamoto, Kojiro Otsuka, Norihiko Ikeda, Toshiaki Takahashi, Haruko Daga, Tetsuya Oguri, Isao Goto, Junji Uchida, Shunichi Sugawara, Chiyoe Kitagawa, Toshiyuki Kozuki, Junya Inata, Kazuhiko Nakagawa, Yoichi Nakanishi Nobuyuki Katakami, Satoshi Morita, Hiroshige Yoshioka, Takashi Seto, Yoshiko Urata, Miyako Satouchi, Yasuo Iwamoto, Kojiro Otsuka, Norihiko Ikeda, Toshiaki Takahashi, Haruko Daga, Tetsuya Oguri, Isao Goto, Junji Uchida, Shunichi Sugawara, Chiyoe Kitagawa, Toshiyuki Kozuki, Junya Inata, Kazuhiko Nakagawa, Yoichi Nakanishi Nobuyuki Katakami, Satoshi Morita, Hiroshige Yoshioka, Takashi Seto, Yoshiko Urata, Miyako Satouchi, Yasuo Iwamoto, Kojiro Otsuka, Norihiko Ikeda, Toshiaki Takahashi, Haruko Daga, Tetsuya Oguri, Isao Goto, Junji Uchida, Shunichi Sugawara, Chiyoe Kitagawa, Toshiyuki Kozuki, Junya Inata, Kazuhiko Nakagawa, Yoichi Nakanishi Randomized phase III study comparing gefitinib (G) with erlotinib (E) in patients (pts) with previously treated advanced lung adenocarcinoma (LA): WJOG 5108L. Randomized phase III study comparing gefitinib (G) with erlotinib (E) in patients (pts) with previously treated advanced lung adenocarcinoma (LA): WJOG 5108L. Randomized phase III study comparing gefitinib (G) with erlotinib (E) in patients (pts) with previously treated advanced lung adenocarcinoma (LA): WJOG 5108L. JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Makoto Ueno, Shinichi Ohkawa, Satoshi Kobayashi, Kazuya Sugimori, Taku Kaneko, Ryo Kameda, Tomoko Andou, Haruo Miwa, Ryonho Ko, Katsuaki Tanaka, Manabu Morimoto, Masataka Taguri, Satoshi Morita Makoto Ueno, Shinichi Ohkawa, Satoshi Kobayashi, Kazuya Sugimori, Taku Kaneko, Ryo Kameda, Tomoko Andou, Haruo Miwa, Ryonho Ko, Katsuaki Tanaka, Manabu Morimoto, Masataka Taguri, Satoshi Morita Makoto Ueno, Shinichi Ohkawa, Satoshi Kobayashi, Kazuya Sugimori, Taku Kaneko, Ryo Kameda, Tomoko Andou, Haruo Miwa, Ryonho Ko, Katsuaki Tanaka, Manabu Morimoto, Masataka Taguri, Satoshi Morita Subgroup analyses of randomized phase II study on gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer. Subgroup analyses of randomized phase II study on gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer. Subgroup analyses of randomized phase II study on gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Hiroshige Yoshioka, Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka Hiroshige Yoshioka, Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka Hiroshige Yoshioka, Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka Final overall survival results of WJTOG 3405, a randomized phase 3 trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR). Final overall survival results of WJTOG 3405, a randomized phase 3 trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR). Final overall survival results of WJTOG 3405, a randomized phase 3 trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR). JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Akira Inoue, Yukio Hosomi, Makoto Maemondo, Shunichi Sugawara, Terufumi Kato, Kazuhlsa Takahashi, Yuka Fujita, Aklhlko Gamma, Toshiyuki Harada, Satoshi Oizumi, Koichi Minato, Satoshi Morita, Toshihiro Nukiwa Akira Inoue, Yukio Hosomi, Makoto Maemondo, Shunichi Sugawara, Terufumi Kato, Kazuhlsa Takahashi, Yuka Fujita, Aklhlko Gamma, Toshiyuki Harada, Satoshi Oizumi, Koichi Minato, Satoshi Morita, Toshihiro Nukiwa Akira Inoue, Yukio Hosomi, Makoto Maemondo, Shunichi Sugawara, Terufumi Kato, Kazuhlsa Takahashi, Yuka Fujita, Aklhlko Gamma, Toshiyuki Harada, Satoshi Oizumi, Koichi Minato, Satoshi Morita, Toshihiro Nukiwa NEJ009 trial: A randomized phase III study of gefitinib (G) on combination with carboplatin (C) plus pemetrexed (P) versus G alone in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) with EGFR mutation NEJ009 trial: A randomized phase III study of gefitinib (G) on combination with carboplatin (C) plus pemetrexed (P) versus G alone in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) with EGFR mutation NEJ009 trial: A randomized phase III study of gefitinib (G) on combination with carboplatin (C) plus pemetrexed (P) versus G alone in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) with EGFR mutation JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Hiroshige Yoshioka, Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Hiroyasu Kaneda, Koji Takeda, Tomonori Hirashima, Yoshihito Kogure, Tatsuo Kimura, Toshiaki Takahashi, Shinji Atagi, Takashi Seto, Toshiyuki Sawa, Masashi Yamamoto, Miyako Satouchi, Motoyasu Okuno, Seisuke Nagase, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Hiroshige Yoshioka, Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Hiroyasu Kaneda, Koji Takeda, Tomonori Hirashima, Yoshihito Kogure, Tatsuo Kimura, Toshiaki Takahashi, Shinji Atagi, Takashi Seto, Toshiyuki Sawa, Masashi Yamamoto, Miyako Satouchi, Motoyasu Okuno, Seisuke Nagase, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Hiroshige Yoshioka, Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Hiroyasu Kaneda, Koji Takeda, Tomonori Hirashima, Yoshihito Kogure, Tatsuo Kimura, Toshiaki Takahashi, Shinji Atagi, Takashi Seto, Toshiyuki Sawa, Masashi Yamamoto, Miyako Satouchi, Motoyasu Okuno, Seisuke Nagase, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio Multiplex genomic profiling of non-small cell lung cancer patients enrolled in the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin (WJOG6611LTR) Multiplex genomic profiling of non-small cell lung cancer patients enrolled in the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin (WJOG6611LTR) Multiplex genomic profiling of non-small cell lung cancer patients enrolled in the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin (WJOG6611LTR) JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Masato Nakamura, Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto, Hideo Baba, Kazuhiro Yoshida, Motoki Yoshida, Shigeyoshi Iwamoto, Ken Shimada, Yoshito Komatsu, Yasutsuna Sasaki, Taroh Satoh, Keiichi Takahashi, Hideyuki Mishima, Kei Muro, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Masato Nakamura, Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto, Hideo Baba, Kazuhiro Yoshida, Motoki Yoshida, Shigeyoshi Iwamoto, Ken Shimada, Yoshito Komatsu, Yasutsuna Sasaki, Taroh Satoh, Keiichi Takahashi, Hideyuki Mishima, Kei Muro, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Masato Nakamura, Yasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto, Hideo Baba, Kazuhiro Yoshida, Motoki Yoshida, Shigeyoshi Iwamoto, Ken Shimada, Yoshito Komatsu, Yasutsuna Sasaki, Taroh Satoh, Keiichi Takahashi, Hideyuki Mishima, Kei Muro, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara Updated results of the SOFT study: A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/I-LV/oxaliplatin (mFOLFOX6) plus bevacizumab in patients with metastatic colorectal cancer (mCRC). Updated results of the SOFT study: A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/I-LV/oxaliplatin (mFOLFOX6) plus bevacizumab in patients with metastatic colorectal cancer (mCRC). Updated results of the SOFT study: A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/I-LV/oxaliplatin (mFOLFOX6) plus bevacizumab in patients with metastatic colorectal cancer (mCRC). JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 研究発表ペーパー・要旨(国際会議) 公開
Yoshiro Nakahara, Yukio Hosomi, Kazuhiko Yamada, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Satoshi Morita, Hideo Kunitoh, Koshiro Watanabe Yoshiro Nakahara, Yukio Hosomi, Kazuhiko Yamada, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Satoshi Morita, Hideo Kunitoh, Koshiro Watanabe Yoshiro Nakahara, Yukio Hosomi, Kazuhiko Yamada, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Satoshi Morita, Hideo Kunitoh, Koshiro Watanabe A prospective, multicenter phase II trial of low-dose erlotinib monotherapy for patients with previously treated non-small cell lung cancer (NSCLC) with activating mutation of epidermal growth factor receptor (EGFR): Thoracic Oncology 1 Research Group (TORG) 0911 A prospective, multicenter phase II trial of low-dose erlotinib monotherapy for patients with previously treated non-small cell lung cancer (NSCLC) with activating mutation of epidermal growth factor receptor (EGFR): Thoracic Oncology 1 Research Group (TORG) 0911 A prospective, multicenter phase II trial of low-dose erlotinib monotherapy for patients with previously treated non-small cell lung cancer (NSCLC) with activating mutation of epidermal growth factor receptor (EGFR): Thoracic Oncology 1 Research Group (TORG) 0911 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 JOURNAL OF CLINICAL ONCOLOGY, 32, 15 2014/05 英語 研究発表ペーパー・要旨(国際会議) 公開
熊谷基之, 丸井晃, 田畑泰彦, 吉川英治, 武田崇秀, 山本雅哉, 米澤淳, 池田隆文, 松原和夫, 川上浩司, 森田智視, 横出正之, 清水章, 坂田隆造 熊谷基之, 丸井晃, 田畑泰彦, 吉川英治, 武田崇秀, 山本雅哉, 米澤淳, 池田隆文, 松原和夫, 川上浩司, 森田智視, 横出正之, 清水章, 坂田隆造 KUMAGAI MOTOYUKI, MARUI AKIRA, TABATA YASUHIKO, YOSHIKAWA EIJI, TAKEDA TAKAHIDE, YAMAMOTO MASAYA, YONEZAWA ATSUSHI, IKEDA TAKAFUMI, MATSUBARA KAZUO, KAWAKAMI HIROSHI, MORITA SATOSHI, YOKODE MASAYUKI, SHIMIZU AKIRA, SAKATA RYUZO ゼラチンハイドロゲルを用いたbFGF徐放投与による血管新生療法の可能性 ゼラチンハイドロゲルを用いたbFGF徐放投与による血管新生療法の可能性 ゼラチンハイドロゲルを用いたbFGF徐放投与による血管新生療法の可能性 再生医療, 13, 208 再生医療, 13, 208 再生医療, 13, 208 2014/01/27 日本語 公開
Etsuko Miyagi, Yoko Motoki, Mikiko Asai-Sato, Masataka Taguri, Satoshi Morita, Fumiki Hirahara, John D. Wark, Suzanne M. Garland Etsuko Miyagi, Yoko Motoki, Mikiko Asai-Sato, Masataka Taguri, Satoshi Morita, Fumiki Hirahara, John D. Wark, Suzanne M. Garland Etsuko Miyagi, Yoko Motoki, Mikiko Asai-Sato, Masataka Taguri, Satoshi Morita, Fumiki Hirahara, John D. Wark, Suzanne M. Garland Web-based recruiting for a survey on knowledge and awareness of Cervical cancer prevention among young women living in Kanagawa prefecture, Japan Web-based recruiting for a survey on knowledge and awareness of Cervical cancer prevention among young women living in Kanagawa prefecture, Japan Web-based recruiting for a survey on knowledge and awareness of Cervical cancer prevention among young women living in Kanagawa prefecture, Japan International Journal of Gynecological Cancer, 24, 7, 1347-1355 International Journal of Gynecological Cancer, 24, 7, 1347-1355 International Journal of Gynecological Cancer, 24, 7, 1347-1355 2014 英語 書評論文、書評、文献紹介等 公開
Satoshi Morita Satoshi Morita Satoshi Morita Handling of missing data in clinical trials: From the academic viewpoint Handling of missing data in clinical trials: From the academic viewpoint Handling of missing data in clinical trials: From the academic viewpoint Japanese Journal of Clinical Pharmacology and Therapeutics, 45, 4, 131-134 Japanese Journal of Clinical Pharmacology and Therapeutics, 45, 4, 131-134 Japanese Journal of Clinical Pharmacology and Therapeutics, 45, 4, 131-134 2014 日本語 書評論文、書評、文献紹介等 公開
Tsunehiro Takahashi, Kazuhiro Nishikawa, Akira Miki, Hirokazu Noshiro, Takaki Yoshikawa, Yasunori Nishida, Satoru Iwasa, Hiroto Miwa, Toshiki Masuishi, Kazuhiro Yoshida, Yasuhiro Kodera, Narikazu Boku, Yasuhide Yamada, Satoshi Morita, Mitsuru Sasako, Yoshihiko Maehara, Masaki Kitajima, Junichi Sakamoto, Shigetoyo Saji, Yuko Kitagawa Tsunehiro Takahashi, Kazuhiro Nishikawa, Akira Miki, Hirokazu Noshiro, Takaki Yoshikawa, Yasunori Nishida, Satoru Iwasa, Hiroto Miwa, Toshiki Masuishi, Kazuhiro Yoshida, Yasuhiro Kodera, Narikazu Boku, Yasuhide Yamada, Satoshi Morita, Mitsuru Sasako, Yoshihiko Maehara, Masaki Kitajima, Junichi Sakamoto, Shigetoyo Saji, Yuko Kitagawa Tsunehiro Takahashi, Kazuhiro Nishikawa, Akira Miki, Hirokazu Noshiro, Takaki Yoshikawa, Yasunori Nishida, Satoru Iwasa, Hiroto Miwa, Toshiki Masuishi, Kazuhiro Yoshida, Yasuhiro Kodera, Narikazu Boku, Yasuhide Yamada, Satoshi Morita, Mitsuru Sasako, Yoshihiko Maehara, Masaki Kitajima, Junichi Sakamoto, Shigetoyo Saji, Yuko Kitagawa Efficacy and safety result of trastuzumab (T-mab) and paclitaxel for T-mab naive patients with HER2-positive previously treated advanced or recurrent gastric cancer (JFMC45-1102): Final report Efficacy and safety result of trastuzumab (T-mab) and paclitaxel for T-mab naive patients with HER2-positive previously treated advanced or recurrent gastric cancer (JFMC45-1102): Final report Efficacy and safety result of trastuzumab (T-mab) and paclitaxel for T-mab naive patients with HER2-positive previously treated advanced or recurrent gastric cancer (JFMC45-1102): Final report JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 2014/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Naotoshi Sugimoto, Akira Tsuburaya, Ryohei Kawabata, Kazuhiro Nishikawa, Haruhiko Imamoto, Toshimasa Tsujinaka, Taito Esaki, Yosuke Horita, Yutaka Kimura, Tsuneaki Fujiya, Osamu Takayama, Ryo Oono, Hiroshi Yabusaki, Masataka Taguri, Satoshi Morita, Wasaburo Koizumi, Patrick Tan, Motoki Ninomiya, Hiroshi Furukawa, Mitsuru Sasako Naotoshi Sugimoto, Akira Tsuburaya, Ryohei Kawabata, Kazuhiro Nishikawa, Haruhiko Imamoto, Toshimasa Tsujinaka, Taito Esaki, Yosuke Horita, Yutaka Kimura, Tsuneaki Fujiya, Osamu Takayama, Ryo Oono, Hiroshi Yabusaki, Masataka Taguri, Satoshi Morita, Wasaburo Koizumi, Patrick Tan, Motoki Ninomiya, Hiroshi Furukawa, Mitsuru Sasako Naotoshi Sugimoto, Akira Tsuburaya, Ryohei Kawabata, Kazuhiro Nishikawa, Haruhiko Imamoto, Toshimasa Tsujinaka, Taito Esaki, Yosuke Horita, Yutaka Kimura, Tsuneaki Fujiya, Osamu Takayama, Ryo Oono, Hiroshi Yabusaki, Masataka Taguri, Satoshi Morita, Wasaburo Koizumi, Patrick Tan, Motoki Ninomiya, Hiroshi Furukawa, Mitsuru Sasako Potential predictive markers of chemotherapy for advanced gastric cancer: Biomarker study in GC0301/TOP-002, randomized phase III study of irinotecan plus S-1 versus S-1 Potential predictive markers of chemotherapy for advanced gastric cancer: Biomarker study in GC0301/TOP-002, randomized phase III study of irinotecan plus S-1 versus S-1 Potential predictive markers of chemotherapy for advanced gastric cancer: Biomarker study in GC0301/TOP-002, randomized phase III study of irinotecan plus S-1 versus S-1 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 2014/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Toru Aoyama, Hirohito Fujikawa, Junya Shirai, Kameda Yoichi, Haruhiko Cho, Tsutomu Hayashi, Yasushi Rino, Shinichi Hasegawa, Takashi Oshima, Munetaka Masuda, Mari Saito Oba, Satoshi Morita, Takaki Yoshikawa Toru Aoyama, Hirohito Fujikawa, Junya Shirai, Kameda Yoichi, Haruhiko Cho, Tsutomu Hayashi, Yasushi Rino, Shinichi Hasegawa, Takashi Oshima, Munetaka Masuda, Mari Saito Oba, Satoshi Morita, Takaki Yoshikawa Toru Aoyama, Hirohito Fujikawa, Junya Shirai, Kameda Yoichi, Haruhiko Cho, Tsutomu Hayashi, Yasushi Rino, Shinichi Hasegawa, Takashi Oshima, Munetaka Masuda, Mari Saito Oba, Satoshi Morita, Takaki Yoshikawa Harvesting lymph nodes in gastric cancer surgery: A prospective randomized controlled study Harvesting lymph nodes in gastric cancer surgery: A prospective randomized controlled study Harvesting lymph nodes in gastric cancer surgery: A prospective randomized controlled study JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 2014/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Takaki Yoshikawa, Toru Aoyama, Tsutomu Hayashi, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Toru Aoyama, Tsutomu Hayashi, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Takaki Yoshikawa, Toru Aoyama, Tsutomu Hayashi, Kazuaki Tanabe, Kazuhiro Nishikawa, Yuichi Ito, Haruhiko Cho, Satoshi Morita, Yumi Miyashita, Akira Tsuburaya, Junichi Sakamoto Risk factors for surgical complications after D2 gastrectomy following neoadjuvant chemotherapy for gastric cancer. Risk factors for surgical complications after D2 gastrectomy following neoadjuvant chemotherapy for gastric cancer. Risk factors for surgical complications after D2 gastrectomy following neoadjuvant chemotherapy for gastric cancer. JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 JOURNAL OF CLINICAL ONCOLOGY, 32, 3 2014/01 英語 研究発表ペーパー・要旨(国際会議) 公開
Kazuhiko Yamada, Hideo Kunitoh, Yukio Hosomi, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Satoshi Morita, Koshiro Watanabe Kazuhiko Yamada, Hideo Kunitoh, Yukio Hosomi, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Satoshi Morita, Koshiro Watanabe Kazuhiko Yamada, Hideo Kunitoh, Yukio Hosomi, Hiroaki Okamoto, Terufumi Kato, Yuko Komase, Masanori Nishikawa, Satoshi Morita, Koshiro Watanabe A PROSPECTIVE, MULTI-CENTER PHASE II TRIAL ON THE EFFICACY AND SAFETY OF LOW-DOSE ERLOTINIB MONOTHERAPY FOR PATIENTS WITH EGFR MUTATION-POSITIVE, PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER: RESULTS OF THORACIC ONCOLOGY RESEARCH GROUP (TORG) TRIAL 0911 A PROSPECTIVE, MULTI-CENTER PHASE II TRIAL ON THE EFFICACY AND SAFETY OF LOW-DOSE ERLOTINIB MONOTHERAPY FOR PATIENTS WITH EGFR MUTATION-POSITIVE, PREVIOUSLY TREATED NON-S